{"id":"F2010L03137","name":"National Health (Listing of Pharmaceutical Benefits) Instrument 2010 (No. PB 108 of 2010)","slug":"national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":85284,"registerId":"commonwealth-F2010L03137-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Name of Instrument [see Note 1]","content":"1 Name of Instrument [see Note 1]\n\n (1) This Instrument is the National Health (Listing of Pharmaceutical Benefits) Instrument 2010.\n\n (2) This Instrument may also be cited as PB 108 of 2010.\n\n","sortOrder":0},{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"2 Commencement\n\n This Instrument commences on 1 December 2010.\n\n","sortOrder":1},{"sectionNumber":"3","sectionType":"section","heading":"Revocation","content":"3 Revocation\n\n The following instruments are revoked:\n\n (a) Declaration under subsections 85 (2) and 85 (2AA) of the National Health Act 1953; Determination under subsection 85 (2A) of the National Health Act 1953 (PB 14 of 2010);\n\n (b) Determinations under sections 85, 85A and 88 of the National Health Act 1953 (PB 68 of 2010);\n\n (c) Determination under section 84AF of the National Health Act 1953 (PB 69 of 2010);\n\n (d) Determination under subsections 85A (1) and (2) and 88 (1C) of the National Health Act 1953 (PB 11 of 2009).\n\n","sortOrder":2},{"sectionNumber":"4","sectionType":"section","heading":"Definitions","content":"4 Definitions\n\n In this Instrument:\n\nABN has the same meaning as in the A New Tax System (Australian Business Number) Act 1999.\n\nAct means the National Health Act 1953.\n\nauthorised prescriber for a pharmaceutical benefit, means a kind of person identified by a prescriber code mentioned in the column in Schedule 1 headed ‘Authorised Prescriber’ for the benefit.\n\nCFC means chlorofluorocarbon.\n\nCFU means colony forming unit.\n\ncircumstances code means the letter ‘C’ followed by a number.\n\nelectronic communication has the meaning given by subsection 5 (1) of the Electronic Transactions Act 1999.\n\nextemporaneously-prepared pharmaceutical benefit means a pharmaceutical benefit other than a ready-prepared pharmaceutical benefit.\n\nGeneral Statement for Lipid-Lowering Drugs means the statement set out in Part 2 of Schedule 4.\n\nGP Management Plan means a comprehensive written plan for the treatment of a patient, prepared by a medical practitioner, that includes a description of the patient’s health care needs, management goals, actions to be taken by the patient and treatment and services the patient is likely to need.\n\nI.M. means intramuscular.\n\nI.U. means international unit.\n\nI.V. mean intravenous.\n\nmmol means millimole.\n\npalliative care patient means a patient with an active, progressive, far-advanced disease for whom the prognosis is limited and the focus of care is the quality of life.\n\nPBS means Pharmaceutical Benefits Scheme.\n\nprescriber code means any of the following codes identifying the kind of person mentioned for the code:\n\n (a) MP — medical practitioner;\n\n (b) PDP — participating dental practitioner;\n\n (c) AO — authorised optometrist;\n\n (d) MW — authorised midwife;\n\n (e) NP — authorised nurse practitioner.\n\npurposes code means the letter ‘P’ followed by a number.\n\nready-prepared pharmaceutical benefit means a brand of a pharmaceutical item in relation to which a determination under subsection 85(6) of the Act is in force.\n\nRegulations means the National Health (Pharmaceutical Benefits) Regulations 1960.\n\nStreamlined Authority Code means the words ‘Streamlined Authority Code’ followed by a number.\n\nTeam Care Arrangements means a document prepared by a medical practitioner, following consultation with collaborating providers, that includes a description of the treatment and service goals for the patient, the treatment and services that all collaborating providers will provide and the actions to be taken by the patient.\n\nNote Terms used in this Instrument have the same meaning as in the Act — see section 13 of the Legislative Instruments Act 2003. These terms include:\n\n Chief Executive Medicare\n\n pharmaceutical benefit\n\n pharmaceutical item.\n\n","sortOrder":3},{"sectionNumber":"5","sectionType":"section","heading":"Drugs and medicinal preparations to which Part VII applies","content":"5 Drugs and medicinal preparations to which Part VII applies\n\n (1) For paragraph 85 (2) (a) of the Act, Part VII of the Act applies to:\n\n (a) a drug or medicinal preparation mentioned in the column headed ‘Listed Drug’ in:\n\n (i) Schedule 1; or\n\n (ii) Part 1 of Schedule 2; and\n\n (b) a medicinal preparation composed of 1 or more listed drugs mentioned in subparagraph (a) (ii).\n\n (2) For subparagraph 85(2)(b)(i) of the Act, paragraph 85(2)(b) of the Act applies to a listed drug mentioned in subparagraph (1)(a)(ii).\n\n (3) For subparagraph 85(2)(b)(ii) of the Act, paragraph 85(2)(b) of the Act applies to an additive mentioned in Part 2 of Schedule 2.\n\nNote Part VII of the Act applies to medicinal preparations composed of 1 or more listed drugs mentioned in subsection (2) and 1 or more of the additives mentioned in subsection (3) – see paragraph 85(2)(b) of the Act.\n\n6 Form\n\n For subsection 85 (3) of the Act, the column headed ‘Form’ in Schedule 1 lists the form or forms for a listed drug determined for that drug.\n\n","sortOrder":4},{"sectionNumber":"7","sectionType":"section","heading":"Manner of administration","content":"7 Manner of administration\n\n (1) For subsection 85 (5) of the Act, the manner of administration of a form of a listed drug mentioned in Schedule 1 is the manner of administration mentioned for that form of the drug in the column headed ‘Manner of Administration’ in Schedule 1.\n\n (2) For paragraph 85A (2) (c) of the Act, if a manner of administration is mentioned in Schedule 1 for a form of a listed drug, a person writing a prescription for the supply of a pharmaceutical benefit that has the listed drug in that form must, if including a manner of administration in the prescription, direct that the pharmaceutical benefit be administered in that manner.\n\n (3) For subsection (2), the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\n (a) in the form mentioned in Schedule 1 for the listed drug; and\n\n (b) with the manner of administration mentioned in Schedule 1 for the form of the listed drug.\n\n","sortOrder":5},{"sectionNumber":"8","sectionType":"section","heading":"Brand and responsible person","content":"8 Brand and responsible person\n\n (1) A brand mentioned in the column headed ‘Brand’ in Schedule 1 for a pharmaceutical item is determined for subsection 85 (6) of the Act for that pharmaceutical item.\n\n (2) For subsection 84AF (1) of the Act, if a code is mentioned in the column in Schedule 1 headed ‘Responsible Person’ for a brand of a pharmaceutical item, the person mentioned in subsection (3) is the responsible person for the brand of the pharmaceutical item.\n\n (3) For subsection (2), the person is the person mentioned in Schedule 3 for the code, with the ABN, if any, mentioned in Schedule 3 for the person.\n\n (4) For subsections (1) and (2), the pharmaceutical item is the listed drug mentioned in Schedule 1:\n\n","sortOrder":6},{"sectionNumber":"9","sectionType":"section","heading":"Authorised prescriber","content":"9 Authorised prescriber\n\n (1) For subsection 88 (1A) of the Act, a participating dental practitioner is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials PDP are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Schedule 1.\n\n (2) For subsection 88 (1C) of the Act, an authorised optometrist is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials AO are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Schedule 1.\n\n (3) For subsection 88 (1D) of the Act, an authorised midwife is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials MW are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Schedule 1.\n\n (4) For subsection 88 (1E) of the Act, an authorised nurse practitioner is authorised to write a prescription for the supply of a pharmaceutical benefit if the initials NP are mentioned for the pharmaceutical benefit in the column headed ‘Authorised Prescriber’ in Schedule 1.\n\n (5) For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\nNote A medical practitioner may prescribe any pharmaceutical benefit — see subsection 88 (1) of the Act.\n\n","sortOrder":7},{"sectionNumber":"10","sectionType":"section","heading":"Prescription circumstances — Schedule 1","content":"10 Prescription circumstances — Schedule 1\n\n (1) This section applies to a pharmaceutical benefit if at least 1 circumstances code is mentioned in the column in Schedule 1 headed ‘Circumstances’ for the pharmaceutical benefit.\n\n (2) For paragraph 85 (7) (a) of the Act, the pharmaceutical benefit is a relevant pharmaceutical benefit for the purposes of section 88A of the Act.\n\n (3) For paragraph 85 (7) (b) of the Act, the circumstances in which a prescription for the supply of the pharmaceutical benefit may be written are the circumstances mentioned in Part 1 of Schedule 4 for at least 1 of the circumstances codes mentioned in Schedule 1 for the pharmaceutical benefit.\n\n (4) For subsection (1), the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\n","sortOrder":8},{"sectionNumber":"11","sectionType":"section","heading":"Authority required procedures","content":"11 Authority required procedures\n\n (1) This section applies to a pharmaceutical benefit if the circumstances mentioned in Part 1 of Schedule 4 for a circumstances code mentioned in Schedule 1 for the pharmaceutical benefit include any of the following:\n\n (a) Compliance with Authority Required procedures;\n\n (b) Compliance with Written Authority Required procedures;\n\n (c) Compliance with Telephone Authority Required procedures;\n\n (d) Compliance with Written or Telephone Authority Required procedures.\n\n (2) A prescription for the supply of the pharmaceutical benefit must be:\n\n (a) submitted by the authorised prescriber to the Chief Executive Medicare in accordance with section 12; and\n\n (b) authorised by the Chief Executive Medicare in accordance with section 13.\n\n","sortOrder":9},{"sectionNumber":"12","sectionType":"section","heading":"Authority required procedures — submission of prescription","content":"12 Authority required procedures — submission of prescription\n\n (1) The authorised prescriber must:\n\n (a) deliver or post to the Chief Executive Medicare a prescription for the supply of the pharmaceutical benefit, prepared and signed by the authorised prescriber:\n\n (i) in a form approved by the Secretary and completed by the authorised prescriber in ink in his or her own handwriting; or\n\n (ii) in a form, prepared by means of a computer, that is in accordance with the form approved by the Secretary under subparagraph (i); or\n\n (iii) in a form, prepared by means of a computer, approved in writing for the purpose by the Secretary and in the format approved in writing by the Secretary; or\n\n (iv) by a method approved in writing by the Secretary; or\n\n (b) submit to the Chief Executive Medicare, by telephone, details of a prescription for the supply of the pharmaceutical benefit prepared and signed by the authorised prescriber in accordance with subparagraph (a) (i), (ii), (iii) or (iv); or\n\n (c) if the authorised prescriber has attempted give details of the prescription to the Chief Executive Medicare in accordance with paragraph (b) but has been unable to do so because the telephone system established by the Chief Executive Medicare for the provision of such authorisations was unavailable — submit the prescription in accordance with the instructions in an emergency telephone message provided to the authorised prescriber by the Chief Executive Medicare; or\n\n (d) submit to the Chief Executive Medicare, by means of an electronic communication of a kind approved in writing by the Chief Executive Medicare, details of a prescription for the supply of the pharmaceutical benefit prepared and signed by the authorised prescriber in accordance with subparagraph (a) (i), (ii), (iii) or (iv).\n\n (2) If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Written Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1) (a).\n\n (3) If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Telephone Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1) (b) or (c).\n\n (4) If a circumstance mentioned in Part 1 of Schedule 4 for a circumstances code applying to the pharmaceutical benefit includes Compliance with Written or Telephone Authority Required procedures, the authorised prescriber must submit a prescription for the supply of the pharmaceutical benefit to the Chief Executive Medicare in accordance with paragraph (1) (a), (b) or (c).\n\n (5) For paragraph (1) (a), a prescription prepared and signed by the authorised prescriber in accordance with subsection (1) is taken to have been submitted by the authorised prescriber if it is submitted by his or her employee.\n\n","sortOrder":10},{"sectionNumber":"13","sectionType":"section","heading":"Authority required procedures — authorisation","content":"13 Authority required procedures — authorisation \n\n (1) A prescription submitted in accordance with paragraph 12 (1) (a) may be authorised by the Chief Executive Medicare:\n\n (a) signing his or her authorisation on the prescription; and\n\n (b) either:\n\n (i) if the Chief Executive Medicare requires the authorised prescriber to alter the prescription — returning it to the authorised prescriber for alteration before the authorised prescriber gives it to the person in respect of whom it was prepared; or\n\n (ii) in any other case:\n\n (A) returning the authorised prescription to the authorised prescriber; or\n\n (B) sending it to the person in respect of whom it was prepared.\n\n (2) A prescription submitted in accordance with paragraph 12 (1) (b) may be authorised by the Chief Executive Medicare telling the authorised prescriber by telephone, at the time the Chief Executive Medicare is given details of the prescription, that the prescription is authorised.\n\n (3) A prescription submitted in accordance with paragraph 12 (1) (d) may be authorised by the Chief Executive Medicare sending his or her authorisation, by electronic communication, to the authorised prescriber.\n\n (4) If the Chief Executive Medicare authorises a prescription under subsection (2) or (3):\n\n (a) the Chief Executive Medicare must tell the authorised prescriber the number given by the Chief Executive Medicare to the prescription: and\n\n (b) the authorised prescriber must:\n\n (i) mark that number on the prescription; and\n\n (ii) retain a copy of the prescription for 1 year from the date the prescription was authorised. \n\n (5) For paragraph (4) (a), the Chief Executive Medicare must tell the authorised prescriber the number:\n\n (i) if the authorised prescriber is an authorised optometrist — by telephone; and\n\n (ii) in any other case — by telephone or by electronic communication.\n\n (6) A prescription submitted in accordance with paragraph 12 (1) (c) is taken to have been authorised by the Chief Executive Medicare if the authorised prescriber completes the prescription in accordance with the instructions given in the emergency telephone message.\n\n","sortOrder":11},{"sectionNumber":"14","sectionType":"section","heading":"Streamlined authority code","content":"14 Streamlined authority code\n\n (1) This section applies to a pharmaceutical benefit if the circumstances mentioned in Schedule 4 for a circumstances code applying to the pharmaceutical benefit include a Streamlined Authority Code.\n\n (2) The requirements of section 12 are taken to have been complied with, and the Chief Executive Medicare is taken to have authorised the prescription of the pharmaceutical benefit under section 13, if the authorised prescriber has:\n\n (a) prepared and signed a prescription for the supply of the pharmaceutical benefit in accordance with subparagraph 12 (1) (a) (i), (ii), (iii) or (iv); and\n\n (b) written the Streamlined Authority Code on the prescription.\n\n","sortOrder":12},{"sectionNumber":"15","sectionType":"section","heading":"Prescription circumstances — Schedule 2","content":"15 Prescription circumstances — Schedule 2\n\n (1) For paragraph 85 (7) (a) of the Act, a pharmaceutical benefit is a relevant pharmaceutical benefit for the purposes of section 88A if:\n\n (a) it is:\n\n (i) a listed drug mentioned in Part 1 of Schedule 2; or\n\n (ii) an extemporaneously-prepared pharmaceutical benefit that contains the listed drug; and\n\n (b) there are circumstances mentioned for the listed drug in the column headed ‘Circumstances’ in Part 1 of Schedule 2.\n\n (2) For paragraph 85 (7) (b) of the Act, the circumstances in which a prescription for the supply of a pharmaceutical benefit mentioned in subsection (1) may be written are:\n\n (a) for a listed drug mentioned in subparagraph (1) (a) (i) — the circumstances mentioned in the column headed ‘Circumstances’ in Part 1 of Schedule 2 for the drug; and\n\n (b) for an extemporaneously-prepared pharmaceutical benefit mentioned in subparagraph (1) (a) (ii) — the circumstances mentioned in the column headed ‘Circumstances’ in Part 1 of Schedule 2 for each listed drug contained in the pharmaceutical benefit.\n\nNote If an extemporaneously-prepared pharmaceutical benefit contains more than one listed drug, a prescription for the supply of the pharmaceutical benefit may only be written if the circumstances mentioned for each of the listed drugs contained in the pharmaceutical benefit are met.\n\n","sortOrder":13},{"sectionNumber":"16","sectionType":"section","heading":"Maximum quantity — Schedule 1","content":"16 Maximum quantity — Schedule 1\n\n (1) For paragraph 85A (2) (a) of the Act, the maximum quantity or number of units of the pharmaceutical item in a pharmaceutical benefit mentioned in Schedule 1 that may, in 1 prescription for the supply of the pharmaceutical benefit, be directed by an authorised prescriber to be supplied on any 1 occasion is the quantity or number of units mentioned in the column in Schedule 1 headed ‘Maximum Quantity’ for the pharmaceutical benefit and authorised prescriber.\n\n (2) If at least 1 purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’ for a pharmaceutical benefit, the quantity or number of units mentioned in the column headed ‘Maximum Quantity’ is the maximum for the particular purposes mentioned in Schedule 4 for each purposes code.\n\n (3) If no purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’, the quantity or number of units mentioned in the column in Schedule 1 headed ‘Maximum Quantity’ is the maximum for all purposes, other than a purpose for which a different maximum is mentioned for the same pharmaceutical benefit.\n\n (4) For subsection (1) the pharmaceutical item is the listed drug mentioned in Schedule 1:\n\n (5) For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\n","sortOrder":14},{"sectionNumber":"17","sectionType":"section","heading":"Maximum quantity — Schedule 2","content":"17 Maximum quantity — Schedule 2\n\n (1) For paragraph 85A (2) (a) of the Act, the maximum quantity or number of units of an extemporaneously-prepared pharmaceutical benefit of a type mentioned in Part 3 of Schedule 2 that may, in 1 prescription for the supply of the pharmaceutical benefit, be directed by an authorised prescriber to be supplied on any 1 occasion is the quantity or number of units mentioned in the column headed ‘Maximum Quantity’ in Part 3 of Schedule 2 for that type of pharmaceutical benefit.\n\n (2) For subsection (1), the extemporaneously-prepared pharmaceutical benefit is:\n\n (a) the listed drug mentioned in Part 1 of Schedule 2; or\n\n (b) an extemporaneously-prepared pharmaceutical benefit that contains the listed drug.\n\n","sortOrder":15},{"sectionNumber":"18","sectionType":"section","heading":"Maximum number of repeats — Schedule 1","content":"18 Maximum number of repeats — Schedule 1\n\n (1) For paragraph 85A (2) (b) of the Act, the maximum number of occasions an authorised prescriber may, in 1 prescription, direct that the supply of a pharmaceutical benefit mentioned in Schedule 1 be repeated is the number in the column in Schedule 1 headed ‘Number of Repeats’ for the pharmaceutical benefit and the authorised prescriber.\n\n (2) If at least 1 purposes code is mentioned in the column in Schedule 1 headed ‘Purposes’ for the pharmaceutical benefit, the number of repeats mentioned in the column in Schedule 1 headed ‘Number of Repeats’ is the maximum for the particular purposes mentioned in Schedule 4 for each purposes code.\n\n (3) If no purposes code is mentioned in the column headed ‘Purposes’, the number of repeats mentioned in the column headed ‘Number of Repeats’ is the maximum for all purposes, other than a purpose for which a different maximum is mentioned for the same pharmaceutical benefit.\n\n (4) For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\n","sortOrder":16},{"sectionNumber":"19","sectionType":"section","heading":"Maximum number of repeats — Schedule 2","content":"19 Maximum number of repeats — Schedule 2\n\n (1) For paragraph 85A (2) (b) of the Act, the maximum number of occasions an authorised prescriber may, in 1 prescription, direct that the supply of an extemporaneously-prepared pharmaceutical benefit of a type mentioned in Part 3 of Schedule 2 be repeated is the number in the column headed ‘Number of Repeats’ in Part 3 of Schedule 2 for that type of pharmaceutical benefit.\n\n (2) For this section, the extemporaneously-prepared pharmaceutical benefit is:\n\n (a) the listed drug mentioned in Part 1 of Schedule 2; or\n\n (b) an extemporaneously-prepared pharmaceutical benefit that contains the listed drug.\n\n","sortOrder":17},{"sectionNumber":"20","sectionType":"section","heading":"Section 100 only supply","content":"20 Section 100 only supply\n\n (1) For subsection 85 (2A) of the Act, if the letter D is mentioned in the column headed ‘Section 100 only’ in Schedule 1 for a listed drug, the drug can only be supplied under special arrangements under section 100 of the Act.\n\n (2) For paragraph 85 (8) (a) of the Act, if the letters PB are mentioned in the column headed ‘Section 100 only’ in Schedule 1 for a pharmaceutical benefit, the pharmaceutical benefit can only be supplied under special arrangements under section 100 of the Act.\n\n (3) For paragraph 85 (8) (b) of the Act, if the letter C is mentioned in the column headed ‘Section 100 only’ in Schedule 1 for a pharmaceutical benefit, and a circumstances code is mentioned for the pharmaceutical benefit in the column headed ‘Circumstances’, the pharmaceutical benefit can be supplied in the circumstances identified in Part 1 of Schedule 4 for the circumstances code only under special arrangements under section 100 of the Act.\n\n (4) For this section, the pharmaceutical benefit is the brand of the listed drug mentioned in Schedule 1:\n\n","sortOrder":18},{"sectionNumber":"Sch 1","sectionType":"schedule","heading":"Ready-prepared pharmaceutical benefits","content":"Schedule 1 Ready-prepared pharmaceutical benefits\n\n(sections 5 to 10, 16, 18 and 20)\n\n \n\n| Listed Drug | Form | Manner of Administration | Brand | Responsible Person | Authorised Prescriber | Circumstances | Purposes | Max Quantity | Number of Repeats | Section 100 only |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Abacavir | Tablet 300 mg (as sulfate) | Oral | Ziagen | VI | MP See Note 1 | C3586 C3587 C3588 C 3589 | | 120 | 5 | D |\n| | Oral solution 20 mg (as sulfate) per mL, 240 mL | Oral | Ziagen | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 8 | 5 | D |\n| Abacavir with Lamivudine | Tablet containing abacavir 600 mg (as sulfate) with lamivudine 300 mg | Oral | Kivexa | VI | MP See Note 1 | C3590 C3591 C3592 C3593 | | 60 | 5 | D |\n| Abacavir with Lamivudine and Zidovudine | Tablet containing abacavir 300 mg (as sulfate) with lamivudine 150 mg and zidovudine 300 mg | Oral | Trizivir | VI | MP See Note 1 | C3979 C3980 C3981 C3982 | | 120 | 5 | D |\n| Abatacept | Injection 125 mg in 1 mL single dose pre-filled syringe | Injection | Orencia | BQ | MP | C3996 C3997 C3998 | P3996 C3997 | 4 | 3 | |\n| | | | | | MP | C3996 C3997 C3998 | P3998 | 4 | 5 | |\n| | Powder for I.V. infusion 250 mg | Injection | Orencia | BQ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| Abciximab | I.V. injection 10 mg in 5 mL vial | Injection | ReoPro | LY | MP | C1716 C1717 C1718 | | 3 | 0 | |\n| Acamprosate | Tablet (enteric coated) containing acamprosate calcium 333 mg | Oral | Campral | AF | MP NP | C2665 | | 180 | 1 | |\n| Acarbose | Tablet 50 mg | Oral | Glucobay 50 | BN | MP NP | | | 90 | 5 | |\n| | Tablet 100 mg | Oral | Glucobay 100 | BN | MP NP | | | 90 | 5 | |\n| Acetazolamide | Tablet 250 mg | Oral | Diamox | QA | MP NP | | | 100 | 3 | |\n| Aciclovir | Tablet 200 mg | Oral | Acihexal | SZ | MP NP | C3632 C3633 | P3632 | 50 | 0 | |\n| | | | Acyclo-V 200 | AF | MP NP | C3632 C3633 | P3632 | 50 | 0 | |\n| | | | GenRx Aciclovir | GX | MP NP | C3632 C3633 | P3632 | 50 | 0 | |\n| | | | Lovir | GM | MP NP | C3632 C3633 | P3632 | 50 | 0 | |\n| | | | Zovirax 200 mg | GK | MP NP | C3632 C3633 | P3632 | 50 | 0 | |\n| | | | Aciclovir 200 | CR | MP NP | C3633 | P3633 | 90 | 5 | |\n| | | | Aciclovir GH | GQ | MP NP | C3633 | P3633 | 90 | 5 | |\n| | | | Acihexal | SZ | MP NP | C3632 C3633 | P3633 | 90 | 5 | |\n| | | | Acyclo-V 200 | AF | MP NP | C3632 C3633 | P3633 | 90 | 5 | |\n| | | | Chem mart Aciclovir | CH | MP NP | C3633 | P3633 | 90 | 5 | |\n| | | | GenRx Aciclovir | GX | MP NP | C3632 C3633 | P3633 | 90 | 5 | |\n| | | | Lovir | GM | MP NP | C3632 C3633 | P3633 | 90 | 5 | |\n| | | | Ozvir | RA | MP NP | C3633 | P3633 | 90 | 5 | |\n| | | | Terry White Chemists Aciclovir | TW | MP NP | C3633 | P3633 | 90 | 5 | |\n| | | | Zovirax 200 mg | GK | MP NP | C3632 C3633 | P3633 | 90 | 5 | |\n| | Tablet 800 mg | Oral | Aciclovir 800 | CR | MP NP | C3622 C3631 | P3622 P3631 | 35 | 0 | |\n| | | | Acihexal | SZ | MP NP | C3622 C3630 C3631 | P3622 P3631 | 35 | 0 | |\n| | | | Acyclo-V 800 | AF | MP NP | C3622 C3630 C3631 | P3622 P3631 | 35 | 0 | |\n| | | | GenRx Aciclovir | GX | MP NP | C3622 C3631 | P3622 P3631 | 35 | 0 | |\n| | | | Zovirax 800 mg | GK | MP NP | C3622 C3631 | P3622 P3631 | 35 | 0 | |\n| | | | Acihexal | SZ | MP NP | C3622 C3630 C3631 | P3630 | 120 | 5 | |\n| | | | Acyclo-V 800 | AF | MP NP | C3622 C3630 C3631 | P3630 | 120 | 5 | |\n| | Eye ointment 30 mg per g, 4.5 g | Application to the eye | Zovirax | GK | MP NP AO | C1715 | | 1 | 0 | |\n| Acitretin | Capsule 10 mg | Oral | Neotigason | TA | MP | C1363 C1366 | | 100 | 2 | |\n| | Capsule 25 mg | Oral | Neotigason | TA | MP | C1363 C1366 | | 100 | 2 | |\n| Adalimumab | Injection 20 mg in 0.4 mL pre-filled syringe | Injection | Humira | VE | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Humira | VE | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | C |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P2986 P2990 P2993 P3695 P3747 P3753 P3754 | 2 | 2 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P3486 P3502 P3520 P3706 P3743 P3745 P3749 P3751 | 2 | 3 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P3265 P3267 P3758 P3759 | 2 | 4 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P2988 P2995 P3522 P3697 P3744 P3746 P3748 P3750 P3752 P3755 P3756 P3757 P3760 P3761 | 2 | 5 | |\n| | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Humira | VE | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | C |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P2986 P2990 P2993 P3695 P3747 P3753 P3754 | 2 | 2 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P3486 P3502 P3520 P3706 P3743 P3745 P3749 P3751 | 2 | 3 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P3265 P3267 P3758 P3759 | 2 | 4 | |\n| | | | | | MP | C2986 C2988 C2990 C2993 C2995 C3265 C3267 C3486 C3502 C3520 C3522 C3695 C3697 C3706 C3743 C3744 C3745 C3746 C3747 C3748 C3749 C3750 C3751 C3752 C3753 C3754 C3755 C3756 C3757 C3758 C3759 C3760 C3761 | P2988 P2995 P3522 P3697 P3744 P3746 P3748 P3750 P3752 P3755 P3756 P3757 P3760 P3761 | 2 | 5 | |\n| | Injection 40 mg in 0.8 mL pre-filled syringe, 6 | Injection | Humira | VE | MP | C2986 C2990 C2993 C3695 C3747 C3753 C3754 | | 1 | 0 | |\n| | Injection 40 mg in 0.8 mL pre-filled pen, 6 | Injection | Humira | VE | MP | C2986 C2990 C2993 C3695 C3747 C3753 C3754 | | 1 | 0 | |\n| Adapalene with benzoyl peroxide | Gel 1 mg-25 mg per g, 30 g | Application | Epiduo | GA | MP | C3689 C3690 | P3689 | 1 | 1 | |\n| | | | | | MP | C3689 C3690 | P3690 | 1 | 3 | |\n| | | | | | NP | C3690 | | 1 | 3 | |\n| Adefovir | Tablet containing adefovir dipivoxil 10 mg | Oral | Hepsera | GI | MP See Note 1 | C3971 C3972 C3973 C3974 | | 60 | 5 | D |\n| Adrenaline | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection | Link Medical Products Pty Ltd | LM | PDP | | | 5 | 0 | |\n| | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector (EpiPen Jr.) | Injection | EpiPen Jr. | AL | MP NP | C3434 C3435 C3436 | | 1 | 0 | |\n| | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector (Anapen Junior) | Injection | Anapen Junior | LM | MP NP | C3434 C3435 C3436 | | 1 | 0 | |\n| | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector (EpiPen) | Injection | EpiPen | AL | MP NP | C3434 C3435 C3436 | | 1 | 0 | |\n| | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector (Anapen) | Injection | Anapen | LM | MP NP | C3434 C3435 C3436 | | 1 | 0 | |\n| Albendazole | Tablet 200 mg | Oral | Zentel | GK | MP NP | C1388 C1525 C2446 C3241 | P1388 P2446 P3241 | 6 | 0 | |\n| | | | | | MP NP | C1388 C1525 C2446 C3241 | P1525 | 6 | 1 | |\n| | Tablet 400 mg | Oral | Eskazole | GK | MP | C1496 | | 60 | 2 | |\n| Alendronic Acid | Tablet 70 mg (as alendronate sodium) | Oral | Adronat | AF | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Alendrobell 70mg | GQ | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Alendronate-GA | GM | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Alendronate Sandoz | SZ | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Alendro Once Weekly | QA | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | APO-Alendronate | TX | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Chem mart Alendronate 70mg | CH | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Densate 70 | DO | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Fosamax Once Weekly | MK | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Ossmax 70mg | RA | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Terry White Chemists Alendronate 70mg | TW | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | Tablet 40 mg (as alendronate sodium) | Oral | Fosamax 40 mg | MK | MP NP | C3256 | | 30 | 5 | |\n| Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral | Fosamax Plus | MK | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral | Dronalen Plus | GM | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| | | | Fosamax Plus 70 mg/140 mcg | MK | MP NP | C2646 C3070 C3933 | | 4 | 5 | |\n| Alendronic acid with colecalciferol and calcium | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral | Dronalen Plus D-Cal | FR | MP NP | C2646 C3070 C3933 | | 1 | 5 | |\n| | | | Fosamax Plus D-Cal | MK | MP NP | C2646 C3070 C3933 | | 1 | 5 | |\n| Alginic acid with calcium carbonate and sodium bicarbonate | Oral liquid containing alginic acid as sodium alginate 1 g, calcium carbonate 320 mg and sodium bicarbonate 534 mg in 20 mL, 500 mL | Oral | Gaviscon P | RC | MP NP | | | 2 | 5 | |\n| Allopurinol | Tablet 100 mg | Oral | Allopurinol Sandoz | SZ | MP NP | | | 200 | 2 | |\n| | | | Allosig | FM | MP NP | | | 200 | 2 | |\n| | | | Chem mart Allopurinol | CH | MP NP | | | 200 | 2 | |\n| | | | GenRx Allopurinol | GX | MP NP | | | 200 | 2 | |\n| | | | Progout 100 | AF | MP NP | | | 200 | 2 | |\n| | | | Terry White Chemists Allopurinol | TW | MP NP | | | 200 | 2 | |\n| | | | Zyloprim | QA | MP NP | | | 200 | 2 | |\n| | Tablet 300 mg | Oral | Allopurinol Sandoz | SZ | MP NP | | | 60 | 2 | |\n| | | | Allosig | FM | MP NP | | | 60 | 2 | |\n| | | | Chem mart Allopurinol | CH | MP NP | | | 60 | 2 | |\n| | | | GenRx Allopurinol | GX | MP NP | | | 60 | 2 | |\n| | | | Progout 300 | AF | MP NP | | | 60 | 2 | |\n| | | | Terry White Chemists Allopurinol | TW | MP NP | | | 60 | 2 | |\n| | | | Zyloprim | QA | MP NP | | | 60 | 2 | |\n| Alprazolam | Tablet 250 micrograms | Oral | Alprax 0.25 | QA | MP NP | C1975 | | 50 | 0 | |\n| | | | Alprazolam Sandoz | SZ | MP NP | C1975 | | 50 | 0 | |\n| | | | Kalma 0.25 | AF | MP NP | C1975 | | 50 | 0 | |\n| | | | Xanax | PF | MP NP | C1975 | | 50 | 0 | |\n| | Tablet 500 micrograms | Oral | Alprax 0.5 | QA | MP NP | C1975 | | 50 | 0 | |\n| | | | Alprazolam Sandoz | SZ | MP NP | C1975 | | 50 | 0 | |\n| | | | Kalma 0.5 | AF | MP NP | C1975 | | 50 | 0 | |\n| | | | Xanax | PF | MP NP | C1975 | | 50 | 0 | |\n| | Tablet 1 mg | Oral | Alprax 1 | QA | MP NP | C1975 | | 50 | 2 | |\n| | | | Alprazolam Sandoz | SZ | MP NP | C1975 | | 50 | 2 | |\n| | | | Chem mart Alprazolam | CH | MP NP | C1975 | | 50 | 2 | |\n| | | | GenRx Alprazolam | GX | MP NP | C1975 | | 50 | 2 | |\n| | | | Kalma 1 | AF | MP NP | C1975 | | 50 | 2 | |\n| | | | Ralozam | GM | MP NP | C1975 | | 50 | 2 | |\n| | | | Terry White Chemists Alprazolam | TW | MP NP | C1975 | | 50 | 2 | |\n| | | | Xanax | PF | MP NP | C1975 | | 50 | 2 | |\n| | Tablet 2 mg | Oral | Alprax 2 | QA | MP NP | C1975 | | 50 | 2 | |\n| | | | Alprazolam Sandoz | SZ | MP NP | C1975 | | 50 | 2 | |\n| | | | Chem mart Alprazolam | CH | MP NP | C1975 | | 50 | 2 | |\n| | | | GenRx Alprazolam | GX | MP NP | C1975 | | 50 | 2 | |\n| | | | Kalma 2 | AF | MP NP | C1975 | | 50 | 2 | |\n| | | | Ralozam | GM | MP NP | C1975 | | 50 | 2 | |\n| | | | Terry White Chemists Alprazolam | TW | MP NP | C1975 | | 50 | 2 | |\n| | | | Xanax Tri-Score | PF | MP NP | C1975 | | 50 | 2 | |\n| Aluminium Hydroxide with Magnesium Hydroxide | Oral suspension 200 mg-200 mg per 5 mL, 500 mL | Oral | Mylanta P | JT | MP NP | | | 2 | 5 | |\n| Aluminium Hydroxide with Magnesium Trisilicate and Magnesium Hydroxide | Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL | Oral | Gastrogel | FM | MP NP | | | 2 | 5 | |\n| Amantadine | Capsule containing amantadine hydrochloride 100 mg | Oral | Symmetrel 100 | NV | MP NP | C1258 | | 100 | 5 | |\n| Ambrisentan | Tablet 5 mg | Oral | Volibris | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Tablet 10 mg | Oral | Volibris | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (HCU Anamix junior LQ) | Oral | HCU Anamix junior LQ | SB | MP NP | C1314 | | 4 | 5 | |\n| Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (TYR Anamix junior LQ) | Oral | TYR Anamix junior LQ | SB | MP NP | C1453 | | 4 | 5 | |\n| Amino acid formula without phenylalanine | Capsules 500 mg, 200 (Phlexy-10) | Oral | Phlexy-10 | SB | MP NP | C1286 | | 16 | 5 | |\n| | Tablets 1 g, 75 (Phlexy-10) | Oral | Phlexy-10 | SB | MP NP | C1286 | | 24 | 5 | |\n| | Sachets containing oral powder 20 g, 30 (Phlexy-10 Drink Mix) | Oral | Phlexy-10 Drink Mix | SB | MP NP | C1286 | | 7 | 5 | |\n| Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine | Oral powder 400 g (PKU Anamix infant) | Oral | PKU Anamix infant | SB | MP NP | C1286 | | 8 | 5 | |\n| Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Sachets containing oral powder 24 g, 30 (GA gel) | Oral | GA gel | VF | MP NP | C3134 | | 4 | 5 | |\n| | Oral powder 400 g (GA1 Anamix infant) | Oral | GA1 Anamix infant | SB | MP NP | C2612 | | 8 | 5 | |\n| | Oral powder 500 g (XLYS, LOW TRY Maxamaid) | Oral | XLYS, LOW TRY Maxamaid | SB | MP NP | C3550 | | 8 | 5 | |\n| | Sachets containing oral powder 25 g, 30 (GA express 15) | Oral | GA express 15 | VF | MP NP | C3678 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without methionine | Oral powder 400 g (HCU Anamix infant) | Oral | HCU Anamix infant | SB | MP NP | C1484 | | 8 | 5 | |\n| | Sachets containing oral powder 24 g, 30 (HCU gel) | Oral | HCU gel | VF | MP NP | C1314 | | 4 | 5 | |\n| | Sachets containing oral powder 25 g, 30 (HCU express 15) | Oral | HCU express 15 | VF | MP NP | C1314 | | 4 | 5 | |\n| | Oral powder 500 g (XMET Maxamaid) | Oral | XMET Maxamaid | SB | MP NP | C1314 | | 8 | 5 | |\n| | Oral powder 500 g (XMET Maxamum) | Oral | XMET Maxamum | SB | MP NP | C1314 | | 8 | 5 | |\n| | Oral liquid 125 mL, 30 (HCU Lophlex LQ 20) | Oral | HCU Lophlex LQ 20 | SB | MP NP | C1314 | | 3 | 5 | |\n| | Oral liquid 130 mL, 30 (HCU Cooler) | Oral | HCU Cooler | VF | MP NP | C1314 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Sachets containing oral powder 25 g, 30 (MMA/PA express 15) | Oral | MMA/PA express 15 | VF | MP NP | C1225 C1307 | | 4 | 5 | |\n| | Sachets containing oral powder 24 g, 30 (MMA/PA gel) | Oral | MMA/PA gel | VF | MP NP | C1225 C1307 | | 4 | 5 | |\n| | Oral powder 400 g (MMA/PA Anamix infant) | Oral | MMA/PA Anamix infant | SB | MP NP | C1225 C1307 | | 8 | 5 | |\n| | Oral powder 500 g (XMTVI Maxamaid) | Oral | XMTVI Maxamaid | SB | MP NP | C1225 C1307 | | 8 | 5 | |\n| | Oral powder 500 g (XMTVI Maxamum) | Oral | XMTVI Maxamum | SB | MP NP | C1225 C1307 | | 8 | 5 | |\n| | Oral liquid 130 mL, 30 (MMA/PA cooler) | Oral | MMA/PA cooler | VF | MP NP | C1225 C1307 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 18.2 g, 60 (add-ins) | Oral | add-ins | SB | MP NP | C1286 | | 3 | 5 | |\n| | Sachets containing oral powder 24 g, 30 (PKU gel) | Oral | PKU gel | VF | MP NP | C1286 | | 4 | 5 | |\n| | Sachets containing oral powder 25 g, 30 (PKU express 15) | Oral | PKU express 15 | VF | MP NP | C1286 | | 4 | 5 | |\n| | Sachets containing oral powder 27.8 g, 30 (Lophlex) | Oral | Lophlex | SB | MP NP | C1286 | | 3 | 5 | |\n| | Sachets containing oral powder 29 g, 30 (PKU Anamix Junior) | Oral | PKU Anamix Junior | SB | MP NP | C1286 | | 4 | 5 | |\n| | Sachets containing oral powder 34 g, 30 (PKU express 20) | Oral | PKU express 20 | VF | MP NP | C1286 | | 4 | 5 | |\n| | Sachets containing oral powder 50 g, 30 (XP Maxamum) | Oral | XP Maxamum | SB | MP NP | C1286 | | 3 | 5 | |\n| | Oral gel 85 g, 30 (PKU squeezie) | Oral | PKU squeezie | VF | MP NP | C1286 | | 4 | 5 | |\n| | Oral powder 400 g (Phenex-2) | Oral | Phenex-2 | AB | MP NP | C1286 | | 8 | 5 | |\n| | Oral powder 500 g (XP Maxamaid) | Oral | XP Maxamaid | SB | MP NP | C1286 | | 8 | 5 | |\n| | Oral powder 500 g (XP Maxamum) | Oral | XP Maxamum | SB | MP NP | C1286 | | 8 | 5 | |\n| | Oral liquid 250 mL (Easiphen) | Oral | Easiphen | SB | MP NP | C1286 | | 90 | 5 | |\n| | Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10) | Oral | PKU Lophlex LQ 10 | SB | MP NP | C1286 | | 2 | 5 | |\n| | Oral liquid 87 mL, 30 (PKU Cooler 10) | Oral | PKU Cooler 10 | VF | MP NP | C1286 | | 4 | 5 | |\n| | Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) | Oral | PKU Lophlex LQ 20 | SB | MP NP | C1286 | | 3 | 5 | |\n| | Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) | Oral | PKU Anamix Junior LQ | SB | MP NP | C1286 | | 4 | 5 | |\n| | Oral liquid 130 mL, 30 (PKU Cooler 15) | Oral | PKU Cooler 15 | VF | MP NP | C1286 | | 4 | 5 | |\n| | Oral liquid 174 mL, 30 (PKU Cooler 20) | Oral | PKU Cooler 20 | VF | MP NP | C1286 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Sachets containing oral powder 24 g, 30 (TYR gel) | Oral | TYR gel | VF | MP NP | C1453 | | 4 | 5 | |\n| | Sachets containing oral powder 25 g, 30 (TYR express 15) | Oral | TYR express 15 | VF | MP NP | C1453 | | 4 | 5 | |\n| | Sachets containing oral powder 29 g, 30 (TYR Anamix Junior) | Oral | TYR Anamix Junior | SB | MP NP | C1453 | | 4 | 5 | |\n| | Oral powder 400 g (TYR Anamix infant) | Oral | TYR Anamix infant | SB | MP NP | C1453 | | 8 | 5 | |\n| | Oral powder 500 g (XPhen, Tyr Maxamaid) | Oral | XPhen, Tyr Maxamaid | SB | MP NP | C1453 | | 8 | 5 | |\n| | Oral powder 500 g (XPhen, Tyr Maxamum) | Oral | XPhen, Tyr Maxamum | SB | MP NP | C1453 | | 8 | 5 | |\n| | Oral liquid 125 mL, 30 (TYR Lophlex LQ 20) | Oral | TYR Lophlex LQ 20 | SB | MP NP | C1453 | | 3 | 5 | |\n| | Oral liquid 130 mL, 30 (TYR Cooler) | Oral | TYR Cooler | VF | MP NP | C1453 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Sachets containing oral powder 24 g, 30 (MSUD gel) | Oral | MSUD gel | VF | MP NP | C1220 | | 4 | 5 | |\n| | Sachets containing oral powder 25 g, 30 (MSUD express 15) | Oral | MSUD express 15 | VF | MP NP | C1220 | | 4 | 5 | |\n| | Sachets containing oral powder 29 g, 30 (MSUD Anamix Junior) | Oral | MSUD Anamix Junior | SB | MP NP | C1220 | | 4 | 5 | |\n| | Sachets containing oral powder 34 g, 30 (MSUD express 20) | Oral | MSUD express 20 | VF | MP NP | C1220 | | 4 | 5 | |\n| | Oral powder 400 g (MSUD Anamix infant) | Oral | MSUD Anamix infant | SB | MP NP | C1220 | | 8 | 5 | |\n| | Oral powder 500 g (MSUD AID III) | Oral | MSUD AID III | SB | MP NP | C1220 | | 4 | 5 | |\n| | Oral powder 500 g (MSUD Maxamaid) | Oral | MSUD Maxamaid | SB | MP NP | C1220 | | 8 | 5 | |\n| | Oral powder 500 g (MSUD Maxamum) | Oral | MSUD Maxamum | SB | MP NP | C1220 | | 8 | 5 | |\n| | Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20) | Oral | MSUD Lophlex LQ 20 | SB | MP NP | C1220 | | 3 | 5 | |\n| | Oral liquid 130 mL, 30 (MSUD Cooler) | Oral | MSUD Cooler | VF | MP NP | C1220 | | 4 | 5 | |\n| Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ) | Oral | MSUD Anamix Junior LQ | SB | MP NP | C1220 | | 4 | 5 | |\n| Amino acids — synthetic, formula | Oral powder 400 g (EleCare) | Oral | EleCare | AB | MP NP | C1687 C1688 C2734 C2735 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | P1687 P1688 P4033 P4034 P4035 P4036 P4037 P4038 P4039 | 8 | 5 | |\n| | Oral powder 400 g (Neocate Advance) | Oral | Neocate Advance | SB | MP NP | C1687 C1688 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | | 8 | 5 | |\n| | Oral powder 400 g (Neocate Advance Tropical Flavour) | Oral | Neocate Advance Tropical Flavour | SB | MP NP | C1687 C1688 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | | 8 | 5 | |\n| | Oral powder 400 g (Neocate Advance Vanilla) | Oral | Neocate Advance Vanilla | SB | MP NP | C1687 C1688 C2734 C2735 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | P1687 P1688 P4033 P4034 P4035 P4036 P4037 P4038 P4039 | 8 | 5 | |\n| Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids | Oral powder 400 g (Neocate LCP) | Oral | Neocate LCP | SB | MP NP | C1687 C1688 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | | 8 | 5 | |\n| | Oral powder 400 g (EleCare LCP) | Oral | EleCare LCP | AB | MP NP | C1687 C1688 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | | 8 | 5 | |\n| | | | | | | | | | | |\n| Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides | Oral powder 400 g (Neocate Gold) | Oral | Neocate Gold | SB | MP NP | C1687 C1688 C2734 C2735 C4033 C4034 C4035 C4036 C4037 C4038 C4039 | P1687 P1688 P4033 P4034 P4035 P4036 P4037 P4038 P4039 | 8 | 5 | |\n| Amiodarone | Tablet containing amiodarone hydrochloride 100 mg | Oral | Amiodarone Sandoz | SZ | MP NP | C1350 | | 30 | 5 | |\n| | | | Aratac 100 | AF | MP NP | C1350 | | 30 | 5 | |\n| | | | Cordarone X 100 | SW | MP NP | C1350 | | 30 | 5 | |\n| | Tablet containing amiodarone hydrochloride 200 mg | Oral | Amiodarone Sandoz | SZ | MP NP | C1350 | | 30 | 5 | |\n| | | | Aratac 200 | AF | MP NP | C1350 | | 30 | 5 | |\n| | | | Chem mart Amiodarone | CH | MP NP | C1350 | | 30 | 5 | |\n| | | | Cordarone X 200 | SW | MP NP | C1350 | | 30 | 5 | |\n| | | | GenRx Amiodarone | GX | MP NP | C1350 | | 30 | 5 | |\n| | | | Rithmik 200 | QA | MP NP | C1350 | | 30 | 5 | |\n| | | | Terry White Chemists Amiodarone | TW | MP NP | C1350 | | 30 | 5 | |\n| Amisulpride | Tablet 100 mg | Oral | Amisulpride 100 Winthrop | WA | MP NP | C1589 | | 30 | 5 | |\n| | | | Amisulpride Sandoz | SZ | MP NP | C1589 | | 30 | 5 | |\n| | | | APO-Amisulpride | TX | MP NP | C1589 | | 30 | 5 | |\n| | | | Solian 100 | SW | MP NP | C1589 | | 30 | 5 | |\n| | | | Sulprix | AF | MP NP | C1589 | | 30 | 5 | |\n| | Tablet 200 mg | Oral | Amisulpride 200 Winthrop | WA | MP NP | C1589 | | 60 | 5 | |\n| | | | Amisulpride Sandoz | SZ | MP NP | C1589 | | 60 | 5 | |\n| | | | APO-Amisulpride | TX | MP NP | C1589 | | 60 | 5 | |\n| | | | Solian 200 | SW | MP NP | C1589 | | 60 | 5 | |\n| | | | Sulprix | AF | MP NP | C1589 | | 60 | 5 | |\n| | Tablet 400 mg | Oral | Amipride 400 | QA | MP NP | C1589 | | 60 | 5 | |\n| | | | Amisulpride 400 Winthrop | WA | MP NP | C1589 | | 60 | 5 | |\n| | | | Amisulpride Sandoz | SZ | MP NP | C1589 | | 60 | 5 | |\n| | | | APO-Amisulpride | TX | MP NP | C1589 | | 60 | 5 | |\n| | | | Solian 400 | SW | MP NP | C1589 | | 60 | 5 | |\n| | | | Sulprix | AF | MP NP | C1589 | | 60 | 5 | |\n| | Oral solution 100 mg per mL, 60 mL | Oral | Solian Solution | SW | MP NP | C1589 | | 2 | 5 | |\n| Amitriptyline | Tablet containing amitriptyline hydrochloride 10 mg | Oral | Endep 10 | AF | MP NP | | | 50 | 2 | |\n| | Tablet containing amitriptyline hydrochloride 25 mg | Oral | Endep 25 | AF | MP NP | | | 50 | 2 | |\n| | Tablet containing amitriptyline hydrochloride 50 mg | Oral | Endep 50 | AF | MP NP | | | 50 | 2 | |\n| Amlodipine | Tablet 5 mg (as besylate) | Oral | Amlodipine-DRLA | RZ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine-GA | GM | MP NP | | | 30 | 5 | |\n| | | | Amlodipine generichealth | GQ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine Pfizer | FZ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | | | APO-Amlodipine | TX | MP NP | | | 30 | 5 | |\n| | | | Auro-Amlodipine 5 | DO | MP NP | | | 30 | 5 | |\n| | | | Chem mart Amlodipine | CH | MP NP | | | 30 | 5 | |\n| | | | Nordip | AF | MP NP | | | 30 | 5 | |\n| | | | Norvapine | GN | MP NP | | | 30 | 5 | |\n| | | | Norvasc | PF | MP NP | | | 30 | 5 | |\n| | | | Ozlodip | RA | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Amlodipine 5 | CR | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Amlodipine | TW | MP NP | | | 30 | 5 | |\n| | Tablet 5 mg (as maleate) | Oral | Amlo 5 | ZP | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg (as besylate) | Oral | Amlodipine-DRLA | RZ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine-GA | GM | MP NP | | | 30 | 5 | |\n| | | | Amlodipine generichealth | GQ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine Pfizer | FZ | MP NP | | | 30 | 5 | |\n| | | | Amlodipine Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | | | APO-Amlodipine | TX | MP NP | | | 30 | 5 | |\n| | | | Auro-Amlodipine 10 | DO | MP NP | | | 30 | 5 | |\n| | | | Chem mart Amlodipine | CH | MP NP | | | 30 | 5 | |\n| | | | Nordip | AF | MP NP | | | 30 | 5 | |\n| | | | Norvapine | GN | MP NP | | | 30 | 5 | |\n| | | | Norvasc | PF | MP NP | | | 30 | 5 | |\n| | | | Ozlodip | RA | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Amlodipine 10 | CR | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Amlodipine | TW | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg (as maleate) | Oral | Amlo 10 | ZP | MP NP | | | 30 | 5 | |\n| Amlodipine with Atorvastatin | Tablet 5 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium) | Oral | Cadatin 5/10 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 5/10 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 5 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium) | Oral | Cadatin 5/20 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 5/20 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 5 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium) | Oral | Cadatin 5/40 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 5/40 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 5 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium) | Oral | Cadatin 5/80 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 5/80 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 10 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium) | Oral | Cadatin 10/10 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 10/10 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 10 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium) | Oral | Cadatin 10/20 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 10/20 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 10 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium) | Oral | Cadatin 10/40 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 10/40 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | Tablet 10 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium) | Oral | Cadatin 10/80 | FZ | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| | | | Caduet 10/80 | PF | MP NP | C2449 C2450 C2451 | | 30 | 5 | |\n| Amlodipine with valsartan | Tablet 5 mg (as besylate)-80 mg | Oral | Exforge 5/80 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 5 mg (as besylate)-160 mg | Oral | Exforge 5/160 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 5 mg (as besylate)-320 mg | Oral | Exforge 5/320 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 10 mg (as besylate)-160 mg | Oral | Exforge 10/160 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 10 mg (as besylate)-320 mg | Oral | Exforge 10/320 | NV | MP NP | C3307 | | 28 | 5 | |\n| Amlodipine with valsartan and hydrochlorothiazide | Tablet 5 mg (as besylate)-160 mg-12.5 mg | Oral | Exforge HCT 5/160/12.5 | NV | MP NP | C3539 | | 28 | 5 | |\n| | Tablet 5 mg (as besylate)-160 mg-25 mg | Oral | Exforge HCT 5/160/25 | NV | MP NP | C3539 | | 28 | 5 | |\n| | Tablet 10 mg (as besylate)-160 mg-12.5 mg | Oral | Exforge HCT 10/160/12.5 | NV | MP NP | C3539 | | 28 | 5 | |\n| | Tablet 10 mg (as besylate)-160 mg-25 mg | Oral | Exforge HCT 10/160/25 | NV | MP NP | C3539 | | 28 | 5 | |\n| | Tablet 10 mg (as besylate)-320 mg-25 mg | Oral | Exforge HCT 10/320/25 | NV | MP NP | C3539 | | 28 | 5 | |\n| Amoxycillin | Tablet 1 g (as trihydrate) | Oral | Amoxycillin Sandoz | BG | MP NP | C1582 | | 14 | 1 | |\n| | | | Maxamox | SZ | MP NP | C1582 | | 14 | 1 | |\n| | Capsule 250 mg (as trihydrate) | Oral | Alphamox 250 | AF | PDP | | | 20 | 0 | |\n| | | | Amoxil | GK | PDP | | | 20 | 0 | |\n| | | | Amoxycillin-GA | GM | PDP | | | 20 | 0 | |\n| | | | Amoxycillin-PS | FZ | PDP | | | 20 | 0 | |\n| | | | Amoxycillin Ranbaxy | RA | PDP | | | 20 | 0 | |\n| | | | Amoxycillin Sandoz | SZ | PDP | | | 20 | 0 | |\n| | | | APO-Amoxycillin | TX | PDP | | | 20 | 0 | |\n| | | | Chem mart Amoxycillin | CH | PDP | | | 20 | 0 | |\n| | | | Cilamox | QA | PDP | | | 20 | 0 | |\n| | | | GenRx Amoxycillin | GX | PDP | | | 20 | 0 | |\n| | | | Terry White Chemists Amoxycillin | TW | PDP | | | 20 | 0 | |\n| | | | Alphamox 250 | AF | MP NP MW | | | 20 | 1 | |\n| | | | Amoxil | GK | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin-GA | GM | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin-PS | FZ | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin Ranbaxy | RA | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin Sandoz | SZ | MP NP MW | | | 20 | 1 | |\n| | | | APO-Amoxycillin | TX | MP NP MW | | | 20 | 1 | |\n| | | | Chem mart Amoxycillin | CH | MP NP MW | | | 20 | 1 | |\n| | | | Cilamox | QA | MP NP MW | | | 20 | 1 | |\n| | | | GenRx Amoxycillin | GX | MP NP MW | | | 20 | 1 | |\n| | | | Terry White Chemists Amoxycillin | TW | MP NP MW | | | 20 | 1 | |\n| | Capsule 500 mg (as trihydrate) | Oral | Alphamox 500 | AF | PDP | | | 20 | 0 | |\n| | | | Amoxil | GK | PDP | | | 20 | 0 | |\n| | | | Amoxycillin-GA | GM | PDP | | | 20 | 0 | |\n| | | | Amoxycillin generichealth 500 | GQ | PDP | | | 20 | 0 | |\n| | | | Amoxycillin-PS | FZ | PDP | | | 20 | 0 | |\n| | | | Amoxycillin Ranbaxy | RA | PDP | | | 20 | 0 | |\n| | | | Amoxycillin Sandoz | SZ | PDP | | | 20 | 0 | |\n| | | | APO-Amoxycillin | TX | PDP | | | 20 | 0 | |\n| | | | Chem mart Amoxycillin | CH | PDP | | | 20 | 0 | |\n| | | | Cilamox | QA | PDP | | | 20 | 0 | |\n| | | | GenRx Amoxycillin | GX | PDP | | | 20 | 0 | |\n| | | | Terry White Chemists Amoxycillin | TW | PDP | | | 20 | 0 | |\n| | | | Alphamox 500 | AF | MP NP MW | | | 20 | 1 | |\n| | | | Amoxil | GK | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin-GA | GM | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin generichealth 500 | GQ | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin-PS | FZ | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin Ranbaxy | RA | MP NP MW | | | 20 | 1 | |\n| | | | Amoxycillin Sandoz | SZ | MP NP MW | | | 20 | 1 | |\n| | | | APO-Amoxycillin | TX | MP NP MW | | | 20 | 1 | |\n| | | | Chem mart Amoxycillin | CH | MP NP MW | | | 20 | 1 | |\n| | | | Cilamox | QA | MP NP MW | | | 20 | 1 | |\n| | | | GenRx Amoxycillin | GX | MP NP MW | | | 20 | 1 | |\n| | | | Terry White Chemists Amoxycillin | TW | MP NP MW | | | 20 | 1 | |\n| | Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral | Amoxil | GK | PDP | | | 1 | 0 | |\n| | | | Amoxil | GK | MP NP | | | 1 | 1 | |\n| | Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral | Alphamox 125 | AF | PDP | | | 1 | 0 | |\n| | | | Amoxil | GK | PDP | | | 1 | 0 | |\n| | | | Amoxycillin Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Bgramin | GM | PDP | | | 1 | 0 | |\n| | | | Chem mart Amoxycillin | CH | PDP | | | 1 | 0 | |\n| | | | GenRx Amoxycillin | GX | PDP | | | 1 | 0 | |\n| | | | Ranmoxy | RA | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Amoxycillin | TW | PDP | | | 1 | 0 | |\n| | | | Alphamox 125 | AF | MP NP | | | 1 | 1 | |\n| | | | Amoxil | GK | MP NP | | | 1 | 1 | |\n| | | | Amoxycillin Sandoz | SZ | MP NP | | | 1 | 1 | |\n| | | | Bgramin | GM | MP NP | | | 1 | 1 | |\n| | | | Chem mart Amoxycillin | CH | MP NP | | | 1 | 1 | |\n| | | | GenRx Amoxycillin | GX | MP NP | | | 1 | 1 | |\n| | | | Ranmoxy | RA | MP NP | | | 1 | 1 | |\n| | | | Terry White Chemists Amoxycillin | TW | MP NP | | | 1 | 1 | |\n| | Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral | Alphamox 250 | AF | PDP | | | 1 | 0 | |\n| | | | Amoxil Forte | GK | PDP | | | 1 | 0 | |\n| | | | Amoxycillin Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Bgramin | GM | PDP | | | 1 | 0 | |\n| | | | Chem mart Amoxycillin | CH | PDP | | | 1 | 0 | |\n| | | | Cilamox | QA | PDP | | | 1 | 0 | |\n| | | | GenRx Amoxycillin | GX | PDP | | | 1 | 0 | |\n| | | | Ranmoxy | RA | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Amoxycillin | TW | PDP | | | 1 | 0 | |\n| | | | Alphamox 250 | AF | MP NP | | | 1 | 1 | |\n| | | | Amoxil Forte | GK | MP NP | | | 1 | 1 | |\n| | | | Amoxycillin Sandoz | SZ | MP NP | | | 1 | 1 | |\n| | | | Bgramin | GM | MP NP | | | 1 | 1 | |\n| | | | Chem mart Amoxycillin | CH | MP NP | | | 1 | 1 | |\n| | | | Cilamox | QA | MP NP | | | 1 | 1 | |\n| | | | GenRx Amoxycillin | GX | MP NP | | | 1 | 1 | |\n| | | | Ranmoxy | RA | MP NP | | | 1 | 1 | |\n| | | | Terry White Chemists Amoxycillin | TW | MP NP | | | 1 | 1 | |\n| | Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL | Oral | Maxamox | SZ | PDP | | | 1 | 0 | |\n| | | | Maxamox | SZ | MP NP | | | 1 | 1 | |\n| Amoxycillin with Clavulanic Acid | Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | Amoxycillin/ Clavulanic Acid 500/125 generichealth | GQ | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | APO-Amoxycillin/ Clavulanic Acid 500/125 | TX | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Augmentin Duo | GK | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Clamoxyl Duo | AL | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Curam Duo 500/125 | SZ | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | GA-Amclav 500/125 | GM | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Moxiclav Duo 500/125 | QA | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Amoxycillin/ Clavulanic Acid 500/125 generichealth | GQ | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | APO-Amoxycillin/ Clavulanic Acid 500/125 | TX | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | Augmentin Duo | GK | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | Clamoxyl Duo | AL | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | Curam Duo 500/125 | SZ | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | GA-Amclav 500/125 | GM | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | | | Moxiclav Duo 500/125 | QA | MP NP MW | C1836 C1837 | | 10 | 1 | |\n| | Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | Amoxycillin/ Clavulanic Acid 875/125 generichealth | GQ | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Augmentin Duo forte | GK | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Chem mart Amoxycillin and Clavulanic Acid | CH | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Clamoxyl Duo forte | AL | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Clavycillin 875/125 | CR | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Curam Duo Forte 875/125 | SZ | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | GA-Amclav Forte 875/125 | GM | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | GenRx Amoxycillin and Clavulanic Acid | GX | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Moxiclav Duo Forte 875/125 | QA | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Terry White Chemists Amoxycillin and Clavulanic Acid | TW | PDP | C1836 C1837 | | 10 | 0 | |\n| | | | Amoxycillin/ Clavulanic Acid 875/125 generichealth | GQ | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Augmentin Duo forte | GK | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Chem mart Amoxycillin and Clavulanic Acid | CH | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Clamoxyl Duo forte | AL | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Clavycillin 875/125 | CR | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Curam Duo Forte 875/125 | SZ | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | GA-Amclav Forte 875/125 | GM | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | GenRx Amoxycillin and Clavulanic Acid | GX | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Moxiclav Duo Forte 875/125 | QA | MP NP | C1836 C1837 | | 10 | 1 | |\n| | | | Terry White Chemists Amoxycillin and Clavulanic Acid | TW | MP NP | C1836 C1837 | | 10 | 1 | |\n| | Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral | Augmentin | GK | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Clamoxyl | AL | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Curam | SZ | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Augmentin | GK | MP NP | C1836 C1837 | | 1 | 1 | |\n| | | | Clamoxyl | AL | MP NP | C1836 C1837 | | 1 | 1 | |\n| | | | Curam | SZ | MP NP | C1836 C1837 | | 1 | 1 | |\n| | Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | Augmentin Duo 400 | GK | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Clamoxyl Duo 400 | AL | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Curam Duo | SZ | PDP | C1836 C1837 | | 1 | 0 | |\n| | | | Augmentin Duo 400 | GK | MP NP | C1836 C1837 | | 1 | 1 | |\n| | | | Clamoxyl Duo 400 | AL | MP NP | C1836 C1837 | | 1 | 1 | |\n| | | | Curam Duo | SZ | MP NP | C1836 C1837 | | 1 | 1 | |\n| Amphotericin | Lozenge 10 mg | Oral | Fungilin | QA | PDP | | | 20 | 0 | |\n| | | | | | MP NP | | | 20 | 1 | |\n| Ampicillin | Powder for injection 500 mg (as sodium) | Injection | Austrapen | LN | PDP | | | 5 | 0 | |\n| | | | Ibimicyn | TS | PDP | | | 5 | 0 | |\n| | | | Austrapen | LN | MP NP | | | 5 | 1 | |\n| | | | Ibimicyn | TS | MP NP | | | 5 | 1 | |\n| | Powder for injection 1 g (as sodium) | Injection | Aspen Ampicyn | AS | PDP | | | 5 | 0 | |\n| | | | Austrapen | LN | PDP | | | 5 | 0 | |\n| | | | Ibimicyn | TS | PDP | | | 5 | 0 | |\n| | | | Aspen Ampicyn | AS | MP NP | | | 5 | 1 | |\n| | | | Austrapen | LN | MP NP | | | 5 | 1 | |\n| | | | Ibimicyn | TS | MP NP | | | 5 | 1 | |\n| Amylopectin, modified long chain | Sachets containing oral powder 60 g, 30 (Glycosade) | Oral | Glycosade | VF | MP NP | C3081 | | 4 | 5 | |\n| Anastrozole | Tablet 1 mg | Oral | Anastrol | QA | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole-DRLA | RZ | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole-GA | GM | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole GH | GQ | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole-PS | FZ | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole RBX | RA | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole Sandoz | SZ | MP NP | C2213 | | 30 | 5 | |\n| | | | Anzole | WQ | MP NP | C2213 | | 30 | 5 | |\n| | | | APO-Anastrozole | TX | MP NP | C2213 | | 30 | 5 | |\n| | | | Arianna | AF | MP NP | C2213 | | 30 | 5 | |\n| | | | Anastrozole Synthon | ZT | MP NP | C2213 | | 30 | 5 | |\n| | | | Arimidex | AP | MP NP | C2213 | | 30 | 5 | |\n| | | | Chem mart Anastrozole | CH | MP NP | C2213 | | 30 | 5 | |\n| | | | Terry White Chemists Anastrozole | TW | MP NP | C2213 | | 30 | 5 | |\n| Apixaban | Tablet 2.5 mg | Oral | Eliquis | BQ | MP NP | C3957 C3991 C4043 C4044 C4046 | P3957 P4043 | 20 | 0 | |\n| | | | | | MP NP | C3957 C3991 C4043 C4044 C4046 | P3991 P4044 | 30 | 0 | |\n| | | | | | MP NP | C3957 C3991 C4043 C4044 C4046 | P4046 | 60 | 0 | |\n| Apomorphine | Injection containing apomorphine hydrochloride 20 mg in 2 mL | Injection | Apomine | HH | MP See Note 1 | C1256 C3314 | | 5 | 0 | D |\n| | Injection containing apomorphine hydrochloride 50 mg in 5 mL | Injection | Apomine | HH | MP See Note 1 | C1256 C3314 | | 5 | 0 | D |\n| | Solution for subcutaneous infusion containing apomorphine hydrochloride 50 mg in 10 mL pre-filled syringe | Injection | Apomine PFS | HH | MP See Note 1 | C1256 C3314 | | 5 | 0 | D |\n| Apraclonidine | Eye drops 5 mg (as hydrochloride) per mL, 10 mL | Application to the eye | Iopidine 0.5% | AQ | MP | C1374 | | 1 | 2 | |\n| Aprepitant | Pack containing 1 capsule 125 mg and 2 capsules 80 mg | Oral | Emend | MK | MP NP See Note 1 | C3619 C3620 C3621 | | 1 | 5 | |\n| Arginine with carbohydrate | Sachets of oral powder 4 g containing 500 mg arginine, 30 (Arginine Amino Acid Supplement) | Oral | Arginine Amino Acid Supplement | VF | MP NP | C1458 | | 4 | 5 | |\n| | Sachets of oral powder 4 g containing 2 g arginine, 30 (Arginine 2000 Amino Acid Supplement) | Oral | Arginine 2000 Amino Acid Supplement | VF | MP NP | C1458 | | 4 | 5 | |\n| Aripiprazole | Tablet 10 mg | Oral | Abilify | BQ | MP NP | C1589 | | 30 | 5 | |\n| | Tablet 15 mg | Oral | Abilify | BQ | MP NP | C1589 | | 30 | 5 | |\n| | Tablet 20 mg | Oral | Abilify | BQ | MP NP | C1589 | | 30 | 5 | |\n| | Tablet 30 mg | Oral | Abilify | BQ | MP NP | C1589 | | 30 | 5 | |\n| Arsenic | Injection concentrate containing arsenic trioxide 10 mg in 10 mL | Injection | Phenasen | PL | MP | C3150 C3891 | | See Note 3 | See Note 3 | D |\n| Artemether with lumefantrine | Tablet 20 mg-120 mg | Oral | Riamet | NV | MP | C3210 | | 24 | 0 | |\n| | Tablet (dispersible) 20 mg-120 mg | Oral | Riamet 20mg/120mg Dispersible | NV | MP | C3551 | | 18 | 0 | |\n| Asenapine | Sublingual wafer 5 mg (as maleate) | Sublingual | Saphris | LU | MP NP | C1589 C3935 C3936 | | 60 | 5 | |\n| | Sublingual wafer 10 mg (as maleate) | Sublingual | Saphris | LU | MP NP | C1589 C3935 C3936 | | 60 | 5 | |\n| Aspirin | Tablet 100 mg | Oral | Astrix | YN | MP NP | | | 112 | 1 | |\n| | | | Mayne Pharma Aspirin | YT | MP NP | | | 112 | 1 | |\n| | | | Spren 100 | QA | MP NP | | | 112 | 1 | |\n| | Tablet, dispersible, 300 mg | Oral | Solprin | RC | PDP | | | 96 | 0 | |\n| | | | | | MP NP | | | 96 | 1 | |\n| Atazanavir | Capsule 100 mg (as sulfate) | Oral | Reyataz | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Capsule 150 mg (as sulfate) | Oral | Reyataz | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Capsule 200 mg (as sulfate) | Oral | Reyataz | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Capsule 300 mg (as sulfate) | Oral | Reyataz | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| Atenolol | Tablet 50 mg | Oral | APO-Atenolol | TX | MP NP | | | 30 | 5 | |\n| | | | Atenolol-GA | GN | MP NP | | | 30 | 5 | |\n| | | | Atenolol generichealth | GQ | MP NP | | | 30 | 5 | |\n| | | | Atenolol-PS | FZ | MP NP | | | 30 | 5 | |\n| | | | Atenolol Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | | | Chem mart Atenolol | CH | MP NP | | | 30 | 5 | |\n| | | | Noten | AF | MP NP | | | 30 | 5 | |\n| | | | Tenormin | AP | MP NP | | | 30 | 5 | |\n| | | | Tensig | QA | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Atenolol | TW | MP NP | | | 30 | 5 | |\n| Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 56 | 5 | |\n| | Capsule 18 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 56 | 5 | |\n| | Capsule 25 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 56 | 5 | |\n| | Capsule 40 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 56 | 5 | |\n| | Capsule 60 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 56 | 5 | |\n| | Capsule 80 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 28 | 5 | |\n| | Capsule 100 mg (as hydrochloride) | Oral | Strattera | LY | MP | C3025 C3026 C3027 C3028 | | 28 | 5 | |\n| Atorvastatin | Tablet 10 mg (as calcium) | Oral | APO-Atorvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 10 | RZ | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lorstat 10 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Torvastat 10 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 10 | RZ | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lorstat 10 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Torvastat 10 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 20 mg (as calcium) | Oral | APO-Atorvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 20 | RZ | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lorstat 20 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Torvastat 20 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 20 | RZ | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lorstat 20 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Torvastat 20 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 40 mg (as calcium) | Oral | APO-Atorvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 40 | RZ | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lorstat 40 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Torvastat 40 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 40 | RZ | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lorstat 40 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Torvastat 40 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 80 mg (as calcium) | Oral | APO-Atorvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 80 | RZ | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lorstat 80 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Torvastat 80 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Atorvastatin SCP 80 | RZ | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lorstat 80 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Torvastat 80 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| Atovaquone | Oral suspension 750 mg per 5 mL, 210 mL | Oral | Wellvone | GK | MP NP | C1433 | | 1 | 0 | |\n| Atovaquone with proguanil | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral | Malarone | GK | MP NP | C3135 | | 12 | 0 | |\n| Atropine | Injection containing atropine sulfate 600 micrograms in 1 mL | Injection | Pfizer Australia Pty Ltd | PF | PDP | | | 10 | 0 | |\n| | | | | | MP NP | | | 10 | 1 | |\n| | Eye drops containing atropine sulfate 10 mg per mL, 15 mL | Application to the eye | Atropt | QA | MP NP | | | 1 | 2 | |\n| Auranofin | Tablet 3 mg | Oral | Ridaura | GH | MP NP | | | 60 | 5 | |\n| | Capsule 3 mg | Oral | Ridaura | BZ | MP NP | | | 60 | 5 | |\n| Aurothiomalate | Injection containing sodium aurothiomalate 10 mg | Injection | Myocrisin | SW | MP NP | | | 10 | 0 | |\n| | Injection containing sodium aurothiomalate 20 mg | Injection | Myocrisin | SW | MP NP | | | 10 | 1 | |\n| | Injection containing sodium aurothiomalate 50 mg | Injection | Myocrisin | SW | MP NP | | | 10 | 1 | |\n| Azacitidine | Powder for injection 100 mg | Injection | Vidaza | CJ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Azathioprine | Tablet 25 mg | Oral | Azathioprine Sandoz | SZ | MP NP | | | 100 | 5 | |\n| | | | Imuran | AS | MP NP | | | 100 | 5 | |\n| | Tablet 50 mg | Oral | Azamun | GM | MP NP | | | 100 | 5 | |\n| | | | Azapin | QA | MP NP | | | 100 | 5 | |\n| | | | Azathioprine-PS | FZ | MP NP | | | 100 | 5 | |\n| | | | Azathioprine Sandoz | SZ | MP NP | | | 100 | 5 | |\n| | | | GenRx Azathioprine | GX | MP NP | | | 100 | 5 | |\n| | | | Imuran | AS | MP NP | | | 100 | 5 | |\n| | | | Thioprine | AF | MP NP | | | 100 | 5 | |\n| Azithromycin | Tablet 500 mg (as dihydrate) | Oral | Azithromycin Sandoz | SZ | MP NP | C1405 C1838 C1839 | P1838 P1839 | 2 | 0 | |\n| | | | Zithromax | PF | MP NP | C1405 C1838 C1839 | P1838 P1839 | 2 | 0 | |\n| | | | Zitrocin | GM | MP NP | C1405 C1838 C1839 | P1838 P1839 | 2 | 0 | |\n| | | | Azithromycin Sandoz | SZ | MP NP | C1405 C1838 C1839 | P1405 | 2 | 2 | |\n| | | | Zithromax | PF | MP NP | C1405 C1838 C1839 | P1405 | 2 | 2 | |\n| | | | Zitrocin | GM | MP NP | C1405 C1838 C1839 | P1405 | 2 | 2 | |\n| | Tablet 600 mg (as dihydrate) | Oral | Zithromax | PF | MP See Note 1 | C1299 C3317 | | 16 | 5 | PB |\n| | Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL | Oral | Zithromax | PF | MP NP | C1405 | | 1 | 0 | |\n| Baclofen | Tablet 10 mg | Oral | Chem mart Baclofen | CH | MP NP | | | 100 | 5 | |\n| | | | Clofen 10 | AF | MP NP | | | 100 | 5 | |\n| | | | GenRx Baclofen | GX | MP NP | | | 100 | 5 | |\n| | | | Lioresal 10 | NV | MP NP | | | 100 | 5 | |\n| | | | Stelax 10 | QA | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Baclofen | TW | MP NP | | | 100 | 5 | |\n| | Tablet 25 mg | Oral | Chem mart Baclofen | CH | MP NP | | | 100 | 5 | |\n| | | | Clofen 25 | AF | MP NP | | | 100 | 5 | |\n| | | | GenRx Baclofen | GX | MP NP | | | 100 | 5 | |\n| | | | Lioresal 25 | NV | MP NP | | | 100 | 5 | |\n| | | | Stelax 25 | QA | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Baclofen | TW | MP NP | | | 100 | 5 | |\n| | Intrathecal injection 10 mg in 5 mL | Injection | Lioresal Intrathecal | NV | MP See Note 1 | C1637 C1638 C1639 C1640 C3318 C3319 C3320 C3321 | | 10 | 0 | PB |\n| Balsalazide | Capsule containing balsalazide sodium 750 mg | Oral | Colazide | PK | MP NP | C1708 C1709 | | 180 | 5 | |\n| \"BCG Immunotherapeutic\" (Bacillus Calmette-Guérin/ Connaught strain) | Powder for intravesical administration containing 6.6 to 19.2 x 10 8 CFU | Intravesical | ImmuCyst | SW | MP See Note 1 | C1419 | | 3 | 1 | |\n| \"BCG-Tice\" (Bacillus Calmette-Guérin/Tice strain) | Vial containing powder for intravesical administration approximately 5 x 10 8 CFU | Intravesical | OncoTICE | MK | MP See Note 1 | C1290 | | 3 | 1 | |\n| Beclomethasone | Pressurised inhalation containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Qvar 50 | IA | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Qvar 100 | IA | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Qvar 50 Autohaler | IA | MP NP | C1266 | | 1 | 5 | |\n| | Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Qvar 100 Autohaler | IA | MP NP | C1266 | | 1 | 5 | |\n| Benzathine benzylpenicillin | Injection 900 mg in 2.3 mL single use pre-filled syringe | Injection | Bicillin L-A | PF | MP NP PDP | | | 10 | 0 | |\n| Benzhexol | Tablet containing benzhexol hydrochloride 2 mg | Oral | Artane | QA | MP NP | | | 200 | 2 | |\n| | Tablet containing benzhexol hydrochloride 5 mg | Oral | Artane | QA | MP NP | | | 200 | 1 | |\n| Benztropine | Tablet containing benztropine mesylate 2 mg | Oral | Benztrop | PL | MP NP | | | 60 | 2 | |\n| | Injection containing benztropine mesylate 2 mg in 2 mL | Injection | Cogentin | FK | MP NP PDP | | | 5 | 0 | |\n| Benzydamine | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL | Oral application | Difflam | IA | MP NP | C1669 C3634 C3635 | P3635 | 1 | 0 | |\n| | | | | | PDP | C1669 | | 1 | 0 | |\n| | | | | | MP NP | C1669 C3634 C3635 | P1669 | 1 | 1 | |\n| | | | | | MP NP | C1669 C3634 C3635 | P3634 | 1 | 3 | |\n| Benzylpenicillin | Powder for injection 600 mg (as sodium) | Injection | BenPen | CS | PDP | | | 10 | 0 | |\n| | | | | | MP NP MW | | | 10 | 1 | |\n| | Powder for injection 3 g (as sodium) | Injection | BenPen | CS | MP NP PDP | | | 10 | 0 | |\n| Betamethasone | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection | Celestone Chronodose | MK | MP NP | C1020 C1102 C1146 C1189 C1191 C1192 C1197 C1237 C1465 | | 5 | 0 | |\n| | | | Celestone Chronodose | MK | PDP | C1102 C1189 C1191 | | 5 | 0 | |\n| | Cream 500 micrograms (as dipropionate) per g, 15 g | Application | Diprosone | MK | MP NP | C1422 | | 1 | 1 | |\n| | | | Eleuphrat | FR | MP NP | C1422 | | 1 | 1 | |\n| | Cream 200 micrograms (as valerate) per g, 100 g | Application | Antroquoril | FR | MP NP | C1422 | | 2 | 0 | |\n| | | | Betnovate 1/5 | QA | MP NP | C1422 | | 2 | 0 | |\n| | | | Celestone-M | MK | MP NP | C1422 | | 2 | 0 | |\n| | | | Cortival 1/5 | FM | MP NP | C1422 | | 2 | 0 | |\n| | Ointment 500 micrograms (as dipropionate) per g, 15 g | Application | Diprosone | MK | MP NP | C1422 | | 1 | 1 | |\n| | | | Eleuphrat | FR | MP NP | C1422 | | 1 | 1 | |\n| | Cream 500 micrograms (as valerate) per g, 15 g | Application | Betnovate 1/2 | QA | MP NP | C1422 | | 1 | 1 | |\n| | | | Cortival 1/2 | FM | MP NP | C1422 | | 1 | 1 | |\n| | Ointment 200 micrograms (as valerate) per g, 100 g | Application | Antroquoril | FR | MP NP | C1422 | | 2 | 0 | |\n| | | | Celestone-M | MK | MP NP | C1422 | | 2 | 0 | |\n| | Ointment 500 micrograms (as valerate) per g, 15 g | Application | Betnovate 1/2 | QA | MP NP | C1422 | | 1 | 1 | |\n| | | | Cortival 1/2 | FM | MP NP | C1422 | | 1 | 1 | |\n| Betaxolol | Eye drops, suspension, 2.5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoptic S | AQ | MP AO | | | 1 | 5 | |\n| | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoptic | AQ | MP AO | | | 1 | 5 | |\n| | | | BetoQuin | IQ | MP AO | | | 1 | 5 | |\n| Bethanechol | Tablet containing bethanechol hydrochloride 10 mg | Oral | Uro-Carb | YN | MP NP | | | 100 | 2 | |\n| Bevacizumab | Solution for I.V. infusion 100 mg in 4 mL | Injection | Avastin | RO | MP | C3430 C3431 C3894 C3896 | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. infusion 400 mg in 16 mL | Injection | Avastin | RO | MP | C3430 C3431 C3894 C3896 | | See Note 3 | See Note 3 | D |\n| Bicalutamide | Tablet 50 mg | Oral | APO-Bicalutamide | TX | MP NP | C3674 | | 28 | 5 | |\n| | | | Bicalutamide-GA | GM | MP NP | C3674 | | 28 | 5 | |\n| | | | Bicalutamide Ranbaxy | RA | MP NP | C3674 | | 28 | 5 | |\n| | | | Calutex | QA | MP NP | C3674 | | 28 | 5 | |\n| | | | Cosamide | AF | MP NP | C3674 | | 28 | 5 | |\n| | | | Cosudex | SZ | MP NP | C3674 | | 28 | 5 | |\n| Bimatoprost | Eye drops 300 micrograms per mL, 3 mL | Application to the eye | Lumigan | AG | MP AO | | | 1 | 5 | |\n| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL | Application to the eye | Ganfort 0.3/5 | AG | MP AO | C3426 C3427 | | 1 | 5 | |\n| Biperiden | Tablet containing biperiden hydrochloride 2 mg | Oral | Akineton | LM | MP NP | | | 200 | 2 | |\n| Bisacodyl | Tablet 5 mg | Oral | Bisalax | AS | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P3643 | 200 | 0 | |\n| | | | Lax-Tab | AE | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P3643 | 200 | 0 | |\n| | | | Bisalax | AS | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 | 200 | 2 | |\n| | | | Lax-Tab | AE | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 | 200 | 2 | |\n| | | | Bisalax | AS | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P3642 | 200 | 3 | |\n| | | | Lax-Tab | AE | MP NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 | P3642 | 200 | 3 | |\n| | Tablets 5 mg, 200 | Oral | Bisalax | AS | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | | | Lax-Tab | AE | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Suppositories 10 mg, 10 | Rectal | Dulcolax | BY | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | Petrus Bisacodyl Suppositories | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | Dulcolax | BY | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | Petrus Bisacodyl Suppositories | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | Dulcolax | BY | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| | | | Petrus Bisacodyl Suppositories | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| | Suppositories 10 mg, 12 | Rectal | Petrus Bisacodyl Suppositories | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 4 See Note 2 | |\n| | Enemas 10 mg in 5 mL, 25 | Rectal | Bisalax | AS | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 1 See Note 2 | 2 See Note 2 | |\n| | | | Petrus Bisacodyl Suppositories | PP | NP | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | APO-Bisoprolol | TX | MP NP | C3234 | | 28 | 5 | |\n| | | | Beprol 2.5 | DO | MP NP | C3234 | | 28 | 5 | |\n| | | | Bicard 2.5 | QA | MP NP | C3234 | | 28 | 5 | |\n| | | | Biso 2.5 | WQ | MP NP | C3234 | | 28 | 5 | |\n| | | | Bispro 2.5 | AF | MP NP | C3234 | | 28 | 5 | |\n| | Tablet containing bisoprolol fumarate 5 mg | Oral | APO-Bisoprolol | TX | MP NP | C3234 | | 28 | 5 | |\n| | | | Beprol 5 | DO | MP NP | C3234 | | 28 | 5 | |\n| | | | Bicard 5 | QA | MP NP | C3234 | | 28 | 5 | |\n| | | | Biso 5 | WQ | MP NP | C3234 | | 28 | 5 | |\n| | | | Bispro 5 | AF | MP NP | C3234 | | 28 | 5 | |\n| | Tablet containing bisoprolol fumarate 10 mg | Oral | APO-Bisoprolol | TX | MP NP | C3234 | | 28 | 5 | |\n| | | | Beprol 10 | DO | MP NP | C3234 | | 28 | 5 | |\n| | | | Bicard 10 | QA | MP NP | C3234 | | 28 | 5 | |\n| | | | Biso 10 | WQ | MP NP | C3234 | | 28 | 5 | |\n| | | | Bispro 10 | AF | MP NP | C3234 | | 28 | 5 | |\n| Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection | Angiomax | XM | MP | C3075 | | 1 | 0 | |\n| Bleomycin | Powder for injection containing bleomycin sulfate 15,000 I.U. | Injection | Bleo 15K | WQ | MP | C1139 C1198 | | See Note 3 | See Note 3 | D |\n| | | | Hospira Pty Limited | HH | MP | C1139 C1198 | | See Note 3 | See Note 3 | D |\n| Bortezomib | Powder for injection 3.5 mg | Injection | Velcade | JC | MP | C3762 C3763 C3764 C3765 C3766 C3767 | | See Note 3 | See Note 3 | D |\n| Bosentan | Tablet 62.5 mg (as monohydrate) | Oral | Tracleer | AT | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Tablet 125 mg (as monohydrate) | Oral | Tracleer | AT | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Botulinum Toxin Type A Purified Neurotoxin Complex | Lyophilised powder for injection 100 units | Injection | Botox | AG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Brimonidine | Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL | Application to the eye | Alphagan P 1.5 | AG | MP AO | | | 1 | 5 | |\n| | Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye | Alphagan | AG | MP AO | | | 1 | 5 | |\n| | | | Enidin | PE | MP AO | | | 1 | 5 | |\n| Brimonidine with Timolol | Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Combigan | AG | MP AO | C3426 C3427 | | 1 | 5 | |\n| Brinzolamide | Eye drops 10 mg per mL, 5 mL | Application to the eye | Azopt | AQ | MP AO | | | 1 | 5 | |\n| | | | BrinzoQuin | IQ | MP AO | | | 1 | 5 | |\n| Brinzolamide with timolol | Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Azarga | AQ | MP AO | C3426 C3427 | | 1 | 5 | |\n| Bromocriptine | Tablet 2.5 mg (as mesylate) | Oral | Kripton 2.5 | AF | NP | C1289 | | 30 | 0 | |\n| | | | | | MP | C1001 C1255 C1289 C1841 C1842 C1843 C1844 | P1289 | 30 | 0 | |\n| | | | Parlodel | NV | NP | C1289 | | 30 | 0 | |\n| | | | | | MP | C1001 C1255 C1289 C1841 C1842 C1843 C1844 | P1289 | 30 | 0 | |\n| | | | Kripton 2.5 | AF | MP | C1001 C1255 C1289 C1841 C1842 C1843 C1844 | P1001 P1255 P1841 P1842 P1843 P1844 | 60 | 5 | |\n| | | | Parlodel | NV | MP | C1001 C1255 C1289 C1841 C1842 C1843 C1844 | P1001 P1255 P1841 P1842 P1843 P1844 | 60 | 5 | |\n| | Capsule 5 mg (as mesylate) | Oral | Kripton 5 | AF | MP | C1001 C1255 C1841 C1842 C1843 C1844 | | 60 | 5 | |\n| | Capsule 10 mg (as mesylate) | Oral | Kripton 10 | AF | MP | C1001 C1255 C1841 C1842 C1843 C1844 | | 100 | 5 | |\n| Budesonide | Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 | Inhalation | Pulmicort Respules | AP | MP NP | C1351 | | 1 | 5 | |\n| | Nebuliser suspension 1 mg in 2 mL single dose units, 30 | Inhalation | Pulmicort Respules | AP | MP NP | C1351 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses | Inhalation by mouth | Pulmicort Turbuhaler | AP | MP NP | | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses | Inhalation by mouth | Pulmicort Turbuhaler | AP | MP NP | | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses | Inhalation by mouth | Pulmicort Turbuhaler | AP | MP NP | | | 1 | 5 | |\n| Budesonide with Eformoterol | Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Turbuhaler 100/6 | AP | MP NP | C1756 C1757 C2671 C2672 C2673 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with eformoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth | Symbicort Turbuhaler 200/6 | AP | MP NP | C1756 C1757 C2671 C2672 C2673 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2 | Inhalation by mouth | Symbicort Turbuhaler 400/12 | AP | MP NP | C1756 C1757 C2680 | | 1 | 5 | |\n| Buprenorphine | Tablet (sublingual) 400 micrograms (as hydrochloride) | Sublingual | Subutex | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Tablet (sublingual) 2 mg (as hydrochloride) | Sublingual | Subutex | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Tablet (sublingual) 8 mg (as hydrochloride) | Sublingual | Subutex | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Transdermal patch 5 mg | Transdermal | Norspan | MF | MP NP | C1062 | | 2 | 0 | |\n| | Transdermal patch 10 mg | Transdermal | Norspan | MF | MP NP | C1062 | | 2 | 0 | |\n| | Transdermal patch 20 mg | Transdermal | Norspan | MF | MP NP | C1062 | | 2 | 0 | |\n| Buprenorphine with naloxone | Tablet (sublingual) 2 mg (as hydrochloride)-0.5 mg (as hydrochloride) | Sublingual | Suboxone | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Tablet (sublingual) 8 mg (as hydrochloride)-2 mg (as hydrochloride) | Sublingual | Suboxone | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Film (soluble) 2 mg (as hydrochloride)-0.5 mg (as hydrochloride) | Sublingual | Suboxone Film 2/0.5 | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Film (soluble) 8 mg (as hydrochloride)-2 mg (as hydrochloride) | Sublingual | Suboxone Film 8/2 | RC | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral | Prexaton | GM | MP NP | C2774 C2775 C2776 | P2774 P2775 | 30 | 0 | |\n| | | | Zyban | GK | MP NP | C2774 C2775 C2776 | P2774 P2775 | 30 | 0 | |\n| | | | Prexaton | GM | MP NP | C2774 C2775 C2776 | P2776 | 90 | 0 | |\n| | | | Zyban | GK | MP NP | C2774 C2775 C2776 | P2776 | 90 | 0 | |\n| Busulfan | Tablet 2 mg | Oral | Myleran | AS | MP | | | 100 | 0 | |\n| Cabazitaxel | Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent | Injection | Jevtana | SW | MP | C7000 C7001 | | See Note 3
| See Note 3 | D |\n| Cabergoline | Tablet 500 micrograms | Oral | Dostan | GM | NP | C1289 | | 2 | 0 | |\n| | | | | | MP | C1289 C2659 C2660 C2661 C2662 | P1289 | 2 | 0 | |\n| | | | Dostinex | PF | NP | C1289 | | 2 | 0 | |\n| | | | | | MP | C1289 C2659 C2660 C2661 C2662 | P1289 | 2 | 0 | |\n| | | | Dostan | GM | MP | C1289 C2659 C2660 C2661 C2662 | P2659 P2660 P2661 P2662 | 8 | 5 | |\n| | | | Dostinex | PF | MP | C1289 C2659 C2660 C2661 C2662 | P2659 P2660 P2661 P2662 | 8 | 5 | |\n| | | | Tinexa | QA | MP | C2659 C2660 C2661 C2662 | P2659 P2660 P2661 P2662 | 8 | 5 | |\n| | Tablet 1 mg | Oral | Bergoline 1 | QA | MP NP | C1255 | | 30 | 5 | |\n| | | | Cabaser | PF | MP NP | C1255 | | 30 | 5 | |\n| | | | Cobasol | GM | MP NP | C1255 | | 30 | 5 | |\n| | Tablet 2 mg | Oral | Bergoline 2 | QA | MP NP | C1255 | | 30 | 5 | |\n| | | | Cabaser | PF | MP NP | C1255 | | 30 | 5 | |\n| | | | Cobasol | GM | MP NP | C1255 | | 30 | 5 | |\n| Calcipotriol | Cream 50 micrograms (as monohydrate) per g, 30 g | Application | Daivonex | LO | MP NP | C1066 | | 1 | 1 | |\n| Calcipotriol with betamethasone | Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application | Daivobet | LO | MP NP | C3209 | | 1 | 1 | |\n| | Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application | Daivobet 50/500 gel | LO | MP NP | C3827 | | 1 | 1 | |\n| Calcitriol | Capsule 0.25 microgram | Oral | Calciprox | GN | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Calcitriol-GA | GM | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Calcitriol-PS | FZ | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Calcitriol Sandoz | SZ | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | GenRx Calcitriol | GX | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Kosteo | QA | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Rocaltrol | RO | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| | | | Sical | AF | MP NP | C1165 C1166 C1167 C1467 C2636 | | 100 | 3 | |\n| Calcium | Tablet, chewable, 500 mg (as carbonate) | Oral | Cal-Sup | IA | MP NP | C2212 | | 240 | 1 | |\n| | Tablet 600 mg (as carbonate) | Oral | Calci-Tab 600 | AE | MP NP | C2212 | | 240 | 1 | |\n| Candesartan | Tablet containing candesartan cilexetil 4 mg | Oral | Atacand | AP | MP NP | | | 30 | 5 | |\n| | Tablet containing candesartan cilexetil 8 mg | Oral | Atacand | AP | MP NP | | | 30 | 5 | |\n| | Tablet containing candesartan cilexetil 16 mg | Oral | Atacand | AP | MP NP | | | 30 | 5 | |\n| | Tablet containing candesartan cilexetil 32 mg | Oral | Atacand | AP | MP NP | | | 30 | 5 | |\n| Candesartan with Hydrochlorothiazide | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | Oral | Atacand Plus 16/12.5 | AP | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral | Atacand Plus 32/12.5 | AP | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral | Atacand Plus 32/25 | AP | MP NP | C3307 | | 30 | 5 | |\n| Capecitabine | Tablet 150 mg | Oral | Xeloda | RO | MP | C1522 C1614 C1738 C1739 C3509 C3942 | | 60 | 2 | |\n| | Tablet 500 mg | Oral | Xeloda | RO | MP | C1522 C1614 C1738 C1739 C3509 C3942 | | 120 | 2 | |\n| Captopril | Tablet 12.5 mg | Oral | Captopril Sandoz | SZ | MP NP | | | 90 | 5 | |\n| | Tablet 25 mg | Oral | Capoten | QA | MP NP | | | 90 | 5 | |\n| | | | Captopril Sandoz | SZ | MP NP | | | 90 | 5 | |\n| | Tablet 50 mg | Oral | Capoten | QA | MP NP | | | 90 | 5 | |\n| | | | Captopril Sandoz | SZ | MP NP | | | 90 | 5 | |\n| | Oral solution 5 mg per mL, 95 mL | Oral | Capoten | QA | MP NP | C1998 | | 1 | 5 | |\n| Carbamazepine | Tablet 100 mg | Oral | Carbamazepine Sandoz | SZ | PDP | | | 200 | 0 | |\n| | | | Tegretol 100 | NV | PDP | | | 200 | 0 | |\n| | | | Carbamazepine Sandoz | SZ | MP NP | | | 200 | 2 | |\n| | | | Tegretol 100 | NV | MP NP | | | 200 | 2 | |\n| | Tablet 200 mg | Oral | Carbamazepine Sandoz | SZ | PDP | | | 200 | 0 | |\n| | | | Tegretol 200 | NV | PDP | | | 200 | 0 | |\n| | | | Teril | AF | PDP | | | 200 | 0 | |\n| | | | Carbamazepine Sandoz | SZ | MP NP | | | 200 | 2 | |\n| | | | Tegretol 200 | NV | MP NP | | | 200 | 2 | |\n| | | | Teril | AF | MP NP | | | 200 | 2 | |\n| | Tablet 200 mg (controlled release) | Oral | Tegretol CR 200 | NV | PDP | | | 200 | 0 | |\n| | | | | | MP NP | | | 200 | 2 | |\n| | Tablet 400 mg (controlled release) | Oral | Tegretol CR 400 | NV | PDP | | | 200 | 0 | |\n| | | | | | MP NP | | | 200 | 2 | |\n| | Oral suspension 100 mg per 5 mL, 300 mL | Oral | Tegretol Liquid | NV | PDP | | | 1 | 0 | |\n| | | | | | MP NP | | | 1 | 5 | |\n| Carbimazole | Tablet 5 mg | Oral | Neo-Mercazole | LM | MP NP | | | 200 | 2 | |\n| Carbohydrate, fat, vitamins, minerals and trace elements | Oral powder 400 g (Energivit) | Oral | Energivit | SB | MP NP | C1276 | | 8 | 5 | |\n| Carbomer | Eye gel 2 mg per g, 10 g | Application to the eye | GelTears | BU | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | PAA | IQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | Viscotears | AQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | GelTears | BU | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | PAA | IQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | Viscotears | AQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | Eye gel 2 mg per g, single dose units 0.6 mL, 30 | Application to the eye | Viscotears Gel PF | AQ | MP NP | C1359 | | 3 | 5 | |\n| Carbomer 974 | Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 | Application to the eye | Poly Gel | AQ | MP NP | C1359 | | 3 | 5 | |\n| Carboplatin | Solution for I.V. injection 50 mg in 5 mL | Injection | Carboplatin Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. injection 150 mg in 15 mL | Injection | Carboplatin Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. injection 450 mg in 45 mL | Injection | Carboplatin Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Carboplatin Kabi | PK | MP | | | See Note 3 | See Note 3 | D |\n| Carmellose | Eye drops containing carmellose sodium 5 mg per mL, 15 mL | Application to the eye | Refresh Tears Plus | AG | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Eye drops containing carmellose sodium 10 mg per mL, 15 mL | Application to the eye | Refresh Liquigel | AG | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Eye drops containing carmellose sodium 2.5 mg per mL, single dose units 0.6 mL, 24 | Application to the eye | TheraTears | CX | MP NP | C1359 | | 4 | 5 | |\n| | | | | | AO | C2802 | | 4 | 5 | |\n| | Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | Cellufresh | AG | MP NP | C1359 | | 3 | 5 | |\n| | Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | Celluvisc | AG | MP NP | C1359 | | 3 | 5 | |\n| | Ocular lubricating gel containing carmellose sodium 10 mg per mL, single dose units 0.6 mL, 28 | Application to the eye | TheraTears | CX | MP NP | C1359 | | 3 | 5 | |\n| | Mouth spray containing carmellose sodium 10 mg per mL, 25 mL | Oral application | Aquae | VT | MP NP | C3636 C3637 | P3637 | 1 | 0 | |\n| | Mouth spray containing carmellose sodium 10 mg per mL, 100 mL | Oral application | Aquae | VT | MP NP | C3636 C3637 | P3637 | 1 | 0 | |\n| Carmellose with glycerin | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL | Application to the eye | Optive | AG | MP | C1362 C3036 | P1362 | 1 | 3 | |\n| | | | | | NP AO | C1362 | | 1 | 3 | |\n| | | | | | MP | C1362 C3036 | P3036 | 1 | 7 | |\n| | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, single dose units 0.4 mL, 30 | Application to the eye | Optive | AG | AO | C2802 | | 3 | 5 | |\n| | | | | | MP NP | C1359 | | 3 | 5 | |\n| Carmustine | Implants 7.7 mg, 8 | Implantation | Gliadel | OA | MP | C2462 | | 1 | 0 | |\n| Carvedilol | Tablet 3.125 mg | Oral | APO-Carvedilol | TX | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | Chem mart Carvedilol 3.125 mg | CH | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | Dilatrend 3.125 | RO | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | GenRx Carvedilol | GX | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | GN-Carvedilol | GM | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | Terry White Chemists Carvedilol 3.125 mg | TW | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | Vedilol 3.125 | QA | MP NP | C1735 C3234 | | 30 | 0 | |\n| | | | Volirop 3.125 | DO | MP NP | C1735 C3234 | | 30 | 0 | |\n| | Tablet 6.25 mg | Oral | APO-Carvedilol | TX | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Chem mart Carvedilol 6.25 mg | CH | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Dilatrend 6.25 | RO | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Terry White Chemists Carvedilol 6.25 mg | TW | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Vedilol 6.25 | QA | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Volirop 6.25 | DO | MP NP | C1735 C3234 | | 60 | 5 | |\n| | Tablet 12.5 mg | Oral | APO-Carvedilol | TX | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Chem mart Carvedilol 12.5 mg | CH | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Dilatrend 12.5 | RO | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Terry White Chemists Carvedilol 12.5 mg | TW | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Vedilol 12.5 | QA | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Volirop 12.5 | DO | MP NP | C1735 C3234 | | 60 | 5 | |\n| | Tablet 25 mg | Oral | APO-Carvedilol | TX | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Chem mart Carvedilol 25 mg | CH | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Dilatrend 25 | RO | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Terry White Chemists Carvedilol 25 mg | TW | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Vedilol 25 | QA | MP NP | C1735 C3234 | | 60 | 5 | |\n| | | | Volirop 25 | DO | MP NP | C1735 C3234 | | 60 | 5 | |\n| Cefaclor | Tablet (sustained release) 375 mg (as monohydrate) | Oral | Ceclor CD | AS | PDP | | | 10 | 0 | |\n| | | | Cefaclor-GA | GN | PDP | | | 10 | 0 | |\n| | | | Cefaclor GH | GQ | PDP | | | 10 | 0 | |\n| | | | Chem mart Cefaclor CD | CH | PDP | | | 10 | 0 | |\n| | | | GenRx Cefaclor CD | GX | PDP | | | 10 | 0 | |\n| | | | Karlor CD | LN | PDP | | | 10 | 0 | |\n| | | | Keflor CD | AF | PDP | | | 10 | 0 | |\n| | | | Ozcef | RA | PDP | | | 10 | 0 | |\n| | | | Terry White Chemists Cefaclor CD | TW | PDP | | | 10 | 0 | |\n| | | | Ceclor CD | AS | MP | | | 10 | 1 | |\n| | | | Cefaclor-GA | GN | MP | | | 10 | 1 | |\n| | | | Cefaclor GH | GQ | MP | | | 10 | 1 | |\n| | | | Chem mart Cefaclor CD | CH | MP | | | 10 | 1 | |\n| | | | GenRx Cefaclor CD | GX | MP | | | 10 | 1 | |\n| | | | Karlor CD | LN | MP | | | 10 | 1 | |\n| | | | Keflor CD | AF | MP | | | 10 | 1 | |\n| | | | Ozcef | RA | MP | | | 10 | 1 | |\n| | | | Terry White Chemists Cefaclor CD | TW | MP | | | 10 | 1 | |\n| | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral | Aclor 125 | QA | PDP | | | 1 | 0 | |\n| | | | Ceclor | AS | PDP | | | 1 | 0 | |\n| | | | Cefaclor Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Chem mart Cefaclor | CH | PDP | | | 1 | 0 | |\n| | | | GenRx Cefaclor | GX | PDP | | | 1 | 0 | |\n| | | | Keflor | AF | PDP | | | 1 | 0 | |\n| | | | Ozcef | RA | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Cefaclor | TW | PDP | | | 1 | 0 | |\n| | | | Aclor 125 | QA | MP | | | 1 | 1 | |\n| | | | Ceclor | AS | MP | | | 1 | 1 | |\n| | | | Cefaclor Sandoz | SZ | MP | | | 1 | 1 | |\n| | | | Chem mart Cefaclor | CH | MP | | | 1 | 1 | |\n| | | | GenRx Cefaclor | GX | MP | | | 1 | 1 | |\n| | | | Keflor | AF | MP | | | 1 | 1 | |\n| | | | Ozcef | RA | MP | | | 1 | 1 | |\n| | | | Terry White Chemists Cefaclor | TW | MP | | | 1 | 1 | |\n| | Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral | Aclor 250 | QA | PDP | | | 1 | 0 | |\n| | | | Ceclor | AS | PDP | | | 1 | 0 | |\n| | | | Cefaclor Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Chem mart Cefaclor | CH | PDP | | | 1 | 0 | |\n| | | | GenRx Cefaclor | GX | PDP | | | 1 | 0 | |\n| | | | Keflor | AF | PDP | | | 1 | 0 | |\n| | | | Ozcef | RA | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Cefaclor | TW | PDP | | | 1 | 0 | |\n| | | | Aclor 250 | QA | MP | | | 1 | 1 | |\n| | | | Ceclor | AS | MP | | | 1 | 1 | |\n| | | | Cefaclor Sandoz | SZ | MP | | | 1 | 1 | |\n| | | | Chem mart Cefaclor | CH | MP | | | 1 | 1 | |\n| | | | GenRx Cefaclor | GX | MP | | | 1 | 1 | |\n| | | | Keflor | AF | MP | | | 1 | 1 | |\n| | | | Ozcef | RA | MP | | | 1 | 1 | |\n| | | | Terry White Chemists Cefaclor | TW | MP | | | 1 | 1 | |\n| Cefalotin | Powder for injection 1 g (as sodium) | Injection | Cefalotin Sandoz | SZ | PDP | | | 10 | 0 | |\n| | | | Hospira Pty Limited | HH | PDP | | | 10 | 0 | |\n| | | | Keflin Neutral | AS | PDP | | | 10 | 0 | |\n| | | | Cefalotin Sandoz | SZ | MP NP | | | 10 | 1 | |\n| | | | Hospira Pty Limited | HH | MP NP | | | 10 | 1 | |\n| | | | Keflin Neutral | AS | MP NP | | | 10 | 1 | |\n| Cefepime | Powder for injection 1 g (as hydrochloride) | Injection | Cefepime Sandoz | SZ | MP NP | C1427 | | 10 | 0 | |\n| | | | DBL Cefepime | HH | MP NP | C1427 | | 10 | 0 | |\n| | | | Omegapharm Pty Ltd | OE | MP NP | C1427 | | 10 | 0 | |\n| | Powder for injection 2 g (as hydrochloride) | Injection | Cefepime Sandoz | SZ | MP NP | C1427 | | 10 | 0 | |\n| | | | DBL Cefepime | HH | MP NP | C1427 | | 10 | 0 | |\n| | | | Maxipime | BQ | MP NP | C1427 | | 10 | 0 | |\n| | | | Omegapharm Pty Ltd | OE | MP NP | C1427 | | 10 | 0 | |\n| Cefotaxime | Powder for injection 1 g (as sodium) | Injection | Cefotaxime Sandoz | SZ | MP NP | C1169 C1846 C1847 | | 10 | 0 | |\n| | | | Hospira Pty Limited | HH | MP NP | C1169 C1846 C1847 | | 10 | 0 | |\n| | Powder for injection 2 g (as sodium) | Injection | Cefotaxime Sandoz | SZ | MP NP | C1169 C1846 C1847 | | 10 | 0 | |\n| | | | Hospira Pty Limited | HH | MP NP | C1169 C1846 C1847 | | 10 | 0 | |\n| Ceftriaxone | Powder for injection 500 mg (as sodium) | Injection | Ceftriaxone-AFT | AE | MP NP | C1143 C1169 C1846 C1847 | P1143 | 1 | 0 | |\n| | | | Ceftriaxone ICP | PP | MP NP | C1143 C1169 C1846 C1847 | P1143 | 1 | 0 | |\n| | | | Ceftriaxone-AFT | AE | MP NP | C1143 C1169 C1846 C1847 | P1169 P1846 P1847 | 5 | 0 | |\n| | | | Ceftriaxone ICP | PP | MP NP | C1143 C1169 C1846 C1847 | P1169 P1846 P1847 | 5 | 0 | |\n| | Powder for injection 1 g (as sodium) | Injection | Ceftriaxone-AFT | AE | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Ceftriaxone ICP | PP | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Ceftriaxone Sandoz | SZ | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | DBL Ceftriaxone | HH | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Max Pharma Ceftriaxone | GQ | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Rocephin | RO | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | Powder for injection 2 g (as sodium) | Injection | Ceftriaxone-AFT | AE | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Ceftriaxone ICP | PP | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Ceftriaxone Sandoz | SZ | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | DBL Ceftriaxone | HH | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| | | | Rocephin | RO | MP NP | C1169 C1846 C1847 | | 5 | 0 | |\n| Cefuroxime | Tablet 250 mg (as axetil) | Oral | Zinnat | GK | PDP | | | 14 | 0 | |\n| | | | | | MP | | | 14 | 1 | |\n| | Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL | Oral | Zinnat | GK | PDP | | | 1 | 0 | |\n| | | | | | MP | | | 1 | 1 | |\n| Celecoxib | Capsule 100 mg | Oral | Celebrex | PF | MP NP | C1547 C1848 | | 60 | 3 | |\n| | Capsule 200 mg | Oral | Celebrex | PF | MP NP | C1547 C1848 | | 30 | 3 | |\n| Cephalexin | Capsule 250 mg (anhydrous) | Oral | Cefalexin Sandoz | SZ | PDP | | | 20 | 0 | |\n| | | | Cephalexin generichealth | GQ | PDP | | | 20 | 0 | |\n| | | | Cephalexin-PS | FZ | PDP | | | 20 | 0 | |\n| | | | Cephatrust 250 | MI | PDP | | | 20 | 0 | |\n| | | | Chem mart Cephalexin | CH | PDP | | | 20 | 0 | |\n| | | | Cilex | GM | PDP | | | 20 | 0 | |\n| | | | GenRx Cephalexin | GX | PDP | | | 20 | 0 | |\n| | | | Ialex | LN | PDP | | | 20 | 0 | |\n| | | | Ibilex 250 | AF | PDP | | | 20 | 0 | |\n| | | | Keflex | AS | PDP | | | 20 | 0 | |\n| | | | Pharmacor Cephalexin 250 | CR | PDP | | | 20 | 0 | |\n| | | | Rancef | RA | PDP | | | 20 | 0 | |\n| | | | Terry White Chemists Cephalexin | TW | PDP | | | 20 | 0 | |\n| | | | Cefalexin Sandoz | SZ | MP NP MW | | | 20 | 1 | |\n| | | | Cephalexin generichealth | GQ | MP NP MW | | | 20 | 1 | |\n| | | | Cephalexin-PS | FZ | MP NP MW | | | 20 | 1 | |\n| | | | Cephatrust 250 | MI | MP NP MW | | | 20 | 1 | |\n| | | | Chem mart Cephalexin | CH | MP NP MW | | | 20 | 1 | |\n| | | | Cilex | GM | MP NP MW | | | 20 | 1 | |\n| | | | GenRx Cephalexin | GX | MP NP MW | | | 20 | 1 | |\n| | | | Ialex | LN | MP NP MW | | | 20 | 1 | |\n| | | | Ibilex 250 | AF | MP NP MW | | | 20 | 1 | |\n| | | | Keflex | AS | MP NP MW | | | 20 | 1 | |\n| | | | Pharmacor Cephalexin 250 | CR | MP NP MW | | | 20 | 1 | |\n| | | | Rancef | RA | MP NP MW | | | 20 | 1 | |\n| | | | Terry White Chemists Cephalexin | TW | MP NP MW | | | 20 | 1 | |\n| | Capsule 500 mg (anhydrous) | Oral | Cefalexin Sandoz | SZ | PDP | | | 20 | 0 | |\n| | | | Cephalexin generichealth | GQ | PDP | | | 20 | 0 | |\n| | | | Cephalexin-PS | FZ | PDP | | | 20 | 0 | |\n| | | | Cephatrust 500 | MI | PDP | | | 20 | 0 | |\n| | | | Chem mart Cephalexin | CH | PDP | | | 20 | 0 | |\n| | | | Cilex | GM | PDP | | | 20 | 0 | |\n| | | | GenRx Cephalexin | GX | PDP | | | 20 | 0 | |\n| | | | Ialex | LN | PDP | | | 20 | 0 | |\n| | | | Ibilex 500 | AF | PDP | | | 20 | 0 | |\n| | | | Keflex | AS | PDP | | | 20 | 0 | |\n| | | | Pharmacor Cephalexin 500 | CR | PDP | | | 20 | 0 | |\n| | | | Rancef | RA | PDP | | | 20 | 0 | |\n| | | | Terry White Chemists Cephalexin | TW | PDP | | | 20 | 0 | |\n| | | | Cefalexin Sandoz | SZ | MP NP MW | | | 20 | 1 | |\n| | | | Cephalexin generichealth | GQ | MP NP MW | | | 20 | 1 | |\n| | | | Cephalexin-PS | FZ | MP NP MW | | | 20 | 1 | |\n| | | | Cephatrust 500 | MI | MP NP MW | | | 20 | 1 | |\n| | | | Chem mart Cephalexin | CH | MP NP MW | | | 20 | 1 | |\n| | | | Cilex | GM | MP NP MW | | | 20 | 1 | |\n| | | | GenRx Cephalexin | GX | MP NP MW | | | 20 | 1 | |\n| | | | Ialex | LN | MP NP MW | | | 20 | 1 | |\n| | | | Ibilex 500 | AF | MP NP MW | | | 20 | 1 | |\n| | | | Keflex | AS | MP NP MW | | | 20 | 1 | |\n| | | | Pharmacor Cephalexin 500 | CR | MP NP MW | | | 20 | 1 | |\n| | | | Rancef | RA | MP NP MW | | | 20 | 1 | |\n| | | | Terry White Chemists Cephalexin | TW | MP NP MW | | | 20 | 1 | |\n| | Granules for oral suspension 125 mg per 5 mL, 100 mL | Oral | APO-Cephalexin | TX | PDP | | | 1 | 0 | |\n| | | | Cefalexin Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Chem mart Cephalexin | CH | PDP | | | 1 | 0 | |\n| | | | Cilex | GM | PDP | | | 1 | 0 | |\n| | | | GenRx Cephalexin | GX | PDP | | | 1 | 0 | |\n| | | | Ialex | LN | PDP | | | 1 | 0 | |\n| | | | Ibilex 125 | AF | PDP | | | 1 | 0 | |\n| | | | Keflex | AS | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Cephalexin | TW | PDP | | | 1 | 0 | |\n| | | | APO-Cephalexin | TX | MP NP | | | 1 | 1 | |\n| | | | Cefalexin Sandoz | SZ | MP NP | | | 1 | 1 | |\n| | | | Chem mart Cephalexin | CH | MP NP | | | 1 | 1 | |\n| | | | Cilex | GM | MP NP | | | 1 | 1 | |\n| | | | GenRx Cephalexin | GX | MP NP | | | 1 | 1 | |\n| | | | Ialex | LN | MP NP | | | 1 | 1 | |\n| | | | Ibilex 125 | AF | MP NP | | | 1 | 1 | |\n| | | | Keflex | AS | MP NP | | | 1 | 1 | |\n| | | | Terry White Chemists Cephalexin | TW | MP NP | | | 1 | 1 | |\n| | Granules for oral suspension 250 mg per 5 mL, 100 mL | Oral | APO-Cephalexin | TX | PDP | | | 1 | 0 | |\n| | | | Cefalexin Sandoz | SZ | PDP | | | 1 | 0 | |\n| | | | Chem mart Cephalexin | CH | PDP | | | 1 | 0 | |\n| | | | Cilex | GM | PDP | | | 1 | 0 | |\n| | | | GenRx Cephalexin | GX | PDP | | | 1 | 0 | |\n| | | | Ialex | LN | PDP | | | 1 | 0 | |\n| | | | Ibilex 250 | AF | PDP | | | 1 | 0 | |\n| | | | Keflex | AS | PDP | | | 1 | 0 | |\n| | | | Terry White Chemists Cephalexin | TW | PDP | | | 1 | 0 | |\n| | | | APO-Cephalexin | TX | MP NP | | | 1 | 1 | |\n| | | | Cefalexin Sandoz | SZ | MP NP | | | 1 | 1 | |\n| | | | Chem mart Cephalexin | CH | MP NP | | | 1 | 1 | |\n| | | | Cilex | GM | MP NP | | | 1 | 1 | |\n| | | | GenRx Cephalexin | GX | MP NP | | | 1 | 1 | |\n| | | | Ialex | LN | MP NP | | | 1 | 1 | |\n| | | | Ibilex 250 | AF | MP NP | | | 1 | 1 | |\n| | | | Keflex | AS | MP NP | | | 1 | 1 | |\n| | | | Terry White Chemists Cephalexin | TW | MP NP | | | 1 | 1 | |\n| Cephazolin | Powder for injection 500 mg (as sodium) | Injection | Cefazolin-AFT | AE | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Hospira Pty Limited | HH | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | Powder for injection 1 g (as sodium) | Injection | Cefazolin-AFT | AE | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Cefazolin Sandoz | SZ | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Cephazolin Alphapharm | AF | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Hospira Pty Limited | HH | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Kefzol | AS | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | Powder for injection 2 g (as sodium) | Injection | Cefazolin Sandoz | SZ | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| | | | Cephazolin Alphapharm | AF | MP NP | C1169 C1846 C1847 C3132 | | 10 | 0 | |\n| Certolizumab pegol | Injection 200 mg in 1 mL single use pre-filled syringe | Injection | Cimzia | UC | MP | C3714 C3768 C3769 | | 2 | 5 | |\n| Cetrorelix | Powder for injection 250 micrograms (as acetate) with diluent | Injection | Cetrotide | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Cetuximab | Solution for I.V. infusion 100 mg in 20 mL | Injection | Erbitux | SG | MP | C2713 C2714 C2715 C3843 C3844 C3903 C3904 C3919 C3920 C3921 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for I.V. infusion 500 mg in 100 mL | Injection | Erbitux | SG | MP | C2713 C2714 C2715 C3843 C3844 C3903 C3904 C3919 C3920 C3921 | See Note 3 | See Note 3 | See Note 3 | D |\n| Chlorambucil | Tablet 2 mg | Oral | Leukeran | AS | MP | | | 100 | 2 | |\n| Chloramphenicol | Ear drops (aqueous) 5 mg per mL, 5 mL | Application to the ear | Chloromycetin | PF | MP NP | | | 1 | 2 | |\n| | Eye drops 5 mg per mL, 10 mL | Application to the eye | Chloromycetin | PF | PDP | | | 1 | 0 | |\n| | | | Chlorsig | QA | PDP | | | 1 | 0 | |\n| | | | Chloromycetin | PF | AO MP NP MW | | | 1 | 2 | |\n| | | | Chlorsig | QA | AO MP NP MW | | | 1 | 2 | |\n| | Eye ointment 10 mg per g, 4 g | Application to the eye | Chloromycetin | PF | AO MP NP MW | | | 1 | 0 | |\n| | | | Chlorsig | QA | AO MP NP MW | | | 1 | 0 | |\n| Chlorpromazine | Tablet containing chlorpromazine hydrochloride 10 mg | Oral | Largactil | SW | MP NP | | | 100 | 5 | |\n| | Tablet containing chlorpromazine hydrochloride 25 mg | Oral | Largactil | SW | MP NP | | | 100 | 5 | |\n| | Tablet containing chlorpromazine hydrochloride 100 mg | Oral | Largactil | SW | MP NP | | | 100 | 5 | |\n| | Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral | Largactil | SW | MP NP | | | 1 | 5 | |\n| | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection | Largactil | SW | MP NP | | | 10 | 0 | |\n| Chlorthalidone | Tablet 25 mg | Oral | Hygroton 25 | LM | MP NP | | | 100 | 1 | |\n| Cholestyramine | Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50 | Oral | Questran Lite | QA | MP NP | | | 2 | 5 | |\n| | | | Questran Lite | QA | MP | | P3035 | 2 | 11 | |\n| Choriogonadotropin alfa | Solution for injection 250 micrograms in 0.5 mL pre-filled syringe | Injection | Ovidrel | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 250 micrograms in 0.5 mL pre-filled pen | Injection | Ovidrel | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Chorionic Gonadotrophin | Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL | Injection | Pregnyl | MK | MP See Note 1 | C1116 C1117 C1118 C1120 C1878 See Note 2 | See Note 2 | 1 See Note 2 | 5 See Note 2 | |\n| | Powder for injection 5,000 units with solvent | Injection | Pregnyl | MK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| Ciclesonide | Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Alvesco 80 | NQ | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Alvesco 160 | NQ | MP NP | | | 1 | 5 | |\n| Cidofovir | Solution for I.V. infusion 375 mg (anhydrous) in 5 mL single use vial | Injection | Vistide | GI | MP See Note 1 | C1610 C3322 | | 4 | 3 | D |\n| Cimetidine | Tablet 400 mg | Oral | Magicul 400 | AF | MP NP | | | 60 | 5 | |\n| | Tablet 800 mg | Oral | Magicul 800 | AF | MP NP | | | 30 | 5 | |\n| Cinacalcet | Tablet 30 mg (as hydrochloride) | Oral | Sensipar | AN | MP | C3672 C3673 | P3672 P3673 | 28 | 5 | |\n| | Tablet 60 mg (as hydrochloride) | Oral | Sensipar | AN | MP | C3672 C3673 | P3672 P3673 | 28 | 5 | |\n| | Tablet 90 mg (as hydrochloride) | Oral | Sensipar | AN | MP | C3672 C3673 | P3672 P3673 | 28 | 5 | |\n| Ciprofloxacin | Tablet 250 mg (as hydrochloride) | Oral | C-Flox 250 | AL | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Cifran | RA | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-DRLA | RZ | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin Sandoz | SZ | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprol 250 | QA | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciproxin 250 | BN | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | GenRx Ciprofloxacin | GX | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Profloxin | HX | MP NP | C1143 C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | Tablet 500 mg (as hydrochloride) | Oral | C-Flox 500 | AL | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Cifran | RA | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin 500 | CR | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-BW | GQ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-DRLA | RZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-GA | GM | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-PS | FZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin Sandoz | SZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprol 500 | QA | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciproxin 500 | BN | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | GenRx Ciprofloxacin | GX | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Loxip 500 | DO | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | Tablet 750 mg (as hydrochloride) | Oral | C-Flox 750 | AL | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Cifran | RA | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin 750 | CR | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-BW | GQ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-DRLA | RZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-GA | GM | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin-PS | FZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprofloxacin Sandoz | SZ | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciprol 750 | QA | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Ciproxin 750 | BN | MP NP | C1431 C1432 C1572 C1573 C3680 | | 14 | 0 | |\n| | | | GenRx Ciprofloxacin | GX | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | | | Loxip 750 | DO | MP NP | C1431 C1432 C1572 C1573 | | 14 | 0 | |\n| | Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the ear | Ciloxan | AQ | MP NP | C2615 C3191 C3192 | | 1 | 1 | |\n| | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye | CiloQuin | IQ | MP | C1031 | | 2 | 0 | |\n| | | | Ciloxan | AQ | MP | C1031 | | 2 | 0 | |\n| Cisplatin | I.V. injection 50 mg in 50 mL | Injection | Hospira Pty Limited | HH | MP | | | See Note 3 | See Note 3 | D |\n| | I.V. injection 100 mg in 100 mL | Injection | Cisplatin Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Celapram | AF | MP NP | C1211 | | 28 | 5 | |\n| | Tablet 20 mg (as hydrobromide) | Oral | APO-Citalopram | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Auro-Citalopram 20 | DO | MP NP | C1211 | | 28 | 5 | |\n| | | | Celapram | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Celica | RA | MP NP | C1211 | | 28 | 5 | |\n| | | | Chem mart Citalopram | CH | MP NP | C1211 | | 28 | 5 | |\n| | | | Ciazil | GM | MP NP | C1211 | | 28 | 5 | |\n| | | | Cipramil | LU | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram 20 | CR | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram-GA | GN | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram generichealth | GQ | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram Pfizer | FZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram Sandoz | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | GenRx Citalopram | GX | MP NP | C1211 | | 28 | 5 | |\n| | | | Pharmacor Citalo 20 | MI | MP NP | C1211 | | 28 | 5 | |\n| | | | Talam | QA | MP NP | C1211 | | 28 | 5 | |\n| | | | Terry White Chemists Citalopram | TW | MP NP | C1211 | | 28 | 5 | |\n| | Tablet 40 mg (as hydrobromide) | Oral | APO-Citalopram | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Auro-Citalopram 40 | DO | MP NP | C1211 | | 28 | 5 | |\n| | | | Celapram | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram Pfizer | FZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Citalopram Sandoz | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | GenRx Citalopram | GX | MP NP | C1211 | | 28 | 5 | |\n| Citrulline with carbohydrate | Sachets of oral powder 4 g containing 1 g citrulline, 30 (Citrulline 1000 Amino Acid Supplement) | Oral | Citrulline 1000 Amino Acid Supplement | VF | MP NP | C3679 | | 4 | 5 | |\n| Cladribine | Injection 10 mg in 5 mL | Injection | Litak | OA | MP | C3180 | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. infusion 10 mg in 10 mL single use vial | Injection | Leustatin | JC | MP | C3180 | | See Note 3 | See Note 3 | D |\n| Clarithromycin | Tablet 250 mg | Oral | APO-Clarithromycin | TX | MP NP | | | 14 | 1 | |\n| | | | Chem mart Clarithromycin | CH | MP NP | | | 14 | 1 | |\n| | | | Clarac | GM | MP NP | | | 14 | 1 | |\n| | | | Clarihexal | SZ | MP NP | | | 14 | 1 | |\n| | | | Clarithro 250 | QA | MP NP | | | 14 | 1 | |\n| | | | Clarithromycin-PS | FZ | MP NP | | | 14 | 1 | |\n| | | | GenRx Clarithromycin | GX | MP NP | | | 14 | 1 | |\n| | | | Kalixocin | AF | MP NP | | | 14 | 1 | |\n| | | | Klacid | AB | MP NP | | | 14 | 1 | |\n| | | | Terry White Chemists Clarithromycin | TW | MP NP | | | 14 | 1 | |\n| | | | Klacid | AB | MP See Note 1 | C1434 C3325 | | 100 | 2 | C |\n| | Tablet 500 mg | Oral | Klacid | AB | MP See Note 1 | C1434 C3325 | | 100 | 2 | PB |\n| | Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral | Klacid | AB | MP NP | C3016 C3017 | | 1 | 0 | |\n| Clindamycin | Capsule 150 mg (as hydrochloride) | Oral | Cleocin | FZ | MP NP MW PDP | C1145 | | 24 | 0 | |\n| | | | Dalacin C | PF | MP NP MW PDP | C1145 | | 24 | 0 | |\n| Clodronic Acid | Capsule containing 400 mg sodium clodronate (as tetrahydrate) | Oral | Bonefos | BN | MP NP | C1035 C1205 C1233 | | 100 | 2 | |\n| | Tablet containing 800 mg sodium clodronate (as tetrahydrate) | Oral | Bonefos 800 mg | BN | MP NP | C1035 C1205 C1233 | | 60 | 2 | |\n| Clomiphene | Tablet containing clomiphene citrate 50 mg | Oral | Clomid | SW | MP | C1026 C1267 | | 10 | 5 | |\n| | | | Serophene | SG | MP | C1026 C1267 | | 10 | 5 | |\n| Clomipramine | Tablet containing clomipramine hydrochloride 25 mg | Oral | Anafranil 25 | NV | MP NP | C1041 C1241 C1287 | | 50 | 2 | |\n| | | | Chem mart Clomipramine | CH | MP NP | C1041 C1241 C1287 | | 50 | 2 | |\n| | | | GenRx Clomipramine | GX | MP NP | C1041 C1241 C1287 | | 50 | 2 | |\n| | | | Placil | AF | MP NP | C1041 C1241 C1287 | | 50 | 2 | |\n| | | | Terry White Chemists Clomipramine | TW | MP NP | C1041 C1241 C1287 | | 50 | 2 | |\n| Clonazepam | Tablet 500 micrograms | Oral | Paxam 0.5 | AF | MP NP | C1574 C3657 C3658 | P3658 | 100 | 0 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P3658 | 100 | 0 | |\n| | | | Paxam 0.5 | AF | MP NP | C1574 C3657 C3658 | P3657 | 100 | 3 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P3657 | 100 | 3 | |\n| | | | Paxam 0.5 | AF | MP NP | C1574 C3657 C3658 | P1574 | 200 | 2 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P1574 | 200 | 2 | |\n| | Tablet 2 mg | Oral | Paxam 2 | AF | MP NP | C1574 C3657 C3658 | P3658 | 100 | 0 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P3658 | 100 | 0 | |\n| | | | Paxam 2 | AF | MP NP | C1574 C3657 C3658 | P3657 | 100 | 3 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P3657 | 100 | 3 | |\n| | | | Paxam 2 | AF | MP NP | C1574 C3657 C3658 | P3657 | 200 | 2 | |\n| | | | Rivotril | RO | MP NP | C1574 C3657 C3658 | P1574 | 200 | 2 | |\n| | Oral liquid 2.5 mg per mL, 10 mL | Oral | Rivotril | RO | MP NP | C1574 C3657 C3658 | P1574 P3658 | 2 | 0 | |\n| | | | | RO | MP NP | C1574 C3657 C3658 | P3657 | 2 | 3 | |\n| | Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection | Rivotril | RO | MP NP | C1093 | | 5 | 0 | |\n| Clonidine | Tablet containing clonidine hydrochloride 100 micrograms | Oral | Catapres 100 | BY | MP NP | | | 100 | 5 | |\n| | Tablet containing clonidine hydrochloride 150 micrograms | Oral | Catapres | BY | MP NP | | | 100 | 5 | |\n| Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | APO-Clopidogrel | TX | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Chem mart Clopidogrel | CH | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel RBX | RA | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel Sandoz | SZ | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel Winthrop | WA | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 C3146 C3879 | | 28 | 5 | |\n| | | | Iscover | BQ | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 C3146 C3879 | | 28 | 5 | |\n| | | | Piax | AF | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Plavicor 75 | MI | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Plavix | SW | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 C3146 C3879 | | 28 | 5 | |\n| | | | Terry White Chemists Clopidogrel | TW | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | Tablet 75 mg (as besilate) | Oral | Clopidogrel Actavis | TA | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel-GA | GM | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel GH | GQ | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clopidogrel-PS | FZ | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | Clovix 75 | QA | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | | | STADA Clopidogrel | TD | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| | Tablet 75 mg | Oral | Clopidogrel-DRLA | RZ | MP NP | C1719 C1720 C1721 C1722 C1723 C1724 | | 28 | 5 | |\n| Clopidogrel with aspirin | Tablet 75 mg (as hydrogen sulfate)-100 mg | Oral | Clopidogrel Winthrop plus aspirin | WA | MP NP | C1722 C3219 C3880 | | 30 | 5 | |\n| | | | CoPlavix | SW | MP NP | C1722 C3219 C3880 | | 30 | 5 | |\n| | | | DuoCover | BQ | MP NP | C1722 C3219 C3880 | | 30 | 5 | |\n| Clostridium Botulinum Type A Toxin—haemagglutinin Complex | Lyophilised powder for I.M. injection 300 units | Injection | Dysport | IS | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Lyophilised powder for I.M. injection 500 units | Injection | Dysport | IS | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Clozapine | Tablet 25 mg | Oral | Clopine 25 | HH | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | | | Clozaril 25 | NV | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | Tablet 50 mg | Oral | Clopine 50 | HH | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | Tablet 100 mg | Oral | Clopine 100 | HH | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | | | Clozaril 100 | NV | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | Tablet 200 mg | Oral | Clopine 200 | HH | MP See Note 1 | C1826 C1827 C3326 C3327 | | 100 | 0 | D |\n| | Oral liquid 50 mg per mL, 100 mL | Oral | Clopine Suspension | HH | MP See Note 1 | C1826 C1827 C3326 C3327 | | 1 | 0 | D |\n| Coal Tar - Prepared | Gel 10 mg per g, 100 mL | Application | Exorex | GM | MP NP | | | 1 | 2 | |\n| Codeine | Tablet containing codeine phosphate 30 mg | Oral | Fawns and McAllan Proprietary Limited | FM | MP NP PDP | | | 20 | 0 | |\n| Codeine with Paracetamol | Tablet containing codeine phosphate 30 mg with paracetamol 500 mg | Oral | APO- Paracetamol/Codeine 500/30 | TX | MP NP PDP | | | 20 | 0 | |\n| | | | Codalgin Forte | FM | MP NP PDP | | | 20 | 0 | |\n| | | | Codapane Forte | AL | MP NP PDP | | | 20 | 0 | |\n| | | | Comfarol Forte | SZ | MP NP PDP | | | 20 | 0 | |\n| | | | Panadeine Forte | SW | MP NP PDP | | | 20 | 0 | |\n| | | | Prodeine Forte | AV | MP NP PDP | | | 20 | 0 | |\n| | | | APO- Paracetamol/Codeine 500/30 | TX | MP NP | | P2064 | 60 | 0 | |\n| | | | Codalgin Forte | FM | MP NP | | P2064 | 60 | 0 | |\n| | | | Codapane Forte | AL | MP NP | | P2064 | 60 | 0 | |\n| | | | Comfarol Forte | SZ | MP NP | | P2064 | 60 | 0 | |\n| | | | Panadeine Forte | SW | MP NP | | P2064 | 60 | 0 | |\n| | | | Prodeine Forte | AV | MP NP | | P2064 | 60 | 0 | |\n| Colchicine | Tablet 500 micrograms | Oral | Colgout | AS | MP NP | | | 30 | 5 | |\n| | | | Lengout | LN | MP NP | | | 30 | 5 | |\n| Colestipol | Oral powder, sachets containing colestipol hydrochloride 5 g, 120 | Oral | Colestid | PF | MP NP | | | 1 | 5 | |\n| Corifollitropin Alfa | Solution for injection 100 micrograms in 0.5 mL single dose pre-filled syringe | Injection | Elonva | MK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 150 micrograms in 0.5 mL single dose pre-filled syringe | Injection | Elonva | MK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Cortisone | Tablet containing cortisone acetate 5 mg | Oral | Cortate | AS | MP NP | | | 50 | 4 | |\n| | Tablet containing cortisone acetate 25 mg | Oral | Cortate | AS | MP NP | | | 60 | 4 | |\n| Cromoglycic Acid | Capsule containing powder for oral inhalation containing sodium cromoglycate 20 mg (for use in Intal Spinhaler or Intal Halermatic) | Inhalation by mouth | Intal Spincaps | GM | MP NP | | | 100 | 5 | |\n| | Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Intal CFC-Free | SW | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC-free formulation) | Inhalation by mouth | Intal Forte CFC-Free | SW | MP NP | | | 1 | 5 | |\n| | Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL | Application to the eye | Cromolux | AE | MP NP AO | C1466 | | 1 | 5 | |\n| | | | Opticrom | SW | MP NP AO | C1466 | | 1 | 5 | |\n| Cyclophosphamide | Tablet 50 mg | Oral | Cycloblastin | PF | MP | | | 50 | 2 | |\n| | Powder for injection 500 mg (anhydrous) | Injection | Endoxan | BX | MP | | | See Note 3 | See Note 3 | PB |\n| | Powder for injection 1 g (anhydrous) | Injection | Endoxan | BX | MP | | | See Note 3 | See Note 3 | PB |\n| | Powder for injection 2 g (anhydrous) | Injection | Endoxan | BX | MP | | | See Note 3 | See Note 3 | PB |\n| Cyclosporin | Capsule 10 mg | Oral | Neoral 10 | NV | MP | C2049 C2050 C2051 C2052 C2053 | | 120 | 3 | |\n| | | | | | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | Capsule 25 mg | Oral | Cyclosporin Sandoz | SZ | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Neoral 25 | NV | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Cyclosporin Sandoz | SZ | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | | | Neoral 25 | NV | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | Capsule 50 mg | Oral | Cyclosporin Sandoz | SZ | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Neoral 50 | NV | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Cyclosporin Sandoz | SZ | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | | | Neoral 50 | NV | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | Capsule 100 mg | Oral | Cyclosporin Sandoz | SZ | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Neoral 100 | NV | MP | C2049 C2050 C2051 C2052 C2053 | | 60 | 3 | |\n| | | | Cyclosporin Sandoz | SZ | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | | | Neoral 100 | NV | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 120 | 5 | C |\n| | Oral liquid 100 mg per mL, 50 mL | Oral | Neoral | NV | MP | C2049 C2050 C2051 C2052 C2053 | | 2 | 3 | |\n| | | | | | MP See Note 1 | C1654 C1655 C1656 C1657 C1658 C3328 C3329 C3330 C3331 C3332 | | 4 | 5 | C |\n| | Solution concentrate for I.V. infusion 50 mg in 1 mL | Injection | Sandimmun | NV | MP See Note 1 | C1504 C3333 | | 10 | 0 | PB |\n| Cyproheptadine | Tablet containing cyproheptadine hydrochloride 4 mg (anhydrous) | Oral | Periactin | AS | MP NP | C1288 | | 100 | 2 | |\n| Cyproterone | Tablet containing cyproterone acetate 50 mg | Oral | Androcur | BN | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Cyprocur 50 | QA | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Cyprohexal | SZ | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Cyprone | AF | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Cyprostat | SY | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | GenRx Cyproterone Acetate | GX | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Procur | GM | MP | C1014 C1230 C1404 | P1230 | 20 | 5 | |\n| | | | Androcur | BN | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | Cyprocur 50 | QA | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | Cyprohexal | SZ | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | Cyprone | AF | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | Cyprostat | SY | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | GenRx Cyproterone Acetate | GX | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | | | Procur | GM | MP | C1014 C1230 C1404 | P1014 P1404 | 100 | 5 | |\n| | Tablet containing cyproterone acetate 100 mg | Oral | Androcur-100 | BN | MP | C1014 C1404 | | 50 | 5 | |\n| | | | Cyprocur 100 | QA | MP | C1014 C1404 | | 50 | 5 | |\n| | | | Cyprohexal | SZ | MP | C1014 C1404 | | 50 | 5 | |\n| | | | Cyprostat-100 | SY | MP | C1014 C1404 | | 50 | 5 | |\n| | | | GenRx Cyproterone Acetate | GX | MP | C1014 C1404 | | 50 | 5 | |\n| | | | Procur 100 | GM | MP | C1014 C1404 | | 50 | 5 | |\n| Cystine with carbohydrate | Sachets of oral powder 4 g containing 500 mg cystine, 30 (Cystine Amino Acid Supplement) | Oral | Cystine Amino Acid Supplement | VF | MP NP | C1314 | | 4 | 5 | |\n| Cytarabine | Injection 100 mg in 5 mL vial | Injection | Pfizer Australia Pty Ltd | PF | MP | | | See Note 3 | See Note 3 | D |\n| Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C3957 C4047 C4048 | P3957 | 20 | 0 | |\n| | | | | | MP NP | C3957 C4047 C4048 | P4047 | 20 | 1 | |\n| | | | | | MP NP | C3957 C4047 C4048 | P4048 | 60 | 0 | |\n| | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C3957 C4047 C4048 | P3957 | 20 | 0 | |\n| | | | | | MP NP | C3957 C4047 C4048 | P4047 | 20 | 1 | |\n| | | | | | MP NP | C3957 C4047 C4048 | P4048 | 60 | 0 | |\n| Dalteparin | Injection containing dalteparin sodium 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | | | 20 | 0 | |\n| | Injection containing dalteparin sodium 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | | | 20 | 0 | |\n| | Injection containing dalteparin sodium 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | | | 10 | 1 | |\n| | | | | | | | P3688 | 30 | 5 | |\n| | Injection containing dalteparin sodium 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | | | 10 | 1 | |\n| | | | | | MP NP | | P3688 | 30 | 5 | |\n| | Injection containing dalteparin sodium 12,500 I.U. (anti-Xa) in 0.5 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | | | 10 | 1 | |\n| | | | | | MP NP | | P3688 | 30 | 5 | |\n| | Injection containing dalteparin sodium 15,000 I.U. (anti-Xa) in 0.6 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | C3688 | | 30 | 5 | |\n| | Injection containing dalteparin sodium 18,000 I.U. (anti-Xa) in 0.72 mL single dose pre-filled syringe | Injection | Fragmin | PF | MP NP | C3688 | | 30 | 5 | |\n| Danazol | Capsule 100 mg | Oral | Azol 100 | AF | MP | C1090 C1151 C2639 C2640 | | 100 | 5 | |\n| | Capsule 200 mg | Oral | Azol 200 | AF | MP | C1090 C1151 C2639 C2640 | | 100 | 5 | |\n| Dantrolene | Capsule containing dantrolene sodium 25 mg | Oral | Dantrium | PF | MP NP | C1421 | | 100 | 2 | |\n| | Capsule containing dantrolene sodium 50 mg | Oral | Dantrium | PF | MP NP | C1421 | | 100 | 2 | |\n| Dapsone | Tablet 25 mg | Oral | Link Medical Products Pty Ltd | LM | MP NP | | | 100 | 1 | |\n| | Tablet 100 mg | Oral | Link Medical Products Pty Ltd | LM | MP NP | | | 100 | 1 | |\n| Darbepoetin Alfa | Injection 10 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 20 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 20 micrograms in 0.5 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 30 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 40 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 40 micrograms in 0.4 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 50 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 60 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 60 micrograms in 0.3 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 80 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 80 micrograms in 0.4 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 100 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 100 micrograms in 0.5 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 150 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| | Injection 150 micrograms in 0.3 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP See Note 1 | C1957 C3334 | | 8 | 5 | D |\n| Darunavir | Tablet 150 mg (as ethanolate) | Oral | Prezista | JC | MP See Note 1 | C3594 C3595 | | 240 | 5 | D |\n| | Tablet 400 mg (as ethanolate) | Oral | Prezista | JC | MP See Note 1 | C3940 C3941 | | 120 | 5 | D |\n| | Tablet 600 mg (as ethanolate) | Oral | Prezista | JC | MP See Note 1 | C3594 C3595 | | 120 | 5 | D |\n| Dasatinib | Tablet 20 mg | Oral | Sprycel | BQ | MP | C2769 C2770 C2771 C3999 C4000 C4003 C4004 | P2769 P2770 P2771 | 60 | 2 | |\n| | Tablet 50 mg | Oral | Sprycel | BQ | MP | C2769 C2770 C2771 C3999 C4000 C4003 C4004 | P2769 P2770 P2771 | 60 | 2 | |\n| | Tablet 70 mg | Oral | Sprycel | BQ | MP | C2769 C2770 C2771 C3999 C4000 C4003 C4004 | P2769 P2770 P2771 | 60 | 2 | |\n| | Tablet 100 mg | Oral | Sprycel | BQ | MP | C2769 C2770 C2771 C3999 C4000 C4003 C4004 | P2769 P2770 P2771 | 30 | 2 | |\n| | | | | | MP | C2769 C2770 C2771 C3999 C4000 C4003 C4004 | P3999 P4000 P4003 P4004 | 30 | 5 | |\n| Deferasirox | Tablet, dispersible, 125 mg | Oral | Exjade | NV | MP See Note 1 | C3828 C3829 | | 168 | 5 | D |\n| | Tablet, dispersible, 250 mg | Oral | Exjade | NV | MP See Note 1 | C3828 C3829 | | 168 | 5 | D |\n| | Tablet, dispersible, 500 mg | Oral | Exjade | NV | MP See Note 1 | C3828 C3829 | | 168 | 5 | D |\n| Deferiprone | Tablet 500 mg | Oral | Ferriprox | OA | MP See Note 1 | C1911 C1912 C3338 C3339 | | 600 | 5 | D |\n| | Oral solution 100 mg per mL, 250 mL | Oral | Ferriprox | OA | MP See Note 1 | C1911 C1912 C3338 C3339 | | 5 | 5 | D |\n| Degarelix | Powder for injection 80 mg (as acetate), injection set | Injection | Firmagon 80mg | FP | MP | C3229 | | 1 | 5 | |\n| | Powder for injection 120 mg (as acetate), 2, injection set | Injection | Firmagon 120mg | FP | MP | C3229 | | 1 | 0 | |\n| Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Prolia | AN | MP NP | C3987 C4054 | | 1 | 0 | |\n| | Injection 120 mg in 1.7 mL | Injection | Xgeva | AN | MP NP | C1035 C4051 | | 1 | 5 | |\n| Desferrioxamine | Powder for injection containing desferrioxamine mesylate 500 mg | Injection | Desferal 500 mg | NV | MP See Note 1 | C1085 C3340 | | 400 | 5 | D |\n| | | | Hospira Pty Limited | HH | MP See Note 1 | C1085 C3340 | | 400 | 5 | D |\n| | Powder for injection containing desferrioxamine mesylate 2 g | Injection | Desferal 2 g | NV | MP See Note 1 | C1085 C3340 | | 60 | 5 | D |\n| | | | Hospira Pty Limited | HH | MP See Note 1 | C1085 C3340 | | 60 | 5 | D |\n| Desmopressin | Tablet containing desmopressin acetate 200 micrograms | Oral | Minirin | FP | MP | C1678 C2641 C2642 | P2641 P2642 | 30 | 5 | |\n| | | | | | NP | C2641 C2642 | | 30 | 5 | |\n| | | | | | MP | C1678 C2641 C2642 | P1678 | 90 | 5 | |\n| | Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle | Nasal | Minirin | FP | MP | C1678 | | 5 | 5 | |\n| | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal | Minirin Nasal Spray | FP | MP | C1678 C2641 C2642 | P2641 P2642 | 1 | 5 | |\n| | | | | | NP | C2641 C2642 | | 1 | 5 | |\n| | | | | | MP | C1678 C2641 C2642 | P1678 | 2 | 5 | |\n| | Wafer 120 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C2641 C2642 | | 30 | 5 | |\n| | Wafer 240 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C2641 C2642 | | 30 | 5 | |\n| Desvenlafaxine | Tablet (extended release) 50 mg (as succinate) | Oral | Pristiq | PF | MP NP | C1211 | | 28 | 5 | |\n| | Tablet (extended release) 100 mg (as succinate) | Oral | Pristiq | PF | MP NP | C1211 | | 28 | 5 | |\n| Dexamethasone | Tablet 500 micrograms | Oral | Dexmethsone | AS | MP NP | | | 30 | 4 | |\n| | Tablet 4 mg | Oral | Dexmethsone | AS | MP NP | | | 30 | 4 | |\n| | Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL | Injection | Dexmethsone | AS | MP NP | | | 5 | 0 | |\n| | | | Hospira Pty Limited | HH | MP NP | | | 5 | 0 | |\n| | Injection containing dexamethasone sodium phosphate equivalent to 8 mg dexamethasone phosphate in 2 mL | Injection | Dexmethsone | AS | MP NP | | | 5 | 1 | |\n| | | | Hospira Pty Limited | HH | MP NP | | | 5 | 1 | |\n| | Eye drops 1 mg per mL, 5 mL | Application to the eye | Maxidex | AQ | AO | | | 1 | 0 | |\n| Dexamethasone with Framycetin and Gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | Otodex | AV | MP NP | | | 1 | 2 | |\n| | | | Sofradex | SW | MP NP | | | 1 | 2 | |\n| Dexamphetamine | Tablet containing dexamphetamine sulfate 5 mg | Oral | Aspen Pharma Pty Ltd | QA | MP NP | C1236 C1461 | | 100 | 5 | |\n| Diazepam | Tablet 2 mg | Oral | Antenex 2 | AF | MP NP PDP | | | 50 | 0 | |\n| | | | APO-Diazepam | TX | MP NP PDP | | | 50 | 0 | |\n| | | | Ranzepam | | MP NP PDP | | | 50 | 0 | |\n| | | | Valium | RO | MP NP PDP | | | 50 | 0 | |\n| | | | Valpam 2 | QA | MP NP PDP | | | 50 | 0 | |\n| | | | Antenex 2 | AF | MP NP | | P3655 | 50 | 3 | |\n| | | | APO-Diazepam | TX | MP NP | | P3655 | 50 | 3 | |\n| | | | Ranzepam | RA | MP NP | | P3655 | 50 | 3 | |\n| | | | Valium | RO | MP NP | | P3655 | 50 | 3 | |\n| | | | Valpam 2 | QA | MP NP | | P3655 | 50 | 3 | |\n| | Tablet 5 mg | Oral | Antenex 5 | AF | MP NP PDP | | | 50 | 0 | |\n| | | | APO-Diazepam | TX | MP NP PDP | | | 50 | 0 | |\n| | | | Diazepam-GA | GM | MP NP PDP | | | 50 | 0 | |\n| | | | Ranzepam | RA | MP NP PDP | | | 50 | 0 | |\n| | | | Valium | RO | MP NP PDP | | | 50 | 0 | |\n| | | | Valpam 5 | QA | MP NP PDP | | | 50 | 0 | |\n| | | | Antenex 5 | AF | MP NP | | P3655 | 50 | 3 | |\n| | | | APO-Diazepam | TX | MP NP | | P3655 | 50 | 3 | |\n| | | | Diazepam-GA | GM | MP NP | | P3655 | 50 | 3 | |\n| | | | Ranzepam | RA | MP NP | | P3655 | 50 | 3 | |\n| | | | Valium | RO | MP NP | | P3655 | 50 | 3 | |\n| | | | Valpam 5 | QA | MP NP | | P3655 | 50 | 3 | |\n| | Injection 10 mg in 2 mL | Injection | Hospira Pty Limited | HH | MP NP PDP | | | 5 | 0 | |\n| Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | APO-Diclofenac | TX | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Chem mart Diclofenac | CH | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Clonac 25 | QA | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Diclofenac-GA | GM | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Diclofenac Sandoz | SZ | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Fenac 25 | AF | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Terry White Chemists Diclofenac | TW | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Voltaren 25 | NV | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | APO-Diclofenac | TX | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Chem mart Diclofenac | CH | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Clonac 25 | QA | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Diclofenac-GA | GM | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Diclofenac-GA | GM | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Fenac 25 | AF | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Terry White Chemists Diclofenac | TW | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Voltaren 25 | NV | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | APO-Diclofenac | TX | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Chem mart Diclofenac | CH | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Clonac 50 | QA | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Diclofenac-GA | GM | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Diclofenac Sandoz | SZ | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Fenac | AF | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Terry White Chemists Diclofenac | TW | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Voltaren 50 | NV | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | APO-Diclofenac | TX | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Chem mart Diclofenac | CH | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Clonac 50 | QA | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Diclofenac-GA | GM | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Diclofenac Sandoz | SZ | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Fenac | AF | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Terry White Chemists Diclofenac | TW | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Voltaren 50 | NV | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | Suppository containing diclofenac sodium 100 mg | Rectal | Voltaren 100 | NV | MP NP | | P3666 | 40 | 0 | |\n| | | | | | PDP | | | 40 | 0 | |\n| | | | | | MP NP MW | | | 40 | 3 | |\n| | | | | | MP NP | | P3665 | 40 | 3 | |\n| Dicloxacillin | Capsule 250 mg (as sodium) | Oral | Distaph 250 | AF | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | Capsule 500 mg (as sodium) | Oral | Diclocil | BQ | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | | | Distaph 500 | AF | MP NP MW PDP | C1345 | | 24 | 0 | |\n| Didanosine | Capsule 125 mg (containing enteric coated beadlets) | Oral | Videx EC | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | Capsule 200 mg (containing enteric coated beadlets) | Oral | Videx EC | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | Capsule 250 mg (containing enteric coated beadlets) | Oral | Videx EC | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | Capsule 400 mg (containing enteric coated beadlets) | Oral | Videx EC | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| Digoxin | Tablet 62.5 micrograms | Oral | Lanoxin-PG | QA | MP NP | | | 200 | 1 | |\n| | | | Sigmaxin-PG | FM | MP NP | | | 200 | 1 | |\n| | Tablet 250 micrograms | Oral | Lanoxin | QA | MP NP | | | 100 | 1 | |\n| | | | Sigmaxin | FM | MP NP | | | 100 | 1 | |\n| | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral | Lanoxin | QA | MP NP | | | 2 | 3 | |\n| Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | SW | MP NP | | | 90 | 5 | |\n| | | | Chem mart Diltiazem | CH | MP NP | | | 90 | 5 | |\n| | | | Coras | AF | MP NP | | | 90 | 5 | |\n| | | | Diltiazem Sandoz | SZ | MP NP | | | 90 | 5 | |\n| | | | Dilzem 60 mg | GM | MP NP | | | 90 | 5 | |\n| | | | GenRx Diltiazem | GX | MP NP | | | 90 | 5 | |\n| | | | Terry White Chemists Diltiazem | TW | MP NP | | | 90 | 5 | |\n| | | | Vasocardol | AV | MP NP | | | 90 | 5 | |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | SW | MP NP | | | 30 | 5 | |\n| | | | Chem mart Diltiazem CD | CH | MP NP | | | 30 | 5 | |\n| | | | GenRx Diltiazem CD | GX | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Diltiazem CD | TW | MP NP | | | 30 | 5 | |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | SW | MP NP | | | 30 | 5 | |\n| | | | Chem mart Diltiazem CD | CH | MP NP | | | 30 | 5 | |\n| | | | Diltahexal CD | HX | MP NP | | | 30 | 5 | |\n| | | | GenRx Diltiazem CD | GX | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Diltiazem CD | TW | MP NP | | | 30 | 5 | |\n| | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | SW | MP NP | | | 30 | 5 | |\n| | | | Diltahexal CD | HX | MP NP | | | 30 | 5 | |\n| Diphenoxylate with Atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms | Oral | Lofenoxal | HC | MP NP | | | 20 | 0 | |\n| | | | Lomotil | BI | MP NP | | | 20 | 0 | |\n| Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | Injection | ADT Booster | CS | MP NP | | | 5 | 0 | |\n| Dipyridamole | Capsule 200 mg (sustained release) | Oral | Persantin SR | BY | MP NP | C1725 C1726 C1727 | | 60 | 5 | |\n| Dipyridamole with Aspirin | Capsule 200 mg (sustained release)-25 mg | Oral | Asasantin SR | BY | MP NP | C1728 | | 60 | 5 | |\n| Disopyramide | Capsule 100 mg | Oral | Rythmodan | SW | MP NP | | | 100 | 5 | |\n| | Capsule 150 mg | Oral | Rythmodan | SW | MP NP | | | 100 | 5 | |\n| Docetaxel | Solution concentrate for I.V. infusion 140 mg in 7 mL | Injection | Oncotaxel 140 | TA | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 160 mg in 16 mL | Injection | DBL Docetaxel Concentrated Injection | HH | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 20 mg with solvent | Injection | Docetaxel SUN | ZF | MP | C3186 C3890 C3955 C7002 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 80 mg with solvent | Injection | Docetaxel SUN | ZF | MP | C3186 C3890 C3955 C7002 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 20 mg in 1 mL | Injection | Oncotaxel 20 | TA | MP | C3186 C7002 C3888 C3890 C3892 C3916 C3955 C3956 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Taxotere | SW | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 20 mg in 2 mL | Injection | DBL Docetaxel Concentrated Injection | HH | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Docetaxel Ebewe | HX | MP | C3186 C3888 C3890 C3916 C3955 C7002 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Docetaxel Sandoz | SZ | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 80 mg in 4 mL | Injection | Oncotaxel 80 | TA | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | | | Taxotere | SW | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 80 mg in 8 mL | Injection | DBL Docetaxel Concentrated Injection | HH | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | | | Docetaxel Ebewe | HX | MP | C3186 C3888 C3890 C3916 C3955 C7002 | | See Note 3 | See Note 3 | D |\n| | | | Docetaxel Sandoz | SZ | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| | Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent | Injection | Taxotere | SW | MP | C3186 C3888 C3890 C3892 C3916 C3955 C3956 C7002 | | See Note 3 | See Note 3 | D |\n| Domperidone | Tablet 10 mg | Oral | Motilium | JC | MP NP | | | 25 | 0 | |\n| Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | PF | MP NP | C2934 C2938 C3875 C3876 | | 28 | 5 | |\n| | Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | PF | MP NP | C2934 C2938 C3875 C3876 | | 28 | 5 | |\n| Dornase Alfa | Solution for inhalation 2.5 mg (2,500 units) in 2.5 mL | Inhalation | Pulmozyme | RO | MP See Note 1 | C1507 C3200 C3201 C3202 C3344 C3345 C3346 C3347 | | 60 | 5 | D |\n| Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusopt | MK | MP AO | | | 1 | 5 | |\n| Dorzolamide with Timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | MK | MP AO | C3426 C3427 | | 1 | 5 | |\n| Dothiepin | Capsule containing dothiepin hydrochloride 25 mg | Oral | Dothep 25 | AF | MP NP | | | 50 | 2 | |\n| | Tablet containing dothiepin hydrochloride 75 mg | Oral | Dothep 75 | AF | MP NP | | | 30 | 2 | |\n| Doxepin | Tablet 50 mg (as hydrochloride) | Oral | Deptran 50 | AF | MP NP | | | 50 | 2 | |\n| | Capsule 10 mg (as hydrochloride) | Oral | Deptran 10 | AF | MP NP | | | 50 | 2 | |\n| | | | Sinequan | PF | MP NP | | | 50 | 2 | |\n| | Capsule 25 mg (as hydrochloride) | Oral | Deptran 25 | AF | MP NP | | | 50 | 2 | |\n| | | | Sinequan | PF | MP NP | | | 50 | 2 | |\n| Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 10 mg in 5 mL single dose vial | Injection/ intravesical | Accord Doxorubicin | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/ intravesical | Adriamycin Solution | PF | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 100 mg in 50 mL single dose vial | Injection/ intravesical | Doxorubicin Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/ intravesical | Accord Doxorubicin | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Adriamycin | PF | MP | | | See Note 3 | See Note 3 | D |\n| Doxorubicin – Pegylated Liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Caelyx | JC | MP | C1568 C1795 C1796 C3905 C3910 C3911 | | See Note 3 | See Note 3 | D |\n| | | | | | MP See Note 1 | C1828 C1829 C3348 C3349 | | 4 | 5 | D |\n| | | | Lipodox | ZF | MP | C1568 C1795 C1796 C3905 C3910 C3911 | | See Note 3 | See Note 3 | D |\n| | | | | | MP See Note 1 | C1828 C1829 C3348 C3349 | | 4 | 5 | D |\n| | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 50 mg in 25 mL | Injection | Caelyx | JC | MP
| C1568 C1795 C1796 C3905 C3910 C3911 | | See Note 3 | See Note 3 | D |\n| | | | Lipodox 50 | ZF | MP | C1568 C1795 C1796 C3905 C3910 C3911 | | See Note 3 | See Note 3 | D |\n| Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Chem mart Doxycycline | CH | PDP | | | 7 | 0 | |\n| | | | Doxyhexal | SZ | PDP | | | 7 | 0 | |\n| | | | GenRx Doxycycline | GX | PDP | | | 7 | 0 | |\n| | | | Terry White Chemists Doxycycline | TW | PDP | | | 7 | 0 | |\n| | | | Chem mart Doxycycline | CH | MP NP | | | 7 | 1 | |\n| | | | Doxyhexal | SZ | MP NP | | | 7 | 1 | |\n| | | | GenRx Doxycycline | GX | MP NP | | | 7 | 1 | |\n| | | | Terry White Chemists Doxycycline | TW | MP NP | | | 7 | 1 | |\n| | | | Chem mart Doxycycline | CH | MP NP | | P1459 | 21 | 0 | |\n| | | | Doxyhexal | SZ | MP NP | | P1459 | 21 | 0 | |\n| | | | GenRx Doxycycline | GX | MP NP | | P1459 | 21 | 0 | |\n| | | | Terry White Chemists Doxycycline | TW | MP NP | | P1459 | 21 | 0 | |\n| | | | Chem mart Doxycycline | CH | MP NP | | P1279 | 28 | 0 | |\n| | | | Doxyhexal | SZ | MP NP | | P1279 | 28 | 0 | |\n| | | | GenRx Doxycycline | GX | MP NP | | P1279 | 28 | 0 | |\n| | | | Terry White Chemists Doxycycline | TW | MP NP | | P1279 | 28 | 0 | |\n| | Tablet 50 mg (as monohydrate) | Oral | Chem mart Doxycycline | CH | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Doxyhexal | SZ | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Frakas | QA | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | GenRx Doxycycline | GX | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Terry White Chemists Doxycycline | TW | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | Tablet 50 mg (as hydrochloride) | Oral | Doxy-50 | GM | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Doxylin 50 | AF | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Vibra-Tabs | PF | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | YN | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | | | Mayne Pharma Doxycycline | YT | MP NP | C1346 C1851 C1852 | | 25 | 5 | |\n| | Tablet 100 mg (as hydrochloride) | Oral | Doxsig | QA | PDP | | | 7 | 0 | |\n| | | | Doxy-100 | GM | PDP | | | 7 | 0 | |\n| | | | Doxylin 100 | AF | PDP | | | 7 | 0 | |\n| | | | Doxsig | QA | MP NP | | | 7 | 1 | |\n| | | | Doxy-100 | GM | MP NP | | | 7 | 1 | |\n| | | | Doxylin 100 | AF | MP NP | | | 7 | 1 | |\n| | | | Doxsig | QA | MP NP | | P1459 | 21 | 0 | |\n| | | | Doxy-100 | GM | MP NP | | P1459 | 21 | 0 | |\n| | | | Doxylin 100 | AF | MP NP | | P1459 | 21 | 0 | |\n| | | | Doxsig | QA | MP NP | | P1279 | 28 | 0 | |\n| | | | Doxy-100 | GM | MP NP | | P1279 | 28 | 0 | |\n| | | | Doxylin 100 | AF | MP NP | | P1279 | 28 | 0 | |\n| | Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | YN | PDP | | | 7 | 0 | |\n| | | | Mayne Pharma Doxycycline | YT | PDP | | | 7 | 0 | |\n| | | | Doryx | YN | MP NP | | | 7 | 1 | |\n| | | | Mayne Pharma Doxycycline | YT | MP NP | | | 7 | 1 | |\n| | | | Doryx | YN | MP NP | | P1459 | 21 | 0 | |\n| | | | Mayne Pharma Doxycycline | YT | MP NP | | P1459 | 21 | 0 | |\n| | | | Doryx | YN | MP NP | | P1279 | 28 | 0 | |\n| | | | Mayne Pharma Doxycycline | YT | MP NP | | P1279 | 28 | 0 | |\n| Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Cymbalta | LY | MP NP | C1211 | | 28 | 0 | |\n| | Capsule 60 mg (as hydrochloride) | Oral | Cymbalta | LY | MP NP | C1211 | | 28 | 5 | |\n| Dutasteride | Capsule 500 micrograms | Oral | Avodart | GK | MP NP | C3667 | | 30 | 5 | |\n| Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Duodart 500ug/400ug | GK | MP NP | C3687 | | 30 | 5 | |\n| Efavirenz | Tablet 200 mg | Oral | Stocrin | MK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 180 | 5 | D |\n| | Tablet 600 mg | Oral | Stocrin | MK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | Oral solution 30 mg per mL, 180 mL | Oral | Stocrin | MK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 7 | 5 | D |\n| Eformoterol | Capsule containing powder for oral inhalation containing eformoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth | Foradile | NV | MP NP | C1752 C1753 | | 60 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C1752 C1753 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C1752 C1753 | | 1 | 5 | |\n| Electrolyte Replacement, Oral | Oral rehydration salts containing glucose 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral | O.R.S. | AS | MP NP | | | 1 | 0 | |\n| | | | Repalyte New Formulation | SW | MP NP | | | 1 | 0 | |\n| | | | restore O.R.S. | GM | MP NP | | | 1 | 0 | |\n| Electrolyte Replacement, Solution | Electrolyte replacement solution containing sodium chloride 5.26 g, sodium acetate 3.68 g, sodium gluconate 5.02 g, potassium chloride 370 mg and magnesium chloride 300 mg per L, 1 L | Injection | Plasma-Lyte 148 | BX | MP NP | | | 2 | 1 | |\n| Eletriptan | Tablet 40 mg (as hydrobromide) | Oral | Relpax | PF | MP NP | C3233 | | 4 | 5 | |\n| | Tablet 80 mg (as hydrobromide) | Oral | Relpax | PF | MP NP | C3233 | | 4 | 5 | |\n| Eltrombopag | Tablet 25 mg (as olamine) | Oral | Revolade | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Tablet 50 mg (as olamine) | Oral | Revolade | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Emtricitabine | Capsule 200 mg | Oral | Emtriva | GI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Acetec | AL | MP NP | | | 30 | 5 | |\n| | | | Renitec M | MK | MP NP | | | 30 | 5 | |\n| | Tablet containing enalapril maleate 10 mg | Oral | Acetec | AL | MP NP | | | 30 | 5 | |\n| | | | Renitec | MK | MP NP | | | 30 | 5 | |\n| | Tablet containing enalapril maleate 20 mg | Oral | Acetec | AL | MP NP | | | 30 | 5 | |\n| | | | Renitec 20 | MK | MP NP | | | 30 | 5 | |\n| Enalapril with Hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Enalapril/HCT Sandoz | SZ | MP NP | C3307 | | 30 | 5 | |\n| | | | Renitec Plus 20/6 | MK | MP NP | C3307 | | 30 | 5 | |\n| Enfuvirtide | Pack containing 60 vials powder for injection 90 mg with 60 vials water for injections 1.1 mL (with syringes and swabs) | Injection | Fuzeon | RO | MP See Note 1 | C3596 C3597 | | 2 | 5 | D |\n| Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Clexane | SW | MP NP | | | 20 | 0 | |\n| | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Clexane | SW | MP NP | | | 20 | 0 | |\n| | Solution for injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL | Injection | Clexane | SW | MP NP | | | 20 | 0 | |\n| | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Clexane | SW | MP NP | | | 10 | 1 | |\n| | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane | SW | MP NP | | | 10 | 1 | |\n| | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane | SW | MP NP | | | 10 | 1 | |\n| Entacapone | Tablet 200 mg | Oral | Comtan | NV | MP NP | C2067 | | 200 | 4 | |\n| Entecavir | Tablet containing entecavir monohydrate 0.5 mg | Oral | Baraclude | BQ | MP See Note 1 | C3959 C3960 C3961 C3962 | | 60 | 5 | D |\n| | Tablet containing entecavir monohydrate 1 mg | Oral | Baraclude | BQ | MP See Note 1 | C3963 C3964 C3965 C3966 | | 60 | 5 | D |\n| Epirubicin
| Solution for injection containing epirubicin hydrochloride 10 mg in 5 mL | Injection/ intravesical | Epiccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Actavis 10 | TA | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection containing epirubicin hydrochloride 20 mg in 10 mL | Injection/ intravesical | Epiccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Actavis 20 | TA | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/ intravesical | Epiccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Actavis 50 | TA | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Kabi | PK | MP | | | See Note 3 | See Note 3 | D |\n| | | | Pharmorubicin Solution | PF | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/ intravesical | Epirubicin Actavis 100 | TA | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/ intravesical | DBL Epirubicin Hydrochloride Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epiccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Actavis 200 | TA | MP | | | See Note 3 | See Note 3 | D |\n| | | | Epirubicin Kabi | PK | MP | | | See Note 3 | See Note 3 | D |\n| Eplerenone | Tablet 25 mg | Oral | Inspra | PF | MP NP | C2637 | | 30 | 5 | |\n| | Tablet 50 mg | Oral | Inspra | PF | MP NP | C2637 | | 30 | 5 | |\n| Epoetin Alfa | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 1000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 2,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 2000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | Eprex 3000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 4,000 units in 0.4 mL pre-filled syringe | Injection | Eprex 4000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 5,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 5000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 6,000 units in 0.6 mL pre-filled syringe | Injection | Eprex 6000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 8,000 units in 0.8 mL pre-filled syringe | Injection | Eprex 8000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 10,000 units in 1 mL pre-filled syringe | Injection | Eprex 10000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 20,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 20,000 | JC | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 40,000 units in 1 mL pre-filled syringe | Injection | Eprex 40,000 | JC | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| Epoetin Beta | Injection 2,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 4,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 5,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 6,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 10,000 units in 0.6 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 20,000 units in 0.6 mL pre-filled syringe | Injection | NeoRecormon | RO | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| Epoetin Lambda | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 2,000 units in 1 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 4,000 units in 0.4 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 5,000 units in 0.5 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 6,000 units in 0.6 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 8,000 units in 0.8 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| | Injection 10,000 units in 1 mL pre-filled syringe | Injection | Novicrit | NV | MP See Note 1 | C1957 C3334 | | 12 | 5 | D |\n| Epoprostenol | Powder for I.V. infusion, 500 micrograms (as sodium) infusion administration set | Injection | Flolan Kit | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion, 1.5 mg (as sodium) infusion administration set | Injection | Flolan Kit | GK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Eprosartan | Tablet 400 mg (as mesylate) | Oral | Teveten | AB | MP NP | | | 56 | 5 | |\n| | Tablet 600 mg (as mesylate) | Oral | Teveten | AB | MP NP | | | 28 | 5 | |\n| Eprosartan with Hydrochlorothiazide | Tablet 600 mg eprosartan (as mesylate) with 12.5 mg hydrochlorothiazide | Oral | Teveten Plus 600/12.5 | AB | MP NP | C3307 | | 28 | 5 | |\n| Eptifibatide | Solution for I.V. injection 20 mg (as acetate) in 10 mL | Injection | Integrilin | MK | MP | C1884 | | 2 | 0 | |\n| | Solution for I.V. infusion 75 mg (as acetate) in 100 mL | Injection | Integrilin | MK | MP | C1884 | | 3 | 0 | |\n| Erlotinib | Tablet 25 mg (as hydrochloride) | Oral | Tarceva | RO | MP | C2971 C2972 | | 30 | 3 | |\n| | Tablet 100 mg (as hydrochloride) | Oral | Tarceva | RO | MP | C2971 C2972 | | 30 | 3 | |\n| | Tablet 150 mg (as hydrochloride) | Oral | Tarceva | RO | MP | C2971 C2972 | | 30 | 3 | |\n| Erythromycin | Tablet 400 mg (as ethyl succinate) | Oral | E.E.S. 400 Filmtab | LM | PDP | | | 25 | 0 | |\n| | | | E-Mycin | AF | PDP | | | 25 | 0 | |\n| | | | E.E.S. 400 Filmtab | LM | MP NP | | | 25 | 1 | |\n| | | | E-Mycin | AF | MP NP | | | 25 | 1 | |\n| | Capsule 250 mg (containing enteric coated pellets) | Oral | Eryc | YN | PDP | | | 25 | 0 | |\n| | | | Mayne Pharma Erythromycin | YT | PDP | | | 25 | 0 | |\n| | | | Eryc | YN | MP NP | | | 25 | 1 | |\n| | | | Mayne Pharma Erythromycin | YT | MP NP | | | 25 | 1 | |\n| | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E.E.S. 200 | LM | PDP | | | 1 | 0 | |\n| | | | E-Mycin 200 | AF | PDP | | | 1 | 0 | |\n| | | | E.E.S. 200 | LM | MP NP | | | 1 | 1 | |\n| | | | E-Mycin 200 | AF | MP NP | | | 1 | 1 | |\n| | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E.E.S. Granules | LM | PDP | | | 1 | 0 | |\n| | | | E-Mycin 400 | AF | PDP | | | 1 | 0 | |\n| | | | E.E.S. Granules | LM | MP NP | | | 1 | 1 | |\n| | | | E-Mycin 400 | AF | MP NP | | | 1 | 1 | |\n| | Powder for I.V. infusion 1 g (as lactobionate) | Injection | Erythrocin-I.V. | LM | MP NP PDP | | | 5 | 0 | |\n| Escitalopram | Tablet 10 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Chem mart Escitalopram | CH | MP NP | C1211 | | 28 | 5 | |\n| | | | Escicor 10 | MI | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram-DRLA | RZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram GA | GN | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram generichealth | GQ | MP NP | C1211 | | 28 | 5 | |\n| | | | Esipram | GM | MP NP | C1211 C2964 C2965 C2966 C2967 C2968 C2969 | | 28 | 5 | |\n| | | | Esitalo | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Lexam 10 | QA | MP NP | C1211 | | 28 | 5 | |\n| | | | Lexapro | LU | MP NP | C1211 C2964 C2965 C2966 C2967 C2968 C2969 | | 28 | 5 | |\n| | | | LoxaLate | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Pharmacor Escitalopram 10 | CR | MP NP | C1211 | | 28 | 5 | |\n| | | | Terry White Chemists Escitalopram | TW | MP NP | C1211 | | 28 | 5 | |\n| | Tablet 20 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Chem mart Escitalopram | CH | MP NP | C1211 | | 28 | 5 | |\n| | | | Escicor 20 | MI | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram-DRLA | RZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram GA | GN | MP NP | C1211 | | 28 | 5 | |\n| | | | Escitalopram generichealth | GQ | MP NP | C1211 | | 28 | 5 | |\n| | | | Esipram | GM | MP NP | C1211 C2964 C2965 C2966 C2967 C2968 C2969 | | 28 | 5 | |\n| | | | Esitalo | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Lexam 20 | QA | MP NP | C1211 | | 28 | 5 | |\n| | | | Lexapro | LU | MP NP | C1211 C2964 C2965 C2966 C2967 C2968 C2969 | | 28 | 5 | |\n| | | | LoxaLate | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Pharmacor Escitalopram 20 | CR | MP NP | C1211 | | 28 | 5 | |\n| | | | Terry White Chemists Escitalopram | TW | MP NP | C1211 | | 28 | 5 | |\n| | Oral solution 10 mg (as oxalate) per mL, 28 mL | Oral | Lexapro | LU | MP NP | C1211 C2964 C2965 C2967 C2968 C3092 C3093 | | 1 | 5 | |\n| Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral | Nexium | AP | MP NP | C1337 C1629 C2273 C3429 | P2273 | 30 | 1 | |\n| | | | | | MP NP | C1337 C1629 C2273 C3429 | P1337 P1629 P3429 | 30 | 5 | |\n| | Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral | Nexium | AP | MP NP | C1337 C1628 C3429 | P1628 | 30 | 1 | |\n| | | | | | MP NP | C1337 C1628 C3429 | P1337 P3429 | 30 | 5 | |\n| Esomeprazole and Clarithromycin and Amoxycillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin 500 mg (as trihydrate) | Oral | Nexium Hp7 | AP | MP NP | C1096 | | 1 | 0 | |\n| Essential amino acids formula | Oral powder 200 g (Essential Amino Acid Mix) | Oral | Essential Amino Acid Mix | SB | MP NP | C1147 C1458 | | 6 | 5 | |\n| Essential amino acids formula with minerals and vitamin C | Oral powder 400 g (Dialamine) | Oral | Dialamine | SB | MP NP | C1147 C1458 | | 5 | 5 | |\n| Essential amino acids formula with vitamins and minerals | Sachets containing oral powder 12.5 g, 50 (EAA Supplement) | Oral | EAA Supplement | VF | MP NP | C1147 C1458 | | 4 | 5 | |\n| Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | C |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3273 P3275 P3489 P3510 P3524 P3708 P3770 P3772 P3774 P3776 P3778 P3779 P4057 P4058 P4059 P4060 | 2 | 3 | |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3771 P3773 P3775 P3777 P3780 P3781 | 2 | 5 | |\n| | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | C |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3273 P3275 P3489 P3510 P3524 P3708 P3770 P3772 P3774 P3776 P3778 P3779 P4057 P4058 P4059 P4060 | 1 | 3 | |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3771 P3773 P3775 P3777 P3780 P3781 | 1 | 5 | |\n| | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | C |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3273 P3275 P3489 P3510 P3524 P3708 P3770 P3772 P3774 P3776 P3778 P3779 P4057 P4058 P4059 P4060 | 1 | 3 | |\n| | | | | | MP | C3273 C3275 C3489 C3510 C3524 C3708 C3770 C3771 C3772 C3773 C3774 C3775 C3776 C3777 C3778 C3779 C3780 C3781 C4057 C4058 C4059 C4060 | P3771 P3773 P3775 P3777 P3780 P3781 | 1 | 5 | |\n| Ethacrynic Acid | Tablet 25 mg | Oral | Edecrin | FK | MP NP | C1261 | | 200 | 1 | |\n| Ethosuximide | Capsule 250 mg | Oral | Zarontin | PF | MP NP | | | 200 | 2 | |\n| | Oral solution 250 mg per 5 mL, 200 mL | Oral | Zarontin | PF | MP NP | | | 1 | 5 | |\n| Etonogestrel | Subcutaneous implant 68 mg | Implantation | Implanon NXT | MK | MP NP MW | | | 1 | 0 | |\n| Etoposide | Capsule 50 mg | Oral | Vepesid | BQ | MP | | | 20 | 0 | |\n| | Capsule 100 mg | Oral | Vepesid | BQ | MP | | | 10 | 0 | |\n| | Solution for I.V. infusion 100 mg in 5 mL vial | Injection | Etoposide Ebewe | SZ | MP | | | See Note 3 | See Note 3 | PB |\n| | | | Hospira Pty Limited | HH | MP | | | See Note 3 | See Note 3 | PB |\n| | Powder for I.V. infusion 100 mg (as phosphate) | Injection | Etopophos | BQ | MP | | | See Note 3 | See Note 3 | PB |\n| | Powder for I.V. infusion 1 g (as phosphate) | Injection | Etopophos | BQ | MP | | | See Note 3 | See Note 3 | PB |\n| Etravirine | Tablet 200 mg | Oral | Intelence | JC | MP See Note 1 | C3596 C3597 | | 120 | 5 | D |\n| Everolimus | Tablet 0.25 mg | Oral | Certican | NV | MP | C2133 C2134 | | 60 | 3 | |\n| | | | | | MP See Note 1 | C1650 C1651 C3355 C3356 | | 120 | 5 | C |\n| | Tablet 0.5 mg | Oral | Certican | NV | MP | C2133 C2134 | | 60 | 3 | |\n| | | | | | MP See Note 1 | C1650 C1651 C3355 C3356 | | 120 | 5 | C |\n| | Tablet 0.75 mg | Oral | Certican | NV | MP | C2133 C2134 | | 120 | 3 | |\n| | | | | | MP See Note 1 | C1650 C1651 C3355 C3356 | | 240 | 5 | C |\n| | Tablet 1 mg | Oral | Certican | NV | MP | C2133 C2134 | | 120 | 3 | |\n| | | | | | MP See Note 1 | C1650 C1651 C3355 C3356 | | 240 | 5 | C |\n| Exemestane | Tablet 25 mg | Oral | APO-Exemestane | TX | MP NP | C1541 C2457 | | 30 | 5 | |\n| | | | Aromasin | PF | MP NP | C1541 C2457 | | 30 | 5 | |\n| | | | Exaccord | RA | MP NP | C1541 C2457 | | 30 | 5 | |\n| | | | Exemestane Pfizer | FZ | MP NP | C1541 C2457 | | 30 | 5 | |\n| | | | Exemestane Sandoz | SZ | MP NP | C1541 C2457 | | 30 | 5 | |\n| Exenatide | Injection solution 5 micrograms per dose in pre-filled pen, 60 doses | Injection | Byetta 5 microgram | LY | MP NP | C3540 C3542 | | 1 | 5 | |\n| | Injection solution 10 micrograms per dose in pre-filled pen, 60 doses | Injection | Byetta 10 microgram | LY | MP NP | C3540 C3542 | | 1 | 5 | |\n| Ezetimibe | Tablet 10 mg | Oral | Ezetrol | MK | MP NP | C1989 C1991 C2438 C3724 C3725 C3726 C3727 C3728 C3729 C3730 C3731 | | 30 | 5 | |\n| Ezetimibe with Simvastatin | Tablet 10 mg-10 mg | Oral | Vytorin | MK | MP NP | C2431 C3739 | | 30 | 5 | |\n| | Tablet 10 mg-20 mg | Oral | Vytorin | MK | MP NP | C2431 C3739 | | 30 | 5 | |\n| | Tablet 10 mg-40 mg | Oral | Vytorin | MK | MP NP | C2431 C3732 C3733 C3734 C3735 C3736 C3737 C3738 | | 30 | 5 | |\n| | Tablet 10 mg-80 mg | Oral | Vytorin | MK | MP NP | C2431 C3732 C3733 C3734 C3735 C3736 C3737 C3738 | | 30 | 5 | |\n| Famciclovir | Tablet 125 mg | Oral | APO-Famciclovir | TX | MP NP | C3624 | | 40 | 1 | |\n| | | | Ezovir | AF | MP NP | C3624 | | 40 | 1 | |\n| | | | Famvir | NV | MP NP | C3624 | | 40 | 1 | |\n| | | | Favic 125 | QA | MP NP | C3624 | | 40 | 1 | |\n| | Tablet 250 mg | Oral | APO-Famciclovir | TX | MP NP | C3622 C3623 C3624 | P3624 | 20 | 1 | |\n| | | | Ezovir | AF | MP NP | C3622 C3623 C3624 | P3624 | 20 | 1 | |\n| | | | Famciclovir Sandoz | SZ | MP NP | C3622 C3623 C3624 | P3624 | 20 | 1 | |\n| | | | Famvir | NV | MP NP | C3622 C3623 C3624 | P3624 | 20 | 1 | |\n| | | | Favic 250 | QA | MP NP | C3622 C3623 C3624 | P3624 | 20 | 1 | |\n| | | | APO-Famciclovir | TX | MP NP | C3622 C3623 C3624 | P3622 | 21 | 0 | |\n| | | | Ezovir | AF | MP NP | C3622 C3623 C3624 | P3622 | 21 | 0 | |\n| | | | Famciclovir Sandoz | SZ | MP NP | C3622 C3623 C3624 | P3622 | 21 | 0 | |\n| | | | Famvir | NV | MP NP | C3622 C3623 C3624 | P3622 | 21 | 0 | |\n| | | | Favic 250 | QA | MP NP | C3622 C3623 C3624 | P3622 | 21 | 0 | |\n| | | | APO-Famciclovir | TX | MP NP | C3622 C3623 C3624 | P3623 | 56 | 5 | |\n| | | | Ezovir | AF | MP NP | C3622 C3623 C3624 | P3623 | 56 | 5 | |\n| | | | Famciclovir Sandoz | SZ | MP NP | C3622 C3623 C3624 | P3623 | 56 | 5 | |\n| | | | Famvir | NV | MP NP | C3622 C3623 C3624 | P3623 | 56 | 5 | |\n| | | | Favic 250 | QA | MP NP | C3622 C3623 C3624 | P3623 | 56 | 5 | |\n| | Tablet 500 mg | Oral | APO-Famciclovir | TX | MP NP | C3625 C3626 C3627 C3628 C3629 | P3625 | 30 | 0 | |\n| | | | Chem mart Famciclovir | CH | MP NP | C3625 C3626 C3627 C3628 C3629 | P3625 | 30 | 0 | |\n| | | | Famvir | NV | MP NP | C3625 C3626 C3627 C3628 C3629 | P3625 | 30 | 0 | |\n| | | | Favic 500 | QA | MP NP | C3625 C3626 C3627 C3628 C3629 | P3625 | 30 | 0 | |\n| | | | Terry White Chemists Famciclovir | TW | MP NP | C3625 C3626 C3627 C3628 C3629 | P3625 | 30 | 0 | |\n| | | | APO-Famciclovir | TX | MP NP | C3625 C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| | | | Chem mart Famciclovir | CH | MP NP | C3625 C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| | | | Ezovir | AF | MP NP | C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| | | | Famvir | NV | MP NP | C3625 C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| | | | Favic 500 | QA | MP NP | C3625 C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| | | | Terry White Chemists Famciclovir | TW | MP NP | C3625 C3626 C3627 C3628 C3629 | P3626 P3627 P3628 P3629 | 56 | 5 | |\n| Famotidine | Tablet 20 mg | Oral | Ausfam 20 | QA | MP NP | | | 60 | 5 | |\n| | | | Chem mart Famotidine | CH | MP NP | | | 60 | 5 | |\n| | | | Famotidine-PS | FZ | MP NP | | | 60 | 5 | |\n| | | | Famotidine Sandoz | SZ | MP NP | | | 60 | 5 | |\n| | | | GenRx Famotidine | GX | MP NP | | | 60 | 5 | |\n| | | | Pamacid 20 | AF | MP NP | | | 60 | 5 | |\n| | | | Pepzan | GM | MP NP | | | 60 | 5 | |\n| | | | Terry White Chemists Famotidine | TW | MP NP | | | 60 | 5 | |\n| | Tablet 40 mg | Oral | Ausfam 40 | QA | MP NP | | | 30 | 5 | |\n| | | | Chem mart Famotidine | CH | MP NP | | | 30 | 5 | |\n| | | | Famotidine-PS | FZ | MP NP | | | 30 | 5 | |\n| | | | Famotidine Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | | | GenRx Famotidine | GX | MP NP | | | 30 | 5 | |\n| | | | Pamacid 40 | AF | MP NP | | | 30 | 5 | |\n| | | | Pepcidine | MK | MP NP | | | 30 | 5 | |\n| | | | Pepzan | GM | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Famotidine | TW | MP NP | | | 30 | 5 | |\n| Felodipine | Tablet 2.5 mg (extended release) | Oral | Felodur ER 2.5 mg | AL | MP NP | | | 30 | 5 | |\n| | Tablet 5 mg (extended release) | Oral | Felodil XR 5 | QA | MP NP | | | 30 | 5 | |\n| | | | Felodur ER 5 mg | AL | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg (extended release) | Oral | Felodil XR 10 | QA | MP NP | | | 30 | 5 | |\n| | | | Felodur ER 10 mg | AL | MP NP | | | 30 | 5 | |\n| Fenofibrate | Tablet 48 mg | Oral | Lipidil | AB | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | | | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | Tablet 145 mg | Oral | Lipidil | AB | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| Fentanyl | Lozenge 200 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Lozenge 400 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Lozenge 600 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Lozenge 800 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Lozenge 1200 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Lozenge 1600 micrograms (as citrate) | Buccal | Actiq | OA | MP NP | C3663 C3664 | P3663 | 9 | 0 | |\n| | Transdermal patch 1.28 mg | Transdermal | Denpax | AF | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 2.063 mg | Transdermal | Fenpatch 12 | ZP | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 2.1 mg | Transdermal | Durogesic 12 | JC | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 2.55 mg | Transdermal | Denpax | AF | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 4.125 mg | Transdermal | Fenpatch 25 | ZP | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 4.2 mg | Transdermal | Durogesic 25 | JC | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 5.10 mg | Transdermal | Denpax | AF | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 7.65 mg | Transdermal | Denpax | AF | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 8.25 mg | Transdermal | Fenpatch 50 | ZP | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 8.4 mg | Transdermal | Durogesic 50 | JC | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 10.20 mg | Transdermal | Denpax | AF | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 12.375 mg | Transdermal | Fenpatch 75 | ZP | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 12.6 mg | Transdermal | Durogesic 75 | JC | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 16.5 mg | Transdermal | Fenpatch 100 | ZP | MP NP | C1062 | | 5 | 0 | |\n| | Transdermal patch 16.8 mg | Transdermal | Durogesic 100 | JC | MP NP | C1062 | | 5 | 0 | |\n| Ferrous fumarate | Tablet 200 mg (equivalent to 67.5 mg iron) | Oral | Ferro-tab | AE | MP NP | | | 60 | 1 | |\n| Ferrous Fumarate with Folic Acid | Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms | Oral | Ferro-f-tab | AE | MP NP | | | 60 | 1 | |\n| Ferrous Sulfate | Oral liquid 30 mg per mL, 250 mL | Oral | Ferro-Liquid | AE | MP NP | | | 1 | 2 | |\n| Filgrastim | Injection 120 micrograms in 0.2 mL single use pre-filled syringe (Nivestim) | Injection | Nivestim | HH | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 300 micrograms in 1 mL | Injection | Neupogen | AN | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 300 micrograms in 0.5 mL single use pre-filled syringe (Neupogen) | Injection | Neupogen | AN | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 300 micrograms in 0.5 mL single use pre-filled syringe (Nivestim) | Injection | Nivestim | HH | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 300 micrograms in 0.5 mL single use pre-filled syringe (TevaGrastim) | Injection | TevaGrastim | AS | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 480 micrograms in 1.6 mL | Injection | Neupogen | AN | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 480 micrograms in 0.5 mL single use pre-filled syringe (Neupogen) | Injection | Neupogen | AN | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 480 micrograms in 0.5 mL single use pre-filled syringe (Nivestim) | Injection | Nivestim | HH | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| | Injection 480 micrograms in 0.8 mL single use pre-filled syringe (TevaGrastim) | Injection | TevaGrastim | AS | MP See Note 1 | C2912 C2913 C2914 C2915 C2916 C2917 C2918 C2919 C2920 C2921 C2922 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3358 C3359 C3360 C3361 C3362 C3363 C3364 C3365 C3366 C3367 C3368 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 20 | 11 | D |\n| Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Gilenya | NV | MP | C3845 C3846 | | 28 | 5 | |\n| Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | IA | MP NP | C1731 C1732 | | 60 | 5 | |\n| | Tablet containing flecainide acetate 100 mg | Oral | Flecatab | AF | MP NP | C1731 C1732 | | 60 | 5 | |\n| | | | Tambocor | IA | MP NP | C1731 C1732 | | 60 | 5 | |\n| Flucloxacillin | Capsule 250 mg (as sodium) | Oral | Flopen | AS | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | | | Staphylex 250 | AF | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | Capsule 500 mg (as sodium) | Oral | Flopen | AS | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | | | Staphylex 500 | AF | MP NP MW PDP | C1345 | | 24 | 0 | |\n| | Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL | Oral | Flucil | LN | MP NP PDP | C1345 | | 1 | 0 | |\n| | Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL | Oral | Flucil | LN | MP NP PDP | C1345 | | 1 | 0 | |\n| | Powder for injection 500 mg (as sodium) | Injection | Flubiclox | TS | MP NP PDP | | | 5 | 0 | |\n| | | | Flucil | AS | MP NP PDP | | | 5 | 0 | |\n| | Powder for injection 1 g (as sodium) | Injection | Flubiclox | TS | PDP | | | 5 | 0 | |\n| | | | Flucil | AS | PDP | | | 5 | 0 | |\n| | | | Hospira Pty Limited | HH | PDP | | | 5 | 0 | |\n| | | | Flubiclox | TS | MP NP | | | 5 | 1 | |\n| | | | Flucil | AS | MP NP | | | 5 | 1 | |\n| | | | Hospira Pty Limited | HH | MP NP | | | 5 | 1 | |\n| Fluconazole | Capsule 50 mg | Oral | Diflucan | PF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | | | Dizole 50 | AF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | Capsule 100 mg | Oral | Diflucan | PF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | | | Dizole 100 | AF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | Capsule 200 mg | Oral | APO-Fluconazole | TX | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | | | Diflucan | PF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | | | Dizole 200 | AF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | | | Fluzole 200 | QA | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 28 | 5 | |\n| | Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral | Diflucan | PF | MP NP | C3835 C3836 C3837 C3838 C3839 C3840 | | 1 | 0 | |\n| | Solution for I.V. infusion 100 mg in 50 mL | Injection | Diflucan | PF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole-Claris | AE | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole Hexal | HX | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole Sandoz | SZ | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | Solution for I.V. infusion 200 mg in 100 mL | Injection | Baxter Healthcare Pty Ltd | BX | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Diflucan | PF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole Alphapharm | AF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole-Claris | AE | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole Hexal | HX | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | | | Fluconazole Sandoz | SZ | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 7 | 0 | |\n| | Solution for I.V. infusion 400 mg in 200 mL | Injection | Baxter Healthcare Pty Ltd | BX | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 1 | 0 | |\n| | | | Fluconazole Alphapharm | AF | MP NP | C3613 C3614 C3615 C3616 C3617 C3618 | | 1 | 0 | |\n| Fludarabine | Tablet containing fludarabine phosphate 10 mg | Oral | Fludara | GZ | MP | C3015 | | 20 | 5 | |\n| | Powder for I.V. injection containing fludarabine phosphate 50 mg | Injection | Farine | WQ | MP | C3887 | | See Note 3 | See Note 3 | PB |\n| | | | Fludara | GZ | MP | C3887 | | See Note 3 | See Note 3 | PB |\n| | | | Fludarabine Actavis | TA | MP | C3887 | | See Note 3 | See Note 3 | PB |\n| | Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL | Injection | Fludarabine Ebewe | SZ | MP | C3887 | | See Note 3 | See Note 3 | PB |\n| Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral | Florinef | QA | MP NP | | | 200 | 1 | |\n| Fluorometholone | Eye drops 1 mg per mL, 5 mL | Application to the eye | Flucon | AQ | AO | | | 1 | 0 | |\n| | | | FML Liquifilm | AG | AO | | | 1 | 0 | |\n| | | | Flucon | AQ | MP NP | | | 1 | 5 | |\n| | | | FML Liquifilm | AG | MP NP | | | 1 | 5 | |\n| | Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL | Application to the eye | Flarex | AQ | AO | | | 1 | 0 | |\n| Fluorouracil | Injection 500 mg in 10 mL | Injection | Fluorouracil Ebewe | SZ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Hospira Pty Limited | HH | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1000 mg in 20 mL | Injection | DBL Fluorouracil Injection BP | HH | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Fluorouracil Ebewe | SZ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 2500 mg in 50 mL | Injection | DBL Fluorouracil Injection BP | HH | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Fluorouracil Ebewe | SZ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | SZ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Fluoxetine | Tablet, dispersible, 20 mg (as hydrochloride) | Oral | Lovan 20 Tab | AL | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Prozac Tab | LY | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Zactin Tablet | AF | MP NP | C1211 C1241 | | 28 | 5 | |\n| | Capsule 20 mg (as hydrochloride) | Oral | Auscap | QA | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Chem mart Fluoxetine | CH | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine 20 | CR | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine-GA | GM | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine generichealth | GQ | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine-PS | FZ | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine RBX | RA | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Fluoxetine Sandoz | SZ | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | GenRx Fluoxetine | GX | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Lovan | AL | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Prozac 20 | LY | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Terry White Chemists Fluoxetine | TW | MP NP | C1211 C1241 | | 28 | 5 | |\n| | | | Zactin | AF | MP NP | C1211 C1241 | | 28 | 5 | |\n| Flupenthixol Decanoate | Oily I.M. injection 20 mg in 1 mL | Injection | Fluanxol Depot | LU | MP NP | | | 5 | 0 | |\n| | Oily I.M. injection 100 mg in 1 mL ampoule | Injection | Fluanxol Concentrated Depot | LU | MP NP | | | 5 | 0 | |\n| Fluphenazine Decanoate | Injection 12.5 mg in 0.5 mL ampoule | Injection | Modecate | BQ | MP NP | | | 5 | 0 | |\n| | Injection 25 mg in 1 mL ampoule | Injection | Modecate | BQ | MP NP | | | 5 | 0 | |\n| | Injection 50 mg in 2 mL ampoule | Injection | Modecate | BQ | MP NP | | | 5 | 0 | |\n| Flurbiprofen | Eye drops containing flurbiprofen sodium 300 micrograms per mL, single dose units 0.4 mL, 5 | Application to the eye | Ocufen | AG | AO MP NP | | | 1 | 0 | |\n| Flutamide | Tablet 250 mg | Oral | Eulexin | MK | MP NP | C3674 | | 100 | 5 | |\n| | | | Flutamin | AF | MP NP | C3674 | | 100 | 5 | |\n| Fluticasone | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide Junior | GK | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide | GK | MP NP | | | 1 | 5 | |\n| | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide | GK | MP NP | | | 1 | 1 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Junior Accuhaler | GK | MP NP | | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Accuhaler | GK | MP NP | | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Accuhaler | GK | MP NP | | | 1 | 1 | |\n| Fluticasone with Salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 50/25 | GK | MP NP | C1758 C1759 | | 1 | 5 | |\n| | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 125/25 | GK | MP NP | C1758 C1759 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 100/50 | GK | MP NP | C1758 C1759 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 250/50 | GK | MP NP | C1758 C1759 | | 1 | 5 | |\n| | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 250/25 | GK | MP NP | C1758 C1759 C2680 | | 1 | 5 | |\n| | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 500/50 | GK | MP NP | C1758 C1759 C2680 | | 1 | 5 | |\n| Fluvastatin | Capsule 20 mg (as sodium) | Oral | Lescol | NV | MP | C1540 C3047 | P1540 | 28 | 5 | |\n| | | | Vastin | NM | MP | C1540 C3047 | P1540 | 28 | 5 | |\n| | | | Lescol | NV | MP | C1540 C3047 | P3047 | 28 | 11 | |\n| | | | Vastin | NM | MP | C1540 C3047 | P3047 | 28 | 11 | |\n| | Capsule 40 mg (as sodium) | Oral | Lescol | NV | MP | C1540 C3047 | P1540 | 28 | 5 | |\n| | | | Vastin | NM | MP | C1540 C3047 | P1540 | 28 | 5 | |\n| | | | Lescol | NV | MP | C1540 C3047 | P3047 | 28 | 11 | |\n| | | | Vastin | NM | MP | C1540 C3047 | P3047 | 28 | 11 | |\n| | Tablet (prolonged release) 80 mg (as sodium) | Oral | Lescol XL | NV | MP | C1540 C3047 | P1540 | 28 | 5 | |\n| | | | | | MP | C1540 C3047 | P3047 | 28 | 11 | |\n| Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | APO-Fluvoxamine | TX | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Faverin 50 | QA | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Fluvoxamine GA | GM | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Luvox | AB | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Movox 50 | AL | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Voxam | SZ | MP NP | C1211 C1241 | | 30 | 5 | |\n| | Tablet containing fluvoxamine maleate 100 mg | Oral | APO-Fluvoxamine | TX | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Faverin 100 | QA | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Fluvoxamine GA | GM | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Luvox | AB | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Movox 100 | AF | MP NP | C1211 C1241 | | 30 | 5 | |\n| | | | Voxam | SZ | MP NP | C1211 C1241 | | 30 | 5 | |\n| Folic Acid | Tablet 500 micrograms | Oral | Megafol 0.5 | AF | MP NP | | | 200 | 0 | |\n| | Tablet 5 mg | Oral | Megafol 5 | AF | MP NP | | | 200 | 1 | |\n| Folinic acid | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral | Leucovorin Calcium (Hospira Pty Limited) | HH | MP See Note 1 | C1028 | | 10 | 0 | |\n| | Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection | Calcium Folinate Ebewe | SZ | MP See Note 1 | | | 5 | 5 | |\n| | | | Leucovorin Calcium (Hospira Pty Limited) | HH | MP See Note 1 | | | 5 | 5 | |\n| | | | Leucovorin Calcium (Pfizer Australia Pty Ltd) | PF | MP See Note 1 | | | 5 | 5 | |\n| | Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL | Injection | Calcium Folinate Ebewe | SZ | MP See Note 1 | | | 10 | 1 | |\n| | | | Leucovorin Calcium (Pfizer Australia Pty Ltd) | PF | MP See Note 1 | | | 10 | 1 | |\n| | Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL | Injection | Calcium Folinate Ebewe | SZ | MP See Note 1 | | | 4 | 1 | |\n| | | | Leucovorin Calcium (Hospira Pty Limited) | HH | MP See Note 1 | | | 4 | 1 | |\n| | Injection containing calcium folinate equivalent to 1000 mg folinic acid in 100 mL | Injection | Calcium Folinate Ebewe | SZ | MP | | | 1 | 1 | |\n| Follitropin Alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP See Note 1 | C1119 C1878 See Note 2 | | 3 See Note 2 | 5 See Note 2 | |\n| | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP See Note 1 | C1119 C1878 See Note 2 | | 3 See Note 2 | 5 See Note 2 | |\n| | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP See Note 1 | C1119 C1878 See Note 2 | | 2 See Note 2 | 5 See Note 2 | |\n| Follitropin Beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Puregon 300 IU/0.36 mL | MK | MP See Note 1 | C1119 C1878 See Note 2 | See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| | Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection | Puregon 600 IU/0.72 mL | MK | MP See Note 1 | C1119 C1878 See Note 2 | See Note 2 | 2 See Note 2 | 5 See Note 2 | |\n| | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Puregon 900 IU/1.08 mL | MK | MP See Note 1 | C1119 C1878 See Note 2 | See Note 2 | 2 See Note 2 | 5 See Note 2 | |\n| Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre-filled syringe | Injection | Arixtra | GK | MP NP | C2005 C2006 | | 7 | 0 | |\n| Fosamprenavir | Tablet 700 mg (as calcium) | Oral | Telzir | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Oral liquid 50 mg (as calcium) per mL, 225 mL | Oral | Telzir | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 8 | 5 | D |\n| Foscarnet | I.V. infusion containing foscarnet sodium 24 mg per mL, 250 mL | Injection | Foscavir | IX | MP See Note 1 | C1413 C1610 C3322 C3378 | | 6 | 1 | D |\n| Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral | Fosipril 10 | QA | MP NP | | | 30 | 5 | |\n| | | | GenRx Fosinopril | GX | MP NP | | | 30 | 5 | |\n| | | | Monace 10 | AF | MP NP | | | 30 | 5 | |\n| | | | Monopril | BQ | MP NP | | | 30 | 5 | |\n| | Tablet containing fosinopril sodium 20 mg | Oral | Fosipril 20 | QA | MP NP | | | 30 | 5 | |\n| | | | GenRx Fosinopril | GX | MP NP | | | 30 | 5 | |\n| | | | Monace 20 | AF | MP NP | | | 30 | 5 | |\n| | | | Monopril | BQ | MP NP | | | 30 | 5 | |\n| Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg | Oral | APO-Fosinopril HCTZ 10/12.5 | TX | MP NP | C3307 | | 30 | 5 | |\n| | | | Fosinopril/HCTZ-GA 10/12.5 | GM | MP NP | C3307 | | 30 | 5 | |\n| | | | Hyforil | RA | MP NP | C3307 | | 30 | 5 | |\n| | | | Monoplus 10/12.5 | BQ | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral | APO-Fosinopril HCTZ 20/12.5 | TX | MP NP | C3307 | | 30 | 5 | |\n| | | | Fosetic 20/12.5 | ZP | MP NP | C3307 | | 30 | 5 | |\n| | | | Fosinopril/HCTZ-GA 20/12.5 | GM | MP NP | C3307 | | 30 | 5 | |\n| | | | Hyforil | RA | MP NP | C3307 | | 30 | 5 | |\n| | | | Monoplus 20/12.5 | BQ | MP NP | C3307 | | 30 | 5 | |\n| Fotemustine | Powder for injection 208 mg with solvent | Injection | Muphoran | SE | MP | C3181 | | See Note 3 | See Note 3 | D |\n| Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear | Soframycin | SW | MP NP MW AO | | | 1 | 2 | |\n| Frusemide | Tablet 20 mg | Oral | Chem mart Frusemide | CH | MP NP | | | 100 | 1 | |\n| | | | Frusemide-PS | FZ | MP NP | | | 100 | 1 | |\n| | | | Frusid | GM | MP NP | | | 100 | 1 | |\n| | | | GenRx Frusemide | GX | MP NP | | | 100 | 1 | |\n| | | | Lasix-M | SW | MP NP | | | 100 | 1 | |\n| | | | Terry White Chemists Frusemide | TW | MP NP | | | 100 | 1 | |\n| | | | Urex-M | FM | MP NP | | | 100 | 1 | |\n| | Tablet 40 mg | Oral | Chem mart Frusemide | CH | MP NP | | | 100 | 1 | |\n| | | | Frusax | GN | MP NP | | | 100 | 1 | |\n| | | | Frusemide-PS | FZ | MP NP | | | 100 | 1 | |\n| | | | Frusemide Sandoz | SZ | MP NP | | | 100 | 1 | |\n| | | | Frusid | GM | MP NP | | | 100 | 1 | |\n| | | | GenRx Frusemide | GX | MP NP | | | 100 | 1 | |\n| | | | Lasix | SW | MP NP | | | 100 | 1 | |\n| | | | Terry White Chemists Frusemide | TW | MP NP | | | 100 | 1 | |\n| | | | Uremide | AF | MP NP | | | 100 | 1 | |\n| | | | Urex | FM | MP NP | | | 100 | 1 | |\n| | Tablet 500 mg | Oral | Urex-Forte | FM | MP NP | | | 50 | 3 | |\n| | Oral solution 10 mg per mL, 30 mL | Oral | Lasix | SW | MP NP | | | 1 | 3 | |\n| | Injection 20 mg in 2 mL | Injection | Frusemide Sandoz | SZ | MP NP | | | 5 | 0 | |\n| | | | Frusemide-Claris | AE | MP NP | | | 5 | 0 | |\n| | | | Lasix | SW | MP NP | | | 5 | 0 | |\n| Fusidic Acid | Tablet containing sodium fusidate 250 mg | Oral | Fucidin | CS | MP | C1130 | | 36 | 1 | |\n| Gabapentin | Capsule 100 mg | Oral | APO-Gabapentin | TX | MP NP | C2664 | | 100 | 5 | |\n| | | | DBL Gabapentin | HH | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabatine 100 | QA | MP NP | C2664 | | 100 | 5 | |\n| | | | Nupentin 100 | AF | MP NP | C2664 | | 100 | 5 | |\n| | Capsule 300 mg | Oral | DBL Gabapentin | HH | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabapentin 300 | CR | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabapentin-GA | GM | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabapentin Sandoz | SZ | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabatine 300 | QA | MP NP | C2664 | | 100 | 5 | |\n| | | | Nupentin 300 | AF | MP NP | C2664 | | 100 | 5 | |\n| | Capsule 400 mg | Oral | DBL Gabapentin | HH | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabapentin 400 | CR | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabapentin Sandoz | SZ | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabatine 400 | QA | MP NP | C2664 | | 100 | 5 | |\n| | | | Nupentin 400 | AF | MP NP | C2664 | | 100 | 5 | |\n| | Tablet 600 mg | Oral | Gabaran | RA | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabatine 600 | QA | MP NP | C2664 | | 100 | 5 | |\n| | | | Nupentin Tabs | AF | MP NP | C2664 | | 100 | 5 | |\n| | | | Pharmacor Gabapentin 600 | CR | MP NP | C2664 | | 100 | 5 | |\n| | Tablet 800 mg | Oral | Gabaran | RA | MP NP | C2664 | | 100 | 5 | |\n| | | | Gabatine 800 | QA | MP NP | C2664 | | 100 | 5 | |\n| | | | Nupentin Tabs | AF | MP NP | C2664 | | 100 | 5 | |\n| | | | Pharmacor Gabapentin 800 | CR | MP NP | C2664 | | 100 | 5 | |\n| Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C2934 C2938 C3875 C3876 | | 28 | 5 | |\n| | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C2934 C2938 C3875 C3876 | | 28 | 5 | |\n| | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C2934 C2938 C3875 C3876 | | 28 | 5 | |\n| Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | Cymevene | RO | MP See Note 1 | C1612 C1830 C1831 C3379 C3380 C3381 | | 10 | 1 | D |\n| | Intravitreal implant 4.5 mg | Implantation | Vitrasert | BU | MP See Note 1 | C1612 C3379 | | 1 | 0 | D |\n| Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | Orgalutran | MK | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Gefitinib | Tablet 250 mg | Oral | Iressa | AP | MP | C4029 C4030 | | 30 | 3 | |\n| Gelatin - Succinylated | I.V. infusion 20 g per 500 mL, 500 mL | Injection | Gelofusine | BR | MP NP | | | 3 | 0 | |\n| Gemcitabine | Solution for injection 200 mg (as hydrochloride) in 5.3 mL | Injection | DBL Gemcitabine Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | DBL Gemcitabine for Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemaccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Actavis | TA | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Sun | ZF | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcite | ZP | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemplan | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemzar | LY | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection 1 g (as hydrochloride) in 26.3 mL | Injection | DBL Gemcitabine Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | DBL Gemcitabine for Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemaccord | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Actavis | TA | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcitabine Sun | ZF | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemcite | ZP | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemplan | WQ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Gemzar | LY | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 1000 mg (as hydrochloride) in 100 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution for injection 2 g (as hydrochloride) in 52.6 mL | Injection | DBL Gemcitabine Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 2 g (as hydrochloride) | Injection | DBL Gemcitabine for Injection | HH | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 5 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 1 g (as hydrochloride) in 25 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 2 g (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| Gemfibrozil | Tablet 600 mg | Oral | Ausgem | QA | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Chem mart Gemfibrozil | CH | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Gemhexal | SZ | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | GenRx Gemfibrozil | GX | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Jezil | GN | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Lipazil 600 mg | GM | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Lipigem | AF | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Lopid | PF | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Pharmacor Gemfibrozil 600 | CR | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Terry White Chemists Gemfibrozil | TW | MP | C1540 C3047 | P1540 | 60 | 5 | |\n| | | | Ausgem | QA | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Chem mart Gemfibrozil | CH | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Gemhexal | SZ | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | GenRx Gemfibrozil | GX | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Jezil | GN | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Lipazil 600 mg | GM | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Lipigem | AF | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Lopid | PF | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Pharmacor Gemfibrozil 600 | CR | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| | | | Terry White Chemists Gemfibrozil | TW | MP | C1540 C3047 | P3047 | 60 | 11 | |\n| Gentamicin | Injection 80 mg (as sulfate) in 2 mL | Injection | Pfizer Australia Pty Ltd | PF | MP NP | | | 10 | 1 | |\n| | Eye drops 3 mg (as sulfate) per mL, 5 mL | Application to the eye | Genoptic | AG | MP | C1188 C1391 C1714 | | 1 | 2 | |\n| | | | | | AO | C1391 C1714 | | 1 | 2 | |\n| Gestrinone | Capsule 2.5 mg | Oral | Dimetriose | SW | MP | C3652 | | 8 | 5 | |\n| Glatiramer | Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe | Injection | Copaxone | CS | MP | C1175 C1751 | | 28 | 5 | |\n| Glibenclamide | Tablet 5 mg | Oral | Daonil | SW | MP NP | | | 100 | 5 | |\n| | | | Glimel | AF | MP NP | | | 100 | 5 | |\n| Gliclazide | Tablet 30 mg (modified release) | Oral | APO-Gliclazide MR | TX | MP NP | | | 100 | 5 | |\n| | | | Chem mart Gliclazide MR | CH | MP NP | | | 100 | 5 | |\n| | | | Glyade MR | AF | MP NP | | | 100 | 5 | |\n| | | | Oziclide MR | RA | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Gliclazide MR | TW | MP NP | | | 100 | 5 | |\n| | Tablet 60 mg (modified release) | Oral | Diamicron 60mg MR | SE | MP NP | | | 60 | 5 | |\n| | Tablet 80 mg | Oral | Chem mart Gliclazide | CH | MP NP | | | 100 | 5 | |\n| | | | GenRx Gliclazide | GX | MP NP | | | 100 | 5 | |\n| | | | Glyade | AF | MP NP | | | 100 | 5 | |\n| | | | Nidem | QA | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Gliclazide | TW | MP NP | | | 100 | 5 | |\n| Glimepiride | Tablet 1 mg | Oral | Amaryl | SW | MP NP | | | 30 | 5 | |\n| | | | Aylide 1 | AF | MP NP | | | 30 | 5 | |\n| | | | Diapride 1 | QA | MP NP | | | 30 | 5 | |\n| | | | Glimepiride GA 1 | GM | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Glimepiride 1 | CR | MP NP | | | 30 | 5 | |\n| | Tablet 2 mg | Oral | Amaryl | SW | MP NP | | | 30 | 5 | |\n| | | | Aylide 2 | AF | MP NP | | | 30 | 5 | |\n| | | | Diapride 2 | QA | MP NP | | | 30 | 5 | |\n| | | | Glimepiride GA 2 | GM | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Glimepiride 2 | CR | MP NP | | | 30 | 5 | |\n| | Tablet 3 mg | Oral | Amaryl | SW | MP NP | | | 30 | 5 | |\n| | | | Aylide 3 | AF | MP NP | | | 30 | 5 | |\n| | | | Diapride 3 | QA | MP NP | | | 30 | 5 | |\n| | | | Glimepiride GA 3 | GM | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Glimepiride 3 | CR | MP NP | | | 30 | 5 | |\n| | Tablet 4 mg | Oral | Amaryl | SW | MP NP | | | 30 | 5 | |\n| | | | Aylide 4 | AF | MP NP | | | 30 | 5 | |\n| | | | Diapride 4 | QA | MP NP | | | 30 | 5 | |\n| | | | Glimepiride GA 4 | GM | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Glimepiride 4 | CR | MP NP | | | 30 | 5 | |\n| Glipizide | Tablet 5 mg | Oral | Melizide | AF | MP NP | | | 100 | 5 | |\n| | | | Minidiab | PF | MP NP | | | 100 | 5 | |\n| Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | GlucaGen Hypokit | NO | PDP | | | 1 | 0 | |\n| | | | GlucaGen Hypokit | NO | MP NP | | | 1 | 1 | |\n| Glucose | I.V. infusion 69.5 mmol (anhydrous) per 250 mL, 250 mL | Injection | B. Braun Australia Pty Ltd | BR | MP NP | | | 5 | 1 | |\n| | | | Glucose 5% Freeflex | PK | MP NP | | | 5 | 1 | |\n| | I.V. infusion 278 mmol (anhydrous) per L, 1 L | Injection | B. Braun Australia Pty Ltd | BR | PDP | | | 5 | 0 | |\n| | | | Baxter Healthcare Pty Ltd | BX | PDP | | | 5 | 0 | |\n| | I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL | Injection | B. Braun Australia Pty Ltd | BR | PDP | | | 5 | 0 | |\n| | I.V. infusion 278 mmol (anhydrous) per 500 mL, 500 mL | Injection | Fresenius Kabi Australia Pty Limited | PK | MP NP | | | 5 | 1 | |\n| Glucose and Ketone Indicator—Urine | Test strips, 50 (Keto-Diabur-Test 5000) | For external use | Keto-Diabur- Test 5000 | RD | MP NP | | | 2 | 2 | |\n| | Test strips, 50 (Keto-Diastix) | For external use | Keto-Diastix | BN | MP NP | | | 2 | 2 | |\n| Glucose Indicator—Blood | Test strips, 50 (Accu-Chek Aviva) | For external use | Accu-Chek Aviva | RD | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Accu-Chek Go) | For external use | Accu-Chek Go | RD | MP NP | | | 2 | 5 | |\n| | Test strips, 51 (Accu-Chek Integra) | For external use | Accu-Chek Integra | RD | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (AgaMatrix Jazz) | For external use | AgaMatrix Jazz | HE | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Betachek) | For external use | Betachek | NA | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Betachek G5) | For external use | Betachek G5 | NA | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Bionime Rightest) | For external use | Bionime Rightest | QB | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (CareSens) | For external use | CareSens | LB | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (CareSens N) | For external use | CareSens N | LB | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Glucocard 01 Sensor) | For external use | Glucocard 01 Sensor | OZ | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Glucoflex-R) | For external use | Glucoflex-R | NA | MP NP | | | 2 | 5 | |\n| | | | | NA | MP | | P3035 | 2 | 11 | |\n| | Test strips, 50 (GlucoOz) | For external use | GlucoOz | OZ | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Lifeline Attest) | For external use | Lifeline Attest | OI | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (MyGlucoHealth) | For external use | MyGlucoHealth | EH | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Omnitest EZ) | For external use | Omnitest EZ | BR | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (OneTouch Verio) | For external use | OneTouch Verio | JJ | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (Optium Omega) | For external use | Optium Omega | MS | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (SensoCard) | For external use | SensoCard | PX | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (TRUEbalance) | For external use | TRUEbalance | NX | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (TRUEresult) | For external use | TRUEresult | NX | MP NP | | | 2 | 5 | |\n| | Test strips, 50 (TrueTrack) | For external use | TrueTrack | NX | MP NP | | | 2 | 5 | |\n| | Test strips, 100 (Accu-Chek Active) | For external use | Accu-Chek Active | RD | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (Accu-Chek Advantage/Sensor Comfort) | For external use | Accu-Chek Advantage/Sensor Comfort | RD | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (Accu-Chek Mobile) | For external use | Accu-Chek Mobile | RD | MP | C3552 C3553 | P3552 | 1 | 5 | |\n| | | | | | NP | C3552 | | 1 | 5 | |\n| | | | | | MP | C3552 C3553 | P3553 | 1 | 11 | |\n| | Test strips, 100 (Accu-Chek Performa) | For external use | Accu-Chek Performa | RD | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (BGStar) | For external use | BGStar | SW | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (Contour) | For external use | Contour | IK | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (FreeStyle Lite) | For external use | FreeStyle Lite | MS | MP NP | | | 1 | 5 | |\n| | Test strips, 100 (FreeStyle Optium) | For external use | FreeStyle Optium | MS | MP NP | | | 1 | 5 | |\n| Glucose Indicator—Urine | Test strips, 50 (Diastix) | For external use | Diastix | BN | MP NP | | | 2 | 2 | |\n| Glycerol | Suppositories 700 mg, 12 | Rectal | Petrus Pharmaceuticals Pty Ltd | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| | Suppositories 1.4 g, 12 | Rectal | Petrus Pharmaceuticals Pty Ltd | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| | Suppositories 2.8 g, 12 | Rectal | Petrus Pharmaceuticals Pty Ltd | PP | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 3 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 3 See Note 2 | 3 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 3 See Note 2 | 5 See Note 2 | |\n| Glyceryl Trinitrate | Tablets 600 micrograms, 100 | Buccal/ sublingual | Anginine Stabilised | QA | PDP | | | 1 | 0 | |\n| | | | Lycinate | FM | PDP | | | 1 | 0 | |\n| | | | Anginine Stabilised | QA | MP NP | | | 1 | 5 | |\n| | | | Lycinate | FM | MP NP | | | 1 | 5 | |\n| | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual | Nitrolingual Pumpspray | SW | MP NP | | | 1 | 5 | |\n| | Transdermal patch 18 mg | Transdermal | Minitran 5 | IA | MP NP | | | 30 | 5 | |\n| | Transdermal patch 25 mg | Transdermal | Transiderm-Nitro 25 | NV | MP NP | | | 30 | 5 | |\n| | Transdermal patch 40 mg | Transdermal | Nitro-Dur 5 | MK | MP NP | | | 30 | 5 | |\n| | Transdermal patch 36 mg | Transdermal | Minitran 10 | IA | MP NP | | | 30 | 5 | |\n| | Transdermal patch 50 mg | Transdermal | Transiderm-Nitro 50 | NV | MP NP | | | 30 | 5 | |\n| | Transdermal patch 80 mg | Transdermal | Nitro-Dur 10 | MK | MP NP | | | 30 | 5 | |\n| | Transdermal patch 54 mg | Transdermal | Minitran 15 | IA | MP NP | | | 30 | 5 | |\n| | Transdermal patch 120 mg | Transdermal | Nitro-Dur 15 | MK | MP NP | | | 30 | 5 | |\n| Golimumab | Injection 50 mg in 0.5 mL single use pre-filled syringe | Injection | Simponi | JC | MP | C3495 C3497 C3516 C3518 C3718 C3782 C3783 C3784 C3785 C3786 C3787 | P3495 P3516 P3718 P3782 P3784 P3786 | 1 | 3 | |\n| | | | | | MP | C3495 C3497 C3516 C3518 C3718 C3782 C3783 C3784 C3785 C3786 C3787 | P3497 P3518 P3783 P3785 P3787 | 1 | 5 | |\n| | Injection 50 mg in 0.5 mL single use pre-filled pen | Injection | Simponi | JC | MP | C3495 C3497 C3516 C3518 C3718 C3782 C3783 C3784 C3785 C3786 C3787 | P3495 P3516 P3718 P3782 P3784 P3786 | 1 | 3 | |\n| | | | | | MP | C3495 C3497 C3516 C3518 C3718 C3782 C3783 C3784 C3785 C3786 C3787 | P3497 P3518 P3783 P3785 P3787 | 1 | 5 | |\n| Goserelin | Subcutaneous implant 3.6 mg (as acetate) in pre-filled injection syringe | Implantation | Zoladex Implant | AP | MP | C1377 C1871 C1872 C3228 | | 1 | 5 | |\n| | Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre-filled injection syringe | Implantation | Zoladex 10.8 Implant | AP | MP | C3229 | | 1 | 1 | |\n| Goserelin and Bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/ oral | ZolaCos CP 3.6/50 | AP | MP | C3239 | | 1 | 5 | |\n| | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/ oral | ZolaCos CP 10.8/50(28) | AP | MP | C3239 | | 1 | 0 | |\n| | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral | ZolaCos CP 10.8/50(84) | AP | MP | C3239 | | 1 | 1 | |\n| Granisetron | Tablet 2 mg (as hydrochloride) | Oral | Kytril | HH | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 2 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C3050 C3611 See Note 2 | P3611 See Note 2 | 5 See Note 2 | 1 See Note 2 | |\n| | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Granisetron Kabi | PK | MP NP See Note 1 | C3050 C3611 See Note 2 | | 1 See Note 2 | 0 See Note 2 | |\n| | | | Kytril | HH | MP NP See Note 1 | C3050 C3611 See Note 2 | | 1 See Note 2 | 0 See Note 2 | |\n| Griseofulvin | Tablet 125 mg | Oral | Grisovin | QA | MP NP | | | 100 | 2 | |\n| | Tablet 500 mg | Oral | Grisovin 500 | QA | MP NP | | | 28 | 2 | |\n| Haloperidol | Tablet 500 micrograms | Oral | Serenace | QA | MP NP | | | 100 | 5 | |\n| | Tablet 1.5 mg | Oral | Serenace | QA | MP NP | | | 100 | 5 | |\n| | Tablet 5 mg | Oral | Serenace | QA | MP NP | | | 50 | 5 | |\n| | Oral solution 2 mg per mL, 100 mL | Oral | Serenace | QA | MP NP | | | 1 | 5 | |\n| | Injection 5 mg in 1 mL | Injection | Serenace | QA | MP NP | | | 10 | 0 | |\n| Haloperidol Decanoate | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection | Haldol decanoate | JC | MP NP | | | 5 | 0 | |\n| | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection | Haldol decanoate | JC | MP NP | | | 5 | 0 | |\n| Heparin | Injection 5,000 units (as sodium) in 0.2 mL | Injection | Hospira Pty Limited | HH | MP NP | | | 5 | 5 | |\n| | Injection (preservative-free) 5,000 I.U. (as sodium) in 5 mL | Injection | Pfizer Australia Pty Ltd | PF | MP NP | | | 50 | 5 | |\n| | Injection 35,000 units (as sodium) in 35 mL | Injection | Hospira Pty Limited | HH | MP NP | | | 12 | 5 | |\n| Hexamine | Tablet containing hexamine hippurate 1 g | Oral | Hiprex | IA | MP NP | | | 100 | 5 | |\n| High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral powder 300 g (KetoCal) | Oral | KetoCal | SB | MP NP | C1578 C1579 C1580 | | 24 | 5 | |\n| Homatropine | Eye drops containing homatropine hydrobromide 20 mg per mL, 15 mL | Application to the eye | Isopto Homatropine | AQ | MP NP | | | 1 | 2 | |\n| Hydralazine | Tablet containing hydralazine hydrochloride 25 mg | Oral | Alphapress 25 | AF | MP NP | | | 200 | 2 | |\n| | Tablet containing hydralazine hydrochloride 50 mg | Oral | Alphapress 50 | AF | MP NP | | | 200 | 2 | |\n| Hydrochlorothiazide | Tablet 25 mg | Oral | Dithiazide | PL | MP NP | | | 100 | 1 | |\n| Hydrochlorothiazide with Amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral | Moduretic | AS | MP NP | | | 100 | 1 | |\n| Hydrochlorothiazide with Triamterene | Tablet 25 mg-50 mg | Oral | Hydrene 25/50 | AF | MP NP | | | 100 | 1 | |\n| Hydrocortisone | Tablet 4 mg | Oral | Hysone 4 | AF | MP NP | | | 50 | 4 | |\n| | Tablet 20 mg | Oral | Hysone 20 | AF | MP NP | | | 60 | 4 | |\n| | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP | | | 2 | 0 | |\n| | | | | | PDP | C1128 | | 6 | 0 | |\n| | | | | | MP NP | | P1128 | 6 | 0 | |\n| | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP | | | 1 | 0 | |\n| | | | | | MP NP | | P1128 | 6 | 0 | |\n| | | | | | PDP | C1128 | | 6 | 0 | |\n| | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye | Hycor | QA | AO MP NP | | | 1 | 0 | |\n| | Cream containing hydrocortisone acetate 10 mg per g, 30 g | Application | Cortic-DS 1% | FM | PDP | C1422 | | 1 | 0 | |\n| | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | FM | PDP | C1422 | | 1 | 0 | |\n| | Ointment containing hydrocortisone acetate 10 mg per g, 30 g | Application | Cortic-DS 1% | FM | PDP | C1422 | | 1 | 0 | |\n| | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | FM | PDP | C1422 | | 1 | 0 | |\n| | Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g | Rectal | Colifoam | AS | MP NP | C1294 C1454 | | 2 | 3 | |\n| Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | MP NP PDP | C1358 | | 20 | 0 | |\n| | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | MP NP PDP | C1358 | | 20 | 0 | |\n| | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | MP NP PDP | C1358 | | 20 | 0 | |\n| | Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral | Jurnista | JC | MP NP | C1062 | | 14 | 0 | |\n| | Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral | Jurnista | JC | MP NP | C1062 | | 14 | 0 | |\n| | Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral | Jurnista | JC | MP NP | C1062 | | 14 | 0 | |\n| | Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral | Jurnista | JC | MP NP | C1062 | | 14 | 0 | |\n| | Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral | Jurnista | JC | MP NP | C1062 | | 14 | 0 | |\n| | Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 473 mL | Oral | Dilaudid | MF | MP NP PDP | C1358 | | 1 | 0 | |\n| | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid | MF | MP NP | | | 5 | 0 | |\n| | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP | MF | MP NP | | | 5 | 0 | |\n| | Injection containing hydromorphone hydrochloride 50 mg in 5 mL | Injection | Dilaudid-HP | MF | MP NP | | | 5 | 0 | |\n| | Injection containing hydromorphone hydrochloride 500 mg in 50 mL | Injection | Dilaudid-HP | MF | MP NP | | | 1 | 0 | |\n| Hydroxocobalamin | Injection 1 mg (as chloride) in 1 mL | Injection | Hydroxo-B12 | AS | MP NP | C1250 C1281 C1298 | | 3 | 0 | |\n| | | | Neo-B12 | HH | MP NP | C1250 C1281 C1298 | | 3 | 0 | |\n| Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | APO-Hydroxychloroquine | TX | MP NP | | | 100 | 1 | |\n| | | | Chem mart Hydroxychloroquine | CH | MP NP | | | 100 | 1 | |\n| | | | Plaquenil | SW | MP NP | | | 100 | 1 | |\n| | | | Terry White Chemist Hydroxychloroquine | TW | MP NP | | | 100 | 1 | |\n| Hydroxyethyl starch 130/0.4 | I.V. infusion 30 g per 500 mL, 500 mL | Injection | Voluven 6% | PK | MP NP | | | 3 | 0 | |\n| Hydroxyurea | Capsule 500 mg | Oral | Hydrea | BQ | MP | | | 100 | 0 | |\n| Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | Buscopan | BY | MP NP | C3638 C3639 | P3639 | 30 | 0 | |\n| | | | | | MP NP | C3638 C3639 | P3638 | 30 | 3 | |\n| Hypromellose | Eye drops 3 mg per mL, 15 mL | Application to the eye | Genteal | AQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | In a Wink Moisturising | IQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | Genteal | AQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | In a Wink Moisturising | IQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | Eye drops 5 mg per mL, 15 mL | Application to the eye | Methopt | QA | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Oral gel 20 mg per g, 100 g | Oral application | Aquae Gel | VT | MP NP | C3636 C3637 | P3637 | 1 | 0 | |\n| Hypromellose with Carbomer 980 | Ocular lubricating gel 3 mg-2 mg per g, 10 g | Application to the eye | Genteal gel | AQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | HPMC PAA | IQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | Genteal gel | AQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | HPMC PAA | IQ | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| Hypromellose with Dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Poly-Tears | IQ | MP NP AO | C1362 | | 1 | 5 | |\n| | | | Tears Naturale | AQ | MP NP AO | C1362 | | 1 | 5 | |\n| | | | Poly-Tears | IQ | MP | C3036 | | 1 | 11 | |\n| | | | Tears Naturale | AQ | MP | C3036 | | 1 | 11 | |\n| | Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 | Application to the eye | Bion Tears | AQ | MP NP | C1359 | | 3 | 5 | |\n| Ibandronic acid | Tablet 50 mg (as ibandronate sodium monohydrate) | Oral | Bondronat | HH | MP NP | C1035 | | 28 | 2 | |\n| | Concentrated injection for I.V. infusion 6 mg (as ibandronate sodium monohydrate) in 6 mL | Injection | Bondronat | HH | MP See Note 1 | C1035 C3343 | | 1 | 11 | PB |\n| Ibuprofen | Tablet 400 mg | Oral | Brufen | AB | MP NP MW PDP | | | 30 | 0 | |\n| | | | | | MP NP | | P3666 | 90 | 0 | |\n| | | | | | PDP | | P1036 P1054 | 90 | 0 | |\n| | | | | | MP NP | | P1036 P1054 P3665 | 90 | 3 | |\n| Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection | Firazyr | ZI | MP | C4055 C4056 | | 1 | 1 | |\n| Idarubicin | Capsule containing idarubicin hydrochloride 5 mg | Oral | Zavedos | PF | MP | C1006 | | 3 | 0 | |\n| | Capsule containing idarubicin hydrochloride 10 mg | Oral | Zavedos | PF | MP | C1006 | | 3 | 0 | |\n| | Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL | Injection | Idarubicin Ebewe | SZ | MP | C1006 | | See Note 3 | See Note 3 | PB |\n| | | | Zavedos Solution | PF | MP | C1006 | | See Note 3 | See Note 3 | PB |\n| | Solution for I.V. injection containing idarubicin hydrochloride 10 mg in 10 mL | Injection | Idarubicin Ebewe | SZ | MP | C1006 | | See Note 3 | See Note 3 | PB |\n| | | | Zavedos Solution | PF | MP | C1006 | | See Note 3 | See Note 3 | PB |\n| Ifosfamide | Powder for I.V. injection 1 g in single dose vial | Injection | Holoxan | BX | MP | C1325 C1327 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. injection 2 g in single dose vial | Injection | Holoxan | BX | MP | C1325 C1327 | | See Note 3 | See Note 3 | D |\n| Iloprost | Solution for inhalation 20 micrograms (as trometamol) in 2 mL | Inhalation | Ventavis | BN | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Imatinib | Tablet 100 mg (as mesylate) | Oral | Glivec | NV | MP | C1816 C1817 C1818 C1819 C2766 C2767 C2978 C2979 C2980 C2981 C2982 C2984 C3033 C3034 C3144 C3847 C3848 C3849 C3850 C4007 C4008 | P1816 P1817 P1818 P1819 P2766 P2767 P2978 P2979 P2980 P2981 P2982 P2984 P3033 P3034 P3144 P3849 P3850 | 60 | 2 | |\n| | | | | | MP | C1816 C1817 C1818 C1819 C2766 C2767 C2978 C2979 C2980 C2981 C2982 C2984 C3033 C3034 C3144 C3847 C3848 C3849 C3850 C4007 C4008 | P3847 P3848 P4007 P4008 | 60 | 5 | |\n| | Tablet 400 mg (as mesylate) | Oral | Glivec | NV | MP | C1816 C1817 C1818 C1819 C2766 C2767 C2978 C2979 C2980 C2981 C2982 C2984 C3033 C3034 C3144 C3847 C3848 C3849 C3850 C4007 C4008 | P1816 P1817 P1818 P1819 P2766 P2767 P2978 P2979 P2980 P2981 P2982 P2984 P3033 P3034 P3144 P3849 P3850 | 30 | 2 | |\n| | | | | | MP | C1816 C1817 C1818 C1819 C2766 C2767 C2978 C2979 C2980 C2981 C2982 C2984 C3033 C3034 C3144 C3847 C3848 C3849 C3850 C4007 C4008 | P3847 P3848 P4007 P4008 | 30 | 5 | |\n| Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral | Tofranil 10 | LM | MP NP | | | 50 | 2 | |\n| | | | Tolerade 10 | PQ | MP NP | | | 50 | 2 | |\n| | Tablet containing imipramine hydrochloride 25 mg | Oral | Tofranil 25 | LM | MP NP | | | 50 | 2 | |\n| | | | Tolerade 25 | PQ | MP NP | | | 50 | 2 | |\n| Imiquimod | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | Aldara | IA | MP | C2816 | | 1 | 1 | |\n| Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C3883 | | 30 | 5 | |\n| | Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C3883 | | 30 | 5 | |\n| Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | SE | MP NP | | | 90 | 1 | |\n| | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Chem mart Indapamide | CH | MP NP | | | 90 | 1 | |\n| | | | Dapa-Tabs | AF | MP NP | | | 90 | 1 | |\n| | | | GenRx Indapamide | GX | MP NP | | | 90 | 1 | |\n| | | | Indapamide-GA | GM | MP NP | | | 90 | 1 | |\n| | | | Indapamide-PS | FZ | MP NP | | | 90 | 1 | |\n| | | | Indapamide Sandoz | SZ | MP NP | | | 90 | 1 | |\n| | | | Insig | QA | MP NP | | | 90 | 1 | |\n| | | | Natrilix | SE | MP NP | | | 90 | 1 | |\n| | | | Terry White Chemists Indapamide | TW | MP NP | | | 90 | 1 | |\n| Indinavir | Capsule 400 mg (as sulfate) | Oral | Crixivan 400 mg | MK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 360 | 5 | D |\n| Indomethacin | Capsule 25 mg | Oral | Arthrexin | AF | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Indocid | AS | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Arthrexin | AF | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Indocid | AS | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | Suppository 100 mg | Rectal | Indocid | AS | MP NP | | P3666 | 40 | 0 | |\n| | | | | | PDP | | | 40 | 0 | |\n| | | | | | MP NP | | | 40 | 3 | |\n| | | | | | MP NP | | P3665 | 40 | 3 | |\n| Infliximab | Powder for I.V. infusion 100 mg | Injection | Remicade | JC | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Insect Allergen Extract—Honey Bee Venom | Injection set containing 550 micrograms | Injection | Albey Bee Venom | HL | MP | | | 1 | 0 | |\n| Insect Allergen Extract—Paper Wasp Venom | Injection set containing 550 micrograms | Injection | Albey Paper Wasp Venom | HL | MP | | | 1 | 0 | |\n| Insect Allergen Extract—Yellow Jacket Venom | Injection set containing 550 micrograms | Injection | Albey Yellow Jacket Venom | HL | MP | | | 1 | 0 | |\n| Insulin Aspart | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | NovoRapid | NO | MP NP | | | 5 | 2 | |\n| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | NovoRapid FlexPen | NF | MP NP | | | 5 | 1 | |\n| | | | NovoRapid Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| Insulin Aspart with Insulin Aspart Protamine Suspension | Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | NovoMix 30 FlexPen | NF | MP NP | | | 5 | 1 | |\n| | | | NovoMix 30 Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| Insulin Detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Levemir FlexPen | NF | MP NP | C2418 | | 5 | 1 | |\n| | | | Levemir Penfill | NO | MP NP | C2418 | | 5 | 1 | |\n| Insulin Glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Lantus | SW | MP NP | | | 5 | 1 | |\n| | | | Lantus SoloStar | AV | MP NP | | | 5 | 1 | |\n| Insulin Glulisine | Injection (human analogue) 100 units per mL, 10 mL | Injection | Apidra | SW | MP NP | | | 5 | 2 | |\n| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Apidra | AV | MP NP | | | 5 | 1 | |\n| | | | Apidra SoloStar | SW | MP NP | | | 5 | 1 | |\n| Insulin Isophane | Injection (bovine) 100 units per mL, 10 mL | Injection | Hypurin Isophane | AS | MP NP | | | 5 | 2 | |\n| | Injection (human) 100 units per mL, 10 mL | Injection | Humulin NPH | LY | MP NP | | | 5 | 2 | |\n| | | | Protaphane | NO | MP NP | | | 5 | 2 | |\n| | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humulin NPH | LY | MP NP | | | 5 | 1 | |\n| | | | Protaphane InnoLet | NI | MP NP | | | 5 | 1 | |\n| | | | Protaphane Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| Insulin Lispro | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | Humalog | LY | MP NP | | | 5 | 2 | |\n| | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humalog | LY | MP NP | | | 5 | 1 | |\n| | | | Humalog KwikPen | KP | MP NP | | | 5 | 1 | |\n| Insulin Lispro with Insulin Lispro Protamine Suspension | Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 | Injection | Humalog Mix25 | LY | MP NP | | | 5 | 1 | |\n| | | | Humalog Mix25 KwikPen | KP | MP NP | | | 5 | 1 | |\n| | Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | Humalog Mix50 | LY | MP NP | | | 5 | 1 | |\n| | | | Humalog Mix50 KwikPen | KP | MP NP | | | 5 | 1 | |\n| Insulin Neutral | Injection (bovine) 100 units per mL, 10 mL | Injection | Hypurin Neutral | AS | MP NP | | | 5 | 2 | |\n| | Injection (human) 100 units per mL, 10 mL | Injection | Actrapid | NO | MP NP | | | 5 | 2 | |\n| | | | Humulin R | LY | MP NP | | | 5 | 2 | |\n| | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Actrapid Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| | | | Humulin R | LY | MP NP | | | 5 | 1 | |\n| Insulin Neutral with Insulin Isophane | Injection (human) 30 units-70 units per mL, 10 mL | Injection | Humulin 30/70 | LY | MP NP | | | 5 | 2 | |\n| | Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | Humulin 30/70 | LY | MP NP | | | 5 | 1 | |\n| | | | Mixtard 30/70 InnoLet | NI | MP NP | | | 5 | 1 | |\n| | | | Mixtard 30/70 Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| | Injections (human), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | Mixtard 50/50 Penfill 3 mL | NO | MP NP | | | 5 | 1 | |\n| Interferon Alfa-2a | Injection 3,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | Roferon-A | RO | MP See Note 1 | C1149 C1196 C1234 C3180 C3895 C3899 | P1149 P1234 P3180 P3899 | 15 | 4 | |\n| | | | | | MP See Note 1 | C1149 C1196 C1234 C3180 C3895 C3899 | P1196 P3895 | 15 | 5 | |\n| | Injection 4,500,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | Roferon-A | RO | MP See Note 1 | C1196 C1234 C3895 C3899 | P1234 P3899 | 5 | 4 | |\n| | Injection 6,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | Roferon-A | RO | MP See Note 1 | C1196 C1234 C3895 C3899 | P1234 P3899 | 5 | 4 | |\n| | Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe | Injection | Roferon-A | RO | MP See Note 1 | C1196 C1234 C3895 C3899 | P1234 P3899 | 5 | 4 | |\n| | | | | | MP See Note 1 | C1463 C3382 C3959 C3960 C3961 C3962 | | 30 | 5 | C |\n| Interferon Alfa-2b | Solution for injection 10,000,000 I.U. in 1 mL single dose vial | Injection | Intron A | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 15 | 5 | PB |\n| | Solution for injection 18,000,000 I.U. in 3 mL single dose vial | Injection | Intron A | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 15 | 5 | PB |\n| | Solution for injection 18,000,000 I.U. in 1.2 mL multi-dose injection pen | Injection | Intron A Redipen | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 2 | 5 | C |\n| | | | | | MP See Note 1 | C1149 C1196 C1206 C3180 C3895 C3898 | P1149 P3180 | 3 | 4 | |\n| | | | | | MP See Note 1 | C1149 C1196 C1206 C3180 C3895 C3898 | P1196 P1206 P3895 P3898 | 3 | 5 | |\n| | Solution for injection 25,000,000 I.U. in 2.5 mL single dose vial | Injection | Intron A | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 15 | 5 | PB |\n| | Solution for injection 60,000,000 I.U. in 1.2 mL multi-dose injection pen | Injection | Intron A Redipen | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 2 | 5 | PB |\n| | Solution for injection 30,000,000 I.U. in 1.2 mL multi-dose injection pen | Injection | Intron A Redipen | MK | MP See Note 1 | C1009 C1463 C3382 C3384 C3959 C3960 C3961 C3962 | | 2 | 5 | C |\n| | | | | | MP See Note 1 | C1196 C1206 C3895 C3898 | | 3 | 5 | |\n| Interferon Beta-1a | Injection set comprising 1 vial powder for injection 30 micrograms (6,000,000 I.U.) with diluent | Injection | Avonex | BD | MP | C1175 C1751 | | 4 | 5 | |\n| | Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection | Avonex | BD | MP | C1175 C1751 | | 4 | 5 | |\n| | Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre-filled syringe | Injection | Rebif 44 | SG | MP | C1175 C1751 | | 12 | 5 | |\n| | Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose autoinjector | Injection | Rebif 44 | SG | MP | C1175 C1751 | | 12 | 5 | |\n| | Solution for injection 132 micrograms in 1.5 mL multidose cartridge | Injection | Rebif 44 | SG | MP | C1175 C1751 | | 4 | 5 | |\n| Interferon Beta-1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection | Betaferon | BN | MP | C1175 C1751 | | 15 | 5 | |\n| Interferon Gamma-1b | Injection 2,000,000 I.U. in 0.5 mL | Injection | Imukin | BY | MP See Note 1 | C1058 C3385 | | 12 | 11 | D |\n| Ipratropium | Pressurised inhalation containing ipratropium bromide 21 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Atrovent | BY | MP NP | | | 2 | 5 | |\n| | Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | Aeron 250 | QA | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | APO-Ipratropium | TX | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Atrovent | BY | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ipratrin | AF | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ipravent | PF | MP NP | C1754 C1755 | | 2 | 5 | |\n| | Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30 | Inhalation | Aeron 500 | QA | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | APO-Ipratropium | TX | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Atrovent Adult | BY | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ipratrin Adult | AF | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ipravent | PF | MP NP | C1754 C1755 | | 2 | 5 | |\n| Irbesartan | Tablet 75 mg | Oral | Avapro | BQ | MP NP | | | 30 | 5 | |\n| | Tablet 150 mg | Oral | Avapro | BQ | MP NP | | | 30 | 5 | |\n| | Tablet 300 mg | Oral | Avapro | BQ | MP NP | | | 30 | 5 | |\n| Irbesartan with Hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Avapro HCT 150/12.5 | BQ | MP NP | C3307 | | 30 | 5 | |\n| | | | Karvezide 150/12.5 | SW | MP NP | C3307 | | 30 | 5 | |\n| | Tablet 300 mg-12.5 mg | Oral | Avapro HCT 300/12.5 | BQ | MP NP | C3307 | | 30 | 5 | |\n| | | | Karvezide 300/12.5 | SW | MP NP | C3307 | | 30 | 5 | |\n| | Tablet 300 mg-25 mg | Oral | Avapro HCT 300/25 | BQ | MP NP | C3307 | | 30 | 5 | |\n| | | | Karvezide 300/25 | SW | MP NP | C3307 | | 30 | 5 | |\n| Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | | Hospira Pty Limited | HH | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinoccord | WQ | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinotecan Actavis | TA | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinotecan Kabi | PK | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Omegapharm Irinotecan | OE | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Camptosar | PF | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Hospira Pty Limited | HH | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinoccord | WQ | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinotecan Actavis | TA | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinotecan Kabi | PK | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Omegapharm Irinotecan | OE | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL | Injection | Camptosar | PF | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Hospira Pty Limited | HH | MP | C3184 | | See Note 3 | See Note 3 | D |\n| | | | Irinotecan Actavis 500 | TA | MP | C3184 | | See Note 3 | See Note 3 | D |\n| Iron Polymaltose Complex | Injection 100 mg (iron) in 2 mL ampoule | Injection | Ferrosig | SI | MP NP | | | 5 | 0 | |\n| | | | Ferrum H | AS | MP NP | | | 5 | 0 | |\n| Iron Sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL ampoule | Injection | Venofer | AS | MP NP | C2070 | | 5 | 0 | |\n| Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine Amino Acid Supplement) | Oral | Isoleucine Amino Acid Supplement | VF | MP NP | C1220 | | 4 | 5 | |\n| | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000 Amino Acid Supplement) | Oral | Isoleucine 1000 Amino Acid Supplement | VF | MP NP | C1220 | | 4 | 5 | |\n| Isoniazid | Tablet 100 mg | Oral | Fawns and McAllan Proprietary Limited | FM | MP NP | | | 100 | 2 | |\n| Isosorbide Dinitrate | Tablet 5 mg (sublingual) | Oral | Isordil Sublingual | QA | MP NP | | | 200 | 2 | |\n| Isosorbide Mononitrate | Tablet 60 mg (sustained release) | Oral | Chem mart Isosorbide Mononitrate | CH | MP NP | | | 30 | 5 | |\n| | | | Duride | AF | MP NP | | | 30 | 5 | |\n| | | | GenRx Isosorbide Mononitrate | GX | MP NP | | | 30 | 5 | |\n| | | | Imdur Durule | AP | MP NP | | | 30 | 5 | |\n| | | | Imtrate 60 mg | GM | MP NP | | | 30 | 5 | |\n| | | | Isomonit | SZ | MP NP | | | 30 | 5 | |\n| | | | Isosorbide-PS | FZ | MP NP | | | 30 | 5 | |\n| | | | Monodur 60 mg | PM | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Isosorbide Mononitrate | TW | MP NP | | | 30 | 5 | |\n| | Tablet 120 mg (sustained release) | Oral | Imdur 120 mg | AP | MP NP | | | 30 | 5 | |\n| | | | Monodur 120 mg | PM | MP NP | | | 30 | 5 | |\n| Isotretinoin | Capsule 10 mg | Oral | APO-Isotretinoin | TX | MP | C1354 | | 60 | 3 | |\n| | | | Oratane | GM | MP | C1354 | | 60 | 3 | |\n| | | | Roaccutane | RO | MP | C1354 | | 60 | 3 | |\n| | | | Rocta 10 | QA | MP | C1354 | | 60 | 3 | |\n| | Capsule 20 mg | Oral | APO-Isotretinoin | TX | MP | C1354 | | 60 | 3 | |\n| | | | GenRx Isotretinoin | GX | MP | C1354 | | 60 | 3 | |\n| | | | Oratane | GM | MP | C1354 | | 60 | 3 | |\n| | | | Roaccutane | RO | MP | C1354 | | 60 | 3 | |\n| | | | Rocta 20 | QA | MP | C1354 | | 60 | 3 | |\n| | Capsule 40 mg | Oral | Oratane | GM | MP | C1354 | | 30 | 3 | |\n| Itraconazole | Capsule 100 mg | Oral | Sporanox | JC | MP NP | C3607 C3608 C3609 C3610 C3612 C3613 C3614 | | 60 | 5 | |\n| Ivermectin | Tablet 3 mg | Oral | Stromectol | MK | MP NP | C1242 C1388 | | 4 | 0 | |\n| Ketoconazole | Tablet 200 mg | Oral | Nizoral | JC | MP NP | C3604 C3605 C3606 | P3606 | 10 | 0 | |\n| | | | | | MP NP | C3604 C3605 C3606 | P3604 P3605 | 30 | 5 | |\n| | Cream 20 mg per g, 30 g | Application | Nizoral 2% Cream | JT | MP NP | C2354 | | 1 | 2 | |\n| | Shampoo 10 mg per g, 100 mL | Application | Nizoral 1% | JT | MP NP | C2354 | | 1 | 1 | |\n| | Shampoo 20 mg per g, 60 mL | Application | Nizoral 2% | JT | MP NP | C2354 | | 1 | 1 | |\n| Ketoprofen | Capsule 200 mg (sustained release) | Oral | Orudis SR 200 | SW | PDP | C1054 | | 28 | 0 | |\n| | | | Oruvail SR | AV | PDP | C1054 | | 28 | 0 | |\n| | | | Orudis SR 200 | SW | MP NP | C1054 | | 28 | 3 | |\n| | | | Oruvail SR | AV | MP NP | C1054 | | 28 | 3 | |\n| | Suppository 100 mg | Rectal | Orudis | SW | PDP | | | 40 | 0 | |\n| | | | | | MP NP | | | 40 | 3 | |\n| Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | Presolol 100 | AF | MP NP | | | 100 | 5 | |\n| | | | Trandate | QA | MP NP | | | 100 | 5 | |\n| | Tablet containing labetalol hydrochloride 200 mg | Oral | Presolol 200 | AF | MP NP | | | 100 | 5 | |\n| | | | Trandate | QA | MP NP | | | 100 | 5 | |\n| Lacosamide | Tablet 50 mg | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 14 | 1 | |\n| | Tablets 100 mg, 14 | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 1 | 1 | |\n| | Tablet 100 mg | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 56 | 5 | |\n| | Tablets 150 mg, 14 | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 1 | 1 | |\n| | Tablet 150 mg | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 56 | 5 | |\n| | Tablet 200 mg | Oral | Vimpat | UC | MP NP | C3303 C3304 | | 56 | 5 | |\n| Lactulose | Solution BP 3.34 g per 5 mL, 500 mL | Oral | Actilax | AF | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | Duphalac | AB | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | Genlac | QA | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | GenRx Lactulose | GX | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | Lac-Dol | GM | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | Lactocur | SZ | MP NP | C1150 C1613 C3642 C3643 | P3643 | 3 | 0 | |\n| | | | Actilax | AF | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | Duphalac | AB | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | Genlac | QA | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | GenRx Lactulose | GX | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | Lac-Dol | GM | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | Lactocur | SZ | MP NP | C1150 C1613 C3642 C3643 | P3642 | 3 | 3 | |\n| | | | Actilax | AF | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| | | | Duphalac | AB | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| | | | Genlac | QA | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| | | | GenRx Lactulose | GX | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| | | | Lac-Dol | GM | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| | | | Lactocur | SZ | MP NP | C1150 C1613 C3642 C3643 | P1150 P1613 | 1 | 5 | |\n| Lamivudine | Tablet 100 mg | Oral | Zeffix | GK | MP See Note 1 | C3959 C3960 C3961 C3962 | | 56 | 5 | D |\n| | | | Zetlam | AF | MP See Note 1 | C3959 C3960 C3961 C3962 | | 56 | 5 | D |\n| | Tablet 150 mg | Oral | 3TC | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | | | Alphapharm Lamivudine | AF | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | | | Lamivudine RBX | RA | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Tablet 300 mg | Oral | 3TC | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | | | Alphapharm Lamivudine | AF | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | | | Lamivudine RBX | RA | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| | Oral solution 5 mg per mL, 240 mL | Oral | Zeffix | GK | MP See Note 1 | C3959 C3960 C3961 C3962 | | 5 | 5 | D |\n| | Oral solution 10 mg per mL, 240 mL | Oral | 3TC | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 8 | 5 | D |\n| Lamivudine with Zidovudine | Tablet 150 mg-300 mg | Oral | Combivir | VI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| Lamotrigine | Tablet 5 mg | Oral | Lamictal | GK | MP NP | C1426 | | 56 | 5 | |\n| | | | Seaze 5 | QA | MP NP | C1426 | | 56 | 5 | |\n| | Tablet 25 mg | Oral | APO-Lamotrigine | TX | MP NP | C1426 | | 56 | 5 | |\n| | | | Lamotrust 25 | MI | MP NP | C1426 | | 56 | 5 | |\n| | | | Seaze 25 | QA | MP NP | C1426 | | 56 | 5 | |\n| | | | Torlemo DT 25 | TA | MP NP | C1426 | | 56 | 5 | |\n| | Tablet 50 mg | Oral | APO-Lamotrigine | TX | MP NP | C1426 | | 56 | 5 | |\n| | | | Lamotrust 50 | MI | MP NP | C1426 | | 56 | 5 | |\n| | | | Seaze 50 | QA | MP NP | C1426 | | 56 | 5 | |\n| | | | Torlemo DT 50 | TA | MP NP | C1426 | | 56 | 5 | |\n| | Tablet 100 mg | Oral | APO-Lamotrigine | TX | MP NP | C1426 | | 56 | 5 | |\n| | | | Lamotrust 100 | MI | MP NP | C1426 | | 56 | 5 | |\n| | | | Seaze 100 | QA | MP NP | C1426 | | 56 | 5 | |\n| | | | Torlemo DT 100 | TA | MP NP | C1426 | | 56 | 5 | |\n| | Tablet 200 mg | Oral | APO-Lamotrigine | TX | MP NP | C1426 | | 56 | 5 | |\n| | | | Lamotrust 200 | MI | MP NP | C1426 | | 56 | 5 | |\n| | | | Seaze 200 | QA | MP NP | C1426 | | 56 | 5 | |\n| | | | Torlemo DT 200 | TA | MP NP | C1426 | | 56 | 5 | |\n| Lanreotide | Powder for suspension for injection 30 mg (as acetate) with diluent | Injection | Somatuline LA | IS | MP See Note 1 | C2619 C3387 | | 2 | 11 | D |\n| | Injection 60 mg (as acetate) in single dose pre-filled syringe | Injection | Somatuline Autogel | IS | MP See Note 1 | C2620 C2621 C3388 C3389 | | 2 | 11 | D |\n| | Injection 90 mg (as acetate) in single dose pre-filled syringe | Injection | Somatuline Autogel | IS | MP See Note 1 | C2620 C2621 C3388 C3389 | | 2 | 11 | D |\n| | Injection 120 mg (as acetate) in single dose pre-filled syringe | Injection | Somatuline Autogel | IS | MP See Note 1 | C2620 C2621 C3388 C3389 | | 2 | 11 | D |\n| Lansoprazole | Tablet 30 mg (orally disintegrating) | Oral | Zoton FasTabs | PF | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | |\n| | | | | | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | |\n| | Capsule 30 mg | Oral | APO-Lansoprazole | TX | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | |\n| | | | Lanzopran | RA | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | |\n| | | | Zopral | AF | MP NP | C1177 C1337 C1533 | P1177 | 28 | 1 | |\n| | | | APO-Lansoprazole | TX | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | |\n| | | | Lanzopran | RA | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | |\n| | | | Zopral | AF | MP NP | C1177 C1337 C1533 | P1337 P1533 | 28 | 5 | |\n| | Tablet 15 mg (orally disintegrating) | Oral | Zoton FasTabs | PF | MP NP | C1337 C1533 | | 28 | 5 | |\n| | Capsule 15 mg | Oral | Zopral | AF | MP NP | C1337 C1533 | | 30 | 5 | |\n| Lanthanum | Tablet, chewable, 500 mg (as carbonate hydrate) | Oral | Fosrenol | ZI | MP | C3546 C3547 | P3546 P3547 | 90 | 5 | |\n| | Tablet, chewable, 750 mg (as carbonate hydrate) | Oral | Fosrenol | ZI | MP | C3546 C3547 | P3546 P3547 | 90 | 5 | |\n| | Tablet, chewable, 1000 mg (as carbonate hydrate) | Oral | Fosrenol | ZI | MP | C3546 C3547 | P3546 P3547 | 90 | 5 | |\n| Lapatinib | Tablet 250 mg (as ditosylate monohydrate) | Oral | Tykerb | GK | MP | C2890 C3433 | | 140 | 2 | |\n| | | | | | | | | | | |\n| Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye | APO-Latanoprost | TX | MP AO | | | 1 | 5 | |\n| | | | Chem mart Latanoprost | CH | MP AO | | | 1 | 5 | |\n| | | | Latanoprost Pfizer | FZ | MP AO | | | 1 | 5 | |\n| | | | Latanoprost Sandoz | SZ | MP AO | | | 1 | 5 | |\n| | | | Terry White Chemists Latanoprost | TW | MP AO | | | 1 | 5 | |\n| | | | Xalatan | PF | MP AO | | | 1 | 5 | |\n| Latanoprost with Timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Latanocom | FZ | MP AO | C3426 C3427 | | 1 | 5 | |\n| | | | Xalacom | PF | MP AO | C3426 C3427 | | 1 | 5 | |\n| Leflunomide | Pack containing 3 tablets leflunomide 100 mg and 30 tablets leflunomide 20 mg | Oral | Arava | SW | MP | C2643 C2681 | | 1 | 0 | |\n| | Tablet 10 mg | Oral | APO-Leflunomide | TX | MP | C2644 | | 30 | 5 | |\n| | | | Arabloc | AV | MP | C2644 C2682 | | 30 | 5 | |\n| | | | Arava | SW | MP | C2644 C2682 | | 30 | 5 | |\n| | | | Lunava 10 | ZP | MP | C2644 | | 30 | 5 | |\n| | Tablet 20 mg | Oral | APO-Leflunomide | TX | MP | C2644 | | 30 | 5 | |\n| | | | Arabloc | AV | MP | C2644 C2682 | | 30 | 5 | |\n| | | | Arava | SW | MP | C2644 C2682 | | 30 | 5 | |\n| | | | Lunava 20 | ZP | MP | C2644 | | 30 | 5 | |\n| Lenalidomide | Capsule 5 mg | Oral | Revlimid | CJ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Capsule 10 mg | Oral | Revlimid | CJ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Capsule 15 mg | Oral | Revlimid | CJ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Capsule 25 mg | Oral | Revlimid | CJ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Lenograstim | Powder for injection 13,400,000 I.U. (105 micrograms) | Injection | Granocyte 13 | HH | MP See Note 1 | C1005 C1046 C1051 C1097 C1140 C1168 C1228 C1238 C1240 C1249 C1274 C1324 C1333 C1555 C3392 C3393 C3394 C3395 C3396 C3397 C3398 C3399 C3400 C3401 C3402 C3403 C3404 C3405 | | 20 | 11 | D |\n| | Powder for injection 33,600,000 I.U. (263 micrograms) | Injection | Granocyte 34 | HH | MP See Note 1 | C1005 C1046 C1051 C1097 C1140 C1168 C1228 C1238 C1240 C1249 C1274 C1324 C1333 C1555 C3392 C3393 C3394 C3395 C3396 C3397 C3398 C3399 C3400 C3401 C3402 C3403 C3404 C3405 | | 20 | 11 | D |\n| Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral | APO-Lercanidipine | TX | MP NP | | | 28 | 5 | |\n| | | | Chem mart Lercanidipine | CH | MP NP | | | 28 | 5 | |\n| | | | Lercadip | GM | MP NP | | | 28 | 5 | |\n| | | | Lercan | QA | MP NP | | | 28 | 5 | |\n| | | | Lercanidipine Sandoz | SZ | MP NP | | | 28 | 5 | |\n| | | | Terry White Chemists Lercanidipine | TW | MP NP | | | 28 | 5 | |\n| | | | Zanidip | AB | MP NP | | | 28 | 5 | |\n| | | | Zircol | AF | MP NP | | | 28 | 5 | |\n| | Tablet containing lercanidipine hydrochloride 20 mg | Oral | APO-Lercanidipine | TX | MP NP | | | 28 | 5 | |\n| | | | Chem mart Lercanidipine | CH | MP NP | | | 28 | 5 | |\n| | | | Lercadip | GM | MP NP | | | 28 | 5 | |\n| | | | Lercan | QA | MP NP | | | 28 | 5 | |\n| | | | Lercanidipine Sandoz | SZ | MP NP | | | 28 | 5 | |\n| | | | Terry White Chemists Lercanidipine | TW | MP NP | | | 28 | 5 | |\n| | | | Zanidip | AB | MP NP | | | 28 | 5 | |\n| | | | Zircol | AF | MP NP | | | 28 | 5 | |\n| Lercanidipine with enalapril | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg | Oral | Zan-Extra 10/10 | AB | MP NP | C3307 | | 28 | 5 | |\n| | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg | Oral | Zan-Extra 10/20 | AB | MP NP | C3307 | | 28 | 5 | |\n| Letrozole | Tablet 2.5 mg | Oral | APO-Letrozole | TX | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Chem mart Letrozole | CH | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Femara 2.5 mg | NV | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Femolet | AF | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Fera | QA | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letara | FZ | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole Actavis | TA | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole-DRLA | RZ | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole-GA | GM | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole generichealth | GQ | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole RBX | RA | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole Sandoz | SZ | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Letrozole-Synthon | ZT | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| ` | | | Lezole | WQ | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| | | | Terry White Chemists Letrozole | TW | MP NP | C1608 C2691 C2692 | | 30 | 5 | |\n| Leuprorelin | I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre-filled dual-chamber syringe | Injection | Lucrin Depot 7.5mg PDS | VE | MP | C3229 | | 1 | 5 | |\n| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set | Injection | Eligard 1 month | HH | MP | C3229 | | 1 | 5 | |\n| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre-filled dual-chamber syringe | Injection | Lucrin Depot 3 Month PDS | VE | MP | C3229 | | 1 | 1 | |\n| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set | Injection | Eligard 3 month | HH | MP | C3229 | | 1 | 1 | |\n| | I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe | Injection | Lucrin Depot 4 Month PDS | VE | MP | C3229 | | 1 | 1 | |\n| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set | Injection | Eligard 4 month | HH | MP | C3229 | | 1 | 1 | |\n| | Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set | Injection | Eligard 6 month | HH | MP | C3229 | | 1 | 0 | |\n| Levetiracetam | Tablet 250 mg | Oral | APO-Levetiracetam | TX | MP NP | C2664 | | 60 | 5 | |\n| | | | Kerron 250 | DO | MP NP | C2664 | | 60 | 5 | |\n| | | | Levecetam 250 | RZ | MP NP | C2664 | | 60 | 5 | |\n| | | | Levitam 250 | QA | MP NP | C2664 | | 60 | 5 | |\n| | Tablet 500 mg | Oral | APO-Levetiracetam | TX | MP NP | C2664 | | 60 | 5 | |\n| | | | Kerron 500 | DO | MP NP | C2664 | | 60 | 5 | |\n| | | | Levecetam 500 | RZ | MP NP | C2664 | | 60 | 5 | |\n| | | | Levitam 500 | QA | MP NP | C2664 | | 60 | 5 | |\n| | Tablet 1 g | Oral | APO-Levetiracetam | TX | MP NP | C2664 | | 60 | 5 | |\n| | | | Kerron 1000 | DO | MP NP | C2664 | | 60 | 5 | |\n| | | | Levecetam 1000 | RZ | MP NP | C2664 | | 60 | 5 | |\n| | | | Levitam 1000 | QA | MP NP | C2664 | | 60 | 5 | |\n| | Oral solution 100 mg per mL, 300 mL | Oral | Keppra | UC | MP NP | C3291 | | 1 | 5 | |\n| Levodopa with Benserazide | Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral | Madopar Rapid 62.5 | RO | MP NP | | | 100 | 5 | |\n| | Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar Rapid 125 | RO | MP NP | | | 100 | 5 | |\n| | Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar 125 | RO | MP NP | | | 100 | 5 | |\n| | Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral | Madopar | RO | MP NP | | | 100 | 5 | |\n| | Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral | Madopar 62.5 | RO | MP NP | | | 100 | 5 | |\n| | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar 125 | RO | MP NP | | | 100 | 5 | |\n| | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release) | Oral | Madopar HBS | RO | MP NP | | | 100 | 5 | |\n| | Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral | Madopar | RO | MP NP | | | 100 | 5 | |\n| Levodopa with Carbidopa | Tablet 200 mg-50 mg (anhydrous) (modified release) | Oral | Sinemet CR | MK | MP NP | C1257 | | 100 | 5 | |\n| | Tablet 100 mg-25 mg (anhydrous) | Oral | Kinson | AF | MP NP | | | 100 | 5 | |\n| | | | Sinemet 100/25 | MK | MP NP | | | 100 | 5 | |\n| | Tablet 250 mg-25 mg (anhydrous) | Oral | Levo/Carbidopa Sandoz | SZ | MP NP | | | 100 | 5 | |\n| | | | Sinemet | MK | MP NP | | | 100 | 5 | |\n| | Intestinal gel 20 mg-5 mg per mL, 100 mL | Intra-intestinal | Duodopa | VE | MP NP | C3703 | | 56 | 5 | |\n| | | | | | MP See Note 1 | C3704 C3705 | | 56 | 5 | C |\n| Levodopa with Carbidopa and Entacapone | Tablet 50 mg-12.5 mg-200 mg | Oral | Stalevo 50/12.5/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| | Tablet 75 mg-18.75 mg-200 mg | Oral | Stalevo 75/18.75/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| | Tablet 100 mg-25 mg-200 mg | Oral | Stalevo 100/25/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| | Tablet 125 mg-31.25 mg-200 mg | Oral | Stalevo 125/31.25/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| | Tablet 150 mg-37.5 mg-200 mg | Oral | Stalevo 150/37.5/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| | Tablet 200 mg-50 mg-200 mg | Oral | Stalevo 200/50/200mg | NV | MP NP | C3305 C3306 | | 200 | 4 | |\n| Levonorgestrel | Tablets 30 micrograms, 28 | Oral | Microlut 28 | BN | MP NP MW | | | 4 | 2 | |\n| | Intrauterine drug delivery system 52 mg | Intrauterine | Mirena | BN | MP NP | C1643 C2689 C2690 | | 1 | 0 | |\n| Levonorgestrel with Ethinyloestradiol | Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets | Oral | Microgynon 50 ED | BN | MP NP | | | 4 | 2 | |\n| | Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets | Oral | Levlen ED | SY | MP NP | | | 4 | 2 | |\n| | | | Microgynon 30 ED | BN | MP NP | | | 4 | 2 | |\n| | | | Monofeme 28 | FZ | MP NP | | | 4 | 2 | |\n| | | | Nordette 28 | PF | MP NP | | | 4 | 2 | |\n| | Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets | Oral | Logynon ED | SY | MP NP | | | 4 | 2 | |\n| | | | Trifeme 28 | FZ | MP NP | | | 4 | 2 | |\n| | | | Triphasil 28 | PF | MP NP | | | 4 | 2 | |\n| | | | Triquilar ED | BN | MP NP | | | 4 | 2 | |\n| Lignocaine | Injection containing lignocaine hydrochloride 100 mg in 5 mL | Injection | Pfizer Australia Pty Ltd | PF | MP NP PDP | | | 5 | 0 | |\n| | Infusion containing lignocaine hydrochloride 500 mg in 5 mL | Injection | Xylocard 500 | AP | MP NP | | | 10 | 0 | |\n| Linagliptin | Tablet 5 mg | Oral | Trajenta | BY | MP NP | C3540 | | 30 | 5 | |\n| Lincomycin | Injection 600 mg (as hydrochloride) in 2 mL | Injection | Lincocin | PF | PDP MP NP MW | | | 5 | 0 | |\n| Liothyronine | Tablet containing liothyronine sodium 20 micrograms | Oral | Tertroxin | QA | MP NP | C1182 C1219 C1858 C1859 | | 100 | 2 | |\n| Lisinopril | Tablet 5 mg | Oral | APO-Lisinopril | TX | MP NP | | | 30 | 5 | |\n| | | | Fibsol 5 | QA | MP NP | | | 30 | 5 | |\n| | | | Lisinopril 5 | CR | MP NP | | | 30 | 5 | |\n| | | | Prinivil 5 | MK | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg | Oral | APO-Lisinopril | TX | MP NP | | | 30 | 5 | |\n| | | | Fibsol 10 | QA | MP NP | | | 30 | 5 | |\n| | | | Lisinopril 10 | CR | MP NP | | | 30 | 5 | |\n| | | | Prinivil 10 | MK | MP NP | | | 30 | 5 | |\n| | Tablet 20 mg | Oral | APO-Lisinopril | TX | MP NP | | | 30 | 5 | |\n| | | | Fibsol 20 | QA | MP NP | | | 30 | 5 | |\n| | | | Lisinopril 20 | CR | MP NP | | | 30 | 5 | |\n| | | | Prinivil 20 | MK | MP NP | | | 30 | 5 | |\n| Lithium | Tablet containing lithium carbonate 250 mg | Oral | Lithicarb | AS | MP NP | | | 200 | 2 | |\n| | Tablet containing lithium carbonate 450 mg (slow release) | Oral | Quilonum SR | GK | MP NP | | | 200 | 2 | |\n| Loperamide | Capsule containing loperamide hydrochloride 2 mg | Oral | Gastro-Stop Loperamide | AS | MP NP | | | 12 | 0 | |\n| | | | Imodium | JT | MP NP | | | 12 | 0 | |\n| Lopinavir with Ritonavir | Tablet 100 mg-25 mg | Oral | Kaletra | VE | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Tablet 200 mg-50 mg | Oral | Kaletra | VE | MP See Note 1 | C3586 C3587 C3588 C3589 | | 240 | 5 | D |\n| | Oral liquid 400 mg-100 mg per 5 mL, 60 mL | Oral | Kaletra | VE | MP See Note 1 | C3586 C3587 C3588 C3589 | | 10 | 5 | D |\n| Losartan | Tablet containing losartan potassium 25 mg | Oral | Cozavan | AF | MP NP | | | 30 | 5 | |\n| | Tablet containing losartan potassium 50 mg | Oral | Cozavan | AF | MP NP | | | 60 | 5 | |\n| Macrogol 3350 | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral | Movicol | NE | MP NP See Note 1 | C1263 C1613 C2693 C2823 C3642 C3643 See Note 2 | P3643 See Note 2 | 2 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1263 C1613 C2693 C2823 C3642 C3643 See Note 2 | P3642 See Note 2 | 2 See Note 2 | 3 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1263 C1613 C2693 C2823 C3642 C3643 See Note 2 | P1263 P1613 P2693 P2823 See Note 2 | 1 See Note 2 | 5 See Note 2 | |\n| | Powder for oral solution 510 g | Oral | MediHealth ClearLax | ON | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3643 | 2 | 0 | |\n| | | | OsmoLax | KY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3643 | 2 | 0 | |\n| | | | your pharmacy Clear Laxative | OY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3643 | 2 | 0 | |\n| | | | MediHealth ClearLax | ON | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3642 | 2 | 3 | |\n| | | | OsmoLax | KY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3642 | 2 | 3 | |\n| | | | your pharmacy Clear Laxative | OY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P3642 | 2 | 3 | |\n| | | | MediHealth ClearLax | ON | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P1263 P1613 P2693 P2823 | 1 | 5 | |\n| | | | OsmoLax | KY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P1263 P1613 P2693 P2823 | 1 | 5 | |\n| | | | your pharmacy Clear Laxative | OY | MP NP | C1263 C1613 C2693 C2823 C3642 C3643 | P1263 P1613 P2693 P2823 | 1 | 5 | |\n| Magnesium | Tablet 37.4 mg (as aspartate dihydrate) | Oral | Mag-Sup | PP | MP NP | C3937 C3938 | | 50 | 5 | |\n| Mannitol | Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers | Inhalation by mouth | bronchitol | XA | MP See Note 1 | C4061 C4062 C4063 C4064 | | 4 | 5 | D |\n| Maraviroc | Tablet 150 mg | Oral | Celsentri | VI | MP See Note 1 | C3598 C3599 | | 120 | 5 | D |\n| | Tablet 300 mg | Oral | Celsentri | VI | MP See Note 1 | C3598 C3599 | | 120 | 5 | D |\n| Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 500 mg | Oral | Provera | PF | MP | C1543 | | 30 | 2 | |\n| | Tablet containing medroxyprogesterone acetate 100 mg | Oral | Provera | PF | MP | C1088 C1542 | | 100 | 2 | |\n| | Tablet containing medroxyprogesterone acetate 200 mg | Oral | Provera | PF | MP | C1088 C1542 | | 60 | 2 | |\n| | Tablet containing medroxyprogesterone acetate 250 mg | Oral | Provera | PF | MP | C1088 C1542 | | 60 | 2 | |\n| | Tablet containing medroxyprogesterone acetate 5 mg | Oral | Provera | PF | MP NP | | | 56 | 2 | |\n| | | | Ralovera | FZ | MP NP | | | 56 | 2 | |\n| | Tablet containing medroxyprogesterone acetate 10 mg | Oral | Medroxyprogesterone Sandoz | SZ | MP NP | | | 30 | 2 | |\n| | | | Provera | PF | MP NP | | | 30 | 2 | |\n| | | | Ralovera | KR | MP NP | | | 30 | 2 | |\n| | | | Provera | PF | MP | | P1089 | 100 | 2 | |\n| | | | Ralovera | FZ | MP | | P1089 | 100 | 2 | |\n| | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | Depo-Provera | PF | MP NP | | | 1 | 1 | |\n| | | | Depo-Ralovera | FZ | MP NP | | | 1 | 1 | |\n| Mefenamic Acid | Capsule 250 mg | Oral | Ponstan | PF | MP NP | C1087 C1222 | | 50 | 2 | |\n| Megestrol | Tablet containing megestrol acetate 160 mg | Oral | Megace | QA | MP | C1543 | | 30 | 2 | |\n| Meloxicam | Tablet 7.5 mg | Oral | Chem mart Meloxicam 7.5 mg | CH | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | GenRx Meloxicam | GX | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxibell | GQ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam-GA | GM | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam-PS | FZ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam Ranbaxy | RA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam Sandoz | SZ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Movalis 7.5 | QA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Moxicam 7.5 | AF | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Pharmacor Meloxicam 7.5 | CR | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Terry White Chemists Meloxicam 7.5 mg | TW | MP NP | C1547 C1848 | | 30 | 3 | |\n| | Tablet 15 mg | Oral | Chem mart Meloxicam 15 mg | CH | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | GenRx Meloxicam | GX | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxibell | GQ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam-GA | GM | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam-PS | FZ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam Ranbaxy | RA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Meloxicam Sandoz | SZ | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Movalis 15 | QA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Moxicam 15 | AF | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Pharmacor Meloxicam 15 | CR | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Terry White Chemists Meloxicam 15 mg | TW | MP NP | C1547 C1848 | | 30 | 3 | |\n| | Capsule 7.5 mg | Oral | APO-Meloxicam | TX | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Chem mart Meloxicam | CH | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Melox 7.5 | GM | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Movalis 7.5 | QA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Terry White Chemists Meloxicam | TW | MP NP | C1547 C1848 | | 30 | 3 | |\n| | Capsule 15 mg | Oral | APO-Meloxicam | TX | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Chem mart Meloxicam | CH | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Melox 15 | GM | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Movalis 15 | QA | MP NP | C1547 C1848 | | 30 | 3 | |\n| | | | Terry White Chemists Meloxicam | TW | MP NP | C1547 C1848 | | 30 | 3 | |\n| Melphalan | Tablet 2 mg | Oral | Alkeran | AS | MP | | | 25 | 1 | |\n| Memantine | Tablet containing memantine hydrochloride 10 mg | Oral | APO-Memantine | TX | MP NP | C2609 C2611 C3877 C3878 | | 56 | 5 | |\n| | | | Ebixa | LU | MP NP | C2609 C2611 C3877 C3878 | | 56 | 5 | |\n| | | | Memanxa | QA | MP NP | C2609 C2611 C3877 C3878 | | 56 | 5 | |\n| | Tablet containing memantine hydrochloride 20 mg | Oral | Ebixa | LU | MP NP | C2609 C2611 C3877 C3878 | | 28 | 5 | |\n| Mercaptopurine | Tablet 50 mg | Oral | Purinethol | AS | MP | | | 100 | 2 | |\n| Mesalazine | Tablet 250 mg (enteric coated) | Oral | Mesasal | GK | MP NP | C1708 C1709 C2268 C2269 | | 100 | 5 | |\n| | Tablet 500 mg (enteric coated) | Oral | Salofalk | OA | MP NP | C1708 C1709 C2268 C2269 | | 200 | 5 | |\n| | Tablet 500 mg (prolonged release) | Oral | Pentasa | FP | MP NP | C1708 C1709 C2268 C2269 | | 200 | 5 | |\n| | Tablet 1 g (prolonged release) | Oral | Pentasa | FP | MP NP | C1708 C1709 C2268 C2269 | | 120 | 5 | |\n| | Tablet 1.2 g (prolonged release) | Oral | Mezavant | ZI | MP NP | C1708 C1709 | | 60 | 5 | |\n| | Sachet containing prolonged release granules, 1 g per sachet | Oral | Pentasa | FP | MP NP | C1708 C1709 C2268 C2269 | | 120 | 5 | |\n| | Sachet containing prolonged release granules, 2 g per sachet | Oral | Pentasa | FP | MP NP | C1708 C1709 C2268 C2269 | | 60 | 5 | |\n| | Sachet containing granules, 500 mg per sachet | Oral | Salofalk | OA | MP NP | C1708 C1709 | | 200 | 5 | |\n| | Sachet containing granules, 1 g per sachet | Oral | Salofalk | OA | MP NP | C1708 C1709 | | 100 | 5 | |\n| | Sachet containing granules, 1.5 g per sachet | Oral | Salofalk | OA | MP NP | C1708 C1709 | | 60 | 5 | |\n| | Suppository 1 g | Rectal | Pentasa | FP | MP NP | C1978 | | 30 | 1 | |\n| | Suppository 1g (moulded) | Rectal | Salofalk | OA | MP NP | C1978 | | 30 | 1 | |\n| | Enemas 1 g in 100 mL, 7 | Rectal | Pentasa | FP | MP NP | C1707 | | 4 | 1 | |\n| | Enemas 2 g in 60 mL, 7 | Rectal | Salofalk | OA | MP NP | C1707 | | 4 | 1 | |\n| | Enemas 4 g in 60 mL, 7 | Rectal | Salofalk | OA | MP NP | C1707 | | 4 | 1 | |\n| | Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | Rectal | Salofalk | OA | MP NP | C1707 | | 4 | 1 | |\n| Mesna | Solution for I.V. injection 400 mg in 4 mL ampoule | Injection | Uromitexan | BX | MP See Note 1 | C1618 | | 15 | 5 | |\n| | Solution for I.V. injection 1 g in 10 mL ampoule | Injection | Uromitexan | BX | MP See Note 1 | C1618 | | 15 | 5 | |\n| Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | APO-Metformin 500 | TX | MP NP | | | 100 | 5 | |\n| | | | Chem mart Metformin | CH | MP NP | | | 100 | 5 | |\n| | | | Diabex | AL | MP NP | | | 100 | 5 | |\n| | | | Diaformin | AF | MP NP | | | 100 | 5 | |\n| | | | Formet Aspen 500 | AS | MP NP | | | 100 | 5 | |\n| | | | Formet 500 | QA | MP NP | | | 100 | 5 | |\n| | | | GenRx Metformin | GX | MP NP | | | 100 | 5 | |\n| | | | Glucobete 500 | DO | MP NP | | | 100 | 5 | |\n| | | | Glucophage | MQ | MP NP | | | 100 | 5 | |\n| | | | Metformin 500 | CR | MP NP | | | 100 | 5 | |\n| | | | Metformin-GA | GM | MP NP | | | 100 | 5 | |\n| | | | Metformin generichealth | GQ | MP NP | | | 100 | 5 | |\n| | | | Metformin Pfizer | FZ | MP NP | | | 100 | 5 | |\n| | | | Metformin Ranbaxy | RA | MP NP | | | 100 | 5 | |\n| | | | Metformin Sandoz | SZ | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Metformin | TW | MP NP | | | 100 | 5 | |\n| | Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | Diabex XR | AL | MP NP | | | 120 | 5 | |\n| | | | Diaformin XR | AF | MP NP | | | 120 | 5 | |\n| | | | Metex XR | QA | MP NP | | | 120 | 5 | |\n| | Tablet containing metformin hydrochloride 850 mg | Oral | APO-Metformin 850 | TX | MP NP | | | 60 | 5 | |\n| | | | Chem mart Metformin | CH | MP NP | | | 60 | 5 | |\n| | | | Diabex 850 | AL | MP NP | | | 60 | 5 | |\n| | | | Diaformin 850 | AF | MP NP | | | 60 | 5 | |\n| | | | Formet Aspen 850 | AS | MP NP | | | 60 | 5 | |\n| | | | Formet 850 | QA | MP NP | | | 60 | 5 | |\n| | | | GenRx Metformin | GX | MP NP | | | 60 | 5 | |\n| | | | Glucobete 850 | DO | MP NP | | | 60 | 5 | |\n| | | | Glucophage | MQ | MP NP | | | 60 | 5 | |\n| | | | Metformin 850 | CR | MP NP | | | 60 | 5 | |\n| | | | Metformin-GA | GM | MP NP | | | 60 | 5 | |\n| | | | Metformin generichealth | GQ | MP NP | | | 60 | 5 | |\n| | | | Metformin Pfizer | FZ | MP NP | | | 60 | 5 | |\n| | | | Metformin Ranbaxy | RA | MP NP | | | 60 | 5 | |\n| | | | Metformin Sandoz | SZ | MP NP | | | 60 | 5 | |\n| | | | Terry White Chemists Metformin | TW | MP NP | | | 60 | 5 | |\n| | Tablet containing metformin hydrochloride 1 g | Oral | APO-Metformin 1000 | TX | MP NP | | | 90 | 5 | |\n| | | | Chem mart Metformin 1000 | CH | MP NP | | | 90 | 5 | |\n| | | | Diabex 1000 | AL | MP NP | | | 90 | 5 | |\n| | | | Diaformin 1000 | AF | MP NP | | | 90 | 5 | |\n| | | | Formet 1000 | QA | MP NP | | | 90 | 5 | |\n| | | | Glucobete 1000 | DO | MP NP | | | 90 | 5 | |\n| | | | Metformin-GA | GM | MP NP | | | 90 | 5 | |\n| | | | Metformin generichealth 1000 | GQ | MP NP | | | 90 | 5 | |\n| | | | Metformin Pfizer | FZ | MP NP | | | 90 | 5 | |\n| | | | Metformin Ranbaxy 1000 | RA | MP NP | | | 90 | 5 | |\n| | | | Metformin Sandoz | SZ | MP NP | | | 90 | 5 | |\n| | | | Pharmacor Metformin 1000 | CR | MP NP | | | 90 | 5 | |\n| | | | Terry White Chemists Metformin 1000 | TW | MP NP | | | 90 | 5 | |\n| | Tablet (extended release) containing metformin hydrochloride 1 g | Oral | Diabex XR 1000 | AL | MP NP | | | 60 | 5 | |\n| Metformin with Glibenclamide | Tablet containing metformin hydrochloride 250 mg with glibenclamide 1.25 mg | Oral | Glucovance 250mg/1.25mg | AL | MP NP | | | 90 | 5 | |\n| | Tablet containing metformin hydrochloride 500 mg with glibenclamide 2.5 mg | Oral | Glucovance 500mg/2.5mg | AL | MP NP | | | 90 | 5 | |\n| | Tablet containing metformin hydrochloride 500 mg with glibenclamide 5 mg | Oral | Glucovance 500mg/5mg | AL | MP NP | | | 90 | 5 | |\n| Methadone | Tablet containing methadone hydrochloride 10 mg | Oral | Physeptone | QA | MP NP | C1358 | | 20 | 0 | |\n| | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL | Oral | Biodone Forte | MW | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | | | Sigma Methadone Syrup | QA | MP NP See Note 1 | C3659 C3660 See Note 2 | P3660 See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C3659 C3660 See Note 2 | P3659 See Note 2 | 1 See Note 2 | 2 See Note 2 | |\n| | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 1 L | Oral | Biodone Forte | MW | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | | | Sigma Methadone Syrup | QA | MP NP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Injection containing methadone hydrochloride 10 mg in 1 mL | Injection | Physeptone | QA | MP NP | C1358 | | 5 | 0 | |\n| Methotrexate | Tablet 2.5 mg | Oral | Hospira Pty Limited | HH | MP | | | 30 | 5 | |\n| | | | Methoblastin | PF | MP | | | 30 | 5 | |\n| | Tablet 10 mg | Oral | Methoblastin | PF | MP | | | 15 | 3 | |\n| | | | | | MP | | P2884 | 50 | 2 | |\n| | Injection 5 mg in 2 mL vial | Injection | Hospira Pty Limited | HH | MP | | See Note 2 | 5 See Note 2 | 0 See Note 2 | |\n| | Injection 50 mg in 2 mL vial | Injection | Hospira Pty Limited | HH | MP | | See Note 2 | 5 See Note 2 | 5 See Note 2 | |\n| | | | Methaccord | WQ | MP | | See Note 2 | 5 See Note 2 | 5 See Note 2 | |\n| | | | Pfizer Australia Pty Ltd | PF | MP | | See Note 2 | 5 See Note 2 | 5 See Note 2 | |\n| | Solution concentrate for I.V. infusion 500 mg in 20 mL vial | Injection | Hospira Pty Limited | HH | MP | | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Solution concentrate for I.V. infusion 1000 mg in 10 mL vial | Injection | Hospira Pty Limited | HH | MP | | See Note 3 | See Note 3 | See Note 3 | PB |\n| | | | Methaccord | WQ | MP | | See Note 3 | See Note 3 | See Note 3 | PB |\n| | | | Methotrexate Ebewe | SZ | MP | | See Note 3 | See Note 3 | See Note 3 | PB |\n| | Solution concentrate for I.V. infusion 5000 mg in 50 mL vial | Injection | Methotrexate Ebewe | SZ | MP | | See Note 3 | See Note 3 | See Note 3 | PB |\n| Methoxyflurane | Liquid for inhalation 999.9 mg per g, 3 mL (with inhaler) | Inhalation by mouth | Penthrox | DV | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Methoxy polyethylene glycol-epoetin beta | Injection 30 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 50 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 75 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 100 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 120 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 200 micrograms in 0.3 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| | Injection 360 micrograms in 0.6 mL pre-filled syringe | Injection | Mircera | RO | MP See Note 1 | C1957 C3334 | | 2 | 5 | D |\n| Methyldopa | Tablet 250 mg | Oral | Aldomet | AS | MP NP | | | 100 | 5 | |\n| | | | Hydopa | AF | MP NP | | | 100 | 5 | |\n| Methylnaltrexone | Solution for injection containing methylnaltrexone bromide 12 mg in 0.6 mL | Injection | Relistor | LM | MP NP | C3235 C3238 | P3235 | 3 | 0 | |\n| | | | | | MP NP | C3235 C3238 | P3238 | 7 | 0 | |\n| Methylphenidate | Tablet containing methylphenidate hydrochloride 10 mg | Oral | Ritalin 10 | NV | MP NP | C1461 | | 100 | 5 | |\n| | Tablet containing methylphenidate hydrochloride 18 mg (extended release) | Oral | Concerta | JC | MP NP | C3188 | | 30 | 5 | |\n| | Tablet containing methylphenidate hydrochloride 27 mg (extended release) | Oral | Concerta | JC | MP NP | C3188 | | 30 | 5 | |\n| | Tablet containing methylphenidate hydrochloride 36 mg (extended release) | Oral | Concerta | JC | MP NP | C3188 | | 30 | 5 | |\n| | Tablet containing methylphenidate hydrochloride 54 mg (extended release) | Oral | Concerta | JC | MP NP | C3188 | | 30 | 5 | |\n| | Capsule containing methylphenidate hydrochloride 10 mg (modified release) | Oral | Ritalin LA | NV | MP NP | C3189 | | 30 | 5 | |\n| | Capsule containing methylphenidate hydrochloride 20 mg (modified release) | Oral | Ritalin LA | NV | MP NP | C3189 | | 30 | 5 | |\n| | Capsule containing methylphenidate hydrochloride 30 mg (modified release) | Oral | Ritalin LA | NV | MP NP | C3189 | | 30 | 5 | |\n| | Capsule containing methylphenidate hydrochloride 40 mg (modified release) | Oral | Ritalin LA | NV | MP NP | C3189 | | 30 | 5 | |\n| Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection | Depo-Medrol | PF | MP NP PDP | C1102 | | 5 | 0 | |\n| | | | Depo-Nisolone | FZ | MP NP PDP | C1102 | | 5 | 0 | |\n| | Powder for injection 40 mg (as sodium succinate) | Injection | Methylpred | AS | MP NP | | | 5 | 0 | |\n| | Powder for injection 40 mg (as sodium succinate) with diluent | Injection | Solu-Medrol | PF | MP NP | | | 5 | 0 | |\n| | Powder for injection 1 g (as sodium succinate) with diluent | Injection | Solu-Medrol | PF | MP NP | | | 1 | 0 | |\n| | Powder for injection 1 g (as sodium succinate) | Injection | Methylpred | AS | MP NP | | | 1 | 0 | |\n| | | | Methylprednisolone Alphapharm | AF | MP NP | | | 1 | 0 | |\n| | Cream containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan | CS | MP NP | C1422 | | 1 | 0 | |\n| | Ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan | CS | MP NP | C1422 | | 1 | 0 | |\n| | Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application | Advantan | CS | MP NP | C1422 | | 1 | 0 | |\n| | Lotion containing methylprednisolone aceponate 1 mg per g, 20 g | Application | Advantan | CS | MP NP | C1622 | | 1 | 0 | |\n| Methysergide | Tablet 1 mg (as maleate) | Oral | Deseril | LM | MP NP | | | 100 | 2 | |\n| Metoclopramide | Tablet containing metoclopramide hydrochloride 10 mg | Oral | Maxolon | VT | MP NP MW PDP | | | 25 | 0 | |\n| | | | Pramin | AF | MP NP MW PDP | | | 25 | 0 | |\n| | Injection containing metoclopramide hydrochloride 10 mg in 2 mL | Injection | Maxolon | VT | MP NP MW PDP | | | 10 | 0 | |\n| Metoprolol | Tablet containing metoprolol tartrate 50 mg | Oral | Betaloc | AP | MP NP | | | 100 | 5 | |\n| | | | Chem mart Metoprolol | CH | MP NP | | | 100 | 5 | |\n| | | | GenRx Metoprolol | GX | MP NP | | | 100 | 5 | |\n| | | | Lopresor 50 | NV | MP NP | | | 100 | 5 | |\n| | | | Metohexal | SZ | MP NP | | | 100 | 5 | |\n| | | | Metrol 50 | QA | MP NP | | | 100 | 5 | |\n| | | | Minax 50 | AF | MP NP | | | 100 | 5 | |\n| | | | Terry White Chemists Metoprolol | TW | MP NP | | | 100 | 5 | |\n| | Tablet containing metoprolol tartrate 100 mg | Oral | Betaloc | AP | MP NP | | | 60 | 5 | |\n| | | | Chem mart Metoprolol | CH | MP NP | | | 60 | 5 | |\n| | | | GenRx Metoprolol | GX | MP NP | | | 60 | 5 | |\n| | | | Lopresor 100 | NV | MP NP | | | 60 | 5 | |\n| | | | Metohexal | SZ | MP NP | | | 60 | 5 | |\n| | | | Metrol 100 | QA | MP NP | | | 60 | 5 | |\n| | | | Minax 100 | AF | MP NP | | | 60 | 5 | |\n| | | | Terry White Chemists Metoprolol | TW | MP NP | | | 60 | 5 | |\n| Metoprolol succinate | Tablet 23.75 mg (controlled release) | Oral | Toprol-XL 23.75 | AP | MP NP | C3234 | | 15 | 0 | |\n| | Tablet 47.5 mg (controlled release) | Oral | Toprol-XL 47.5 | AP | MP NP | C3234 | | 30 | 5 | |\n| | Tablet 95 mg (controlled release) | Oral | Toprol-XL 95 | AP | MP NP | C3234 | | 30 | 5 | |\n| | Tablet 190 mg (controlled release) | Oral | Toprol-XL 190 | AP | MP NP | C3234 | | 30 | 5 | |\n| Metronidazole | Tablet 400 mg | Oral | Flagyl | SW | PDP | | P1416 | 21 | 0 | |\n| | | | Metrogyl 400 | AF | PDP | | P1416 | 21 | 0 | |\n| | | | Metronide 400 | AV | PDP | | P1416 | 21 | 0 | |\n| | | | Flagyl | SW | MP NP | | P1416 | 21 | 1 | |\n| | | | Metrogyl 400 | AF | MP NP | | P1416 | 21 | 1 | |\n| | | | Metronide 400 | AV | MP NP | | P1416 | 21 | 1 | |\n| | Tablet 200 mg | Oral | Flagyl | SW | PDP | | | 21 | 0 | |\n| | | | Metrogyl 200 | AF | PDP | | | 21 | 0 | |\n| | | | Metronide 200 | AV | PDP | | | 21 | 0 | |\n| | | | Flagyl | SW | MP NP | | | 21 | 1 | |\n| | | | Metrogyl 200 | AF | MP NP | | | 21 | 1 | |\n| | | | Metronide 200 | AV | MP NP | | | 21 | 1 | |\n| | Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral | Flagyl S | SW | MP NP PDP | | | 1 | 0 | |\n| | I.V. infusion 500 mg in 100 mL | Injection | Baxter Healthcare Pty Ltd | BX | PDP | C1448 | | 5 | 0 | |\n| | | | DBL Metronidazole Intravenous Infusion | HH | PDP | C1448 | | 5 | 0 | |\n| | | | Baxter Healthcare Pty Ltd | BX | MP NP | C1300 C1448 | | 5 | 1 | |\n| | | | DBL Metronidazole Intravenous Infusion | HH | MP NP | C1300 C1448 | | 5 | 1 | |\n| | Suppositories 500 mg, 10 | Rectal | Flagyl | SW | MP NP PDP | | | 1 | 0 | |\n| Mianserin | Tablet containing mianserin hydrochloride 10 mg | Oral | Lumin 10 | AF | MP NP | C1355 | | 50 | 5 | |\n| | | | Tolvon | MK | MP NP | C1355 | | 50 | 5 | |\n| | Tablet containing mianserin hydrochloride 20 mg | Oral | Lumin 20 | AF | MP NP | C1355 | | 50 | 5 | |\n| | | | Tolvon | MK | MP NP | C1355 | | 50 | 5 | |\n| Miconazole | Cream containing miconazole nitrate 20 mg per g, 15 g | Application | Daktarin | JT | MP NP | C2354 | | 2 | 3 | |\n| | Cream containing miconazole nitrate 20 mg per g, 30 g | Application | Daktarin | JT | MP NP | C2354 | | 1 | 2 | |\n| | Cream containing miconazole nitrate 20 mg per g, 70 g | Application | Daktarin | JT | MP NP | C2354 | | 1 | 1 | |\n| | Powder containing miconazole nitrate 20 mg per g, 30 g | Application | Daktarin | JT | MP NP | C2354 | | 1 | 2 | |\n| | Tincture 20 mg per mL, 30 mL | Application | Daktarin | JT | MP NP | C2354 | | 1 | 2 | |\n| | Lotion containing miconazole nitrate 20 mg per mL, 30 g | Application | Daktarin | JT | MP NP | C2354 | | 1 | 2 | |\n| Milk powder — lactose free formula | Oral powder 900 g (S-26 LF) | Oral | S-26 LF | PF | MP NP | C2760 C2762 | P2762 | 5 | 0 | |\n| | | | | | MP NP | C2760 C2762 | P2760 | 5 | 5 | |\n| | Oral powder 900 g (Karicare Aptamil De-Lact) | Oral | Karicare Aptamil De-Lact | NU | MP NP | C2760 C2762 | P2762 | 5 | 0 | |\n| | | | | | MP NP | C2760 C2762 | P2760 | 5 | 5 | |\n| Milk powder — lactose modified | Oral powder 900 g (Digestelact) | Oral | Digestelact | SJ | MP NP | C1790 C2761 | P1790 | 3 | 1 | |\n| | | | | | MP NP | C1790 C2761 | P2761 | 3 | 10 | |\n| Milk powder — synthetic | Low calcium oral powder 400 g (Locasol) | Oral | Locasol | SB | MP NP | C1158 | | 8 | 5 | |\n| Milk protein and fat formula with vitamins and minerals — carbohydrate free | Oral powder 225 g (Carbohydrate Free Mixture) | Oral | Carbohydrate Free Mixture | SB | MP NP | C1578 C1579 C1580 C1581 | | 24 | 5 | |\n| Minocycline | Tablet 50 mg (as hydrochloride) | Oral | Akamin 50 | AF | MP NP | C1347 | | 60 | 5 | |\n| | | | Minomycin-50 | QA | MP NP | C1347 | | 60 | 5 | |\n| Minoxidil | Tablet 10 mg | Oral | Loniten | PF | MP NP | C2759 | | 100 | 5 | |\n| Mirtazapine | Tablet 15 mg | Oral | Axit 15 | AF | MP NP | C1211 | | 30 | 5 | |\n| | Tablet 15 mg (orally disintegrating) | Oral | Avanza SolTab | MK | MP NP | C1211 | | 30 | 5 | |\n| | | | Milivin OD 15 | DO | MP NP | C1211 | | 30 | 5 | |\n| | Tablet 30 mg | Oral | Aurozapine 30 | DO | MP NP | C1211 | | 30 | 5 | |\n| | | | Avanza | MK | MP NP | C1211 | | 30 | 5 | |\n| | | | Axit 30 | AF | MP NP | C1211 | | 30 | 5 | |\n| | | | Chem mart Mirtazapine | CH | MP NP | C1211 | | 30 | 5 | |\n| | | | GenRx Mirtazapine | GX | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazapine-DP | GM | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazapine GH | GQ | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazapine Sandoz | SZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazon | QA | MP NP | C1211 | | 30 | 5 | |\n| | | | Terry White Chemists Mirtazapine | TW | MP NP | C1211 | | 30 | 5 | |\n| | Tablet 30 mg (orally disintegrating) | Oral | Avanza SolTab | MK | MP NP | C1211 | | 30 | 5 | |\n| | | | Milivin OD 30 | DO | MP NP | C1211 | | 30 | 5 | |\n| | Tablet 45 mg | Oral | APO-Mirtazapine | TX | MP NP | C1211 | | 30 | 5 | |\n| | | | Aurozapine 45 | DO | MP NP | C1211 | | 30 | 5 | |\n| | | | Avanza | MK | MP NP | C1211 | | 30 | 5 | |\n| | | | Axit 45 | AF | MP NP | C1211 | | 30 | 5 | |\n| | | | Chem mart Mirtazapine | CH | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazapine GH | GQ | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazapine Sandoz | SZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Mirtazon | QA | MP NP | C1211 | | 30 | 5 | |\n| | | | Terry White Chemists Mirtazapine | TW | MP NP | C1211 | | 30 | 5 | |\n| | Tablet 45 mg (orally disintegrating) | Oral | Avanza SolTab | MK | MP NP | C1211 | | 30 | 5 | |\n| | | | Milivin OD 45 | DO | MP NP | C1211 | | 30 | 5 | |\n| Misoprostol | Tablet 200 micrograms | Oral | Cytotec | PF | MP | C2630 C2631 C2632 | | 120 | 2 | |\n| Mitozantrone | Injection 20 mg (as hydrochloride) in 10 mL | Injection | Hospira Pty Limited | HH | MP | | | See Note 3 | See Note 3 | D |\n| | | | Mitozantrone Ebewe | SZ | MP | | | See Note 3 | See Note 3 | D |\n| | | | Onkotrone | BX | MP | | | See Note 3 | See Note 3 | D |\n| | Injection 25 mg (as hydrochloride) in 12.5 mL | Injection | Onkotrone | BX | MP | | | See Note 3 | See Note 3 | D |\n| Moclobemide | Tablet 150 mg | Oral | Amira 150 | AF | MP NP | C1211 | | 60 | 5 | |\n| | | | Aurorix | VP | MP NP | C1211 | | 60 | 5 | |\n| | | | Chem mart Moclobemide | CH | MP NP | C1211 | | 60 | 5 | |\n| | | | Clobemix | GM | MP NP | C1211 | | 60 | 5 | |\n| | | | GenRx Moclobemide | GX | MP NP | C1211 | | 60 | 5 | |\n| | | | Moclobemide-PS | FZ | MP NP | C1211 | | 60 | 5 | |\n| | | | Moclobemide Sandoz | SZ | MP NP | C1211 | | 60 | 5 | |\n| | | | Mohexal | HX | MP NP | C1211 | | 60 | 5 | |\n| | | | Terry White Chemists Moclobemide | TW | MP NP | C1211 | | 60 | 5 | |\n| | Tablet 300 mg | Oral | Amira 300 | AF | MP NP | C1211 | | 60 | 5 | |\n| | | | Aurorix 300 mg | VP | MP NP | C1211 | | 60 | 5 | |\n| | | | Chem mart Moclobemide | CH | MP NP | C1211 | | 60 | 5 | |\n| | | | Clobemix | GM | MP NP | C1211 | | 60 | 5 | |\n| | | | GenRx Moclobemide | GX | MP NP | C1211 | | 60 | 5 | |\n| | | | Moclobemide-PS | FZ | MP NP | C1211 | | 60 | 5 | |\n| | | | Moclobemide Sandoz | SZ | MP NP | C1211 | | 60 | 5 | |\n| | | | Terry White Chemists Moclobemide | TW | MP NP | C1211 | | 60 | 5 | |\n| Modafinil | Tablet 100 mg | Oral | Modavigil | CS | MP | C2090 C3145 | | 120 | 5 | |\n| Mometasone | Cream containing mometasone furoate 1 mg per g, 15 g | Application | Elocon | MK | MP NP | C1422 | | 1 | 0 | |\n| | Ointment containing mometasone furoate 1 mg per g, 15 g | Application | Elocon | MK | MP NP | C1422 | | 1 | 0 | |\n| | Lotion containing mometasone furoate 1 mg per g, 30 mL | Application | Elocon | MK | MP NP | C1422 | | 1 | 0 | |\n| Montelukast | Tablet, chewable, 4 mg (as sodium) | Oral | Singulair | MK | MP NP | C2617 | | 28 | 5 | |\n| | Tablet, chewable, 5 mg (as sodium) | Oral | Singulair | MK | MP NP | C2618 C3217 | | 28 | 5 | |\n| Morphine | Tablet containing morphine sulfate 10 mg | Oral | Sevredol | MF | MP NP | C1789 C3661 C3662 | P1789 P3662 | 20 | 0 | |\n| | | | | | MP NP | C1789 C3661 C3662 | P3661 | 20 | 2 | |\n| | Tablet containing morphine sulfate 20 mg | Oral | Sevredol | MF | MP NP | C1789 C3661 C3662 | P1789 P3662 | 20 | 0 | |\n| | | | | | MP NP | C1789 C3661 C3662 | P3661 | 20 | 2 | |\n| | Tablet containing morphine sulfate 30 mg | Oral | Anamorph | FM | MP NP PDP | C1358 | | 20 | 0 | |\n| | Tablet containing morphine sulfate 5 mg (controlled release) | Oral | MS Contin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 10 mg (controlled release) | Oral | APOTEX-MORPHINE MR | TX | MP NP | C1062 | | 28 | 0 | |\n| | | | Momex SR 10 | QA | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 15 mg (controlled release) | Oral | MS Contin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 30 mg (controlled release) | Oral | APOTEX-MORPHINE MR | TX | MP NP | C1062 | | 28 | 0 | |\n| | | | Momex SR 30 | QA | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 60 mg (controlled release) | Oral | APOTEX-MORPHINE MR | TX | MP NP | C1062 | | 28 | 0 | |\n| | | | Momex SR 60 | QA | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 100 mg (controlled release) | Oral | APOTEX-MORPHINE MR | TX | MP NP | C1062 | | 28 | 0 | |\n| | | | Momex SR 100 | QA | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing morphine sulfate 200 mg (controlled release) | Oral | MS Contin | MF | MP NP | C1499 C3659 C3660 | P1499 P3660 | 28 | 0 | |\n| | | | | | MP NP | C1499 C3659 C3660 | P3659 | 28 | 2 | |\n| | Capsule containing morphine sulfate 10 mg (containing sustained release pellets) | Oral | Kapanol | GK | MP NP | C1062 | | 28 | 0 | |\n| | Capsule containing morphine sulfate 20 mg (containing sustained release pellets) | Oral | Kapanol | GK | MP NP | C1062 | | 28 | 0 | |\n| | Capsule containing morphine sulfate 30 mg (controlled release) | Oral | MS Mono | MF | MP NP | C1062 | | 14 | 0 | |\n| | Capsule containing morphine sulfate 50 mg (containing sustained release pellets) | Oral | Kapanol | GK | MP NP | C1062 | | 28 | 0 | |\n| | Capsule containing morphine sulfate 60 mg (controlled release) | Oral | MS Mono | MF | MP NP | C1062 | | 14 | 0 | |\n| | Capsule containing morphine sulfate 90 mg (controlled release) | Oral | MS Mono | MF | MP NP | C1062 | | 14 | 0 | |\n| | Capsule containing morphine sulfate 100 mg (containing sustained release pellets) | Oral | Kapanol | GK | MP NP | C1062 | | 28 | 0 | |\n| | Capsule containing morphine sulfate 120 mg (controlled release) | Oral | MS Mono | MF | MP NP | C1062 | | 14 | 0 | |\n| | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 20 mg per sachet | Oral | MS Contin Suspension 20 mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 30 mg per sachet | Oral | MS Contin Suspension 30 mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 60 mg per sachet | Oral | MS Contin Suspension 60 mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 100 mg per sachet | Oral | MS Contin Suspension 100 mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Sachet containing controlled release granules for oral suspension, containing morphine sulfate 200 mg per sachet | Oral | MS Contin Suspension 200 mg | MF | MP NP | C1499 | | 28 | 0 | |\n| | Oral solution containing morphine hydrochloride 2 mg per mL, 200 mL | Oral | Ordine 2 | MF | MP NP PDP | C1358 | | 1 | 0 | |\n| | Oral solution containing morphine hydrochloride 5 mg per mL, 200 mL | Oral | Ordine 5 | MF | MP NP PDP | C1358 | | 1 | 0 | |\n| | Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL | Oral | Ordine 10 | MF | MP NP PDP | C1358 | | 1 | 0 | |\n| | Injection containing morphine sulfate 10 mg in 1 mL | Injection | Hospira Pty Limited | HH | MP NP MW PDP | | | 5 | 0 | |\n| | Injection containing morphine tartrate 120 mg in 1.5 mL | Injection | Hospira Pty Limited | HH | MP NP | | | 5 | 0 | |\n| | Injection containing morphine sulfate 15 mg in 1 mL | Injection | Hospira Pty Limited | HH | MP NP MW PDP | | | 5 | 0 | |\n| | Injection containing morphine sulfate 30 mg in 1 mL | Injection | Hospira Pty Limited | HH | MP NP PDP | | | 5 | 0 | |\n| Moxonidine | Tablet 200 micrograms | Oral | Physiotens | AB | MP NP | C2385 | | 30 | 5 | |\n| | Tablet 400 micrograms | Oral | Physiotens | AB | MP NP | C2385 | | 30 | 5 | |\n| Mupirocin | Nasal ointment 20 mg (as calcium) per g, 3 g | Nasal | Bactroban | GK | MP NP | C3136 | | 1 | 0 | |\n| Mycophenolic Acid | Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral | Myfortic | NV | MP | C1763 | | 120 | 3 | |\n| | | | | | MP See Note 1 | C1650 C3355 | | 240 | 5 | C |\n| | Tablet (enteric coated) containing mycophenolate sodium equivalent to 360 mg mycophenolic acid | Oral | Myfortic | NV | MP | C1763 | | 120 | 3 | |\n| | | | | | MP See Note 1 | C1650 C3355 | | 240 | 5 | C |\n| | Capsule containing mycophenolate mofetil 250 mg | Oral | APO-Mycophenolate | TX | MP | C1765 C1766 | | 300 | 3 | |\n| | | | CellCept | RO | MP | C1765 C1766 | | 300 | 3 | |\n| | | | Ceptolate | AF | MP | C1765 C1766 | | 300 | 3 | |\n| | | | Imulate | QA | MP | C1765 C1766 | | 300 | 3 | |\n| | | | Mycophenolate Sandoz | SZ | MP | C1765 C1766 | | 300 | 3 | |\n| | | | Pharmacor Mycophenolate 250 | CR | MP | C1765 C1766 | | 300 | 3 | |\n| | | | APO-Mycophenolate | TX | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | | | CellCept | RO | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | | | Ceptolate | AF | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | | | Imulate | QA | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | | | Mycophenolate Sandoz | SZ | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | | | Pharmacor Mycophenolate 250 | CR | MP See Note 1 | C1650 C1651 C3355 C3356 | | 600 | 5 | C |\n| | Tablet containing mycophenolate mofetil 500 mg | Oral | APO-Mycophenolate | TX | MP | C1765 C1766 | | 150 | 3 | |\n| | | | CellCept | RO | MP | C1765 C1766 | | 150 | 3 | |\n| | | | Ceptolate | AF | MP | C1765 C1766 | | 150 | 3 | |\n| | | | Imulate | QA | MP | C1765 C1766 | | 150 | 3 | |\n| | | | Mycophenolate Sandoz | SZ | MP | C1765 C1766 | | 150 | 3 | |\n| | | | Pharmacor Mycophenolate 500 | CR | MP | C1765 C1766 | | 150 | 3 | |\n| | | | APO-Mycophenolate | TX | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | | | CellCept | RO | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | | | Ceptolate | AF | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | | | Imulate | QA | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | | | Mycophenolate Sandoz | SZ | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | | | Pharmacor Mycophenolate 500 | CR | MP See Note 1 | C1650 C1651 C3355 C3356 | | 300 | 5 | C |\n| | Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL | Oral | CellCept | RO | MP | C1765 C1766 | | 1 | 3 | |\n| | | | | | MP See Note 1 | C1650 C1651 C3355 C3356 | | 2 | 5 | C |\n| Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | Nasal | Synarel | PF | MP See Note 1 | C1172 C1389 See Note 2 | See Note 2 | 1 See Note 2 | 5 See Note 2 | |\n| Naloxone | Injection containing naloxone hydrochloride 2 mg in 5 mL disposable injection set | Injection | Naloxone Min-I-Jet | CS | MP NP PDP | | | 1 | 0 | |\n| Naltrexone | Tablet containing naltrexone hydrochloride 50 mg | Oral | Naltrexone generichealth | GQ | MP NP | C1135 | | 30 | 1 | |\n| | | | ReVia | BQ | MP NP | C1135 | | 30 | 1 | |\n| Nandrolone Decanoate | Injection 50 mg in 1 mL disposable syringe | Injection | Deca-Durabolin | MK | MP | C1262 C1976 C2024 C2025 C2026 | | 1 | 7 | |\n| Naproxen | Tablet 250 mg | Oral | Inza 250 | AF | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Naprosyn | RO | MP NP | C1036 C1054 C3645 C3646 | P3646 | 100 | 0 | |\n| | | | Inza 250 | AF | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | | | Naprosyn | RO | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 100 | 3 | |\n| | Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | RO | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Crysanal | MD | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Anaprox 550 | RO | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Crysanal | MD | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | Tablet 500 mg | Oral | Inza 500 | AF | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Naprosyn | RO | MP NP | C1036 C1054 C3645 C3646 | P3646 | 50 | 0 | |\n| | | | Inza 500 | AF | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | | | Naprosyn | RO | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 50 | 3 | |\n| | Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | RO | MP NP | C1036 C1054 C3645 C3646 | P3646 | 28 | 0 | |\n| | | | Proxen SR 750 | MD | MP NP | C1036 C1054 C3645 C3646 | P3646 | 28 | 0 | |\n| | | | Naprosyn SR750 | RO | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 28 | 3 | |\n| | | | Proxen SR 750 | MD | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 28 | 3 | |\n| | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | RO | MP NP | C1036 C1054 C3645 C3646 | P3646 | 28 | 0 | |\n| | | | Proxen SR 1000 | MD | MP NP | C1036 C1054 C3645 C3646 | P3646 | 28 | 0 | |\n| | | | Naprosyn SR1000 | RO | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 28 | 3 | |\n| | | | Proxen SR 1000 | MD | MP NP | C1036 C1054 C3645 C3646 | P1036 P1054 P3645 | 28 | 3 | |\n| Naratriptan | Tablet 2.5 mg (as hydrochloride) | Oral | Naramig | GK | MP NP | C3280 C3281 C3282 C3283 C3284 C3285 | | 4 | 5 | |\n| Natalizumab | Solution concentrate for I.V. infusion 300 mg in 15 mL | Injection | Tysabri | BD | MP See Note 1 | C3423 C3424 C3425 | | 1 | 5 | D |\n| Nebivolol | Tablet 1.25 mg (as hydrochloride), 28 | Oral | Nebilet | CS | MP NP | C3234 | | 1 | 5 | |\n| | Tablet 1.25 mg (as hydrochloride) | Oral | Nebilet | CS | MP NP | C3234 | | 56 | 5 | |\n| | Tablet 5 mg (as hydrochloride) | Oral | Nebilet | CS | MP NP | C3234 | | 28 | 5 | |\n| | Tablet 10 mg (as hydrochloride) | Oral | Nebilet | CS | MP NP | C3234 | | 28 | 5 | |\n| Nedocromil | Pressurised inhalation containing nedocromil sodium 2 mg per dose, 112 doses (CFC-free formulation) | Inhalation by mouth | Tilade CFC-Free | SW | MP NP | | | 1 | 5 | |\n| Neomycin with Bacitracin | Ear ointment 3.5 mg neomycin (as undecenoate) with bacitracin zinc 400 units per g, 10 g | Application to the ear | Nemdyn | HA | MP NP | | | 1 | 0 | |\n| Nevirapine | Tablet 200 mg | Oral | Viramune | BY | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Tablet 400 mg (extended release) | Oral | Viramune XR | BY | MP See Note 1 | C3587 C3589 C3994 C3995 | | 60 | 5 | D |\n| | Oral suspension 50 mg (as hemihydrate) per 5 mL, 240 mL | Oral | Viramune | BY | MP See Note 1 | C3586 C3587 C3588 C3589 | | 10 | 5 | D |\n| Nicorandil | Tablets 10 mg, 60 | Oral | Ikorel | SW | MP NP | | | 1 | 5 | |\n| | Tablets 20 mg, 60 | Oral | Ikorel | SW | MP NP | | | 1 | 5 | |\n| Nicotine | Transdermal patch 17.5 mg | Transdermal | Nicotinell Step 3 | NC | MP NP | C3447 C3448 | | 28 | 0 | |\n| | Transdermal patch 24.9 mg | Transdermal | Nicorette Patch | JT | MP NP | C3042 C3447 C3448 | | 28 | 2 | |\n| | Transdermal patch 35 mg | Transdermal | Nicotinell Step 2 | NC | MP NP | C3447 C3448 | | 28 | 0 | |\n| | Transdermal patch 52.5 mg | Transdermal | Nicotinell Step 1 | NC | MP NP | C3042 C3447 C3448 | P3447 P3448 | 28 | 0 | |\n| | | | | | MP NP | C3042 C3447 C3448 | P3042 | 28 | 2 | |\n| | Transdermal patch 114 mg | Transdermal | Nicabate P | GC | MP NP | C3042 C3447 C3448 | | 28 | 2 | |\n| Nifedipine | Tablet 10 mg | Oral | Adalat 10 | BN | MP NP | | | 60 | 5 | |\n| | | | Adefin 10 | AF | MP NP | | | 60 | 5 | |\n| | Tablet 20 mg | Oral | Adalat 20 | BN | MP NP | | | 60 | 5 | |\n| | | | Adefin 20 | AF | MP NP | | | 60 | 5 | |\n| | | | GenRx Nifedipine | GX | MP NP | | | 60 | 5 | |\n| | | | Nifehexal | SZ | MP NP | | | 60 | 5 | |\n| | Tablet 20 mg (controlled release) | Oral | Adalat Oros 20mg | BN | MP NP | | | 30 | 5 | |\n| | Tablet 30 mg (controlled release) | Oral | Adalat Oros 30 | BN | MP NP | | | 30 | 5 | |\n| | | | Addos XR 30 | QA | MP NP | | | 30 | 5 | |\n| | | | Adefin XL 30 | AF | MP NP | | | 30 | 5 | |\n| | | | APO-Nifedipine XR | TX | MP NP | | | 30 | 5 | |\n| | Tablet 60 mg (controlled release) | Oral | Adalat Oros 60 | BN | MP NP | | | 30 | 5 | |\n| | | | Addos XR 60 | QA | MP NP | | | 30 | 5 | |\n| | | | Adefin XL 60 | AF | MP NP | | | 30 | 5 | |\n| | | | APO-Nifedipine XR | TX | MP NP | | | 30 | 5 | |\n| Nilotinib | Capsule 150 mg (as hydrochloride monohydrate) | Oral | Tasigna | NV | MP | C4005 C4006 | | 120 | 5 | |\n| | Capsule 200 mg (as hydrochloride monohydrate) | Oral | Tasigna | NV | MP | C4001 C4002 | | 120 | 5 | |\n| Nilutamide | Tablet 150 mg | Oral | Anandron | SW | MP NP | C3300 C3675 | | 30 | 5 | |\n| Nitrazepam | Tablet 5 mg | Oral | Alodorm | AF | MP NP PDP | | | 25 | 0 | |\n| | | | Mogadon | VT | MP NP PDP | | | 25 | 0 | |\n| | | | Alodorm | AF | MP NP | | P3654 | 50 | 0 | |\n| | | | Mogadon | VT | MP NP | | P3654 | 50 | 0 | |\n| | | | Alodorm | AF | MP NP | | P3653 | 50 | 3 | |\n| | | | Mogadon | VT | MP NP | | P3653 | 50 | 3 | |\n| | | | Alodorm | AF | MP NP | | P1123 P1126 P1216 P1235 | 50 | 5 | |\n| | | | Mogadon | VT | MP NP | | P1123 P1126 P1216 P1235 | 50 | 5 | |\n| Nitrofurantoin | Capsule 50 mg | Oral | Macrodantin | PF | MP NP MW | | | 30 | 1 | |\n| | Capsule 100 mg | Oral | Macrodantin | PF | MP NP MW | | | 30 | 1 | |\n| Nizatidine | Capsule 150 mg | Oral | Nizac | LN | MP NP | | | 60 | 5 | |\n| | | | Tacidine | AF | MP NP | | | 60 | 5 | |\n| | | | Tazac | AS | MP NP | | | 60 | 5 | |\n| | Capsule 300 mg | Oral | Nizac | LN | MP NP | | | 30 | 5 | |\n| | | | Tacidine | AF | MP NP | | | 30 | 5 | |\n| | | | Tazac | AS | MP NP | | | 30 | 5 | |\n| Norethisterone | Tablets 350 micrograms, 28 | Oral | Locilan 28 Day | FZ | MP NP | | | 4 | 2 | |\n| | | | Micronor | JC | MP NP | | | 4 | 2 | |\n| | | | Noriday 28 Day | PF | MP NP | | | 4 | 2 | |\n| | Tablet 5 mg | Oral | Primolut N | BN | MP NP | | | 30 | 2 | |\n| Norethisterone with Ethinyloestradiol | Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets | Oral | Brevinor | PF | MP NP | | | 4 | 2 | |\n| | | | Norimin 28 Day | FZ | MP NP | | | 4 | 2 | |\n| | Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets | Oral | Brevinor-1 | PF | MP NP | | | 4 | 2 | |\n| | | | Norimin-1 28 Day | FZ | MP NP | | | 4 | 2 | |\n| | Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets | Oral | Improvil 28 Day | FZ | MP NP | | | 4 | 2 | |\n| Norethisterone with Mestranol | Pack containing 21 tablets 1 mg-50 micrograms and 7 inert tablets | Oral | Norinyl-1/28 | PF | MP NP | | | 4 | 2 | |\n| Norfloxacin | Tablet 400 mg | Oral | Chem mart Norfloxacin | CH | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | GenRx Norfloxacin | GX | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Norfloxacin-GA | GM | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Norfloxacin-PS | FZ | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Norfloxacin Sandoz | SZ | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Noroxin | MK | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Nufloxib | AF | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Roxin | QA | MP NP | C1002 C1070 | | 14 | 1 | |\n| | | | Terry White Chemists Norfloxacin | TW | MP NP | C1002 C1070 | | 14 | 1 | |\n| Nortriptyline | Tablet 10 mg (as hydrochloride) | Oral | Allegron | AS | MP NP | C1860 C1861 | | 50 | 2 | |\n| | Tablet 25 mg (as hydrochloride) | Oral | Allegron | AS | MP NP | C1860 C1861 | | 50 | 2 | |\n| Nystatin | Tablet 500,000 units | Oral | Nilstat | QA | MP NP PDP | | | 50 | 0 | |\n| | Capsule 500,000 units | Oral | Nilstat | QA | MP NP PDP | | | 50 | 0 | |\n| | Oral suspension 100,000 units per mL, 24 mL | Oral | Mycostatin | FM | PDP | | | 1 | 0 | |\n| | | | Nilstat | QA | PDP | | | 1 | 0 | |\n| | | | Mycostatin | FM | MP NP | | | 1 | 1 | |\n| | | | Nilstat | QA | MP NP | | | 1 | 1 | |\n| | Cream 100,000 units per g, 15 g | Application | Mycostatin | FM | MP NP | C2354 | | 2 | 3 | |\n| Octreotide | Injection 50 micrograms (as acetate) in 1 mL | Injection | Hospira Pty Limited | HH | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | | | Sandostatin 0.05 | NV | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | Injection 100 micrograms (as acetate) in 1 mL | Injection | Hospira Pty Limited | HH | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | | | Sandostatin 0.1 | NV | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | Injection 500 micrograms (as acetate) in 1 mL | Injection | Hospira Pty Limited | HH | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | | | Sandostatin 0.5 | NV | MP See Note 1 | C2622 C2623 C3407 C3408 | | 90 | 11 | D |\n| | Injection (modified release) 10 mg (as acetate), vial and diluent syringe | Injection | Sandostatin LAR | NV | MP See Note 1 | C2624 C2625 C3409 C3410 | | 1 | 11 | D |\n| | Injection (modified release) 20 mg (as acetate), vial and diluent syringe | Injection | Sandostatin LAR | NV | MP See Note 1 | C2624 C2625 C3409 C3410 | | 1 | 11 | D |\n| | Injection (modified release) 30 mg (as acetate), vial and diluent syringe | Injection | Sandostatin LAR | NV | MP See Note 1 | C2624 C2625 C3409 C3410 | | 1 | 11 | D |\n| Oestradiol | Tablet 2 mg | Oral | Zumenon | AB | MP NP | | | 56 | 2 | |\n| | Tablet containing oestradiol valerate 1 mg | Oral | Progynova | BN | MP NP | | | 56 | 2 | |\n| | Tablet containing oestradiol valerate 2 mg | Oral | Progynova | BN | MP NP | | | 56 | 2 | |\n| | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal | Sandrena | AS | MP NP | | | 1 | 5 | |\n| | Transdermal patches 390 micrograms, 8 | Transdermal | Estradot 25 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal | Estraderm MX 25 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 2 mg, 4 | Transdermal | Climara 25 | BN | MP NP | | | 1 | 5 | |\n| | Transdermal patches 585 micrograms, 8 | Transdermal | Estradot 37.5 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal | Estraderm MX 50 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 3.8 mg, 4 | Transdermal | Climara 50 | BN | MP NP | | | 1 | 5 | |\n| | Transdermal patches 780 micrograms, 8 | Transdermal | Estradot 50 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 5.7 mg, 4 | Transdermal | Climara 75 | BN | MP NP | | | 1 | 5 | |\n| | Transdermal patches 1.17 mg, 8 | Transdermal | Estradot 75 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal | Estraderm MX 100 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches 7.6 mg, 4 | Transdermal | Climara 100 | BN | MP NP | | | 1 | 5 | |\n| | Transdermal patches 1.56 mg, 8 | Transdermal | Estradot 100 | NV | MP NP | | | 1 | 5 | |\n| | Vaginal tablets 25 micrograms, 15 | Vaginal | Vagifem | NO | MP NP | | | 1 | 2 | |\n| Oestradiol and Oestradiol with Dydrogesterone | Pack containing 14 tablets oestradiol 2 mg and 14 tablets oestradiol 2 mg with dydrogesterone 10 mg | Oral | Femoston 2/10 | AB | MP NP | | | 1 | 5 | |\n| Oestradiol and Oestradiol with Norethisterone | Pack containing 4 transdermal patches 780 micrograms oestradiol (as hemihydrate) and 4 transdermal patches 620 micrograms oestradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal | Estalis sequi 50/140 | NV | MP NP | | | 1 | 5 | |\n| | Pack containing 4 transdermal patches 780 micrograms oestradiol (as hemihydrate) and 4 transdermal patches 510 micrograms oestradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal | Estalis sequi 50/250 | NV | MP NP | | | 1 | 5 | |\n| Oestradiol with Norethisterone | Transdermal patches containing 620 micrograms oestradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/140 | NV | MP NP | | | 1 | 5 | |\n| | Transdermal patches containing 510 micrograms oestradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/250 | NV | MP NP | | | 1 | 5 | |\n| Oestriol | Pessaries 500 micrograms, 15 | Vaginal | Ovestin Ovula | MK | MP NP | | | 1 | 2 | |\n| | Vaginal cream 1 mg per g, 15 g | Application | Ovestin | MK | MP NP | | | 1 | 1 | |\n| Ofloxacin | Eye drops 3 mg per mL, 5 mL | Application to the eye | Ocuflox | AG | MP | C1031 | | 2 | 0 | |\n| Olanzapine | Tablet 2.5 mg | Oral | APO-Olanzapine | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Ozin 2.5 | DO | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Pharmacor Olanzapine 2.5 | CR | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap 2.5 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 5 mg | Oral | APO-Olanzapine | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Ozin 5 | DO | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Pharmacor Olanzapine 5 | CR | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap 5 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 7.5 mg | Oral | APO-Olanzapine | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Ozin 7.5 | DO | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Pharmacor Olanzapine 7.5 | CR | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap 7.5 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 10 mg | Oral | APO-Olanzapine | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Ozin 10 | DO | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Pharmacor Olanzapine 10 | CR | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap 10 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 2.5 mg (as benzoate) | Oral | Olanzapine generichealth 2.5 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 5 mg (as benzoate) | Oral | Olanzapine generichealth 5 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 7.5 mg (as benzoate) | Oral | Olanzapine generichealth 7.5 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 10 mg (as benzoate) | Oral | Olanzapine generichealth 10 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 5 mg (orally disintegrating) | Oral | APO-Olanzapine ODT | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine-GA ODT | GM | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine ODT-DRLA | RZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine ODT generichealth 5 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine Sandoz ODT 5 | SZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | PS Olanzapine ODT | FZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap ODT 5 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 10 mg (orally disintegrating) | Oral | APO-Olanzapine ODT | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine-GA ODT | GM | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine ODT-DRLA | RZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine ODT generichealth 10 | GQ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Olanzapine Sandoz ODT 10 | SZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | PS Olanzapine ODT | FZ | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zylap ODT 10 | QA | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 15 mg (orally disintegrating) | Oral | APO-Olanzapine ODT | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Tablet 20 mg (orally disintegrating) | Oral | APO-Olanzapine ODT | TX | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Wafer 5 mg | Oral | Lanzek Zydis | EL | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zypine ODT | AF | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zyprexa Zydis | LY | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Wafer 10 mg | Oral | Lanzek Zydis | EL | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zypine ODT | AF | MP NP | C1589 C2044 | | 28 | 5 | |\n| | | | Zyprexa Zydis | LY | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Wafer 15 mg | Oral | Zyprexa Zydis | LY | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Wafer 20 mg | Oral | Zyprexa Zydis | LY | MP NP | C1589 C2044 | | 28 | 5 | |\n| | Powder for injection 210 mg (as pamoate monohydrate) with diluent | Injection | Zyprexa Relprevv | LY | MP NP | C1589 | | 2 | 5 | |\n| | Powder for injection 300 mg (as pamoate monohydrate) with diluent | Injection | Zyprexa Relprevv | LY | MP NP | C1589 | | 2 | 5 | |\n| | Powder for injection 405 mg (as pamoate monohydrate) with diluent | Injection | Zyprexa Relprevv | LY | MP NP | C1589 | | 1 | 5 | |\n| Olmesartan | Tablet containing olmesartan medoxomil 20 mg | Oral | Olmetec | MK | MP NP | | | 30 | 5 | |\n| | Tablet containing olmesartan medoxomil 40 mg | Oral | Olmetec | MK | MP NP | | | 30 | 5 | |\n| Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besylate) | Oral | Sevikar 20/5 | MK | MP | C3307 | | 30 | 5 | |\n| | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besylate) | Oral | Sevikar 40/5 | MK | MP | C3307 | | 30 | 5 | |\n| | Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besylate) | Oral | Sevikar 40/10 | MK | MP | C3307 | | 30 | 5 | |\n| Olmesartan with Hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | MK | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral | Olmetec Plus | MK | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | Olmetec Plus | MK | MP NP | C3307 | | 30 | 5 | |\n| Olsalazine | Capsule containing olsalazine sodium 250 mg | Oral | Dipentum | UC | MP NP | C1708 C1709 | | 100 | 5 | |\n| | Tablet containing olsalazine sodium 500 mg | Oral | Dipentum | UC | MP NP | C1708 C1709 | | 100 | 5 | |\n| Omalizumab | Powder for injection 150 mg with diluent | Injection | Xolair | NV | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Omeprazole | Tablet 20 mg (as magnesium) | Oral | Acimax Tablets | AL | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Losec Tablets | AP | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omepral | PM | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole Sandoz | SZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Acimax Tablets | AL | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Losec Tablets | AP | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omepral | PM | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole Sandoz | SZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | Tablet 20 mg | Oral | APO-Omeprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Chem mart Omeprazole | CH | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | GenRx Omeprazole | GX | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Meprazol | SZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole generichealth | GQ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole-PS | FZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole Winthrop | WA | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Ozmep | ZP | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Terry White Chemists Omeprazole | TW | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | APO-Omeprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Chem mart Omeprazole | CH | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | GenRx Omeprazole | GX | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Meprazol | SZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole generichealth | GQ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole-PS | FZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole Winthrop | WA | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Ozmep | ZP | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Terry White Chemists Omeprazole | TW | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | Capsule 20 mg | Oral | APO-Omeprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omeprazole Sandoz | HX | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Omepro-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Pemzo | QA | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Pharmacor Omeprazole 20 | CR | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | Probitor | SZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 1 | |\n| | | | APO-Omeprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omeprazole Sandoz | HX | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Omepro-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pemzo | QA | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pharmacor Omeprazole 20 | CR | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Probitor | SZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | Tablet 10 mg (as magnesium) | Oral | Losec Tablets | AP | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| Omeprazole and Clarithromycin and Amoxycillin | Pack containing 14 capsules omeprazole 20 mg, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin 500 mg (as trihydrate) | Oral | Probitor Hp7 | SZ | MP NP | C1096 | | 1 | 0 | |\n| Ondansetron | Tablet (orally disintegrating) 4 mg | Oral | Ondansetron ODT-DRLA | RZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron ODT 4 | WQ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron ODT-DRLA | RZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Onsetron ODT 4 | WQ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Tablet (orally disintegrating) 8 mg | Oral | Ondansetron ODT-DRLA | RZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron ODT 8 | WQ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron ODT-DRLA | RZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Onsetron ODT 8 | WQ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Tablet 4 mg (as hydrochloride dihydrate) | Oral | APO-Ondansetron | TX | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron-DRLA | RZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron 4 | ZP | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zofran | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zondan | GM | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | APO-Ondansetron | TX | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondansetron-DRLA | RZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondansetron Tabs Pfizer | FZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondaz | SZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Onsetron 4 | ZP | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zilfojim 4 | DO | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zofran | GK | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zondan | GM | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Tablet 8 mg (as hydrochloride dihydrate) | Oral | APO-Ondansetron | TX | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron-DRLA | RZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron 8 | ZP | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zofran | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zondan | GM | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | APO-Ondansetron | TX | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondansetron-DRLA | RZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondansetron Tabs Pfizer | FZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Ondaz | SZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Onsetron 8 | ZP | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zilfojim 8 | DO | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zofran | GK | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zondan | GM | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Wafer 4 mg | Oral | Ondaz Zydis | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zofran Zydis | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz Zydis | SZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zofran Zydis | GK | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Wafer 8 mg | Oral | Ondaz Zydis | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Zofran Zydis | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 4 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz Zydis | SZ | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | | | Zofran Zydis | GK | MP NP | C3050 C3611 | P3611 | 10 | 1 | |\n| | Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL | Oral | Zofran syrup 50mL | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | P3050 See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP | C3050 C3611 | P3611 | 1 | 1 | |\n| | I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL | Injection | Ondansetron Alphapharm | AF | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron-Claris | AE | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron | ZP | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Zofran | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL | Injection | Ondansetron Alphapharm | AF | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Ondansetron-Claris | AE | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Ondaz | SZ | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Onsetron | ZP | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | Zofran | GK | MP NP See Note 1 | C3050 C3611 See Note 2 | See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| Oxaliplatin | Solution concentrate for I.V. infusion 50 mg in 10 mL | Injection | DBL Oxaliplatin Concentrate | HH | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Eloxatin | SW | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliccord | WQ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Kabi | PK | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 50 mg | Injection | Hospira Pty Limited | HH | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxalatin | ZP | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Actavis | TA | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Alphapharm | AF | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Ebewe | SZ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Link | PK | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Xalox | WQ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 100 mg in 20 mL | Injection | DBL Oxaliplatin Concentrate | HH | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Eloxatin | SW | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliccord | WQ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Kabi | PK | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 100 mg | Injection | Hospira Pty Limited | HH | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxalatin | ZP | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Actavis | TA | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Alphapharm | AF | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Ebewe | SZ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Oxaliplatin Link | PK | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | | | Xalox | WQ | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 200 mg in 40 mL | Injection | Eloxatin | SW | MP | C3900 C3901 C3930 C3939 | | See Note 3 | See Note 3 | D |\n| Oxazepam | Tablet 15 mg | Oral | Alepam 15 | AF | MP NP PDP | | | 25 | 0 | |\n| | | | Serepax | QA | MP NP PDP | | | 25 | 0 | |\n| | | | Alepam 15 | AF | MP NP | | P3656 | 50 | 0 | |\n| | | | Serepax | QA | MP NP | | P3656 | 50 | 0 | |\n| | | | Alepam 15 | AF | MP NP | | P3655 | 50 | 3 | |\n| | | | Serepax | QA | MP NP | | P3655 | 50 | 3 | |\n| | | | Alepam 15 | AF | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Serepax | QA | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | Tablet 30 mg | Oral | Alepam 30 | AF | MP NP PDP | | | 25 | 0 | |\n| | | | APO-Oxazepam | TX | MP NP PDP | | | 25 | 0 | |\n| | | | Murelax | FM | MP NP PDP | | | 25 | 0 | |\n| | | | Serepax | QA | MP NP PDP | | | 25 | 0 | |\n| | | | Alepam 30 | AF | MP NP | | P3656 | 50 | 0 | |\n| | | | APO-Oxazepam | TX | MP NP | | P3656 | 50 | 0 | |\n| | | | Murelax | FM | MP NP | | P3656 | 50 | 0 | |\n| | | | Serepax | QA | MP NP | | P3656 | 50 | 0 | |\n| | | | Alepam 30 | AF | MP NP | | P3655 | 50 | 3 | |\n| | | | APO-Oxazepam | TX | MP NP | | P3655 | 50 | 3 | |\n| | | | Murelax | FM | MP NP | | P3655 | 50 | 3 | |\n| | | | Serepax | QA | MP NP | | P3655 | 50 | 3 | |\n| | | | Alepam 30 | AF | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | APO-Oxazepam | TX | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Murelax | FM | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Serepax | QA | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| Oxcarbazepine | Tablet 150 mg | Oral | Trileptal | NV | MP NP | C1587 | | 100 | 5 | |\n| | Tablet 300 mg | Oral | Trileptal | NV | MP NP | C1587 | | 100 | 5 | |\n| | Tablet 600 mg | Oral | Trileptal | NV | MP NP | C1587 | | 100 | 5 | |\n| | Oral suspension 60 mg per mL, 250 mL | Oral | Trileptal | NV | MP NP | C1587 | | 2 | 5 | |\n| Oxprenolol | Tablet containing oxprenolol hydrochloride 20 mg | Oral | Corbeton 20 | AF | MP NP | | | 100 | 5 | |\n| | Tablet containing oxprenolol hydrochloride 40 mg | Oral | Corbeton 40 | AF | MP NP | | | 100 | 5 | |\n| Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral | Ditropan | SW | MP NP | C1081 | | 100 | 5 | |\n| | | | Oxybutynin Sandoz | SZ | MP NP | C1081 | | 100 | 5 | |\n| | | | Oxybutynin Winthrop | WA | MP NP | C1081 | | 100 | 5 | |\n| | Transdermal patches 36 mg, 8 | Transdermal | Oxytrol | HH | MP NP | C3152 | | 1 | 5 | |\n| Oxycodone | Tablet containing oxycodone hydrochloride 5 mg | Oral | Endone | QA | MP NP PDP | C1358 | | 20 | 0 | |\n| | Capsule containing oxycodone hydrochloride 5 mg | Oral | OxyNorm | MF | MP NP PDP | C1358 | | 20 | 0 | |\n| | Capsule containing oxycodone hydrochloride 10 mg | Oral | OxyNorm | MF | MP NP PDP | C1358 | | 20 | 0 | |\n| | Capsule containing oxycodone hydrochloride 20 mg | Oral | OxyNorm | MF | MP NP | C1358 | | 20 | 0 | |\n| | Oral solution containing oxycodone hydrochloride 5 mg per 5 mL, 250 mL | Oral | OxyNorm Liquid 5mg/5mL | MF | MP NP PDP | C1358 | | 1 | 0 | |\n| | Tablet containing oxycodone hydrochloride 5 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 10 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 15 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 20 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 30 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 40 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet containing oxycodone hydrochloride 80 mg (controlled release) | Oral | OxyContin | MF | MP NP | C1062 | | 28 | 0 | |\n| | Suppository 30 mg (as pectinate) | Rectal | Proladone | PL | MP NP PDP | C1358 | | 12 | 0 | |\n| Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg | Oral | Targin 5/2.5mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg | Oral | Targin 10/5mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg | Oral | Targin 20/10mg | MF | MP NP | C1062 | | 28 | 0 | |\n| | Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg | Oral | Targin 40/20mg | MF | MP NP | C1062 | | 28 | 0 | |\n| Paclitaxel | Solution concentrate for I.V. infusion 30 mg in 5 mL | Injection | Anzatax | HH | MP | C3186 C3890 C3902 C3917 C3955 C3956 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 100 mg in 16.7 mL | Injection | Anzatax | HH | MP | C3186 C3890 C3902 C3917 C3955 C3956 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 150 mg in 25 mL | Injection | Anzatax | HH | MP | C3186 C3890 C3902 C3917 C3955 C3956 | | See Note 3 | See Note 3 | D |\n| | Solution concentrate for I.V. infusion 300 mg in 50 mL | Injection | Anzatax | HH | MP | C3186 C3890 C3902 C3917 C3955 C3956 | | See Note 3 | See Note 3 | D |\n| Paclitaxel, nanoparticle albumin-bound | Powder for I.V. injection containing 100 mg paclitaxel | Injection | Abraxane | TS | MP | C3955 C3956 | | See Note 3 | See Note 3 | D |\n| Paliperidone | Tablet 3 mg (prolonged release) | Oral | Invega | JC | MP NP | C1589 | | 28 | 5 | |\n| | Tablet 6 mg (prolonged release) | Oral | Invega | JC | MP NP | C1589 | | 28 | 5 | |\n| | Tablet 9 mg (prolonged release) | Oral | Invega | JC | MP NP | C1589 | | 28 | 5 | |\n| | I.M. injection (modified release) 25 mg (as palmitate) in pre-filled syringe | Injection | Invega Sustenna | JC | MP NP | C1589 | | 1 | 5 | |\n| | I.M. injection (modified release) 50 mg (as palmitate) in pre-filled syringe | Injection | Invega Sustenna | JC | MP NP | C1589 | | 1 | 5 | |\n| | I.M. injection (modified release) 75 mg (as palmitate) in pre-filled syringe | Injection | Invega Sustenna | JC | MP NP | C1589 | | 1 | 5 | |\n| | I.M. injection (modified release) 100 mg (as palmitate) in pre-filled syringe | Injection | Invega Sustenna | JC | MP NP | C1589 | | 1 | 5 | |\n| | I.M. injection (modified release) 150 mg (as palmitate) in pre-filled syringe | Injection | Invega Sustenna | JC | MP NP | C1589 | | 1 | 5 | |\n| Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | Aloxi | TS | MP NP See Note 1 | C3545 | | 1 | 0 | |\n| Pamidronic Acid | Concentrated injection containing disodium pamidronate 15 mg in 5 mL | Injection | Pamisol | HH | MP NP | C3256 | | 4 | 0 | |\n| | | | | | MP See Note 1 | C1500 C3341 | | 4 | 2 | C |\n| | Injection set containing 4 vials powder for I.V. infusion containing disodium pamidronate 15 mg and 4 ampoules solvent 5 mL | Injection | Aredia 15 mg | NV | MP NP | C3256 | | 1 | 0 | |\n| | Concentrated injection containing disodium pamidronate 30 mg in 10 mL | Injection | Pamisol | HH | MP NP | C3256 | | 2 | 0 | |\n| | | | | | MP See Note 1 | C1500 C3341 | | 2 | 2 | C |\n| | Injection set containing 2 vials powder for I.V. infusion containing disodium pamidronate 30 mg and 2 ampoules solvent 10 mL | Injection | Aredia 30 mg | NV | MP MP NP | C3256 | | 1 | 0 | |\n| | Concentrated injection containing disodium pamidronate 60 mg in 10 mL | Injection | Pamisol | HH | MP NP | C3256 | | 1 | 0 | |\n| | Concentrated injection containing disodium pamidronate 90 mg in 10 mL | Injection | Pamisol | HH | MP See Note 1 | C1035 C1233 C1500 C3341 C3342 C3343 | | 1 | 11 | PB |\n| | Injection set containing 1 vial powder for I.V. infusion containing disodium pamidronate 90 mg and 1 ampoule solvent 10 mL | Injection | Aredia 90 mg | NV | MP See Note 1 | C1035 C1233 C1500 C3341 C3342 C3343 | | 1 | 11 | PB |\n| Pancreatic Extract | Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity | Oral | Creon 10,000 | AB | MP NP | | | 500 | 10 | |\n| | | | | | MP | | P3046 | 500 | 21 | |\n| | Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity | Oral | Creon 25,000 | AB | MP NP | | | 200 | 10 | |\n| | Capsule (containing enteric coated minimicrospheres) providing not less than 40,000 BP units of lipase activity | Oral | Creon 40,000 | AB | MP NP | | | 200 | 10 | |\n| | Granules (enteric coated) providing not less than 5,000 BP units of lipase activity per 100 mg, 20 g | Oral | Creon Micro | AB | MP NP | | | 3 | 10 | |\n| | | | | | MP | | P3046 | 3 | 21 | |\n| Pancrelipase | Capsule (containing enteric coated microtablets) providing not less than 25,000 BP units of lipase activity | Oral | Panzytrat 25000 | TM | MP NP | | | 200 | 10 | |\n| Pantoprazole | Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | Oral | APO-Pantoprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Chem mart Pantoprazole | CH | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Ozpan | RA | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Panthron | GN | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Panto | NZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantofast 40 | RZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantoloc | NH | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantoprazole-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantoprazole generichealth | GQ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantoprazole-PS | FZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Pantoprazole Sandoz | SZ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Salpraz | AF | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Somac | NQ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Sozol | QA | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | STADA Pantoprazole | TD | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Terry White Chemists Pantoprazole | TW | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Torzole 40 | TA | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | APO-Pantoprazole | TX | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Chem mart Pantoprazole | CH | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Ozpan | RA | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Panthron | GN | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Panto | NZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantofast 40 | RZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantoloc | NH | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantoprazole-GA | GM | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantoprazole generichealth | GQ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantoprazole-PS | FZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Pantoprazole Sandoz | SZ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Salpraz | AF | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Somac | NQ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Sozol | QA | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | STADA Pantoprazole | TD | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Terry White Chemists Pantoprazole | TW | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | | | Torzole 40 | TA | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | Sachet containing granules 40 mg (as sodium sesquihydrate) | Oral | Somac | NQ | MP NP | C1177 C1337 C1476 C1533 | P1177 | 30 | 2 | |\n| | | | Somac | NQ | MP NP | C1177 C1337 C1476 C1533 | P1337 P1476 P1533 | 30 | 5 | |\n| | Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | Oral | APO-Pantoprazole | TX | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Chem mart Pantoprazole | CH | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Ozpan | RA | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Panto | NZ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantofast 20 | RZ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantoloc | NH | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantoprazole-GA | GM | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantoprazole generichealth | GQ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantoprazole-PS | FZ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Pantoprazole Sandoz | SZ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Salpraz | AF | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Somac | NQ | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Terry White Chemists Pantoprazole | TW | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| | | | Torzole 20 | TA | MP NP | C1337 C1476 C1533 | | 30 | 5 | |\n| Paracetamol | Tablet 500 mg | Oral | APO-Paracetamol | TX | PDP | | | 100 | 0 | |\n| | | | Febridol | GM | PDP | | | 100 | 0 | |\n| | | | Generic Health Pty Ltd | GQ | PDP | | | 100 | 0 | |\n| | | | Panamax | SW | PDP | | | 100 | 0 | |\n| | | | Paracetamol Sandoz | SZ | PDP | | | 100 | 0 | |\n| | | | Paralgin | FM | PDP | | | 100 | 0 | |\n| | | | APO-Paracetamol | TX | MP NP | | | 100 | 1 | |\n| | | | Febridol | GM | MP NP | | | 100 | 1 | |\n| | | | Generic Health Pty Ltd | GQ | MP NP | | | 100 | 1 | |\n| | | | Panamax | SW | MP NP | | | 100 | 1 | |\n| | | | Paracetamol Sandoz | SZ | MP NP | | | 100 | 1 | |\n| | | | Paralgin | FM | MP NP | | | 100 | 1 | |\n| | | | APO-Paracetamol | TX | PDP | | P2046 | 300 | 0 | |\n| | | | Febridol | GM | PDP | | P2046 | 300 | 0 | |\n| | | | Generic Health Pty Ltd | GQ | PDP | | P2046 | 300 | 0 | |\n| | | | Panamax | SW | PDP | | P2046 | 300 | 0 | |\n| | | | Paracetamol Sandoz | SZ | PDP | | P2046 | 300 | 0 | |\n| | | | Paralgin | FM | PDP | | P2046 | 300 | 0 | |\n| | | | APO-Paracetamol | TX | MP NP | | P2046 | 300 | 4 | |\n| | | | Febridol | GM | MP NP | | P2046 | 300 | 4 | |\n| | | | Generic Health Pty Ltd | GQ | MP NP | | P2046 | 300 | 4 | |\n| | | | Panamax | SW | MP NP | | P2046 | 300 | 4 | |\n| | | | Paracetamol Sandoz | SZ | MP NP | | P2046 | 300 | 4 | |\n| | | | Paralgin | FM | MP NP | | P2046 | 300 | 4 | |\n| | Tablet 665 mg (modified release) | Oral | Panadol Osteo | GC | MP NP | C2094 C3649 C3650 | P3650 | 192 | 0 | |\n| | | | | | MP NP | C2094 C3649 C3650 | P3649 | 192 | 3 | |\n| | | | | | MP NP | C2094 C3649 C3650 | P2094 | 192 | 5 | |\n| | Oral liquid 120 mg per 5 mL, 100 mL | Oral | Panamax | SW | PDP | | | 1 | 0 | |\n| | Oral liquid 240 mg per 5 mL, 200 mL | Oral | Panamax 240 Elixir | SW | PDP | | | 1 | 0 | |\n| | Suppositories 500 mg, 24 | Rectal | Panadol | GC | MP NP | C3649 C3650 | P3650 | 4 | 0 | |\n| | | | | | MP NP | C3649 C3650 | P3649 | 4 | 3 | |\n| Paraffin | Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye | Duratears | AQ | MP NP AO | | | 2 | 5 | |\n| | | | Poly Visc | IQ | MP NP AO | | | 2 | 5 | |\n| | | | Duratears | AQ | MP | | P3035 | 2 | 11 | |\n| | | | Poly Visc | IQ | MP | | P3035 | 2 | 11 | |\n| | Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye | Ircal | PE | MP NP AO | | | 1 | 5 | |\n| | | | Lacri-Lube | AG | MP NP AO | | | 1 | 5 | |\n| | | | Poly Visc | IQ | MP NP AO | | | 1 | 5 | |\n| | | | Ircal | PE | MP | | P3035 | 1 | 11 | |\n| | | | Lacri-Lube | AG | MP | | P3035 | 1 | 11 | |\n| | | | Poly Visc | IQ | MP | | P3035 | 1 | 11 | |\n| Paroxetine | Tablet 20 mg (as hydrochloride) | Oral | Aropax | GK | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Chem mart Paroxetine | CH | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Extine 20 | QA | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | GenRx Paroxetine | GX | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Paroxetine 20 | MI | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Paroxetine-GA | GN | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Paroxetine Sandoz | SZ | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Paxtine | AF | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Roxet 20 | DO | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Terry White Chemists Paroxetine | TW | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | Tablet 20 mg (as mesilate) | Oral | Paroxetine generichealth | GQ | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Paroxetine Synthon | ZT | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| | | | Pharmacor Paroxo 20 | MI | MP NP | C1211 C1241 C1862 | | 30 | 5 | |\n| Pegfilgrastim | Injection 6 mg in 0.6 mL single use pre-filled syringe | Injection | Neulasta | AN | MP See Note 1 | C2912 C2917 C2918 C2919 C2923 C2924 C2925 C2926 C2927 C2928 C2929 C2930 C3087 C3187 C3357 C3362 C3363 C3364 C3365 C3369 C3370 C3371 C3372 C3373 C3374 C3375 C3376 C3377 C3833 C3834 | | 1 | 11 | D |\n| Peginterferon Alfa-2a | Injection 135 micrograms in 0.5 mL single use pre-filled syringe | Injection | Pegasys | RO | MP See Note 1 | C2234 C3412 C3975 C3976 C3977 C3978 | | 8 | 5 | D |\n| | Injection 180 micrograms in 0.5 mL single use pre-filled syringe | Injection | Pegasys | RO | MP See Note 1 | C2234 C3412 C3975 C3976 C3977 C3978 | | 8 | 5 | D |\n| Pemetrexed | Powder for I.V. infusion 100 mg (as disodium heptahydrate) | Injection | Alimta | LY | MP | C2957 C2958 C3885 C3886 | | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 500 mg (as disodium heptahydrate) | Injection | Alimta | LY | MP | C2957 C2958 C3885 C3886 | | See Note 3 | See Note 3 | D |\n| Penicillamine | Tablet 125 mg | Oral | D-Penamine | AL | MP NP | | | 100 | 1 | |\n| | Tablet 250 mg | Oral | D-Penamine | AL | MP NP | | | 100 | 1 | |\n| Pergolide | Tablet 50 micrograms (as mesylate) | Oral | Permax | AS | MP NP | C1863 | | 100 | 0 | |\n| | Tablet 250 micrograms (as mesylate) | Oral | Permax | AS | MP NP | C1863 | | 100 | 5 | |\n| | Tablet 1 mg (as mesylate) | Oral | Permax | AS | MP NP | C1863 | | 100 | 5 | |\n| Perhexiline | Tablet containing perhexiline maleate 100 mg | Oral | Pexsig | QA | MP NP | C1023 | | 100 | 5 | |\n| Pericyazine | Tablet 2.5 mg | Oral | Neulactil | SW | MP NP | | | 100 | 5 | |\n| | Tablet 10 mg | Oral | Neulactil | SW | MP NP | | | 100 | 5 | |\n| Perindopril | Tablet containing perindopril erbumine 2 mg | Oral | APO-Perindopril | TX | MP NP | | | 30 | 5 | |\n| | | | Idaprex 2 | SZ | MP NP | | | 30 | 5 | |\n| | | | Indopril 2 | QA | MP NP | | | 30 | 5 | |\n| | | | Perindopril 2 | CR | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril arginine 2.5 mg | Oral | Coversyl 2.5mg | SE | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril erbumine 4 mg | Oral | APO-Perindopril | TX | MP NP | | | 30 | 5 | |\n| | | | Idaprex 4 | SZ | MP NP | | | 30 | 5 | |\n| | | | Indopril 4 | QA | MP NP | | | 30 | 5 | |\n| | | | Perindopril 4 | CR | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril arginine 5 mg | Oral | Coversyl 5mg | SE | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril erbumine 8 mg | Oral | APO-Perindopril | TX | MP NP | | | 30 | 5 | |\n| | | | Idaprex 8 | SZ | MP NP | | | 30 | 5 | |\n| | | | Indopril 8 | QA | MP NP | | | 30 | 5 | |\n| | | | Perindopril 8 | CR | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril arginine 10 mg | Oral | Coversyl 10mg | SE | MP NP | | | 30 | 5 | |\n| Perindopril with amlodipine | Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate) | Oral | Coveram | SE | MP NP | C3307 C3308 | | 30 | 5 | |\n| | | | Reaptan 5/5 | RX | MP NP | C3307 C3308 | | 30 | 5 | |\n| | Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate) | Oral | Coveram | SE | MP NP | C3307 C3308 | | 30 | 5 | |\n| | | | Reaptan 5/10 | RX | MP NP | C3307 C3308 | | 30 | 5 | |\n| | Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate) | Oral | Coveram | SE | MP NP | C3307 C3308 | | 30 | 5 | |\n| | | | Reaptan 10/5 | RX | MP NP | C3307 C3308 | | 30 | 5 | |\n| | Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate) | Oral | Coveram | SE | MP NP | C3307 C3308 | | 30 | 5 | |\n| | | | Reaptan 10/10 | RX | MP NP | C3307 C3308 | | 30 | 5 | |\n| Perindopril with Indapamide | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | Oral | Coversyl Plus LD 2.5mg/0.625mg | SE | MP NP | | | 30 | 5 | |\n| | Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral | Chem mart Perindopril/ Indapamide 4/1.25 | CH | MP NP | C3307 | | 30 | 5 | |\n| | | | GenRx Perindopril/ Indapamide 4/1.25 | GX | MP NP | C3307 | | 30 | 5 | |\n| | | | Idaprex Combi 4/1.25 | SZ | MP NP | C3307 | | 30 | 5 | |\n| | | | Indopril Combi 4/1.25 | QA | MP NP | C3307 | | 30 | 5 | |\n| | | | Perindo Combi 4/1.25 | AF | MP NP | C3307 | | 30 | 5 | |\n| | | | Perindopril/ Indapamide GH 4/1.25 | GQ | MP NP | C3307 | | 30 | 5 | |\n| | | | Terry White Chemists Perindopril/ Indapamide 4/1.25 | TW | MP NP | C3307 | | 30 | 5 | |\n| | Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral | Coversyl Plus 5mg/1.25mg | SE | MP NP | C3307 | | 30 | 5 | |\n| Permethrin | Cream 50 mg per g, 30 g | Application | Lyclear | JT | MP NP | | | 1 | 1 | |\n| Phenelzine | Tablet 15 mg (as sulfate) | Oral | Nardil | LM | MP | C1609 | | 100 | 1 | |\n| Phenobarbitone | Tablet 30 mg | Oral | Aspen Pharma Pty Ltd | QA | MP NP | C1093 | | 200 | 4 | |\n| | Injection containing phenobarbitone sodium 200 mg in 1 mL | Injection | Fawns and McAllan Proprietary Limited | FM | MP NP | C1093 | | 5 | 0 | |\n| Phenoxybenzamine | Capsule containing phenoxybenzamine hydrochloride 10 mg | Oral | Dibenyline | GH | MP NP | C1239 C1285 | | 100 | 5 | |\n| | Capsules containing phenoxybenzamine hydrochloride 10 mg, 30 | Oral | Dibenyline | GH | MP NP | C1239 C1285 | | 3 | 5 | |\n| | Capsules containing phenoxybenzamine hydrochloride 10 mg, 100 | Oral | Dibenzyline | BZ | MP NP | C1239 C1285 | | 1 | 5 | |\n| Phenoxymethyl- penicillin | Tablet 250 mg phenoxymethylpenicillin (as potassium) | Oral | Abbocillin-VK Filmtab | QA | MP NP PDP | | | 50 | 0 | |\n| | | | | | MP NP | | P1304 | 50 | 5 | |\n| | Tablet 500 mg phenoxymethylpenicillin (as potassium) | Oral | Abbocillin-VK Filmtab | QA | MP NP PDP | | | 50 | 0 | |\n| | Capsule 250 mg phenoxymethylpenicillin (as potassium) | Oral | Cilicaine VK | FM | MP NP PDP | | | 50 | 0 | |\n| | | | Cilopen VK | GM | MP NP PDP | | | 50 | 0 | |\n| | | | LPV | VT | MP NP PDP | | | 50 | 0 | |\n| | | | Cilicaine VK | FM | MP NP | | P1304 | 50 | 5 | |\n| | | | Cilopen VK | GM | MP NP | | P1304 | 50 | 5 | |\n| | | | LPV | VT | MP NP | | P1304 | 50 | 5 | |\n| | Capsule 500 mg phenoxymethylpenicillin (as potassium) | Oral | Cilicaine VK | FM | MP NP PDP | | | 50 | 0 | |\n| | | | Cilopen VK | GM | MP NP PDP | | | 50 | 0 | |\n| | | | LPV | VT | MP NP PDP | | | 50 | 0 | |\n| | Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL | Oral | Phenoxymethyl- penicillin-AFT | AE | PDP | | | 2 | 0 | |\n| | Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL | Oral | Abbocillin-V | QA | PDP | | | 2 | 0 | |\n| | | | Cilicaine V | FM | PDP | | | 2 | 0 | |\n| | | | Abbocillin-V | QA | MP NP | | | 2 | 1 | |\n| | | | Cilicaine V | FM | MP NP | | | 2 | 1 | |\n| | Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL | Oral | Phenoxymethyl- penicillin-AFT | AE | PDP | | | 2 | 0 | |\n| Phenylalanine with carbohydrate | Sachets of oral powder 4 g containing 50 mg phenylalanine, 30 (Phenylalanine Amino Acid Supplement) | Oral | Phenylalanine Amino Acid Supplement | VF | MP NP | C1453 | | 4 | 5 | |\n| Phenytoin | Tablet 50 mg | Oral | Dilantin Infatabs | PF | MP NP | | | 200 | 2 | |\n| | Capsule containing phenytoin sodium 30 mg | Oral | Dilantin Sodium | PF | MP NP | | | 200 | 2 | |\n| | Capsule containing phenytoin sodium 100 mg | Oral | Dilantin Sodium | PF | MP NP | | | 200 | 2 | |\n| | Oral suspension 30 mg per 5 mL, 500 mL | Oral | Dilantin | PF | MP NP | | | 1 | 3 | |\n| Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL | Application to the eye | Isopto Carpine | AQ | AO MP | | | 1 | 5 | |\n| | Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL | Application to the eye | Isopto Carpine | AQ | AO MP | | | 1 | 5 | |\n| | Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL | Application to the eye | Isopto Carpine | AQ | AO MP | | | 1 | 5 | |\n| Pimecrolimus | Cream 10 mg per g, 15 g | Application | Elidel | HM | MP | C2455 C2456 | | 1 | 1 | |\n| Pindolol | Tablet 5 mg | Oral | Barbloc 5 | AF | MP NP | | | 100 | 5 | |\n| | Tablet 15 mg | Oral | Barbloc 15 | AF | MP NP | | | 50 | 5 | |\n| | | | Visken 15 | NV | MP NP | | | 50 | 5 | |\n| Pioglitazone | Tablet 15 mg (as hydrochloride) | Oral | Acpio 15 | QA | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pharmacor Pioglitazone 15 | CR | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pioglitazone generichealth 15 | GQ | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Prioten 15 | DO | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | Tablet 30 mg (as hydrochloride) | Oral | Acpio 30 | QA | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pharmacor Pioglitazone 30 | CR | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pioglitazone generichealth 30 | GQ | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Prioten 30 | DO | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | Tablet 45 mg (as hydrochloride) | Oral | Acpio 45 | QA | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pharmacor Pioglitazone 45 | CR | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Pioglitazone generichealth 45 | GQ | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| | | | Prioten 45 | DO | MP NP | C3540 C3541 C3542 | | 28 | 5 | |\n| Piroxicam | Dispersible tablet 10 mg | Oral | Mobilis D-10 | AF | PDP | C1054 | | 50 | 0 | |\n| | | | | | MP NP | C1054 | | 50 | 3 | |\n| | Dispersible tablet 20 mg | Oral | Feldene-D | PF | PDP | C1054 | | 25 | 0 | |\n| | | | Mobilis D-20 | AF | PDP | C1054 | | 25 | 0 | |\n| | | | Feldene-D | PF | MP NP | C1054 | | 25 | 3 | |\n| | | | Mobilis D-20 | AF | MP NP | C1054 | | 25 | 3 | |\n| | Capsule 10 mg | Oral | Chem mart Piroxicam | CH | PDP | C1054 | | 50 | 0 | |\n| | | | Feldene | PF | PDP | C1054 | | 50 | 0 | |\n| | | | GenRx Piroxicam | GX | PDP | C1054 | | 50 | 0 | |\n| | | | Mobilis 10 | AF | PDP | C1054 | | 50 | 0 | |\n| | | | Terry White Chemists Piroxicam | TW | PDP | C1054 | | 50 | 0 | |\n| | | | Chem mart Piroxicam | CH | MP NP | C1054 | | 50 | 3 | |\n| | | | Feldene | PF | MP NP | C1054 | | 50 | 3 | |\n| | | | GenRx Piroxicam | GX | MP NP | C1054 | | 50 | 3 | |\n| | | | Mobilis 10 | AF | MP NP | C1054 | | 50 | 3 | |\n| | | | Terry White Chemists Piroxicam | TW | MP NP | C1054 | | 50 | 3 | |\n| | Capsule 20 mg | Oral | Chem mart Piroxicam | CH | PDP | C1054 | | 25 | 0 | |\n| | | | Feldene | PF | PDP | C1054 | | 25 | 0 | |\n| | | | GenRx Piroxicam | GX | PDP | C1054 | | 25 | 0 | |\n| | | | Mobilis 20 | AF | PDP | C1054 | | 25 | 0 | |\n| | | | Terry White Chemists Piroxicam | TW | PDP | C1054 | | 25 | 0 | |\n| | | | Chem mart Piroxicam | CH | MP NP | C1054 | | 25 | 3 | |\n| | | | Feldene | PF | MP NP | C1054 | | 25 | 3 | |\n| | | | GenRx Piroxicam | GX | MP NP | C1054 | | 25 | 3 | |\n| | | | Mobilis 20 | AF | MP NP | C1054 | | 25 | 3 | |\n| | | | Terry White Chemists Piroxicam | TW | MP NP | C1054 | | 25 | 3 | |\n| Pizotifen | Tablet 500 micrograms (as malate) | Oral | Sandomigran 0.5 | NV | MP NP | | | 100 | 2 | |\n| Pneumococcal Vaccine - Polyvalent | Injection 0.5 mL (23 valent) | Injection | Pneumovax 23 | CS | MP NP | C1282 C1284 C1385 | | 1 | 0 | |\n| Polyethylene glycol 400 | Eye drops 2.5 mg per mL, 15 mL | Application to the eye | Blink Intensive Tears | AO | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Eye drops 2.5 mg per mL, single dose units 0.4 mL, 20 | Application to the eye | Blink Intensive Tears | AO | AO | C2802 | | 5 | 5 | |\n| | | | | | MP NP | C1359 | | 5 | 5 | |\n| Polyethylene Glycol 400 with Propylene Glycol | Eye drops 4 mg-3 mg per mL, 15 mL | Application to the eye | Systane | AQ | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28 | Application to the eye | Systane | AQ | MP NP | C1359 | | 2 | 5 | |\n| | | | | | AO | C2802 | | 2 | 5 | |\n| Poly-l-lactic acid | Powder for injection 150 mg | Injection | Sculptra | SW | MP | C3182 C3183 | P3183 | 2 | 0 | |\n| | | | | | MP | C3182 C3183 | P3182 | 2 | 4 | |\n| Polyvinyl Alcohol | Eye drops 14 mg per mL, 15 mL | Application to the eye | Liquifilm Tears | AG | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | PVA Tears | PE | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | Liquifilm Tears | AG | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | PVA Tears | PE | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) | Application to the eye | Vistil | AE | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | Eye drops 30 mg per mL, 15 mL | Application to the eye | Liquifilm Forte | AG | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | PVA Forte | PE | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| | | | Liquifilm Forte | AG | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | | | PVA Forte | PE | MP | C1362 C3036 | P3036 | 1 | 11 | |\n| | Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative) | Application to the eye | Vistil Forte | AE | MP | C1362 C3036 | P1362 | 1 | 5 | |\n| Posaconazole | Oral suspension 40 mg per mL, 105 mL | Oral | Noxafil | MK | MP NP | C3058 C3059 C3060 | | 1 | 0 | |\n| Potassium Chloride | Tablet 600 mg (sustained release) | Oral | Duro-K | NM | MP NP | | | 200 | 1 | |\n| | | | Slow-K | NV | MP NP | | | 200 | 1 | |\n| | | | Span-K | AS | MP NP | | | 200 | 1 | |\n| Potassium Chloride with Potassium Bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | Oral | Chlorvescent | AS | MP NP | | | 60 | 1 | |\n| Pramipexole | Tablet containing pramipexole hydrochloride 125 micrograms | Oral | Sifrol | BY | MP NP | C3088 C3216 | P3216 | 30 | 0 | |\n| | | | Simipex 0.125 | QA | MP NP | C3088 C3216 | P3216 | 30 | 0 | |\n| | | | Sifrol | BY | MP NP | C3088 C3216 | P3088 | 30 | 2 | |\n| | Tablet containing pramipexole hydrochloride 250 micrograms | Oral | Sifrol | BY | MP NP | C3088 C3216 | P3088 | 100 | 2 | |\n| | | | | | MP NP | C3088 C3216 | P3216 | 100 | 5 | |\n| | | | Simipex 0.25 | QA | MP NP | C3088 C3216 | P3216 | 100 | 5 | |\n| | Tablet containing pramipexole hydrochloride 1 mg | Oral | Sifrol | BY | MP NP | C3216 | | 100 | 5 | |\n| | | | Simipex 1 | QA | MP NP | C3216 | | 100 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 375 micrograms | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 750 micrograms | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 1.5 mg | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 2.25 mg | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 3 mg | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 3.75 mg | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| | Tablet (extended release) containing pramipexole hydrochloride 4.5 mg | Oral | Sifrol ER | BY | MP NP | C3216 | | 30 | 5 | |\n| Prasugrel | Tablet 5 mg (as hydrochloride) | Oral | Effient | LY | MP NP | C3208 | | 28 | 5 | |\n| | Tablet 10 mg (as hydrochloride) | Oral | Effient | LY | MP NP | C3208 | | 28 | 5 | |\n| Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral | APO-Pravastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 10 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipostat 10 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Pravastat 10 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin Actavis 10 | TA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin-GA 10 | GM | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 10 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipostat 10 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Pravastat 10 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin Actavis 10 | TA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin-GA 10 | GM | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet containing pravastatin sodium 20 mg | Oral | APO-Pravastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 20 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholvastin | RA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipostat 20 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Pravastat 20 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin Actavis 20 | TA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin-GA 20 | GM | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 20 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Cholvastin | RA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipostat 20 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Pravastat 20 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin Actavis 20 | TA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin-GA 20 | GM | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet containing pravastatin sodium 40 mg | Oral | APO-Pravastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 40 | AF | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholvastin | RA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipostat 40 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Pravastat 40 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin Actavis 40 | TA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin-GA 40 | GM | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Cholstat 40 | AF | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Cholvastin | RA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipostat 40 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Pravastat 40 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin Actavis 40 | TA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin-GA 40 | GM | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet containing pravastatin sodium 80 mg | Oral | APO-Pravastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipostat 80 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pravastatin-GA 80 | GM | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipostat 80 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pravastatin-GA 80 | GM | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| Praziquantel | Tablet 600 mg | Oral | Biltricide | BN | MP NP | C3147 | | 8 | 0 | |\n| Prazosin | Tablet 1 mg (as hydrochloride) | Oral | APO-Prazosin | TX | MP NP | | | 100 | 5 | |\n| | Tablet 2 mg (as hydrochloride) | Oral | APO-Prazosin | TX | MP NP | | | 100 | 5 | |\n| | Tablet 5 mg (as hydrochloride) | Oral | APO-Prazosin | TX | MP NP | | | 100 | 5 | |\n| Prednisolone | Tablet 1 mg | Oral | Panafcortelone | AS | MP NP | | | 100 | 4 | |\n| | | | Predsolone | LN | MP NP | | | 100 | 4 | |\n| | Tablet 5 mg | Oral | Panafcortelone | AS | MP NP | | | 60 | 4 | |\n| | | | Solone | VT | MP NP | | | 60 | 4 | |\n| | Tablet 25 mg | Oral | Panafcortelone | AS | MP NP | | | 30 | 4 | |\n| | | | Solone | VT | MP NP | | | 30 | 4 | |\n| | Oral solution 5 mg (as sodium phosphate) per mL, 30 mL | Oral | PredMix | LN | MP NP | | | 1 | 5 | |\n| | | | Redipred | AS | MP NP | | | 1 | 5 | |\n| | Enema, retention, 20 mg (as sodium phosphate) in 100 mL | Rectal | Predsol | QA | MP NP | | | 28 | 3 | |\n| | Suppositories 5 mg (as sodium phosphate), 10 | Rectal | Predsol | QA | MP NP | C1294 C1454 | | 3 | 3 | |\n| Prednisolone with Phenylephrine | Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL | Application to the eye | Prednefrin Forte | AG | AO | C1465 | | 1 | 0 | |\n| | | | | | MP NP | C1077 C1465 | | 1 | 2 | |\n| Prednisone | Tablet 1 mg | Oral | Panafcort | AS | MP NP | | | 100 | 4 | |\n| | | | Predsone | LN | MP NP | | | 100 | 4 | |\n| | Tablet 5 mg | Oral | Panafcort | AS | MP NP | | | 60 | 4 | |\n| | | | Sone | VT | MP NP | | | 60 | 4 | |\n| | Tablet 25 mg | Oral | Panafcort | AS | MP NP | | | 30 | 4 | |\n| | | | Sone | VT | MP NP | | | 30 | 4 | |\n| Primidone | Tablet 250 mg | Oral | Mysoline | LM | MP NP | | | 200 | 2 | |\n| Probenecid | Tablet 500 mg | Oral | Pro-Cid | PL | MP NP | | | 100 | 5 | |\n| Procaine Penicillin | Injection 1.5 g in disposable syringe | Injection | Cilicaine | QA | MP NP PDP | | | 5 | 0 | |\n| Prochlorperazine | Tablet containing prochlorperazine maleate 5 mg | Oral | APO-Prochlorperazine | TX | PDP MP NP | | | 25 | 0 | |\n| | | | Pharmacor Prozine 5 | CR | PDP MP NP | | | 25 | 0 | |\n| | | | ProCalm | QA | PDP MP NP | | | 25 | 0 | |\n| | | | Prochlorperazine-GA | GM | PDP MP NP | | | 25 | 0 | |\n| | | | Prochlorperazine GH | GQ | PDP MP NP | | | 25 | 0 | |\n| | | | Prochlorperazine-PS | FZ | PDP MP NP | | | 25 | 0 | |\n| | | | Stemetil | SW | PDP MP NP | | | 25 | 0 | |\n| | | | Stemzine | AV | PDP MP NP | | | 25 | 0 | |\n| | Injection containing prochlorperazine mesylate 12.5 mg in 1 mL | Injection | Stemetil | SW | MP NP PDP | | | 10 | 0 | |\n| | Suppositories containing prochlorperazine equivalent to 25 mg prochlorperazine maleate, 5 | Rectal | Stemetil | SW | PDP | | | 1 | 0 | |\n| Progesterone | Vaginal gel (prolonged release) 90 mg in single dose pre-filled applicator | Vaginal | Crinone 8% | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Pessary 100 mg | Vaginal | Orion Laboratories Pty Ltd | ON | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Pessary 200 mg | Vaginal | Orion Laboratories Pty Ltd | ON | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | Injection | Hospira Pty Limited | HH | MP NP PDP | | | 10 | 0 | |\n| Propantheline | Tablet containing propantheline bromide 15 mg | Oral | Pro-Banthine | QA | MP NP | C1081 | | 200 | 5 | |\n| Propranolol | Tablet containing propranolol hydrochloride 10 mg | Oral | Deralin 10 | AF | MP NP | | | 100 | 5 | |\n| | | | Inderal | AP | MP NP | | | 100 | 5 | |\n| | Tablet containing propranolol hydrochloride 40 mg | Oral | Deralin 40 | AF | MP NP | | | 100 | 5 | |\n| | | | Inderal | AP | MP NP | | | 100 | 5 | |\n| | Tablet containing propranolol hydrochloride 160 mg | Oral | Deralin 160 | AF | MP NP | | | 50 | 5 | |\n| Propylthiouracil | Tablet 50 mg | Oral | PTU | PL | MP NP | | | 200 | 2 | |\n| Protein hydrolysate formula with medium chain triglycerides | Oral powder 400 g (Alfaré) | Oral | Alfaré | NT | MP NP | C1034 C1059 C1068 C1080 C1092 C1310 C1364 C1670 C2567 C4040 C4041 C4042 | | 8 | 5 | |\n| | Oral powder 450 g (Karicare Aptamil Pepti-Junior Gold) | Oral | Karicare Aptamil Pepti-Junior Gold | NU | MP NP | C1034 C1059 C1080 C1092 C1310 C1364 C1670 C2567 C4040 C4041 C4042 | | 8 | 5 | |\n| Pyrantel | Tablet 125 mg (as embonate) | Oral | Anthel 125 | AF | MP NP | | | 6 | 0 | |\n| | Tablet 250 mg (as embonate) | Oral | Anthel 250 | AF | MP NP | | | 6 | 0 | |\n| Pyridostigmine | Tablet containing pyridostigmine bromide 10 mg | Oral | Mestinon | VT | MP | | | 100 | 5 | |\n| | Tablet containing pyridostigmine bromide 60 mg | Oral | Mestinon | VT | MP | | | 150 | 5 | |\n| | Tablet containing pyridostigmine bromide 180 mg (modified release) | Oral | Mestinon Timespan | VT | MP | | | 100 | 5 | |\n| Pyrimethamine | Tablet 25 mg | Oral | Daraprim | GK | MP NP | | | 50 | 0 | |\n| Quetiapine | Tablet 25 mg (as fumarate) | Oral | APO-Quetiapine | TX | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Delucon 25 | DO | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine Actavis 25 | TA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine GH 25 | GQ | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Seronia 25 | QA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet 100 mg (as fumarate) | Oral | APO-Quetiapine | TX | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Chem mart Quetiapine | CH | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Delucon 100 | DO | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiaccord | WQ | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine Actavis 100 | TA | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine-DRLA | RZ | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine GH 100 | GQ | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine Pfizer | FZ | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine RBX | RA | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine Sandoz | SZ | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quetiapine-Synthon | ZT | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Quipine | GM | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Sequase | PM | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Seronia 100 | QA | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Seroquel | AP | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | STADA Quetiapine | TD | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Syquet | AF | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | | | Terry White Chemists Quetiapine | TW | MP NP | C1589 C2044 C2765 | | 90 | 5 | |\n| | Tablet 200 mg (as fumarate) | Oral | APO-Quetiapine | TX | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Delucon 200 | DO | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine Actavis 200 | TA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine GH 200 | GQ | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Seronia 200 | QA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet 300 mg (as fumarate) | Oral | APO-Quetiapine | TX | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Delucon 300 | DO | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine Actavis 300 | TA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Quetiapine GH 300 | GQ | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | | | Seronia 300 | QA | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet (modified release) 50 mg (as fumarate) | Oral | Seroquel XR | AP | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet (modified release) 150 mg (as fumarate) | Oral | Seroquel XR | AP | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet (modified release) 200 mg (as fumarate) | Oral | Seroquel XR | AP | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet (modified release) 300 mg (as fumarate) | Oral | Seroquel XR | AP | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| | Tablet (modified release) 400 mg (as fumarate) | Oral | Seroquel XR | AP | MP NP | C1589 C2044 C2765 | | 60 | 5 | |\n| Quinagolide | Pack containing 3 tablets quinagolide 25 micrograms (as hydrochloride) and 3 tablets quinagolide 50 micrograms (as hydrochloride) | Oral | Norprolac | FP | MP | C2659 C2660 C2661 C2662 | | 1 | 0 | |\n| | Tablet 75 micrograms (as hydrochloride) | Oral | Norprolac | FP | MP | C2659 C2660 C2661 C2662 | | 30 | 5 | |\n| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | Accupril | PF | MP NP | | | 30 | 5 | |\n| | | | Acquin 5 | QA | MP NP | | | 30 | 5 | |\n| | | | Acquin Aspen 5 | AS | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Quinapril 5 | CR | MP NP | | | 30 | 5 | |\n| | | | Qpril 5 | AF | MP NP | | | 30 | 5 | |\n| | | | Quinapril Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg (as hydrochloride) | Oral | Accupril | PF | MP NP | | | 30 | 5 | |\n| | | | Acquin 10 | QA | MP NP | | | 30 | 5 | |\n| | | | Acquin Aspen 10 | AS | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Quinapril 10 | CR | MP NP | | | 30 | 5 | |\n| | | | Qpril 10 | AF | MP NP | | | 30 | 5 | |\n| | Tablet 20 mg (as hydrochloride) | Oral | Accupril | PF | MP NP | | | 30 | 5 | |\n| | | | Acquin 20 | QA | MP NP | | | 30 | 5 | |\n| | | | Acquin Aspen 20 | AS | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Quinapril 20 | CR | MP NP | | | 30 | 5 | |\n| | | | Qpril 20 | AF | MP NP | | | 30 | 5 | |\n| | | | Quinapril-GA | GM | MP NP | | | 30 | 5 | |\n| | | | Quinapril Sandoz | SZ | MP NP | | | 30 | 5 | |\n| Quinapril with Hydrochlorothiazide | Tablet 10 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | Oral | Accuretic 10/12.5mg | PF | MP NP | C3307 | | 30 | 5 | |\n| | Tablet 20 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | Oral | Accuretic 20/12.5mg | PF | MP NP | C3307 | | 30 | 5 | |\n| Quinine | Tablet containing quinine sulfate 300 mg | Oral | Quinate | AS | MP NP | C2142 | | 50 | 2 | |\n| Rabeprazole | Tablet containing rabeprazole sodium 10 mg (enteric coated) | Oral | Pariet | JC | MP NP | C1337 C1533 | | 28 | 5 | |\n| | Tablet containing rabeprazole sodium 20 mg (enteric coated) | Oral | Pariet | JC | MP NP | C1177 C1337 C1533 | P1177 | 30 | 2 | |\n| | | | Pariet | JC | MP NP | C1177 C1337 C1533 | P1337 P1533 | 30 | 5 | |\n| Raloxifene | Tablet containing raloxifene hydrochloride 60 mg | Oral | Evista | LY | MP NP | C2647 | | 28 | 5 | |\n| Raltegravir | Tablet 400 mg (as potassium) | Oral | Isentress | MK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| Raltitrexed | Powder for I.V. infusion 2 mg in single use vial | Injection | Tomudex | HH | MP | C3185 | | See Note 3 | See Note 3 | D |\n| Ramipril | Tablet 1.25 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Prilace 1.25 | QA | MP NP | | | 30 | 5 | |\n| | | | Ramace 1.25 mg | AV | MP NP | | | 30 | 5 | |\n| | | | Tritace 1.25 mg | SW | MP NP | | | 30 | 5 | |\n| | | | Tryzan Tabs 1.25 | AF | MP NP | | | 30 | 5 | |\n| | | | Vascalace 1.25 | DO | MP NP | | | 30 | 5 | |\n| | Capsule 1.25 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Ramipril 1.25 | CR | MP NP | | | 30 | 5 | |\n| | | | Tryzan Caps 1.25 | AF | MP NP | | | 30 | 5 | |\n| | Tablet 2.5 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Prilace 2.5 | QA | MP NP | | | 30 | 5 | |\n| | | | Ramace 2.5 mg | AV | MP NP | | | 30 | 5 | |\n| | | | Tritace 2.5 mg | SW | MP NP | | | 30 | 5 | |\n| | | | Tryzan Tabs 2.5 | AF | MP NP | | | 30 | 5 | |\n| | | | Vascalace 2.5 | DO | MP NP | | | 30 | 5 | |\n| | Capsule 2.5 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Ramipril 2.5 | CR | MP NP | | | 30 | 5 | |\n| | | | Tryzan Caps 2.5 | AF | MP NP | | | 30 | 5 | |\n| | Tablet 5 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Prilace 5 | QA | MP NP | | | 30 | 5 | |\n| | | | Ramace 5 mg | AV | MP NP | | | 30 | 5 | |\n| | | | Tritace 5 mg | SW | MP NP | | | 30 | 5 | |\n| | | | Tryzan Tabs 5 | AF | MP NP | | | 30 | 5 | |\n| | | | Vascalace 5 | DO | MP NP | | | 30 | 5 | |\n| | Capsule 5 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Ramipril 5 | CR | MP NP | | | 30 | 5 | |\n| | | | Tryzan Caps 5 | AF | MP NP | | | 30 | 5 | |\n| | Tablet 10 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | Tritace | SW | MP NP | | | 30 | 5 | |\n| | | | Tryzan Tabs 10 | AF | MP NP | | | 30 | 5 | |\n| | | | Vascalace 10 | DO | MP NP | | | 30 | 5 | |\n| | Capsule 10 mg | Oral | APO-Ramipril | TX | MP NP | | | 30 | 5 | |\n| | | | GenRx Ramipril | GX | MP NP | | | 30 | 5 | |\n| | | | Pharmacor Ramipril 10 | CR | MP NP | | | 30 | 5 | |\n| | | | Prilace 10 | QA | MP NP | | | 30 | 5 | |\n| | | | Ramace 10 mg | AV | MP NP | | | 30 | 5 | |\n| | | | Ramipril-PS | FZ | MP NP | | | 30 | 5 | |\n| | | | Tritace 10 mg | SW | MP NP | | | 30 | 5 | |\n| | | | Tryzan Caps 10 | AF | MP NP | | | 30 | 5 | |\n| | Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg | Oral | Tritace Titration Pack | SW | MP NP | | | 1 | 0 | |\n| Ramipril with Felodipine | Tablet 2.5 mg-2.5 mg (modified release) | Oral | Triasyn 2.5/2.5 | SW | MP NP | C3307 | | 30 | 5 | |\n| | Tablet 5 mg-5 mg (modified release) | Oral | Triasyn 5.0/5.0 | SW | MP NP | C3307 | | 30 | 5 | |\n| Ranibizumab | Solution for intravitreal injection 2.3 mg in 0.23 mL | Injection | Lucentis | NV | MP | C2677 C3859 | | 1 | 2 | |\n| Ranitidine | Tablet 150 mg (as hydrochloride) | Oral | Ausran | QA | MP NP MW | | | 60 | 5 | |\n| | | | Chem mart Ranitidine | CH | MP NP MW | | | 60 | 5 | |\n| | | | GenRx Ranitidine | GX | MP NP MW | | | 60 | 5 | |\n| | | | Rani 2 | AF | MP NP MW | | | 60 | 5 | |\n| | | | Ranitidine-PS | FZ | MP NP MW | | | 60 | 5 | |\n| | | | Ranitidine Sandoz | SZ | MP NP MW | | | 60 | 5 | |\n| | | | Ranoxyl | GM | MP NP MW | | | 60 | 5 | |\n| | | | Terry White Chemists Ranitidine | TW | MP NP MW | | | 60 | 5 | |\n| | | | Ulcaid | RA | MP NP MW | | | 60 | 5 | |\n| | | | Zantac | GK | MP NP MW | | | 60 | 5 | |\n| | Tablet, effervescent, 150 mg (as hydrochloride) | Oral | Zantac | GK | MP NP | | | 60 | 5 | |\n| | Tablet 300 mg (as hydrochloride) | Oral | Ausran | QA | MP NP | | | 30 | 5 | |\n| | | | Chem mart Ranitidine | CH | MP NP | | | 30 | 5 | |\n| | | | GenRx Ranitidine | GX | MP NP | | | 30 | 5 | |\n| | | | Rani 2 | AF | MP NP | | | 30 | 5 | |\n| | | | Ranitidine Sandoz | SZ | MP NP | | | 30 | 5 | |\n| | | | Terry White Chemists Ranitidine | TW | MP NP | | | 30 | 5 | |\n| | | | Ulcaid | RA | MP NP | | | 30 | 5 | |\n| | | | Zantac | GK | MP NP | | | 30 | 5 | |\n| | Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL | Oral | Zantac Syrup | GK | MP NP | | | 2 | 5 | |\n| Rasagiline | Tablet 1 mg (as mesilate) | Oral | Azilect | LU | MP NP | C4053 | | 30 | 5 | |\n| Reboxetine | Tablet 4 mg (as mesilate) | Oral | Edronax | PF | MP NP | C1211 | | 60 | 5 | |\n| Reteplase | Pack containing 2 vials powder for injection 10 units, 2 single use pre-filled syringes with solvent, 2 reconstitution spikes and 2 needles | Injection | Rapilysin 10 U | TA | MP NP | C1480 | | 1 | 0 | |\n| Ribavirin and Peginterferon Alfa-2a | Pack containing 168 tablets ribavirin 200 mg and 4 pre-filled syringes peginterferon alfa-2a injection 135 micrograms | Injection/ oral | Pegasys RBV | RO | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 112 tablets ribavirin 200 mg and 4 pre-filled syringes peginterferon alfa-2a injection 180 micrograms | Injection/ oral | Pegasys RBV | RO | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 140 tablets ribavirin 200 mg and 4 pre-filled syringes peginterferon alfa-2a injection 180 micrograms | Injection/ oral | Pegasys RBV | RO | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 168 tablets ribavirin 200 mg and 4 pre-filled syringes peginterferon alfa-2a injection 180 micrograms | Injection/ oral | Pegasys RBV | RO | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| Ribavirin and Peginterferon Alfa-2b | Pack containing 112 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 50 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3414 C3948 C3949 | | 2 | 5 | D |\n| | Pack containing 84 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 80 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3414 C3948 C3949 | | 2 | 5 | D |\n| | Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 80 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 112 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 100 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3414 C3948 C3949 | | 2 | 5 | D |\n| | Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 120 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 168 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| | Pack containing 196 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent | Injection/ oral | Pegatron | MK | MP See Note 1 | C3053 C3055 C3413 C3414 | | 2 | 5 | D |\n| Rifabutin | Capsule 150 mg | Oral | Mycobutin | PF | MP See Note 1 | C1299 C1435 C3317 C3415 | | 120 | 5 | D |\n| Rifampicin | Capsule 300 mg | Oral | Rimycin 300 | AF | MP NP | C1190 C1297 C1303 | P1297 P1303 | 10 | 0 | |\n| | | | | | MP NP | C1190 C1297 C1303 | P1190 | 100 | 0 | |\n| | Capsule 150 mg | Oral | Rimycin 150 | AF | MP NP | C1190 C1297 C1303 | P1297 P1303 | 10 | 0 | |\n| | | | | | MP NP | C1190 C1297 C1303 | P1190 | 100 | 0 | |\n| | Syrup 100 mg per 5 mL, 60 mL | Oral | Rifadin | SW | MP NP | C1297 C1303 | | 1 | 0 | |\n| Rilpivirine | Tablet 25 mg (as hydrochloride) | Oral | Edurant | JC | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| Riluzole | Tablet 50 mg | Oral | Rilutek | SW | MP NP | C1762 C2718 | | 56 | 5 | |\n| Risedronic Acid | Tablet containing risedronate sodium 5 mg | Oral | Actonel | SW | MP NP | C2645 C2646 C3070 | | 28 | 5 | |\n| | Tablet containing risedronate sodium 35 mg | Oral | Acris Once-a-Week | AF | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | APO-Risedronate | TX | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | Chem mart Risedronate | CH | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | Risedronate-GA | GM | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | Risedronate Sandoz | SZ | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | Risedro once a week | QA | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | | | Terry White Chemists Risedronate | TW | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | Tablet (enteric coated) containing risedronate sodium 35 mg | Oral | Actonel EC | SW | MP NP | C2645 C2646 C3070 | | 4 | 5 | |\n| | Tablet containing risedronate sodium 150 mg | Oral | Actonel Once-a-Month | SW | MP NP | C2645 C2646 C3070 | | 1 | 5 | |\n| | Tablet containing risedronate sodium 30 mg | Oral | Actonel | SW | MP NP | C3256 | | 28 | 1 | |\n| Risedronic Acid and Calcium | Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | Oral | Acris Combi | AF | MP NP | C2645 C2646 C3070 | | 1 | 5 | |\n| | Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | Oral | Actonel EC Combi | SW | MP NP | C2645 C2646 C3070 | | 1 | 5 | |\n| Risedronic acid and calcium with colecalciferol | Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms | Oral | Actonel Combi D | SW | MP NP | C2645 C2646 C3070 | | 1 | 5 | |\n| | Pack containing 4 enteric coated tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms | Oral | Actonel EC Combi D | SW | MP NP | C2645 C2646 C3070 | | 1 | 5 | |\n| Risperidone | Tablet 0.5 mg | Oral | APO-Risperidone | TX | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Ozidal | RA | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Resdone 0.5 | CR | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Rispa | QA | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperdal | JC | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone GH | GQ | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Rixadone | AF | MP NP | C1589 C2061 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | APO-Risperidone | TX | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Ozidal | RA | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Resdone 0.5 | CR | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Rispa | QA | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperdal | JC | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperidone GH | GQ | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | | | Rixadone | AF | MP NP | C1589 C2061 C3083 | P1589 | 60 | 5 | |\n| | Tablet 0.5 mg (orally disintegrating) | Oral | Risperdal Quicklet | JC | MP NP | C1589 C2061 C3083 | P2061 P3083 | 56 | 2 | |\n| | | | | | MP NP | C1589 C2061 C3083 | P1589 | 56 | 5 | |\n| | Tablet 1 mg (orally disintegrating) | Oral | Risperdal Quicklet | JC | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 56 | 2 | |\n| | | | | | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 56 | 5 | |\n| | Tablet 1 mg | Oral | APO-Risperidone | TX | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Ozidal | RA | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Resdone 1 | CR | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Rispa | QA | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperdal | JC | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | Rixadone | AF | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 60 | 2 | |\n| | | | APO-Risperidone | TX | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Ozidal | RA | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Resdone 1 | CR | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Rispa | QA | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperdal | JC | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Rixadone | AF | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | Tablet 2 mg | Oral | APO-Risperidone | TX | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Ozidal | RA | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Resdone 2 | CR | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Rispa | QA | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperdal | JC | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | Rixadone | AF | MP NP | C1589 C2272 C3083 | P3083 | 60 | 2 | |\n| | | | APO-Risperidone | TX | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Ozidal | RA | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Resdone 2 | CR | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Rispa | QA | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperdal | JC | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | | | Rixadone | AF | MP NP | C1589 C2272 C3083 | P1589 P2272 | 60 | 5 | |\n| | Tablet 2 mg (orally disintegrating) | Oral | Risperdal Quicklet | JC | MP NP | C1589 C2272 C3083 | P3083 | 56 | 2 | |\n| | | | | | MP NP | C1589 C2272 C3083 | P1589 P2272 | 56 | 5 | |\n| | Tablet 3 mg | Oral | APO-Risperidone | TX | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Ozidal | RA | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Resdone 3 | CR | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Rispa | QA | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperdal | JC | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Rixadone | AF | MP NP | C1589 C2272 | | 60 | 5 | |\n| | Tablet 3 mg (orally disintegrating) | Oral | Risperdal Quicklet | JC | MP NP | C1589 C2272 | | 56 | 5 | |\n| | Tablet 4 mg | Oral | APO-Risperidone | TX | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Ozidal | RA | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Resdone 4 | CR | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Rispa | QA | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperdal | JC | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone-DRLA | RZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone-GA | GM | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone generichealth | GQ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone Pfizer | FZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Risperidone Sandoz | SZ | MP NP | C1589 C2272 | | 60 | 5 | |\n| | | | Rixadone | AF | MP NP | C1589 C2272 | | 60 | 5 | |\n| | Tablet 4 mg (orally disintegrating) | Oral | Risperdal Quicklet | JC | MP NP | C1589 C2272 | | 56 | 5 | |\n| | Oral solution 1 mg per mL, 100 mL | Oral | Risperdal | JC | MP NP | C1589 C2061 C2272 C3083 | P2061 P3083 | 1 | 2 | |\n| | | | | | MP NP | C1589 C2061 C2272 C3083 | P1589 P2272 | 1 | 5 | |\n| | I.M. injection (modified release), set containing 1 vial powder for injection 25 mg and 1 pre-filled syringe diluent 2 mL | Injection | Risperdal Consta | JC | MP NP | C1589 C3841 | | 2 | 5 | |\n| | I.M. injection (modified release), set containing 1 vial powder for injection 37.5 mg and 1 pre-filled syringe diluent 2 mL | Injection | Risperdal Consta | JC | MP NP | C1589 C3841 | | 2 | 5 | |\n| | I.M. injection (modified release), set containing 1 vial powder for injection 50 mg and 1 pre-filled syringe diluent 2 mL | Injection | Risperdal Consta | JC | MP NP | C1589 C3841 | | 2 | 5 | |\n| Ritonavir | Tablet 100 mg | Oral | Norvir | VE | MP See Note 1 | C3586 C3587 C3588 C3589 | | 720 | 5 | D |\n| | Oral solution 600 mg per 7.5 mL (80 mg per mL), 90 mL | Oral | Norvir | VE | MP See Note 1 | C3586 C3587 C3588 C3589 | | 10 | 5 | D |\n| Rituximab | Solution for I.V. infusion 100 mg in 10 mL | Injection | Mabthera | RO | MP | C1744 C1745 C2068 C2386 C3908 C3909 C3912 C3915 C3931 C3932 | See Note 3 | See Note 3 | See note 3 | D |\n| | Solution for I.V. infusion 500 mg in 50 mL | Injection | Mabthera | RO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See note 3 | D |\n| | | | | RO | MP | C1744 C1745 C2068 C2386 C3908 C3909 C3912 C3915 C3931 C3932 | See Note 3 | See Note 3 | See note 3 | D |\n| Rivaroxaban | Tablet 10 mg | Oral | Xarelto | BN | MP NP | C3957 C3993 C4047 C4048 C4050 | P3957 | 10 | 0 | |\n| | | | | | MP NP | C3957 C3993 C4047 C4048 C4050 | P4047 | 10 | 1 | |\n| | | | | | MP NP | C3957 C3993 C4047 C4048 C4050 | P4050 | 15 | 0 | |\n| | | | | | MP NP | C3957 C3993 C4047 C4048 C4050 | P4048 | 15 | 1 | |\n| | | | | | MP NP | C3957 C3993 C4047 C4048 C4050 | P3993 | 30 | 0 | |\n| Rivastigmine | Capsule 1.5 mg (as hydrogen tartrate) | Oral | Exelon | NV | MP NP | C2934 C2938 C3875 C3876 | | 56 | 5 | |\n| | Capsule 3 mg (as hydrogen tartrate) | Oral | Exelon | NV | MP NP | C2934 C2938 C3875 C3876 | | 56 | 5 | |\n| | Capsule 4.5 mg (as hydrogen tartrate) | Oral | Exelon | NV | MP NP | C2934 C2938 C3875 C3876 | | 56 | 5 | |\n| | Capsule 6 mg (as hydrogen tartrate) | Oral | Exelon | NV | MP NP | C2934 C2938 C3875 C3876 | | 56 | 5 | |\n| | Oral solution 2 mg (as hydrogen tartrate) per mL, 120 mL | Oral | Exelon | NV | MP NP | C2934 C2938 C3875 C3876 | | 1 | 5 | |\n| | Transdermal patch 9 mg | Transdermal | Exelon Patch 5 | NV | MP NP | C2934 C2938 C3875 C3876 | | 30 | 5 | |\n| | Transdermal patch 18 mg | Transdermal | Exelon Patch 10 | NV | MP NP | C2934 C2938 C3875 C3876 | | 30 | 5 | |\n| Rizatriptan | Wafer 10 mg (as benzoate) | Oral | Maxalt | MK | MP NP | C3233 | | 4 | 5 | |\n| Romiplostim | Powder for injection 375 micrograms | Injection | Nplate | AN | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Powder for injection 625 micrograms | Injection | Nplate | AN | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Rosiglitazone | Tablet 4 mg (as maleate) | Oral | Avandia | GK | MP NP | C3722 | | 28 | 5 | |\n| | Tablet 8 mg (as maleate) | Oral | Avandia | GK | MP NP | C3722 | | 28 | 5 | |\n| Rosiglitazone with Metformin | Tablet containing 2 mg rosiglitazone (as maleate) with 500 mg metformin hydrochloride | Oral | Avandamet | GK | MP NP | C3723 | | 56 | 5 | |\n| | Tablet containing 2 mg rosiglitazone (as maleate) with 1 g metformin hydrochloride | Oral | Avandamet | GK | MP NP | C3723 | | 56 | 5 | |\n| | Tablet containing 4 mg rosiglitazone (as maleate) with 500 mg metformin hydrochloride | Oral | Avandamet | GK | MP NP | C3723 | | 56 | 5 | |\n| | Tablet containing 4 mg rosiglitazone (as maleate) with 1 g metformin hydrochloride | Oral | Avandamet | GK | MP NP | C3723 | | 56 | 5 | |\n| Rosuvastatin | Tablet 5 mg (as calcium) | Oral | Crestor | AP | NP | C1540 | | 30 | 5 | |\n| | Tablet 10 mg (as calcium) | Oral | Crestor | AP | NP | C1540 | | 30 | 5 | |\n| | Tablet 20 mg (as calcium) | Oral | Crestor | AP | NP | C1540 | | 30 | 5 | |\n| | Tablet 40 mg (as calcium) | Oral | Crestor | AP | NP | C1540 | | 30 | 5 | |\n| Roxithromycin | Tablet for oral suspension 50 mg | Oral | Rulide D | SW | PDP | | | 10 | 0 | |\n| | | | | | MP NP | | | 10 | 1 | |\n| | Tablet 150 mg | Oral | APO-Roxithromycin | TX | PDP | | | 10 | 0 | |\n| | | | Biaxsig | AV | PDP | | | 10 | 0 | |\n| | | | Chem mart Roxithromycin | CH | PDP | | | 10 | 0 | |\n| | | | Roxar 150 | QA | PDP | | | 10 | 0 | |\n| | | | Roximycin | AF | PDP | | | 10 | 0 | |\n| | | | Roxithromycin-GA | GM | PDP | | | 10 | 0 | |\n| | | | Roxithromycin-PS | FZ | PDP | | | 10 | 0 | |\n| | | | Roxithromycin Sandoz | SZ | PDP | | | 10 | 0 | |\n| | | | Rulide | SW | PDP | | | 10 | 0 | |\n| | | | Terry White Chemists Roxithromycin | TW | PDP | | | 10 | 0 | |\n| | | | APO-Roxithromycin | TX | MP NP | | | 10 | 1 | |\n| | | | Biaxsig | AV | MP NP | | | 10 | 1 | |\n| | | | Chem mart Roxithromycin | CH | MP NP | | | 10 | 1 | |\n| | | | Roxar 150 | QA | MP NP | | | 10 | 1 | |\n| | | | Roximycin | AF | MP NP | | | 10 | 1 | |\n| | | | Roxithromycin-GA | GM | MP NP | | | 10 | 1 | |\n| | | | Roxithromycin-PS | FZ | MP NP | | | 10 | 1 | |\n| | | | Roxithromycin Sandoz | SZ | MP NP | | | 10 | 1 | |\n| | | | Rulide | SW | MP NP | | | 10 | 1 | |\n| | | | Terry White Chemists Roxithromycin | TW | MP NP | | | 10 | 1 | |\n| | Tablet 300 mg | Oral | APO-Roxithromycin | TX | PDP | | | 5 | 0 | |\n| | | | Biaxsig | AV | PDP | | | 5 | 0 | |\n| | | | Chem mart Roxithromycin | CH | PDP | | | 5 | 0 | |\n| | | | Roxar 300 | QA | PDP | | | 5 | 0 | |\n| | | | Roximycin | AF | PDP | | | 5 | 0 | |\n| | | | Roxithromycin-GA | GM | PDP | | | 5 | 0 | |\n| | | | Roxithromycin-PS | FZ | PDP | | | 5 | 0 | |\n| | | | Roxithromycin Sandoz | SZ | PDP | | | 5 | 0 | |\n| | | | Rulide | SW | PDP | | | 5 | 0 | |\n| | | | Terry White Chemists Roxithromycin | TW | PDP | | | 5 | 0 | |\n| | | | APO-Roxithromycin | TX | MP NP | | | 5 | 1 | |\n| | | | Biaxsig | AV | MP NP | | | 5 | 1 | |\n| | | | Chem mart Roxithromycin | CH | MP NP | | | 5 | 1 | |\n| | | | Roxar 300 | QA | MP NP | | | 5 | 1 | |\n| | | | Roximycin | AF | MP NP | | | 5 | 1 | |\n| | | | Roxithromycin-GA | GM | MP NP | | | 5 | 1 | |\n| | | | Roxithromycin-PS | FZ | MP NP | | | 5 | 1 | |\n| | | | Roxithromycin Sandoz | SZ | MP NP | | | 5 | 1 | |\n| | | | Rulide | SW | MP NP | | | 5 | 1 | |\n| | | | Terry White Chemists Roxithromycin | TW | MP NP | | | 5 | 1 | |\n| Salbutamol | Oral solution 2 mg (as sulfate) per 5 mL, 150 mL | Oral | Ventolin | GK | MP NP | | | 2 | 5 | |\n| | Capsule containing powder for oral inhalation 200 micrograms (as sulfate) (for use in Ventolin Rotahaler) | Inhalation by mouth | Ventolin Rotacaps | GK | MP NP | | | 200 | 5 | |\n| | Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Airomir | IA | MP NP | | | 2 | 5 | |\n| | | | APO-Salbutamol Inhaler | TX | MP NP | | | 2 | 5 | |\n| | | | Asmol CFC-free | AL | MP NP | | | 2 | 5 | |\n| | | | Ventolin CFC-free | GK | MP NP | | | 2 | 5 | |\n| | Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Airomir Autohaler | IA | MP NP | C1266 | | 2 | 5 | |\n| | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Asmol 2.5 uni-dose | AF | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Butamol 2.5 | QA | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | GenRx Salbutamol | GX | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Pharmacor Salbutamol 2.5 | CR | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Salbutamol-GA | GM | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Salbutamol Sandoz | SZ | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ventolin Nebules | GK | MP NP | C1754 C1755 | | 2 | 5 | |\n| | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation | Asmol 5 uni-dose | AF | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Butamol 5 | QA | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | GenRx Salbutamol | GX | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Pharmacor Salbutamol 5 | CR | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Salbutamol-GA | GM | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Salbutamol Sandoz | SZ | MP NP | C1754 C1755 | | 2 | 5 | |\n| | | | Ventolin Nebules | GK | MP NP | C1754 C1755 | | 2 | 5 | |\n| | Nebuliser solution 5 mg (as sulfate) per mL, 30 mL | Inhalation | Pfizer Australia Pty Ltd | PF | MP NP | C1754 C1755 | | 2 | 2 | |\n| Salcatonin | Injection 50 I.U. in 1 mL ampoule | Injection | Miacalcic 50 | NV | MP NP | C1412 C3256 | | 30 | 5 | |\n| | Injection 100 I.U. in 1 mL ampoule | Injection | Miacalcic 100 | NV | MP NP | C1412 C3256 | | 15 | 5 | |\n| Salmeterol | Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Serevent Accuhaler | GK | MP NP | C1752 C1753 | | 1 | 5 | |\n| Saquinavir | Tablet 500 mg (as mesylate) | Oral | Invirase | RO | MP See Note 1 | C3586 C3587 C3588 C3589 | | 240 | 5 | D |\n| Saxagliptin | Tablet 5 mg (as hydrochloride) | Oral | Onglyza | BQ | MP NP | C3540 | | 28 | 5 | |\n| Selegiline | Tablet containing selegiline hydrochloride 5 mg | Oral | Eldepryl | AS | MP NP | C1864 | | 100 | 5 | |\n| | | | Selgene | AF | MP NP | C1864 | | 100 | 5 | |\n| Sertraline | Tablet 50 mg (as hydrochloride) | Oral | Auro-Sertraline 50 | DO | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Chem mart Sertraline | CH | MP NP | C1211 | | 30 | 5 | |\n| | | | Eleva 50 | AF | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | GenRx Sertraline | GX | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertra 50 | QA | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertracor 50 | MI | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline 50 | CR | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline-DRLA | RZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline-GA | GM | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline generichealth | GQ | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline Pfizer | FZ | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Sertraline Sandoz | SZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Setrona | RA | MP NP | C1211 | | 30 | 5 | |\n| | | | Terry White Chemists Sertraline | TW | MP NP | C1211 | | 30 | 5 | |\n| | | | Xydep 50 | GN | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Zoloft | PF | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | Tablet 100 mg (as hydrochloride) | Oral | Auro-Sertraline 100 | DO | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Chem mart Sertraline | CH | MP NP | C1211 | | 30 | 5 | |\n| | | | Eleva 100 | AF | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | GenRx Sertraline | GX | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertra 100 | QA | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertracor 100 | MI | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline 100 | CR | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline-DRLA | RZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline-GA | GM | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline generichealth | GQ | MP NP | C1211 | | 30 | 5 | |\n| | | | Sertraline Pfizer | FZ | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Sertraline Sandoz | SZ | MP NP | C1211 | | 30 | 5 | |\n| | | | Setrona | RA | MP NP | C1211 | | 30 | 5 | |\n| | | | Terry White Chemists Sertraline | TW | MP NP | C1211 | | 30 | 5 | |\n| | | | Xydep 100 | GN | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| | | | Zoloft | PF | MP NP | C1211 C1241 C1975 | | 30 | 5 | |\n| Sevelamer | Tablet containing sevelamer hydrochloride 800 mg | Oral | Renagel | GZ | MP NP | C3548 C3549 | | 180 | 5 | |\n| | | | Renagel | GZ | MP See Note 1 | C3103 C3104 C3390 C3391 | | 360 | 5 | C |\n| Sildenafil | Tablet 20 mg (as citrate) | Oral | Revatio | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Silver sulfadiazine | Cream 10 mg per g, 50 g | Application | Flamazine | SN | MP NP | C1386 C1865 C1866 | | 1 | 0 | |\n| Simvastatin | Tablet 5 mg | Oral | Simvastatin Sandoz | SZ | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | Tablet 10 mg | Oral | APO-Simvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 10 | DO | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipex 10 | FR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Simvastatin 10 | MI | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvacor 10 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvar 10 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-GA 10 | GN | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-Spirit 10 | ZP | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 10 | DO | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipex 10 | FR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Simvastatin 10 | MI | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvacor 10 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvar 10 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-GA 10 | GN | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-Spirit 10 | ZP | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 20 mg | Oral | APO-Simvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 20 | DO | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipex 20 | FR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Simvastatin 20 | MI | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvacor 20 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvar 20 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-GA 20 | GN | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-Spirit 20 | ZP | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 20 | DO | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipex 20 | FR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Simvastatin 20 | MI | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvacor 20 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvar 20 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-GA 20 | GN | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-Spirit 20 | ZP | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 40 mg | Oral | APO-Simvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 40 | DO | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipex 40 | FR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Simvastatin 40 | MI | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvacor 40 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvar 40 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-GA 40 | GN | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-Spirit 40 | ZP | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 40 | DO | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipex 40 | FR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Simvastatin 40 | MI | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvacor 40 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvar 40 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-DRLA | RZ | MP | C1540 C3047 | P3407 | 30 | 11 | |\n| | | | Simvastatin-GA 40 | GN | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-Spirit 40 | ZP | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | Tablet 80 mg | Oral | APO-Simvastatin | TX | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 80 | DO | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Lipex 80 | FR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Pharmacor Simvastatin 80 | MI | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvacor 80 | CR | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvar 80 | QA | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-GA 80 | GN | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Simvastatin-Spirit 80 | ZP | MP | C1540 C3047 | P1540 | 30 | 5 | |\n| | | | Auro-Simvastatin 80 | DO | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Lipex 80 | FR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Pharmacor Simvastatin 80 | MI | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvacor 80 | CR | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvar 80 | QA | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-GA 80 | GN | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| | | | Simvastatin-Spirit 80 | ZP | MP | C1540 C3047 | P3047 | 30 | 11 | |\n| Sirolimus | Tablet 0.5 mg | Oral | Rapamune | PF | MP | C1952 | | 100 | 3 | |\n| | Tablet 1 mg | Oral | Rapamune | PF | MP | C1952 | | 100 | 3 | |\n| | Tablet 2 mg | Oral | Rapamune | PF | MP | C1952 | | 100 | 3 | |\n| | Oral solution 1 mg per mL, 60 mL | Oral | Rapamune | PF | MP | C1952 | | 1 | 3 | |\n| | | | | | MP See Note 1 | C1650 C3355 | | 2 | 5 | C |\n| Sitagliptin | Tablet 25 mg (as phosphate monohydrate) | Oral | Januvia | MK | MP NP | C3540 | | 28 | 5 | |\n| | Tablet 50 mg (as phosphate monohydrate) | Oral | Januvia | MK | MP NP | C3540 | | 28 | 5 | |\n| | Tablet 100 mg (as phosphate monohydrate) | Oral | Januvia | MK | MP NP | C3540 | | 28 | 5 | |\n| Sitagliptin with metformin | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 500 mg metformin hydrochloride | Oral | Janumet | MK | MP NP | C3149 C3543 | | 56 | 5 | |\n| | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 850 mg metformin hydrochloride | Oral | Janumet | MK | MP NP | C3149 C3543 | | 56 | 5 | |\n| | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | Oral | Janumet | MK | MP NP | C3149 C3543 | | 56 | 5 | |\n| Sodium Acid Phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral | Phosphate Sandoz | NV | MP NP | C1099 C1157 C1167 C1467 | | 100 | 5 | |\n| Sodium bicarbonate | Capsule 840 mg | Oral | Sodibic | AS | MP NP | | | 100 | 2 | |\n| Sodium Chloride | I.V. infusion 38.5 mmol per 250 mL, 250 mL | Injection | B. Braun Australia Pty Ltd | BR | MP NP | | | 5 | 1 | |\n| | | | Sodium Chloride 0.9% Freeflex | PK | MP NP | | | 5 | 1 | |\n| | I.V. infusion 77 mmol per 500 mL, 500 mL | Injection | B. Braun Australia Pty Ltd | BR | PDP | | | 5 | 0 | |\n| | I.V. infusion 154 mmol per L, 1 L | Injection | B. Braun Australia Pty Ltd | BR | PDP | | | 5 | 0 | |\n| | | | Baxter Healthcare Pty Ltd | BX | PDP | | | 5 | 0 | |\n| | I.V. infusion 513 mmol per L, 1 L | Injection | Baxter Healthcare Pty Ltd | BX | PDP | | | 2 | 0 | |\n| Sodium Chloride Compound | I.V. infusion containing approximately 148 mmol sodium (as chloride), 4 mmol potassium (as chloride), 2 mmol calcium (as chloride) and 156 mmol chloride per L, 1 L | Injection | Baxter Healthcare Pty Ltd | BX | MP NP | | | 4 | 1 | |\n| Sodium Chloride with Glucose | I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L | Injection | Baxter Healthcare Pty Ltd | BX | PDP | | | 5 | 0 | |\n| | I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL | Injection | Baxter Healthcare Pty Ltd | BX | PDP | | | 5 | 0 | |\n| | I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL | Injection | Baxter Healthcare Pty Ltd | BX | PDP | | | 5 | 0 | |\n| Sodium Lactate Compound | I.V. infusion containing approximately 65 mmol sodium (as lactate and chloride), 2.7 mmol potassium (as chloride), 0.9 mmol calcium (as chloride), 14 mmol bicarbonate (as lactate) and 56 mmol chloride per 500 mL, 500 mL | Injection | B. Braun Australia Pty Ltd | BR | MP NP | | | 5 | 1 | |\n| | I.V. infusion containing approximately 131 mmol sodium (as lactate and chloride), 5 mmol potassium (as chloride), 2 mmol calcium (as chloride), 29 mmol bicarbonate (as lactate) and 111 mmol chloride per L, 1 L | Injection | B. Braun Australia Pty Ltd | BR | MP NP | | | 5 | 1 | |\n| Somatropin | Injection 4 mg (12 i.u.) vial with diluent (with preservative) | Injection | Zomacton | FP | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 5 mg (15 i.u.) in 1 mL cartridge (with preservative) | Injection | Genotropin | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Powder for injection 5 mg (15 i.u.) with diluent in pre-filled pen (with preservative) | Injection | Genotropin GoQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative) | Injection | Norditropin SimpleXx | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Omnitrope | SZ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n|
| Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative) in pre-filled pen | Injection | Norditropin FlexPro | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 18 i.u. (6 mg) cartridge with 3.15 mL diluent (with preservative) | Injection | Humatrope | LY | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 8 mg (24 i.u.) vial with 1.37 mL diluent cartridge (with preservative) (for use with one.click auto-injector) | Injection | Saizen 8 mg click.easy | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative) | Injection | Norditropin SimpleXx | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | | | Omnitrope | SZ | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n|
| Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative) in pre-filled pen | Injection | Norditropin FlexPro | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 10 mg (30 i.u.) in 2 mL cartridge (with preservative) | Injection | NutropinAq | IS | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 10 mg (30 i.u.) vial with diluent (with preservative) | Injection | Zomacton | FP | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 36 i.u. (12 mg) cartridge with 3.15 mL diluent (with preservative) | Injection | Humatrope | LY | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 12 mg (36 i.u.) in 1 mL cartridge (with preservative) | Injection | Genotropin | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Powder for injection 12 mg (36 i.u.) with diluent in pre-filled pen (with preservative) | Injection | Genotropin GoQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative) | Injection | Norditropin SimpleXx | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n|
| Solution for injection 15 mg (45 i.u.) in 1.5 mL cartridge (with preservative) in pre-filled pen | Injection | Norditropin FlexPro | NO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 6 mg (18 i.u.) in 1.03 mL cartridge (with preservative) | Injection | Saizen | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 12 mg (36 i.u.) in 1.5 mL cartridge (with preservative) | Injection | Saizen | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Solution for injection 20 mg (60 i.u.) in 2.5 mL cartridge (with preservative) | Injection | Saizen | SG | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 72 i.u. (24 mg) cartridge with 3.15 mL diluent (with preservative) | Injection | Humatrope | LY | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 0.6 mg (1.8 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 0.8 mg (2.4 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1 mg (3 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1.2 mg (3.6 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1.4 mg (4.2 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1.6 mg (4.8 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 1.8 mg (5.4 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Injection 2 mg (6 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin MiniQuick | PF | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Sorafenib | Tablet 200 mg (as tosylate) | Oral | Nexavar | BN | MP | C3071 C3072 | | 120 | 2 | |\n| Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate | Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 | Rectal | Micolette | AE | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 2 See Note 2 | 0 See Note 2 | |\n| | | | Microlax | JT | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 2 See Note 2 | 0 See Note 2 | |\n| | | | Micolette | AE | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 2 See Note 2 | 2 See Note 2 | |\n| | | | Microlax | JT | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 2 See Note 2 | 2 See Note 2 | |\n| | | | Micolette | AE | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 2 See Note 2 | 3 See Note 2 | |\n| | | | Microlax | JT | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 2 See Note 2 | 3 See Note 2 | |\n| Sotalol | Tablet containing sotalol hydrochloride 80 mg | Oral | GenRx Sotalol | GX | MP NP | C1350 | | 60 | 5 | |\n| | | | Solavert | QA | MP NP | C1350 | | 60 | 5 | |\n| | | | Sotacor | FM | MP NP | C1350 | | 60 | 5 | |\n| | | | Sotalol Sandoz | SZ | MP NP | C1350 | | 60 | 5 | |\n| | Tablet containing sotalol hydrochloride 160 mg | Oral | Cardol | AF | MP NP | C1350 | | 60 | 5 | |\n| | | | Chem mart Sotalol | CH | MP NP | C1350 | | 60 | 5 | |\n| | | | GenRx Sotalol | GX | MP NP | C1350 | | 60 | 5 | |\n| | | | Solavert | QA | MP NP | C1350 | | 60 | 5 | |\n| | | | Sotacor | FM | MP NP | C1350 | | 60 | 5 | |\n| | | | Sotalol Sandoz | SZ | MP NP | C1350 | | 60 | 5 | |\n| | | | Terry White Chemists Sotalol | TW | MP NP | C1350 | | 60 | 5 | |\n| Soy lecithin | Eye spray 10 mg per mL, 10 mL | Application | tearsagain | RB | MP NP | C1359 | | 2 | 5 | |\n| | | | | | AO | C2802 | | 2 | 5 | |\n| Soy protein and fat formula with vitamins and minerals — carbohydrate free | Oral liquid 384 mL (RCF) | Oral | RCF | AB | MP NP | C1578 C1579 C1580 C1581 | | 120 | 5 | |\n| Spironolactone | Tablet 25 mg | Oral | Aldactone | PF | MP NP | | | 100 | 5 | |\n| | | | Spiractin 25 | AF | MP NP | | | 100 | 5 | |\n| | Tablet 100 mg | Oral | Aldactone | PF | MP NP | | | 100 | 5 | |\n| | | | Spiractin 100 | AF | MP NP | | | 100 | 5 | |\n| Stavudine | Capsule 20 mg | Oral | Zerit | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Capsule 30 mg | Oral | Zerit | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| | Capsule 40 mg | Oral | Zerit | BQ | MP See Note 1 | C3586 C3587 C3588 C3589 | | 120 | 5 | D |\n| Sterculia with Frangula Bark | Granules 620 mg-80 mg per g, 500 g | Oral | Normacol Plus | NE | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3643 See Note 2 | 1 See Note 2 | 0 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P1025 P1122 P1221 P1254 P1263 P1268 P1400 See Note 2 | 1 See Note 2 | 1 See Note 2 | |\n| | | | | | MP NP See Note 1 | C1025 C1122 C1221 C1254 C1263 C1268 C1400 C3642 C3643 See Note 2 | P3642 See Note 2 | 1 See Note 2 | 3 See Note 2 | |\n| Strontium | Sachet containing granules for oral suspension containing strontium ranelate 2 g | Oral | Protos 2 g | SE | MP NP | C2647 C2758 | | 28 | 5 | |\n| Sucralfate | Tablet equivalent to 1 g anhydrous sucralfate | Oral | Carafate | AS | MP NP | | | 120 | 2 | |\n| | | | Ulcyte | AF | MP NP | | | 120 | 2 | |\n| Sulfasalazine | Tablet 500 mg | Oral | Salazopyrin | PF | MP NP | | | 200 | 5 | |\n| | | | | | MP | | P3035 | 200 | 11 | |\n| | Tablet 500 mg (enteric coated) | Oral | Pyralin EN | FZ | MP NP | | | 200 | 5 | |\n| | | | Salazopyrin-EN | PF | MP NP | | | 200 | 5 | |\n| | | | Pyralin EN | FZ | MP | | P3035 | 200 | 11 | |\n| | | | Salazopyrin-EN | PF | MP | | P3035 | 200 | 11 | |\n| Sulthiame | Tablet 50 mg | Oral | Ospolot | PL | MP NP | | | 200 | 2 | |\n| | Tablet 200 mg | Oral | Ospolot | PL | MP NP | | | 200 | 2 | |\n| Sumatriptan | Tablet 50 mg (as succinate) | Oral | APO-Sumatriptan | TX | MP NP | C3233 | | 4 | 5 | |\n| | | | Chem mart Sumatriptan | CH | MP NP | C3233 | | 4 | 5 | |\n| | | | Imigran | GK | MP NP | C3233 | | 4 | 5 | |\n| | | | Pharmacor Sumatriptan 50 | CR | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumagran 50 | QA | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumagran Aspen 50 | AS | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumatab | AF | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumatriptan-GA | GM | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumatriptan generichealth | GQ | MP NP | C3233 | | 4 | 5 | |\n| | | | Sumatriptan-PS | FZ | MP NP | C3233 | | 4 | 5 | |\n| | | | Terry White Chemists Sumatriptan | TW | MP NP | C3233 | | 4 | 5 | |\n| | Tablet (fast disintegrating) 50 mg (as succinate) | Oral | Imigran FDT | GK | MP NP | C3233 | | 4 | 5 | |\n| | Nasal spray 20 mg in 0.1 mL single dose unit | Nasal | Imigran | GK | MP NP | C3233 | | 2 | 5 | |\n| Sunitinib | Capsule 12.5 mg (as malate) | Oral | Sutent | PF | MP | C3108 C3109 C3110 C3206 C3207 | P3108 P3206 P3207 | 28 | 1 | |\n| | Capsule 25 mg (as malate) | Oral | Sutent | PF | MP | C3108 C3109 C3110 C3206 C3207 | P3108 P3206 P3207 | 28 | 1 | |\n| | Capsule 50 mg (as malate) | Oral | Sutent | PF | MP | C3108 C3109 C3110 C3206 C3207 | P3108 P3206 P3207 | 28 | 1 | |\n| Tacrolimus | Capsule 0.5 mg | Oral | Prograf | JC | MP | C3080 | | 100 | 3 | |\n| | | | Tacrolimus Sandoz | SZ | MP | C3080 | | 100 | 3 | |\n| | | | Prograf | JC | MP See Note 1 | C1654 C3328 | | 200 | 5 | C |\n| | | | Tacrolimus Sandoz | SZ | MP See Note 1 | C1654 C3328 | | 200 | 5 | C |\n| | Capsule 1 mg | Oral | Prograf | JC | MP | C3080 | | 100 | 3 | |\n| | | | Tacrolimus Sandoz | SZ | MP | C3080 | | 100 | 3 | |\n| | | | Prograf | JC | MP See Note 1 | C1654 C3328 | | 200 | 5 | C |\n| | | | Tacrolimus Sandoz | SZ | MP See Note 1 | C1654 C3328 | | 200 | 5 | C |\n| | Capsule 5 mg | Oral | Prograf | JC | MP | C3080 | | 50 | 3 | |\n| | | | Tacrolimus Sandoz | SZ | MP | C3080 | | 50 | 3 | |\n| | | | Prograf | JC | MP See Note 1 | C1654 C3328 | | 100 | 5 | C |\n| | | | Tacrolimus Sandoz | SZ | MP See Note 1 | C1654 C3328 | | 100 | 5 | C |\n| | Capsule 0.5 mg (once daily prolonged release) | Oral | Prograf XL | JC | MP | C3080 | | 30 | 3 | |\n| | | | Prograf XL | JC | MP See Note 1 | C1654 C3328 | | 60 | 5 | C |\n| | Capsule 1 mg (once daily prolonged release) | Oral | Prograf XL | JC | MP | C3080 | | 60 | 3 | |\n| | | | Prograf XL | JC | MP See Note 1 | C1654 C3328 | | 120 | 5 | C |\n| | Capsule 5 mg (once daily prolonged release) | Oral | Prograf XL | JC | MP | C3080 | | 30 | 3 | |\n| | | | Prograf XL | JC | MP See Note 1 | C1654 C3328 | | 60 | 5 | C |\n| Tadalafil | Tablet 20 mg | Oral | Adcirca | LY | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Tamoxifen | Tablet 10 mg (as citrate) | Oral | Genox 10 | AF | MP NP | C1749 | | 60 | 5 | |\n| | Tablet 20 mg (as citrate) | Oral | Genox 20 | AF | MP NP | C1749 | | 60 | 5 | |\n| | | | GenRx Tamoxifen | GX | MP NP | C1749 | | 60 | 5 | |\n| | | | Nolvadex-D | AP | MP NP | C1749 | | 60 | 5 | |\n| | | | Tamosin | QA | MP NP | C1749 | | 60 | 5 | |\n| | | | Tamoxen 20 mg | GM | MP NP | C1749 | | 60 | 5 | |\n| | | | Tamoxifen Sandoz | SZ | MP NP | C1749 | | 60 | 5 | |\n| Telbivudine | Tablet 600 mg | Oral | Sebivo | NV | MP See Note 1 | C3967 C3968 C3969 C3970 | | 56 | 5 | D |\n| Telmisartan | Tablet 40 mg | Oral | Micardis | BY | MP NP | | | 28 | 5 | |\n| | Tablet 80 mg | Oral | Micardis | BY | MP NP | | | 28 | 5 | |\n| Telmisartan with amlodipine | Tablet 40 mg-5 mg (as besylate) | Oral | Twynsta | BY | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 40 mg-10 mg (as besylate) | Oral | Twynsta | BY | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 80 mg-5 mg (as besylate) | Oral | Twynsta | BY | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 80 mg-10 mg (as besylate) | Oral | Twynsta | BY | MP NP | C3307 | | 28 | 5 | |\n| Telmisartan with Hydrochlorothiazide | Tablet 40 mg-12.5 mg | Oral | Micardis Plus 40/12.5 mg | BY | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 80 mg-12.5 mg | Oral | Micardis Plus 80/12.5 mg | BY | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 80 mg-25 mg | Oral | Micardis Plus 80/25 mg | BY | MP NP | C3307 | | 28 | 5 | |\n| Temazepam | Tablet 10 mg | Oral | APO-Temazepam | TX | PDP MP NP | | | 25 | 0 | |\n| | | | Normison | QA | PDP MP NP | | | 25 | 0 | |\n| | | | Temaze | AF | PDP MP NP | | | 25 | 0 | |\n| | | | Temtabs | FM | PDP MP NP | | | 25 | 0 | |\n| | | | APO-Temazepam | TX | MP NP | | P3654 | 50 | 0 | |\n| | | | Normison | QA | MP NP | | P3654 | 50 | 0 | |\n| | | | Temaze | AF | MP NP | | P3654 | 50 | 0 | |\n| | | | Temtabs | FM | MP NP | | P3654 | 50 | 0 | |\n| | | | APO-Temazepam | TX | MP NP | | P3653 | 50 | 3 | |\n| | | | Normison | QA | MP NP | | P3653 | 50 | 3 | |\n| | | | Temaze | AF | MP NP | | P3653 | 50 | 3 | |\n| | | | Temtabs | FM | MP NP | | P3653 | 50 | 3 | |\n| | | | APO-Temazepam | TX | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Normison | QA | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Temaze | AF | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| | | | Temtabs | FM | MP NP | | P1123 P1126 P1216 | 50 | 5 | |\n| Temozolomide | Capsule 140 mg | Oral | Astromide | WQ | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 140 | QA | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 140 | QA | MP | C1736 C1737 C2100 C2101 | P2100 | 15 | 2 | |\n| | Capsule 5 mg | Oral | Astromide | WQ | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 5 | QA | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 5 | QA | MP | C1736 C1737 C2100 C2101 | P2100 | 15 | 2 | |\n| | Capsule 20 mg | Oral | Astromide | WQ | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 20 | QA | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 20 | QA | MP | C1736 C1737 C2100 C2101 | P2100 | 15 | 2 | |\n| | Capsule 100 mg | Oral | Astromide | WQ | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 100 | QA | MP | C1736 C1737 C2100 C2101 | P1736 P1737 P2101 | 5 | 5 | |\n| | | | Temizole 100 | QA | MP | C1736 C1737 C2100 C2101 | P2100 | 15 | 2 | |\n| | Capsule 250 mg | Oral | Astromide | WQ | MP | C1736 C1737 C2101 | | 5 | 5 | |\n| | | | Orion Temozolomide | ON | MP | C1736 C1737 C2101 | | 5 | 5 | |\n| | | | Temizole 250 | QA | MP | C1736 C1737 C2101 | | 5 | 5 | |\n| | | | Temodal | MK | MP | C1736 C1737 C2101 | | 5 | 5 | |\n| Tenecteplase | Powder for injection 40 mg with solvent | Injection | Metalyse | BY | MP NP | C1481 | | 1 | 0 | |\n| | Powder for injection 50 mg with solvent | Injection | Metalyse | BY | MP NP | C1481 | | 1 | 0 | |\n| Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Viread | GI | MP See Note 1 | C3586 C3587 C3588 C3589 C3967 C3968 C3969 C3970 C3971 C3972 C3973 C3974 | | 60 | 5 | D |\n| Tenofovir with Emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral | Truvada | GI | MP See Note 1 | C3586 C3587 C3588 C3589 | | 60 | 5 | D |\n| Tenofovir with emtricitabine and efavirenz | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and efavirenz 600 mg | Oral | Atripla | GI | MP See Note 1 | C3983 C3984 C3985 C3986 | | 60 | 5 | D |\n| Tenofovir with Emtricitabine and Rilpivirine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg and rilpivirine 25 mg (as hydrochloride) | Oral | Eviplera | GI | MP See Note 1 | C3983 C3984 C3985 C3986 | | 60 | 5 | D |\n| Terbinafine | Tablet 250 mg (as hydrochloride) | Oral | GenRx Terbinafine | GX | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Lamisil (Novartis Pharmaceuticals Australia Pty Limited) | NV | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Sebifin 250 | RA | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Tamsil | QA | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbihexal | HX | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbinafine 250 | CR | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbinafine-DRLA | RZ | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbinafine-GA | GM | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbinafine Sandoz | SZ | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Terbix 250 | MI | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | Tinasil | AF | MP NP | C2191 C2865 C3244 | P2865 P3244 | 42 | 0 | |\n| | | | GenRx Terbinafine | GX | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Lamisil (Novartis Pharmaceuticals Australia Pty Limited) | NV | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Sebifin 250 | RA | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Tamsil | QA | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbihexal | HX | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbinafine 250 | CR | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbinafine-DRLA | RZ | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbinafine-GA | GM | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbinafine Sandoz | SZ | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Terbix 250 | MI | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | | | Tinasil | AF | MP NP | C2191 C2865 C3244 | P2191 | 42 | 1 | |\n| | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | Application | Lamisil | NC | MP NP | C2354 C3243 | | 2 | 3 | |\n| Terbutaline | Injection containing terbutaline sulfate 500 micrograms in 1 mL | Injection | Bricanyl | AP | MP NP | | | 5 | 0 | |\n| | Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 200 doses | Inhalation by mouth | Bricanyl Turbuhaler | AP | MP NP | | | 1 | 5 | |\n| Teriparatide | Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen | Injection | Forteo | LY | MP | C4031 C4032 | | 1 | 5 | |\n| Testosterone | Capsule containing testosterone undecanoate 40 mg | Oral | Andriol Testocaps | MK | MP | C1021 C1022 C1226 | | 60 | 5 | |\n| | Subcutaneous implant 100 mg | Implantation | Schering-Plough Pty Limited | MK | MP | C1021 C1022 C1226 | | 6 | 0 | |\n| | Injection containing testosterone enanthate 250 mg in 1 mL | Injection | Primoteston Depot | BN | MP | C1021 C1022 C1226 | | 3 | 3 | |\n| | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | Injection | Reandron 1000 | BN | MP | C1021 C1022 C1226 | | 1 | 1 | |\n| | Subcutaneous implant 200 mg | Implantation | Schering-Plough Pty Limited | MK | MP | C1021 C1022 C1226 | | 3 | 0 | |\n| | Transdermal gel 50 mg in 5 g sachet, 30 | Transdermal | Testogel | BN | MP | C1021 C1022 C1226 | | 1 | 5 | |\n| | Transdermal patches 12.2 mg, 60 | Transdermal | Androderm | HH | MP | C1021 C1022 C1226 | | 1 | 5 | |\n| | Transdermal patches 24.3 mg, 30 | Transdermal | Androderm | HH | MP | C1021 C1022 C1226 | | 1 | 5 | |\n| Tetrabenazine | Tablet 25 mg | Oral | Orphan Australia Pty Ltd | OA | MP NP | C1161 | | 112 | 5 | |\n| Tetracosactrin | Compound depot injection 1 mg in 1 mL | Injection | Synacthen Depot 1 mg/1 mL | NV | MP | | | 5 | 5 | |\n| Thalidomide | Capsule 50 mg | Oral | Thalomid | CJ | MP See Note 1 | C1233 C3342 | | 112 | 0 | D |\n| | Capsule 100 mg | Oral | Thalomid | CJ | MP See Note 1 | C1233 C3342 | | 56 | 0 | D |\n| Theophylline | Tablet 200 mg (sustained release) | Oral | Nuelin-SR 200 | IA | MP NP | | | 100 | 5 | |\n| | Tablet 250 mg (sustained release) | Oral | Nuelin-SR 250 | IA | MP NP | | | 100 | 5 | |\n| | Tablet 300 mg (sustained release) | Oral | Nuelin-SR 300 | IA | MP NP | | | 100 | 5 | |\n| | Oral solution 133.3 mg per 25 mL, 500 mL | Oral | Nuelin | IA | MP NP | | | 1 | 5 | |\n| Thiamine | Tablet containing thiamine hydrochloride 100 mg | Oral | Betamin | SW | MP NP | C2384 | | 100 | 2 | |\n| Thioguanine | Tablet 40 mg | Oral | Lanvis | AS | MP | | | 25 | 1 | |\n| Thyrotropin Alfa | Powder for injection 0.9 mg, 2 | Injection | Thyrogen | GZ | MP | C3193 | | 1 | 0 | |\n| Thyroxine | Tablet containing 50 micrograms anhydrous thyroxine sodium | Oral | Eutroxsig | FM | MP NP | | | 200 | 1 | |\n| | Tablet containing 75 micrograms anhydrous thyroxine sodium | Oral | Eutroxsig | FM | MP NP | | | 200 | 1 | |\n| | Tablet containing 100 micrograms anhydrous thyroxine sodium | Oral | Eutroxsig | FM | MP NP | | | 200 | 1 | |\n| | Tablet containing 200 micrograms anhydrous thyroxine sodium | Oral | Eutroxsig | FM | MP NP | | | 200 | 1 | |\n| Tiagabine | Tablet 5 mg (as hydrochloride) | Oral | Gabitril | OA | MP NP | C2664 | | 100 | 5 | |\n| | Tablet 10 mg (as hydrochloride) | Oral | Gabitril | OA | MP NP | C2664 | | 100 | 5 | |\n| | Tablet 15 mg (as hydrochloride) | Oral | Gabitril | OA | MP NP | C2664 | | 100 | 5 | |\n| Tiaprofenic Acid | Tablet 300 mg | Oral | Surgam | SW | MP NP | C1054 | | 60 | 3 | |\n| Ticagrelor | Tablet 90 mg | Oral | Brilinta | AP | MP NP | C3879 | | 56 | 5 | |\n| Ticarcillin with Clavulanic Acid | Powder for injection containing ticarcillin 3 g (as sodium) with 100 mg clavulanic acid (as potassium clavulanate) | Injection | Timentin | GK | MP NP | C1169 C1846 C1847 | | 10 | 0 | |\n| Ticlopidine | Tablet containing ticlopidine hydrochloride 250 mg | Oral | Tilodene | AF | MP NP | C1260 C1719 C1720 C1721 | | 60 | 5 | |\n| Tiludronic Acid | Tablet 200 mg (as tiludronate disodium) | Oral | Skelid | SW | MP NP | C3256 | | 56 | 2 | |\n| Timolol | Eye gel 1 mg (as maleate) per g, 5 g | Application to the eye | Nyogel | NV | MP AO | | | 1 | 5 | |\n| | Eye drops 2.5 mg (as maleate) per mL, 5 mL | Application to the eye | Tenopt | QA | MP AO | | | 1 | 5 | |\n| | Eye drops 5 mg (as maleate) per mL, 5 mL | Application to the eye | Tenopt | QA | MP AO | | | 1 | 5 | |\n| | | | Timoptol | FR | MP AO | | | 1 | 5 | |\n| | Eye drops (gellan gum solution) 2.5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Timoptol XE | MK | MP AO | | | 1 | 5 | |\n| | Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Timoptol XE | MK | MP AO | | | 1 | 5 | |\n| Tinidazole | Tablet 500 mg | Oral | Fasigyn | PF | MP NP | | | 4 | 0 | |\n| | | | Simplotan | FZ | MP NP | | | 4 | 0 | |\n| Tiotropium | Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) | Inhalation by mouth | Spiriva | BY | MP NP | C3883 | | 30 | 5 | |\n| Tipranavir | Capsule 250 mg | Oral | Aptivus | BY | MP See Note 1 | C3600 C3601 | | 240 | 5 | D |\n| Tirofiban | Solution concentrate for I.V. infusion 12.5 mg (as hydrochloride) in 50 mL | Injection | Aggrastat | AS | MP NP | C1275 C1729 C1730 | | 1 | 2 | |\n| Tobramycin | Injection 80 mg (as sulfate) in 2 mL | Injection | Hospira Pty Limited | HH | MP NP | C1169 C1846 C1847 | | 10 | 1 | |\n| | Injection 80 mg (as sulfate) in 2 mL (without preservative) | Injection | Pfizer Australia Pty Ltd | PF | MP NP | C1169 C1846 C1847 | | 10 | 1 | |\n| | Injection 500 mg (as sulfate) in 5 mL (without preservative) | Injection | Tobra-Day | PL | MP NP | C3190 | | 10 | 1 | |\n| | Solution for inhalation 300 mg in 5 mL | Inhalation | Tobi | NV | MP | C3842 | | 56 | 2 | |\n| | Eye drops 3 mg per mL, 5 mL | Application to the eye | Tobrex | AQ | MP | C1188 C1391 C1714 | | 1 | 2 | |\n| | | | | | AO | C1391 C1714 | | 1 | 2 | |\n| | Eye ointment 3 mg per g, 3.5 g | Application to the eye | Tobrex | AQ | MP | C1188 C1391 C1714 | | 1 | 0 | |\n| | | | | | AO | C1391 C1714 | | 1 | 0 | |\n| Tocilizumab | Concentrate for injection 80 mg in 4 mL | Injection | Actemra | RO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Concentrate for injection 200 mg in 10 mL | Injection | Actemra | RO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Concentrate for injection 400 mg in 20 mL | Injection | Actemra | RO | MP See Note 1 | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Topiramate | Tablet 25 mg | Oral | APO-Topiramate | TX | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Epiramax 25 | QA | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | RBX Topiramate | RA | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Tamate | AF | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topamax | JC | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topiramate-GA | GM | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topiramate Sandoz | SZ | MP NP | C2797 C2799 | | 60 | 5 | |\n| | Tablet 50 mg | Oral | APO-Topiramate | TX | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Epiramax 50 | QA | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | RBX Topiramate | RA | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Tamate | AF | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topamax | JC | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topiramate-GA | GM | MP NP | C2797 C2799 | | 60 | 5 | |\n| | | | Topiramate Sandoz | SZ | MP NP | C2797 C2799 | | 60 | 5 | |\n| | Tablet 100 mg | Oral | APO-Topiramate | TX | MP NP | C2797 | | 60 | 5 | |\n| | | | Epiramax 100 | QA | MP NP | C2797 | | 60 | 5 | |\n| | | | RBX Topiramate | RA | MP NP | C2797 | | 60 | 5 | |\n| | | | Tamate | AF | MP NP | C2797 | | 60 | 5 | |\n| | | | Topamax | JC | MP NP | C2797 | | 60 | 5 | |\n| | | | Topiramate-GA | GM | MP NP | C2797 | | 60 | 5 | |\n| | | | Topiramate Sandoz | SZ | MP NP | C2797 | | 60 | 5 | |\n| | Tablet 200 mg | Oral | APO-Topiramate | TX | MP NP | C2797 | | 60 | 5 | |\n| | | | Epiramax 200 | QA | MP NP | C2797 | | 60 | 5 | |\n| | | | RBX Topiramate | RA | MP NP | C2797 | | 60 | 5 | |\n| | | | Tamate | AF | MP NP | C2797 | | 60 | 5 | |\n| | | | Topamax | JC | MP NP | C2797 | | 60 | 5 | |\n| | | | Topiramate-GA | GM | MP NP | C2797 | | 60 | 5 | |\n| | | | Topiramate Sandoz | SZ | MP NP | C2797 | | 60 | 5 | |\n| | Capsule 15 mg | Oral | Topamax Sprinkle | JC | MP NP | C2798 | | 60 | 5 | |\n| | Capsule 25 mg | Oral | Topamax Sprinkle | JC | MP NP | C2798 | | 60 | 5 | |\n| | Capsule 50 mg | Oral | Topamax Sprinkle | JC | MP NP | C2798 | | 60 | 5 | |\n| Topotecan | Powder for I.V. infusion 4 mg (as hydrochloride) | Injection | Hycamtin | GK | MP | C3186 | | See Note 3 | See Note 3 | D |\n| | | | Topotecan | PK | MP | C3186 | | See Note 3 | See Note 3 | D |\n| Toremifene | Tablet 60 mg (as citrate) | Oral | Fareston | MK | MP | C1750 | | 30 | 5 | |\n| Tramadol | Capsule containing tramadol hydrochloride 50 mg | Oral | APO-Tramadol | TX | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Chem mart Tramadol | CH | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | GA Tramadol 50mg | GM | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | GenRx Tramadol | GX | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Lodam 50 | ZP | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Terry White Chemists Tramadol | TW | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Tramadol Sandoz | SZ | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Tramal | CS | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Tramedo | AF | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | Zydol | QA | MP NP | C1497 C1615 | P1497 | 20 | 0 | |\n| | | | APO-Tramadol | TX | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Chem mart Tramadol | CH | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | GA Tramadol 50mg | GM | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | GenRx Tramadol | GX | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Lodam 50 | ZP | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Terry White Chemists Tramadol | TW | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Tramadol Sandoz | SZ | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Tramal | CS | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Tramedo | AF | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | | | Zydol | QA | MP NP | C1497 C1615 | P1615 | 20 | 2 | |\n| | Tablet (sustained release) containing tramadol hydrochloride 50 mg | Oral | Tramal SR 50 | CS | MP NP | C1537 | | 20 | 0 | |\n| | Tablet (sustained release) containing tramadol hydrochloride 100 mg | Oral | APO-Tramadol SR | TX | MP NP | C1537 | | 20 | 0 | |\n| | | | GA Tramadol SR 100mg | GM | MP NP | C1537 | | 20 | 0 | |\n| | | | Lodam SR 100 | ZP | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramal SR 100 | CS | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramedo SR 100 | AF | MP NP | C1537 | | 20 | 0 | |\n| | | | Zydol SR 100 | QA | MP NP | C1537 | | 20 | 0 | |\n| | Tablet (extended release) containing tramadol hydrochloride 100 mg | Oral | Durotram XR | IA | MP NP | C1537 | | 10 | 0 | |\n| | Tablet (sustained release) containing tramadol hydrochloride 150 mg | Oral | APO-Tramadol SR | TX | MP NP | C1537 | | 20 | 0 | |\n| | | | GA Tramadol SR 150mg | GM | MP NP | C1537 | | 20 | 0 | |\n| | | | Lodam SR 150 | ZP | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramal SR 150 | CS | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramedo SR 150 | AF | MP NP | C1537 | | 20 | 0 | |\n| | | | Zydol SR 150 | QA | MP NP | C1537 | | 20 | 0 | |\n| | Tablet (sustained release) containing tramadol hydrochloride 200 mg | Oral | APO-Tramadol SR | TX | MP NP | C1537 | | 20 | 0 | |\n| | | | GA Tramadol SR 200mg | GM | MP NP | C1537 | | 20 | 0 | |\n| | | | Lodam SR 200 | ZP | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramal SR 200 | CS | MP NP | C1537 | | 20 | 0 | |\n| | | | Tramedo SR 200 | AF | MP NP | C1537 | | 20 | 0 | |\n| | | | Zydol SR 200 | QA | MP NP | C1537 | | 20 | 0 | |\n| | Tablet (extended release) containing tramadol hydrochloride 200 mg | Oral | Durotram XR | IA | MP NP | C1537 | | 10 | 0 | |\n| | Tablet (extended release) containing tramadol hydrochloride 300 mg | Oral | Durotram XR | IA | MP NP | C1537 | | 10 | 0 | |\n| | Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL | Oral | Tramal | CS | MP NP PDP | C1537 | | 1 | 0 | |\n| | Injection containing tramadol hydrochloride 100 mg in 2 mL | Injection | Tramahexal | SZ | MP NP PDP | C1378 | | 5 | 0 | |\n| | | | Tramal 100 | CS | MP NP PDP | C1378 | | 5 | 0 | |\n| Trandolapril | Capsule 500 micrograms | Oral | APO-Trandolapril | TX | MP NP | | | 28 | 5 | |\n| | | | Dolapril 0.5 | QA | MP NP | | | 28 | 5 | |\n| | Capsule 1 mg | Oral | APO-Trandolapril | TX | MP NP | | | 28 | 5 | |\n| | | | Dolapril 1 | QA | MP NP | | | 28 | 5 | |\n| | Capsule 2 mg | Oral | APO-Trandolapril | TX | MP NP | | | 28 | 5 | |\n| | | | Dolapril 2 | QA | MP NP | | | 28 | 5 | |\n| | Capsule 4 mg | Oral | APO-Trandolapril | TX | MP NP | | | 28 | 5 | |\n| | | | Dolapril 4 | QA | MP NP | | | 28 | 5 | |\n| Trandolapril with Verapamil | Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release) | Oral | Tarka 2/180 | AB | MP NP | C3307 | | 28 | 5 | |\n| | Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release) | Oral | Tarka 4/240 | AB | MP NP | C3307 | | 28 | 5 | |\n| Tranexamic Acid | Tablet 500 mg | Oral | Cyklokapron | PF | MP NP | | | 100 | 2 | |\n| Tranylcypromine | Tablet 10 mg (as sulfate) | Oral | Parnate | GH | MP | | | 50 | 2 | |\n| Trastuzumab | Powder for I.V. infusion 60 mg | Injection | Herceptin | RO | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| | Powder for I.V. infusion 150 mg | Injection | Herceptin | RO | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 | D |\n| Travoprost | Eye drops 40 micrograms per mL, 2.5 mL | Application to the eye | Travatan | AQ | MP AO | | | 1 | 5 | |\n| Travoprost with Timolol | Eye drops 40 micrograms travoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Duotrav | AQ | MP AO | C3426 C3427 | | 1 | 5 | |\n| Triamcinolone | Injection containing triamcinolone acetonide 10 mg in 1 mL | Injection | Kenacort-A10 | QA | MP NP | C1020 C1102 C1146 C1189 C1191 C1192 C1197 C1237 C1313 | | 5 | 0 | |\n| | | | | | PDP | C1102 C1189 C1191 | | 5 | 0 | |\n| | Cream containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% | QA | MP NP | C1422 | | 2 | 0 | |\n| | | | Tricortone | FM | MP NP | C1422 | | 2 | 0 | |\n| | Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g | Application | Aristocort 0.02% | QA | MP NP | C1422 | | 2 | 0 | |\n| | | | Tricortone | FM | MP NP | C1422 | | 2 | 0 | |\n| Triamcinolone with Neomycin, Gramicidin and Nystatin | Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL | Application to the ear | Kenacomb Otic | QA | MP NP | | | 1 | 2 | |\n| | | | Otocomb Otic | FM | MP NP | | | 1 | 2 | |\n| | Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g | Application to the ear | Kenacomb Otic | QA | MP NP | | | 1 | 2 | |\n| | | | Otocomb Otic | FM | MP NP | | | 1 | 2 | |\n| Trifluoperazine | Tablet 1 mg (as hydrochloride) | Oral | Stelazine | GH | MP NP | | | 100 | 5 | |\n| | Tablet 2 mg (as hydrochloride) | Oral | Stelazine | GH | MP NP | | | 100 | 5 | |\n| | Tablet 5 mg (as hydrochloride) | Oral | Stelazine | GH | MP NP | | | 100 | 5 | |\n| Triglycerides, long chain with glucose polymer | Oral liquid 250 mL, 18 (ProZero) | Oral | ProZero | VF | MP NP | C1276 | | 6 | 5 | |\n| | Oral liquid 1 L, 6 (ProZero) | Oral | ProZero | VF | MP NP | C1276 | | 4 | 5 | |\n| Triglycerides, medium chain | Oil 500 mL (MCT Oil) | Oral | MCT Oil | SB | MP NP | C1068 C1511 C1513 C1670 C1671 C1672 | | 2 | 5 | |\n| | Oral emulsion 250 mL (Liquigen) | Oral | Liquigen | SB | MP NP | C1068 C1511 C1513 C1670 C1671 C1672 | | 8 | 5 | |\n| Triglycerides — medium chain, formula | Sachets containing oral powder 16 g, 30 (MCT Pro-Cal) | Oral | MCT Pro-Cal | VF | MP NP | C1068 C1511 C1513 C1670 C1671 | | 4 | 5 | |\n| | Oral powder 400 g (Lipistart) | Oral | Lipistart | VF | MP NP | C1068 C1511 C1513 C1670 C1671 | | 8 | 5 | |\n| | Oral powder 400 g (Monogen) | Oral | Monogen | SB | MP NP | C1068 C1511 C1513 C1670 C1671 | | 8 | 5 | |\n| | Oral powder 420 g (Caprilon) | Oral | Caprilon | SB | MP NP | C1068 C1670 C1671 | | 8 | 5 | |\n| Triglycerides, medium chain and long chain with glucose polymer | Oral powder 400 g (Duocal) | Oral | Duocal | SB | MP NP | C1276 | | 8 | 5 | |\n| Trimethoprim | Tablet 300 mg | Oral | Alprim | AF | MP NP | | | 7 | 1 | |\n| | | | Triprim | QA | MP NP | | | 7 | 1 | |\n| Trimethoprim with Sulfamethoxazole | Tablet 160 mg-800 mg | Oral | Bactrim DS | RO | PDP | | | 10 | 0 | |\n| | | | Resprim Forte | AF | PDP | | | 10 | 0 | |\n| | | | Septrin Forte | QA | PDP | | | 10 | 0 | |\n| | | | Bactrim DS | RO | MP NP | | | 10 | 1 | |\n| | | | Resprim Forte | AF | MP NP | | | 10 | 1 | |\n| | | | Septrin Forte | QA | MP NP | | | 10 | 1 | |\n| | Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL | Oral | Bactrim | RO | PDP | | | 1 | 0 | |\n| | | | Septrin | QA | PDP | | | 1 | 0 | |\n| | | | Bactrim | RO | MP NP | | | 1 | 1 | |\n| | | | Septrin | QA | MP NP | | | 1 | 1 | |\n| Triptorelin | Powder for I.M. injection (prolonged release) 3.75 mg (as embonate) with solvent, syringe and needles | Injection | Diphereline | IS | MP | C3229 | | 1 | 5 | |\n| | Powder for I.M. injection (prolonged release) 11.25 mg (as embonate) with solvent, syringe and needles | Injection | Diphereline | IS | MP | C3229 | | 1 | 1 | |\n| | Powder for I.M. injection (prolonged release) 22.5 mg (as embonate) with solvent, syringe and needles | Injection | Diphereline | IS | MP | C3229 | | 1 | 0 | |\n| Tropisetron | Capsule 5 mg (as hydrochloride) | Oral | Navoban | NV | MP NP See Note 1 | C3050 | | 2 | 0 | |\n| | I.V. injection 5 mg (as hydrochloride) in 5 mL | Injection | Navoban | NV | MP NP See Note 1 | C3050 | | 1 | 0 | |\n| Tyrosine with carbohydrate | Sachets of oral powder 4 g containing 1 g tyrosine, 30 (Tyrosine Amino Acid Supplement) | Oral | Tyrosine Amino Acid Supplement | VF | MP NP | C1286 | | 4 | 5 | |\n| Ursodeoxycholic Acid | Capsule 250 mg | Oral | Ursofalk | OA | MP NP | C1700 | | 200 | 2 | |\n| Ustekinumab | Injection 45 mg in 0.5 mL | Injection | Stelara | JC | MP | C3248 C3250 C3789 C3790 C3791 C3792 | P3791 P3792 | 1 | 1 | |\n| | | | | | MP | C3248 C3250 C3789 C3790 C3791 C3792 | P3248 P3250 P3789 P3790 | 1 | 2 | |\n| Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | APO-Valaciclovir | TX | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Chem mart Valaciclovir | CH | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Terry White Chemists Valaciclovir | TW | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Vaclovir | AF | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valaciclovir GA | GN | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valaciclovir Pfizer | FZ | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valaciclovir Sandoz | SZ | MP NP | C3622 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valnir | QA | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valtrex | GK | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Valvala | NV | MP NP | C3622 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | Zelitrex | GM | MP NP | C3622 C3623 C3624 C3631 C3632 | P3632 | 20 | 0 | |\n| | | | APO-Valaciclovir | TX | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Chem mart Valaciclovir | CH | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Shilova 500 | DO | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Terry White Chemists Valaciclovir | TW | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Vaclovir | AF | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Valaciclovir GA | GN | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Valaciclovir generichealth | GQ | MP NP | C3622 C3623 C3624 C3631 | P3623 P3624 | 30 | 5 | |\n| | | | Valaciclovir Pfizer | FZ | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Valaciclovir RBX | RA | MP NP | C3622 C3623 C3624 C3631 | P3623 P3624 | 30 | 5 | |\n| | | | Valaciclovir Sandoz | SZ | MP NP | C3622 C3624 C3631 C3632 | P3624 | 30 | 5 | |\n| | | | Valaciclovir SZ | HX | MP NP | C3623 C3624 | P3623 P3624 | 30 | 5 | |\n| | | | Valacor 500 | CR | MP NP | C3622 C3623 C3624 C3631 | P3623 P3624 | 30 | 5 | |\n| | | | Valnir | QA | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Valtrex | GK | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | Valvala | NV | MP NP | C3622 C3624 C3631 C3632 | P3624 | 30 | 5 | |\n| | | | Zelitrex | GM | MP NP | C3622 C3623 C3624 C3631 C3632 | P3623 P3624 | 30 | 5 | |\n| | | | APO-Valaciclovir | TX | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Chem mart Valaciclovir | CH | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Terry White Chemists Valaciclovir | TW | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Vaclovir | AF | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valaciclovir GA | GN | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valaciclovir generichealth | GQ | MP NP | C3622 C3623 C3624 C3631 | P3622 P3631 | 42 | 0 | |\n| | | | Valaciclovir Pfizer | FZ | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valaciclovir RBX | RA | MP NP | C3622 C3623 C3624 C3631 | P3622 P3631 | 42 | 0 | |\n| | | | Valaciclovir Sandoz | SZ | MP NP | C3622 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valacor 500 | CR | MP NP | C3622 C3623 C3624 C3631 | P3622 P3631 | 42 | 0 | |\n| | | | Valnir | QA | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valtrex | GK | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Valvala | NV | MP NP | C3622 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | Zelitrex | GM | MP NP | C3622 C3623 C3624 C3631 C3632 | P3622 P3631 | 42 | 0 | |\n| | | | APO-Valaciclovir | TX | MP See Note 1 | C1494 C3419 | | 500 | 2 | C |\n| | | | Valaciclovir RBX | RA | MP See Note 1 | C1494 C3419 | | 500 | 2 | C |\n| | | | Valtrex | GK | MP See Note 1 | C1494 C3419 | | 500 | 2 | C |\n| | | | Valvala | NV | MP See Note 1 | C1494 C3419 | | 500 | 2 | C |\n| | | | Zelitrex | GM | MP See Note 1 | C1494 C3419 | | 500 | 2 | C |\n| Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valcyte | RO | MP See Note 1 | C1620 C1964 C3420 C3421 | | 120 | 5 | D |\n| | Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL | Oral | Valcyte | RO | MP See Note 1 | C1620 C1964 C3420 C3421 | | 11 | 5 | D |\n| Valine with carbohydrate | Sachets of oral powder 4 g containing 50 mg valine, 30 (Valine Amino Acid Supplement) | Oral | Valine Amino Acid Supplement | VF | MP NP | C1220 | | 4 | 5 | |\n| | Sachets of oral powder 4 g containing 1 g valine, 30 (Valine 1000 Amino Acid Supplement) | Oral | Valine 1000 Amino Acid Supplement | VF | MP NP | C1220 | | 4 | 5 | |\n| Valproic Acid | Tablet, crushable, containing sodium valproate 100 mg | Oral | Epilim | SW | MP NP | | | 200 | 2 | |\n| | Tablet (enteric coated) containing sodium valproate 200 mg | Oral | Epilim EC | SW | MP NP | | | 200 | 2 | |\n| | | | Sodium Valproate Sandoz | SZ | MP NP | | | 200 | 2 | |\n| | | | Valprease 200 | QA | MP NP | | | 200 | 2 | |\n| | | | Valpro 200 | AF | MP NP | | | 200 | 2 | |\n| | | | Valproate Winthrop EC 200 | WA | MP NP | | | 200 | 2 | |\n| | Tablet (enteric coated) containing sodium valproate 500 mg | Oral | Epilim EC | SW | MP NP | | | 200 | 2 | |\n| | | | Sodium Valproate Sandoz | SZ | MP NP | | | 200 | 2 | |\n| | | | Valprease 500 | QA | MP NP | | | 200 | 2 | |\n| | | | Valpro 500 | AF | MP NP | | | 200 | 2 | |\n| | | | Valproate Winthrop EC 500 | WA | MP NP | | | 200 | 2 | |\n| | Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL | Oral | Epilim Liquid | SW | MP NP | | | 2 | 2 | |\n| | Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL | Oral | Epilim Syrup | SW | MP NP | | | 2 | 2 | |\n| Valsartan | Tablet 40 mg | Oral | Diovan | NV | MP NP | | | 28 | 0 | |\n| | Tablet 80 mg | Oral | Diovan | NV | MP NP | | | 28 | 5 | |\n| | Tablet 160 mg | Oral | Diovan | NV | MP NP | | | 28 | 5 | |\n| | Tablet 320 mg | Oral | Diovan | NV | MP NP | | | 28 | 5 | |\n| Valsartan with hydrochlorothiazide | Tablet 80 mg-12.5 mg | Oral | Co-Diovan 80/12.5 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 160 mg-12.5 mg | Oral | Co-Diovan 160/12.5 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 160 mg-25 mg | Oral | Co-Diovan 160/25 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 320 mg-12.5 mg | Oral | Co-Diovan 320/12.5 | NV | MP NP | C3307 | | 28 | 5 | |\n| | Tablet 320 mg-25 mg | Oral | Co-Diovan 320/25 | NV | MP NP | C3307 | | 28 | 5 | |\n| Vancomycin | Capsule 125 mg (125,000 I.U.) (as hydrochloride) | Oral | Vancocin | AS | MP | C1701 C1702 | | 40 | 0 | |\n| | Capsule 250 mg (250,000 I.U.) (as hydrochloride) | Oral | Vancocin | AS | MP | C1701 C1702 | | 40 | 0 | |\n| | Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection | Hospira Pty Limited | HH | MP | C1091 C1302 C1464 | P1302 | 2 | 0 | |\n| | | | Vancocin CP | AS | MP | C1091 C1302 C1464 | P1302 | 2 | 0 | |\n| | | | Vancomycin Alphapharm | AF | MP | C1091 C1302 C1464 | P1302 | 2 | 0 | |\n| | | | Vancomycin Sandoz | SZ | MP | C1091 C1302 C1464 | P1302 | 2 | 0 | |\n| | | | Vycin IV | WQ | MP | C1091 C1302 C1464 | P1302 | 2 | 0 | |\n| | | | Hospira Pty Limited | HH | MP | C1091 C1302 C1464 | P1091 P1464 | 5 | 0 | |\n| | | | Vancocin CP | AS | MP | C1091 C1302 C1464 | P1091 P1464 | 5 | 0 | |\n| | | | Vancomycin Alphapharm | AF | MP | C1091 C1302 C1464 | P1091 P1464 | 5 | 0 | |\n| | | | Vancomycin Sandoz | SZ | MP | C1091 C1302 C1464 | P1091 P1464 | 5 | 0 | |\n| | | | Vycin IV | WQ | MP | C1091 C1302 C1464 | P1091 P1464 | 5 | 0 | |\n| | Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection | Hospira Pty Limited | HH | MP | C1091 C1302 C1464 | P1302 | 1 | 0 | |\n| | | | Vancomycin Alphapharm | AF | MP | C1091 C1302 C1464 | P1302 | 1 | 0 | |\n| | | | Vancomycin Sandoz | SZ | MP | C1091 C1302 C1464 | P1302 | 1 | 0 | |\n| | | | Vycin IV | WQ | MP | C1091 C1302 C1464 | P1302 | 1 | 0 | |\n| | | | Hospira Pty Limited | HH | MP | C1091 C1302 C1464 | P1091 P1464 | 3 | 0 | |\n| | | | Vancomycin Alphapharm | AF | MP | C1091 C1302 C1464 | P1091 P1464 | 3 | 0 | |\n| | | | Vancomycin Sandoz | SZ | MP | C1091 C1302 C1464 | P1091 P1464 | 3 | 0 | |\n| | | | Vycin IV | WQ | MP | C1091 C1302 C1464 | P1091 P1464 | 3 | 0 | |\n| Varenicline | Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack | Oral | Champix | PF | MP NP | C2774 C2775 | | 1 | 0 | |\n| | Tablet 1 mg (as tartrate) | Oral | Champix | PF | MP NP | C3670 C3671 | P3671 | 56 | 2 | |\n| | | | | | MP NP | C3670 C3671 | P3670 | 112 | 0 | |\n| Venlafaxine | Capsule (modified release) 37.5 mg (as hydrochloride) | Oral | Altven | FZ | MP NP | C1211 | | 28 | 0 | |\n| | | | Efexor-XR | PF | MP NP | C1211 | | 28 | 0 | |\n| | | | Elaxine SR 37.5 | ZP | MP NP | C1211 | | 28 | 0 | |\n| | | | Venla RBX | RA | MP NP | C1211 | | 28 | 0 | |\n| | Capsule (modified release) 75 mg (as hydrochloride) | Oral | Altven | FZ | MP NP | C1211 | | 28 | 5 | |\n| | | | APO-Venlafaxine XR | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Chem mart Venlafaxine XR | CH | MP NP | C1211 | | 28 | 5 | |\n| | | | Efexor-XR | PF | MP NP | C1211 | | 28 | 5 | |\n| | | | Elaxine SR 75 | ZP | MP NP | C1211 | | 28 | 5 | |\n| | | | Enlafax-XR | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Terry White Chemists Venlafaxine XR | TW | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlafaxine generichealth XR | GQ | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlafaxine Sandoz XR | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Venla RBX | RA | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlexor XR | GM | MP NP | C1211 | | 28 | 5 | |\n| | Capsule (modified release) 150 mg (as hydrochloride) | Oral | Altven | FZ | MP NP | C1211 | | 28 | 5 | |\n| | | | APO-Venlafaxine XR | TX | MP NP | C1211 | | 28 | 5 | |\n| | | | Chem mart Venlafaxine XR | CH | MP NP | C1211 | | 28 | 5 | |\n| | | | Efexor-XR | PF | MP NP | C1211 | | 28 | 5 | |\n| | | | Elaxine SR 150 | ZP | MP NP | C1211 | | 28 | 5 | |\n| | | | Enlafax-XR | AF | MP NP | C1211 | | 28 | 5 | |\n| | | | Terry White Chemists Venlafaxine XR | TW | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlafaxine generichealth XR | GQ | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlafaxine Sandoz XR | SZ | MP NP | C1211 | | 28 | 5 | |\n| | | | Venla RBX | RA | MP NP | C1211 | | 28 | 5 | |\n| | | | Venlexor XR | GM | MP NP | C1211 | | 28 | 5 | |\n| Verapamil | Tablet containing verapamil hydrochloride 40 mg | Oral | Anpec 40 | AF | MP NP | | | 100 | 5 | |\n| | | | Isoptin | AB | MP NP | | | 100 | 5 | |\n| | Tablet containing verapamil hydrochloride 80 mg | Oral | Anpec 80 | AF | MP NP | | | 100 | 5 | |\n| | | | Isoptin | AB | MP NP | | | 100 | 5 | |\n| | Tablet containing verapamil hydrochloride 120 mg | Oral | Isoptin | AB | MP NP | | | 100 | 5 | |\n| | Tablet containing verapamil hydrochloride 180 mg (sustained release) | Oral | Cordilox 180 SR | KN | MP NP | | | 30 | 5 | |\n| | | | Isoptin 180 SR | AB | MP NP | | | 30 | 5 | |\n| | Tablet containing verapamil hydrochloride 240 mg (sustained release) | Oral | Cordilox SR | KN | MP NP | | | 30 | 5 | |\n| | | | Isoptin SR | AB | MP NP | | | 30 | 5 | |\n| | Capsule containing verapamil hydrochloride 160 mg (sustained release) | Oral | Veracaps SR | QA | MP NP | | | 30 | 5 | |\n| | Capsule containing verapamil hydrochloride 240 mg (sustained release) | Oral | Veracaps SR | QA | MP NP | | | 30 | 5 | |\n| | Injection containing verapamil hydrochloride 5 mg in 2 mL | Injection | Isoptin | AB | MP NP | | | 5 | 0 | |\n| Verteporfin | Powder for I.V. infusion 15 mg | Injection | Visudyne | NV | MP | C3795 C3860 C3861 | | 1 | 0 | |\n| Vigabatrin | Tablet 500 mg | Oral | Sabril | SW | MP NP | C1426 | | 100 | 5 | |\n| | Oral powder, sachet 500 mg | Oral | Sabril | SW | MP NP | C1426 | | 60 | 5 | |\n| Vildagliptin | Tablet 50 mg | Oral | Galvus | NV | MP NP | C3540 | | 60 | 5 | |\n| Vildagliptin with metformin | Tablet containing 50 mg vildagliptin with 500 mg metformin hydrochloride | Oral | Galvumet 50/500 | NV | MP NP | C3543 C3686 | | 60 | 5 | |\n| | Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride | Oral | Galvumet 50/850 | NV | MP NP | C3543 C3686 | | 60 | 5 | |\n| | Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride | Oral | Galvumet 50/1000 | NV | MP NP | C3543 C3686 | | 60 | 5 | |\n| Vinblastine | Solution for I.V. injection containing vinblastine sulfate 10 mg in 10 mL | Injection | Hospira Pty Limited | HH | MP | | | See Note 3 | See Note 3 | D |\n| Vincristine | I.V. injection containing vincristine sulfate 1 mg in 1 mL | Injection | Hospira Pty Limited | HH | MP | | | See Note 3 | See Note 3 | D |\n| Vinorelbine | Capsule 20 mg (as tartrate) | Oral | Navelbine | FB | MP | C1194 | | 20 | 2 | |\n| | Capsule 30 mg (as tartrate) | Oral | Navelbine | FB | MP | C1194 | | 16 | 2 | |\n| | Solution for I.V. infusion 10 mg (as tartrate) in 1 mL | Injection | Hospira Pty Limited | HH | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | | | Navelbine | FB | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | | | Vinorelbine Ebewe | SZ | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | Solution for I.V. infusion 50 mg (as tartrate) in 5 mL | Injection | Hospira Pty Limited | HH | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | | | Navelbine | FB | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | | | Vinorelbine Ebewe | SZ | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| | | | Vinorelbine Kabi | PK | MP | C3890 C3907 | | See Note 3 | See Note 3 | PB |\n| Vitamins, minerals and trace elements with carbohydrate | Oral powder 200 g (Paediatric Seravit) | Oral | Paediatric Seravit | SB | MP NP | C3301 | | 6 | 5 | |\n| Voriconazole | Tablet 50 mg | Oral | Vfend | PF | MP NP | C3061 C3062 C3065 C3066 C3297 C3298 | | 56 | 2 | |\n| | Tablet 200 mg | Oral | Vfend | PF | MP NP | C3061 C3062 C3065 C3066 C3297 C3298 | | 56 | 2 | |\n| | Powder for oral suspension 40 mg per mL, 70 mL | Oral | Vfend | PF | MP NP | C3061 C3062 C3065 C3066 C3297 C3298 | | 1 | 0 | |\n| Warfarin | Tablet containing warfarin sodium 1 mg | Oral | Coumadin | QA | MP NP | | | 50 | 2 | |\n| | | | Marevan | FM | MP NP | | | 50 | 2 | |\n| | Tablet containing warfarin sodium 2 mg | Oral | Coumadin | QA | MP NP | | | 50 | 2 | |\n| | Tablet containing warfarin sodium 3 mg | Oral | Marevan | FM | MP NP | | | 50 | 2 | |\n| | Tablet containing warfarin sodium 5 mg | Oral | Coumadin | QA | MP NP | | | 50 | 2 | |\n| | | | Marevan | FM | MP NP | | | 50 | 2 | |\n| Whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose | Sachets containing oral powder 100 g, 10 (RenaStart) | Oral | RenaStart | VF | MP NP | C1596 | | 9 | 5 | |\n| Whey protein formula supplemented with amino acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose | Oral powder 400 g (Kindergen) | Oral | Kindergen | SB | MP NP | C1596 | | 16 | 5 | |\n| Zidovudine | Capsule 100 mg | Oral | Retrovir | GK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 400 | 5 | D |\n| | Capsule 250 mg | Oral | Retrovir | GK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 240 | 5 | D |\n| | Syrup 10 mg per mL, 200 mL | Oral | Retrovir | GK | MP See Note 1 | C3586 C3587 C3588 C3589 | | 15 | 5 | D |\n| Ziprasidone | Capsule 20 mg (as hydrochloride) | Oral | Zeldox | PF | MP NP | C1589 C3084 | | 60 | 5 | |\n| | Capsule 40 mg (as hydrochloride) | Oral | Zeldox | PF | MP NP | C1589 C3084 | | 60 | 5 | |\n| | Capsule 60 mg (as hydrochloride) | Oral | Zeldox | PF | MP NP | C1589 C3084 | | 60 | 5 | |\n| | Capsule 80 mg (as hydrochloride) | Oral | Zeldox | PF | MP NP | C1589 C3084 | | 60 | 5 | |\n| Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Aclasta | NV | MP | C3290 C3945 C3946 C3947 | | 1 | 0 | |\n| | Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL | Injection | Zometa | NV | MP See Note 1 | C1035 C1233 C1500 C3341 C3342 C3343 C4051 C4052 | | 1 | 11 | PB |\n| Zolmitriptan | Tablet 2.5 mg | Oral | Zomig | AP | MP NP | C3280 C3281 C3282 C3283 C3284 C3285 | | 4 | 5 | |\n| Zonisamide | Capsule 25 mg | Oral | Zonegran | SA | MP NP | C2664 | | 56 | 5 | |\n| | Capsule 50 mg | Oral | Zonegran | SA | MP NP | C2664 | | 56 | 5 | |\n| | Capsule 100 mg | Oral | Zonegran | SA | MP NP | C2664 | | 112 | 5 | |\n| Zuclopenthixol Decanoate | Oily I.M. injection 200 mg in 1 mL | Injection | Clopixol Depot | LU | MP NP | | | 5 | 0 | |\n\n \n\nNote 1 The pharmaceutical benefit may be covered by a special arrangement under section 100 of the Act. The persons who may prescribe the pharmaceutical benefit may be modified in the special arrangement instrument or the special arrangement instrument may provide for the supply of the pharmaceutical benefit otherwise than on a prescription. When the pharmaceutical benefit is supplied under the special arrangement, the modified matters will apply.\n\nNote 2 The pharmaceutical benefit may be covered by a special arrangement under section 100 of the Act. The matters determined for the pharmaceutical benefit in this instrument relate to its general supply under Part VII of the Act, and may be modified in the special arrangement instrument. When the pharmaceutical benefit is supplied under the special arrangement, the modified matters will apply.\n\nNote 3 This matter has not been determined for the pharmaceutical benefit in this instrument. The pharmaceutical benefit can only be supplied, or can only be supplied in the circumstances mentioned, under special arrangements under section 100 of the Act. The matter may be determined in a special arrangement instrument.\n\n \n\n","sortOrder":19},{"sectionNumber":"Sch 2","sectionType":"schedule","heading":"Extemporaneously-prepared pharmaceutical benefits","content":"Schedule 2 Extemporaneously-prepared pharmaceutical benefits\n\n(sections 5, 17 and 19)\n\n","sortOrder":20},{"sectionNumber":"Part 1","sectionType":"part","heading":"Listed drugs that may be used as ingredients in extemporaneously-prepared pharmaceutical benefits","content":"Part 1 Listed drugs that may be used as ingredients in extemporaneously-prepared pharmaceutical benefits\n\n \n\n| Listed Drug | Circumstances |\n| --- | --- |\n| Acacia BP, powdered | |\n| Acetic Acid (33 per cent) BP | |\n| Alum BP | |\n| Aluminium Acetate Solution BP | |\n| Aqueous Cream APF | For use only as a base combined with active ingredients |\n| Ascorbic Acid BP | For use only as an ingredient of ferrous sulfate mixtures |\n| Aspirin BP | |\n| Belladonna Tincture BP | |\n| Benzocaine BP | |\n| Benzoic Acid BP | |\n| Benzoin Tincture Compound BP | |\n| Boric Acid, Olive Oil and Zinc Oxide Ointment QHF | |\n| Calcium Hydroxide BP | |\n| Cetomacrogol Cream, Aqueous APF | For use only as a base combined with active ingredients |\n| Cetrimide Cream, Aqueous APF | For use only as a base combined with active ingredients |\n| Chlorhexidine Cream, Aqueous APF | For use only as a base combined with active ingredients |\n| Citric Acid Monohydrate BP | |\n| Coal Tar BP | |\n| Coal Tar Solution BP | |\n| Cocaine Hydrochloride BP | |\n| Coconut Oil BP | |\n| Codeine Phosphate BP | May only be prescribed in linctuses, mixtures and mixtures for children |\n| Collodion Flexible BP | |\n| Dithranol BP | |\n| Emulsifying Ointment BP | For use only as a base combined with active ingredients |\n| Ephedrine Hydrochloride BP | May only be prescribed in nasal instillations |\n| Ferrous Sulfate BP | |\n| Formaldehyde Solution BP | |\n| Gentian Alkaline Mixture APF | |\n| Glycerol BP | |\n| Iodine BP | |\n| Kaolin Mixture BPC 1968 | |\n| Kaolin and Opium Mixture APF 14 | |\n| Lactic Acid BP | |\n| Lavender Oil, Spike BPC 1968 | |\n| Levomenthol BP | |\n| Liquorice Liquid Extract BP | |\n| Magnesium Carbonate, Light BP | |\n| Magnesium Sulfate BP | May only be prescribed for other than oral use |\n| Magnesium Trisilicate BP | |\n| Menthol, Racemic BP | |\n| Methyl Hydroxybenzoate BP | |\n| Paraffin, Hard BP | |\n| Paraffin, Light Liquid BP | |\n| Paraffin, Liquid BP | May only be prescribed for other than oral use |\n| Paraffin, Soft White BP | |\n| Paraffin, Soft Yellow BP | |\n| Phenobarbitone Sodium BP | May only be prescribed for the treatment of epilepsy |\n| Phenol, Liquefied BP | Not available for ear drops |\n| Podophyllum Resin BP | |\n| Potassium Citrate BP | |\n| Potassium Iodide BP | |\n| Potassium Permanganate BP | |\n| Propyl Hydroxybenzoate BP | |\n| Propylene Glycol BP | |\n| Red Syrup APF 15 | |\n| Resorcinol BP | |\n| Salicylic Acid BP | |\n| Simple Ointment (white) BP | For use only as a base combined with active ingredients |\n| Simple Ointment (yellow) BP | For use only as a base combined with active ingredients |\n| Sodium Bicarbonate BP | |\n| Sodium Chloride BP | |\n| Sodium Citrate BP | |\n| Starches BP | |\n| Sulfur, Precipitated BP 1980 | |\n| Syrup BP | |\n| Talc, Purified BP, sterilised | |\n| Thymol BP | |\n| Thymol Mouth Wash, Compound APF 15 | |\n| Tragacanth BP, powdered | |\n| Tragacanth Powder, Compound BP 1980 | |\n| Trichloroacetic Acid BP 1980 | |\n| Triethanolamine BP | |\n| Water For Injections, sterilised BP | May only be prescribed in eye drops and eye lotions |\n| Water, Purified BP | |\n| Wool Alcohols Ointment (white) BP | For use only as a base combined with active ingredients |\n| Wool Alcohols Ointment (yellow) BP | For use only as a base combined with active ingredients |\n| Wool Fat BP | |\n| Wool Fat, Hydrous BP | |\n| Zinc Cream BP | For use only as a base combined with active ingredients |\n| Zinc Oxide BP | |\n| Zinc Sulfate BP | |\n\n \n\n","sortOrder":21},{"sectionNumber":"Part 2","sectionType":"part","heading":"Additives","content":"Part 2 Additives\n\n \n\n| Additive |\n| --- |\n| Acetone BP |\n| Anise Water, Concentrated BP |\n| Boric Acid BP |\n| Castor Oil BP |\n| Chlorhexidine Acetate BP |\n| Chloroform BP |\n| Ethanol (96 per cent) BP |\n| Ethanols, Dilute BP |\n| Ether, Solvent BP |\n| Eucalyptus Oil BP |\n| Honey, Purified BP 1993 |\n| Industrial Methylated Spirit BP |\n| Olive Oil BP |\n| Peppermint Oil BP |\n| Peppermint Water, Concentrated APF |\n| Sodium Thiosulfate BP |\n\n \n\n","sortOrder":22},{"sectionNumber":"Part 3","sectionType":"part","heading":"Maximum quantity and number of repeats","content":"Part 3 Maximum quantity and number of repeats\n\n| Type of Pharmaceutical Benefit | Maximum quantity | Maximum number of repeats |\n| --- | --- | --- |\n| Creams | 100 g | 1 |\n| Dusting Powders | 100 g | 1 |\n| Ear Drops | 15 mL | 2 |\n| Eye Drops containing Cocaine Hydrochloride BP | 15 mL | .. |\n| Eye Drops, Other | 15 mL | 5 |\n| Eye Lotions | 200 mL | 2 |\n| Inhalations | 50 mL | 1 |\n| Linctuses containing Codeine Phosphate BP | 100 mL | .. |\n| Linctuses, Other | 100 mL | 2 |\n| Lotions | 200 mL | 2 |\n| Mixtures containing Codeine Phosphate BP | 200 mL | .. |\n| Mixtures, Other | 200 mL | 4 |\n| Mixtures for Children containing Codeine Phosphate BP | 100 mL | .. |\n| Mixtures for Children, Other | 100 mL | 4 |\n| Mouth Washes | 200 mL | 1 |\n| Nasal Instillations | 15 mL | 2 |\n| Ointments, Waxes | 100 g | 1 |\n| Paints | 25 mL | 1 |\n| Pastes containing Cocaine Hydrochloride BP | 25 g | .. |\n| Pastes, Other | 100 g | 1 |\n| Powders for Internal Use | 100 g | 2 |\n| Solutions | 200 mL | 2 |\n\n \n\n","sortOrder":23},{"sectionNumber":"Sch 3","sectionType":"schedule","heading":"Responsible person codes","content":"Schedule 3 Responsible person codes\n\n(subsection 8 (3))\n\n \n\n| Code | Responsible Person | ABN |\n| --- | --- | --- |\n| AB | Abbott Australasia Pty Ltd | 95 000 180 389 |\n| AE | AFT Pharmaceuticals Pty Ltd | 29 105 636 413 |\n| AF | Alphapharm Pty Ltd | 93 002 359 739 |\n| AG | Allergan Australia Pty Limited | 85 000 612 831 |\n| AL | Alphapharm Pty Ltd | 93 002 359 739 |\n| AN | Amgen Australia Pty Limited | 31 051 057 428 |\n| AO | AMO Australia Pty Limited | 95 099 963 194 |\n| AP | AstraZeneca Pty Ltd | 54 009 682 311 |\n| AQ | Alcon Laboratories (Australia) Pty Ltd | 88 000 740 830 |\n| AS | Aspen Pharmacare Australia Pty Limited | 51 096 236 985 |\n| AT | Actelion Pharmaceuticals Australia Pty Ltd | 32 097 278 512 |\n| AV | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |\n| BD | Biogen Idec Australia Pty Ltd | 30 095 760 115 |\n| BG | Sandoz Pty Ltd | 60 075 449 553 |\n| BI | Biotech Pharmaceuticals Pty Ltd | 91 009 701 517 |\n| BN | Bayer Australia Ltd | 22 000 138 714 |\n| BQ | Bristol-Myers Squibb Australia Pty Ltd | 33 004 333 322 |\n| BR | B. Braun Australia Pty Ltd | 56 002 945 155 |\n| BU | Bausch & Lomb (Australia) Pty Ltd | 34 000 650 251 |\n| BX | Baxter Healthcare Pty Ltd | 43 000 392 781 |\n| BY | Boehringer Ingelheim Pty Ltd | 52 000 452 308 |\n| BZ | Boucher & Muir Pty Ltd | 58 000 140 474 |\n| CH | Apotex Pty Ltd | 52 096 916 148 |\n| CJ | Celgene Pty Limited | 42 118 998 771 |\n| CR | Pharmacor Pty Limited | 58 121 020 835 |\n| CS | CSL Biotherapies Pty Ltd | 66 120 398 067 |\n| CX | Contact Lens Centre Australia Limited | 42 092 190 040 |\n| DO | Aurobindo Pharma (Australia) Pty Limited | 45 118 452 369 |\n| DV | Medical Developments International Limited | 14 106 340 667 |\n| EH | Entra Health Systems Pty Ltd | 14 135 973 303 |\n| EL | Eli Lilly Australia Pty Ltd | 39 000 233 992 |\n| FB | Pierre Fabre Medicament Australia Pty Ltd | 30 098 999 850 |\n| FK | Invida Australia Pty Ltd | 62 116 935 758 |\n| FM | Fawns and McAllan Proprietary Limited | 16 004 296 066 |\n| FP | Ferring Pharmaceuticals Pty Limited | 87 003 037 170 |\n| FR | Merck Sharp & Dohme (Australia) Pty Ltd | 14 000 173 508 |\n| FZ | Pfizer Australia Pty Ltd | 50 008 422 348 |\n| GC | GlaxoSmithKline Australia Pty Ltd | 47 100 162 481 |\n| GH | Mercury Pharma (Australia) Pty Limited | 91 118 106 684 |\n| GI | Gilead Sciences Pty Limited | 71 072 611 708 |\n| GK | GlaxoSmithKline Australia Pty Ltd | 47 100 162 481 |\n| GM | Ascent Pharma Pty Ltd | 68 118 734 795 |\n| GN | Ascent Pharmaceuticals Limited | 17 003 854 626 |\n| GQ | Generic Health Pty Ltd | 93 110 617 859 |\n| GX | Apotex Pty Ltd | 52 096 916 148 |\n| GZ | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |\n| HA | Hamilton Pharmaceutical Pty Ltd | 93 008 204 635 |\n| HC | Biotech Pharmaceuticals Pty Ltd | 91 009 701 517 |\n| HE | HealthSense Products Pty. Ltd. | 94 138 207 226 |\n| HH | Hospira Pty Limited | 13 107 058 328 |\n| HL | Helex-A Pty. Ltd. | 89 070 826 176 |\n| HM | Meda Pharmaceuticals Pty Ltd | 59 155 308 679 |\n| HX | Sandoz Pty Ltd | 60 075 449 553 |\n| IA | iNova Pharmaceuticals (Australia) Pty Limited | 88 000 222 408 |\n| IK | Medtronic Australasia Pty Ltd | 47 001 162 661 |\n| IQ | Alcon Laboratories (Australia) Pty Ltd | 88 000 740 830 |\n| IS | Ipsen Pty Ltd | 47 095 036 909 |\n| IX | Clinect Pty Ltd | 76 150 558 473 |\n| JC | Janssen-Cilag Pty Ltd | 47 000 129 975 |\n| JJ | Johnson & Johnson Medical Pty Ltd | 85 000 160 403 |\n| JT | Johnson & Johnson Pacific Pty Limited | 73 001 121 446 |\n| KN | Abbott Australasia Pty Ltd | 95 000 180 389 |\n| KP | Eli Lilly Australia Pty Ltd | 39 000 233 992 |\n| KY | Key Pharmaceuticals Pty Ltd | 21 001 215 130 |\n| LB | Life Bioscience Pty Ltd | 13 108 135 191 |\n| LM | Link Medical Products Pty Ltd | 73 010 971 516 |\n| LN | Aspen Pharmacare Australia Pty Limited | 51 096 236 985 |\n| LO | LEO Pharma Pty Ltd | 72 147 880 617 |\n| LU | Lundbeck Australia Pty Ltd | 86 070 094 290 |\n| LY | Eli Lilly Australia Pty Ltd | 39 000 233 992 |\n| MD | Roche Products Pty Ltd | 70 000 132 865 |\n| MF | Mundipharma Pty Limited | 87 081 322 509 |\n| MI | Meditech Int. Pty Ltd | 17 069 879 465 |\n| MK | Merck Sharp & Dohme (Australia) Pty Ltd | 14 000 173 508 |\n| MQ | Alphapharm Pty Ltd | 93 002 359 739 |\n| MS | Abbott Australasia Pty Ltd | 95 000 180 389 |\n| MW | Biomed Aust Pty Limited | 67 080 084 377 |\n| NA | National Diagnostic Products (Australia) Pty Limited | 61 003 512 598 |\n| NC | Novartis Consumer Health Australasia Pty Ltd | 46 004 535 513 |\n| NE | Norgine Pty Ltd | 78 005 022 882 |\n| NF | Novo Nordisk Pharmaceuticals Pty Limited | 40 002 879 996 |\n| NH | Nycomed Healthcare Pty Limited | 55 140 659 374 |\n| NI | Novo Nordisk Pharmaceuticals Pty Limited | 40 002 879 996 |\n| NM | Novartis Pharmaceuticals Australia Pty Limited | 18 004 244 160 |\n| NO | Novo Nordisk Pharmaceuticals Pty Limited | 40 002 879 996 |\n| NQ | Nycomed Pty Ltd | 71 095 610 870 |\n| NT | Nestle Australia Ltd | 77 000 011 316 |\n| NU | Nutricia Australia Pty Limited | 99 076 246 752 |\n| NV | Novartis Pharmaceuticals Australia Pty Limited | 18 004 244 160 |\n| NX | Nipro Australia Pty Ltd | 81 140 554 169 |\n| NZ | Nycomed Services Pty Limited | 15 140 661 123 |\n| OA | Orphan Australia Pty Ltd | 11 067 189 342 |\n| OE | Omegapharm Pty Ltd | 86 128 078 151 |\n| OI | Boian Surgical Pty Ltd | 25 077 514 464 |\n| ON | Orion Laboratories Pty Ltd | 56 009 293 136 |\n| OY | Orion Laboratories Pty Ltd | 56 009 293 136 |\n| OZ | Medical Specialties Australia Unit Trust | 75 880 043 044 |\n| PE | Allergan Australia Pty Limited | 85 000 612 831 |\n| PF | Pfizer Australia Pty Ltd | 50 008 422 348 |\n| PK | Fresenius Kabi Australia Pty Limited | 39 109 383 593 |\n| PL | The Trustee for Virgo Unit Trust (trading as Phebra) | 77 695 661 635 |\n| PM | Pharmaceutical Manufacturing Company Pty Limited | 99 004 481 529 |\n| PP | Petrus Pharmaceuticals Pty Ltd | 21 108 884 126 |\n| PQ | PMIP Pty Ltd | 39 114 633 117 |\n| PX | Point of Care Diagnostics Australia Pty Ltd | 93 067 939 824 |\n| QA | Aspen Pharma Pty Ltd | 88 004 118 594 |\n| QB | Bionime Australia Pty Ltd | 84 142 133 677 |\n| RA | Ranbaxy Australia Pty Limited | 17 110 871 826 |\n| RB | Bio Revive Pty Ltd | 58 097 360 417 |\n| RC | Reckitt Benckiser (Australia) Pty Limited | 17 003 274 655 |\n| RD | Roche Diagnostics Australia Pty Limited | 29 003 001 205 |\n| RO | Roche Products Pty Ltd | 70 000 132 865 |\n| RX | Servier Laboratories (Aust.) Pty Ltd | 54 004 838 500 |\n| RZ | Dr Reddy's Laboratories (Australia) Pty Ltd | 16 120 092 408 |\n| SA | SciGen (Australia) Pty Limited | 76 055 016 969 |\n| SB | Nutricia Australia Pty Limited | 99 076 246 752 |\n| SE | Servier Laboratories (Aust.) Pty Ltd | 54 004 838 500 |\n| SG | Merck Serono Australia Pty Ltd | 72 006 900 830 |\n| SI | Sigma Company Limited | 44 004 132 923 |\n| SJ | Sharpe Laboratories Pty Ltd | 55 001 334 854 |\n| SN | Smith & Nephew Pty Limited | 68 000 087 507 |\n| SW | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |\n| SY | Bayer Australia Ltd | 22 000 138 714 |\n| SZ | Sandoz Pty Ltd | 60 075 449 553 |\n| TA | Actavis Australia Pty Ltd | 43 122 896 468 |\n| TD | STADA Pharmaceuticals Australia Pty Limited | 73 154 966 944 |\n| TM | Technipro Marketing Pty Ltd | 54 002 730 421 |\n| TS | Specialised Therapeutics Australia Pty Ltd | 73 124 031 241 |\n| TW | Apotex Pty Ltd | 52 096 916 148 |\n| TX | Apotex Pty Ltd | 52 096 916 148 |\n| UC | UCB Australia Proprietary Limited | 48 005 799 208 |\n| VE | AbbVie Pty Ltd | 48 156 384 262 |\n| VF | Vitaflo Australia Pty Limited | 82 097 161 254 |\n| VI | ViiV Healthcare Pty Ltd | 46 138 687 448 |\n| VP | Meda Valeant Pharma Australia Pty Ltd | 61 140 839 658 |\n| VT | Valeant Pharmaceuticals Australasia Pty Limited | 64 001 083 352 |\n| WA | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |\n| WQ | Willow Pharmaceuticals Pty Ltd | 80 118 534 704 |\n| XA | Pharmaxis Ltd | 75 082 811 630 |\n| XM | The Medicines Company (Australia) Pty Limited | 74 138 555 021 |\n| YN | Mayne Pharma International Pty Ltd | 88 007 870 984 |\n| YT | Mayne Products Pty Ltd | 59 140 866 379 |\n| ZF | Sun Pharmaceutical Industries (Australia) Pty Ltd | 64 130119603 |\n| ZI | Shire Australia Pty Limited | 29 128 941 819 |\n| ZP | Spirit Pharmaceuticals Pty Ltd | 67 109 225 747 |\n| ZT | Synthon A.U. Pty Ltd | 58 080 948 698 |\n\n \n\n \n","sortOrder":24}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":1912},"content_quality":"ok","complexity_score":9,"scope_assessment":{"changed":false,"description":"This instrument consolidates several previous separate determinations (revoking PB 14/2010, PB 68/2010, PB 69/2010 and PB 11/2009) into a single legislative text. This is an administrative consolidation to improve clarity and accessibility rather than an expansion of the legislation's scope beyond its original purpose of listing subsidised pharmaceutical benefits."},"complexity_factors":["Massive tabular data in Schedule 1 listing hundreds of specific drug-brand-form combinations with unique rules","Extensive cross-referencing system using alphanumeric codes (e.g., C3586 for circumstances, P1540 for purposes, MP/NP/AO for prescriber types)","Multi-layered conditional logic for authority requirements (Standard Authority, Written Authority, Telephone Authority, Streamlined Authority Codes)","Variable maximum quantities and repeat limits depending on the prescriber type and the specific clinical purpose code","References to external schedules (Schedule 4 for circumstances/purposes) and 'See Note' references not contained within the visible text","Split into two volumes indicating substantial length and detail"],"plain_english_summary":"This legal instrument is the master list for Australia’s Pharmaceutical Benefits Scheme (PBS) – the system that subsidises the cost of medicines for patients. It legally defines which specific drugs, brands, and formulations are covered by government subsidy. The instrument sets out detailed prescribing rules, including: who is authorised to prescribe each medicine (medical practitioners, nurse practitioners, dentists, optometrists, or midwives); the maximum quantity that can be supplied on one prescription; how many times a prescription can be repeated; and whether special approval (authority) is required from Medicare before the medicine can be dispensed. It uses a complex code system (circumstances codes, purposes codes, and prescriber codes) to link specific restrictions to individual medicines. The instrument consolidates several previous legal determinations into a single document to make the rules clearer for doctors and pharmacists."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010","history":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010/history","analysis":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010/analysis","conflicts":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010/conflicts","importantCases":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010/important-cases","documents":"/api/acts/national-health-listing-of-pharmaceutical-benefits-instrument-2010-no-pb-108-of-2010/documents"}}